<SEC-DOCUMENT>0001193125-21-019640.txt : 20210128
<SEC-HEADER>0001193125-21-019640.hdr.sgml : 20210128
<ACCEPTANCE-DATETIME>20210127215400
ACCESSION NUMBER:		0001193125-21-019640
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20210318
FILED AS OF DATE:		20210128
DATE AS OF CHANGE:		20210127

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARROWHEAD PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000879407
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460408024
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38042
		FILM NUMBER:		21561860

	BUSINESS ADDRESS:	
		STREET 1:		177 E COLORADO BLVD
		STREET 2:		SUITE 700
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91105
		BUSINESS PHONE:		626-696-4702

	MAIL ADDRESS:	
		STREET 1:		177 E COLORADO BLVD
		STREET 2:		SUITE 700
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARROWHEAD RESEARCH CORP
		DATE OF NAME CHANGE:	20040112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE GROUP INC
		DATE OF NAME CHANGE:	20020509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d76219ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:11.5pt; font-family:ARIAL" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11.5pt; font-family:ARIAL" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11.5pt; font-family:ARIAL" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>(Rule <FONT STYLE="white-space:nowrap">14a-101)</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B>Proxy Statement
Pursuant to Section&nbsp;14(a) of the </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman">&#9746;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Filed by a Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="font-family:Times New Roman">&#9744;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Check the appropriate box: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, For Use of the Commission Only (as permitted by <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9746;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Pursuant To <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:ARIAL" ALIGN="center"><B>ARROWHEAD PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B>(Name of Registrant as Specified in Its Charter) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement if other than the Registrant) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Payment of filing fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9746;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11</FONT> (set forth
the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Amount Previously Paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Filing party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL">Date filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:8pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g76219g01r22.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g76219g70d20.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:20pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Notice of Annual Meeting of Stockholders </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>To Be Held on Thursday, March&nbsp;18, 2021 </B></FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" BGCOLOR="#e5e5e5"> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Your vote is important,
whether or not you expect to attend the Annual Meeting of Stockholders. Stockholders of record are urged to vote via the Internet or telephone as instructed, or if you are voting by mail, to mark, sign and date and promptly return the proxy in the
postage-prepaid return envelope provided.</B></P> <P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Voting promptly will help
avoid the additional expense of further solicitation to assure a quorum at the meeting.</B></P> <P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on Thursday, March&nbsp;18, 2021:</B></P>
<P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">You may access the following proxy materials at <BR>www.proxyvote.com before
the meeting and www.virtualshareholdermeeting.com/ARWR2021 during the meeting.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Notice of the 2021 Annual Meeting of Stockholders;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Company&#146;s 2021 Proxy Statement;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Company&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended September&nbsp;30, 2020; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Form of Proxy Card</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">TO THE STOCKHOLDERS OF ARROWHEAD PHARMACEUTICALS, INC.:</P> <P STYLE="font-size:5pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">NOTICE IS HEREBY GIVEN that the 2021 Annual Meeting of Stockholders of Arrowhead Pharmaceuticals, Inc., a Delaware corporation (the &#147;Company&#148;), will be held on
Thursday, March&nbsp;18, 2021, at 10:00 a.m., Pacific time (the &#147;Annual Meeting&#148;). This year&#146;s meeting will be a completely &#147;virtual&#148; meeting of stockholders. You can attend the Annual Meeting online, vote your shares
electronically, and submit your questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/ARWR2021. Prior to the Annual Meeting, you will be able to vote at www.proxyvote.com for the purpose of considering and voting upon the
following proposals:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:9pt; font-family:ARIAL">1.&#8195;&#8202;To elect the seven
directors named in the Proxy Statement to serve as members of the Company&#146;s Board of Directors until the next Annual Meeting or until their successors are elected;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:9pt; font-family:ARIAL">2.&#8195;&#8202;To conduct an advisory <FONT STYLE="white-space:nowrap">(non-binding)</FONT> vote to approve executive
compensation;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:9pt; font-family:ARIAL">3.&#8195;&#8202;To approve the Arrowhead
Pharmaceuticals, Inc. 2021 Incentive Plan; and</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:9pt; font-family:ARIAL">4.&#8195;&#8202;To ratify the selection of Rose, Snyder&nbsp;&amp; Jacobs LLP as independent auditors of the Company for the
fiscal year ending September&nbsp;30, 2021;</P> <P STYLE="font-size:5pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The foregoing items of business are more fully
described in the Proxy Statement accompanying this Notice. Proposal No.&nbsp;1 relates solely to the election of the seven directors nominated by the Board of Directors and does not include any other matters relating to the election of directors,
including, without limitation, the election of directors nominated by any stockholder of the Company.</P> <P STYLE="font-size:5pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">All stockholders of record are cordially invited to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/ARWR2021. We anticipate that on or about
January&nbsp;27, 2021, we will mail our stockholders a Notice Regarding the Availability of Proxy Materials (the &#147;Notice of Internet Availability&#148;) containing instructions on how to access our 2021 Proxy Statement and 2020 Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> and to vote online. You will need to have your <FONT STYLE="white-space:nowrap">16-digit</FONT> Control Number included on your Notice of Internet Availability or your proxy card (if you received a
printed copy of the proxy materials) to join the Annual Meeting.</P> <P STYLE="font-size:5pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">If you prefer to receive paper
copies of our proxy materials, please follow the instructions included in the Notice of Internet Availability. To ensure your representation at the meeting, you are urged to vote via the Internet or telephone as instructed in the Notice of Internet
Availability, or to mark, sign, date and return the proxy card as promptly as possible in the postage-prepaid envelope enclosed for that purpose. Any stockholder of record attending the Annual Meeting may vote at the Annual Meeting even if such
stockholder has previously returned a proxy. Each stockholder may appoint only one proxy holder to attend the Annual Meeting on his or her behalf. Please note, however, that if your shares are held of record by a broker, bank or other nominee and
you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">/s/ Patrick O&#146;Brien</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Patrick O&#146;Brien</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL"><I>Secretary</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Pasadena, California</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">January&nbsp;27, 2021</P></TD></TR>
</TABLE> <P STYLE="font-size:10pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#4c4c4c"><B>Arrowhead
Pharmaceuticals, Inc.&nbsp;&nbsp;&nbsp;&nbsp;</B><FONT STYLE="font-family:Times New Roman" COLOR="#0071ce">&#9679;</FONT><FONT STYLE="font-family:ARIAL" COLOR="#4c4c4c"><B></B></FONT><B>&nbsp;&nbsp;&nbsp;&nbsp;177 E. Colorado Blvd., Suite
700&nbsp;&nbsp;&nbsp;&nbsp;</B><FONT STYLE="font-family:Times New Roman" COLOR="#0071ce">&#9679;</FONT><FONT STYLE="font-family:ARIAL" COLOR="#4c4c4c"><B></B></FONT><B>&nbsp;&nbsp;&nbsp;&nbsp;Pasadena, California 91105 </B></FONT></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Table of Contents</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:20pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc"></A>Table of Contents </B></FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_1">General Information Concerning Solicitation and Voting</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>1</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_2">Record Date</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>1</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_3">Revocability of Proxies</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>1</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_4">Voting and Solicitation</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>2</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_5">Quorum; Abstentions; Broker
Non-Votes</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>2</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_6">Deadline for Receipt of Stockholder
Proposals</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>2</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_7">Proposal One &#151; Election of Directors</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>4</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_8">Board Composition and Nominating
Process</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>8</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_9">Corporate Governance Policies and
Practices</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>8</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_10">Stockholder Communications with
Directors</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>9</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_11">Board Meetings and
Committees</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>9</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_12">Director Compensation</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>11</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_13">Proposal Two &#151; Advisory Vote to Approve Executive Compensation</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>12</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_14">Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>13</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_15">Executive Compensation</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>19</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A HREF="#toc76219_16">Compensation Discussion and
Analysis</A></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#4c4c4c"><B>19</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#4c4c4c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_17">Our Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_18">Business Development</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_19">Platform</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_20">Pipeline</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_21">Executive Compensation Philosophy</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_22">Executive Compensation Program Design</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_23">Governance of Executive Compensation Program</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_24">Individual Compensation Elements</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_25">Employment Arrangements</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_26">Post-Employment Compensation Arrangements</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_27">Other Compensation Policies and Practices</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_28">Tax and Accounting Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.44em; font-size:9pt; font-family:ARIAL"><A HREF="#toc76219_29">Compensation Risk Assessment</A></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_30">Compensation Tables</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>39</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_31">Proposal Four &#151; Ratification of Appointment of Independent Auditors</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>46</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_32">Audit Fees</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>47</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_33">Report of the Audit Committee</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>48</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_34">Voting Securities of Principal Stockholders and Management</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>49</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_35">Equity Compensation Plan Information</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>50</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_36">Review and Approval of Related-Party Transactions</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>52</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_37">Certain Relationships and Related Transactions, and Director Independence</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>53</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B><A HREF="#toc76219_38">Exhibit A &#151; Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</A></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT COLOR="#0071ce"><B>54</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>General Information Concerning Solicitation and Voting</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>ARROWHEAD PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>177 E. Colorado Blvd., Suite 700 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Pasadena,
California 91105 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>(626) <FONT STYLE="white-space:nowrap">304-3400</FONT> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>PROXY STATEMENT </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#0071ce"><B>FOR ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#4c4c4c"><B>To be held on Thursday, March&nbsp;18, 2021
</B></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_1"></A>General Information Concerning Solicitation and Voting </B></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The enclosed Proxy is solicited on behalf of Arrowhead Pharmaceuticals, Inc. (the &#147;<B>Company</B>&#148; or &#147;<B>Arrowhead</B>&#148;) for use at the 2021 Annual
Meeting of Stockholders (the &#147;<B>Annual Meeting</B>&#148;) to be held on Thursday, March&nbsp;18, 2021 at 10:00 a.m., Pacific time, and at any adjournment(s) or postponement(s) thereof, for the purposes set forth herein and in the accompanying
Notice of Annual Meeting of Stockholders (the &#147;<B>Notice</B>&#148;). This year&#146;s meeting will be a completely &#147;virtual&#148; meeting of stockholders. If you were a stockholder as of the close of business on the Record Date (as defined
below), you can attend the Annual Meeting online, vote your shares electronically, and submit your questions and view our list of stockholders as of the Record Date during the Annual Meeting, by visiting www.virtualshareholdermeeting.com/ARWR2021.
You will need to have your <FONT STYLE="white-space:nowrap">16-digit</FONT> Control Number included on your Notice Regarding the Availability of Proxy Materials (the &#147;Notice of Internet Availability&#148;) or your proxy card (if you received a
printed copy of the proxy materials) to join the Annual Meeting. The meeting webcast will begin promptly at 10:00 a.m. Pacific Time. Online check-in will begin approximately 15 minutes before then and we encourage you to allow ample time for
check-in procedures. If you experience technical difficulties during the check-in process or during the meeting, please call the number listed on the meeting website for technical support. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We will endeavor to answer as many stockholder-submitted questions as time permits that comply with the Annual Meeting rules of conduct. We reserve the right to edit
profanity or other inappropriate language and to exclude questions regarding topics that are not pertinent to meeting matters or Company business. If we receive substantially similar questions, we may group such questions together and provide a
single response to avoid repetition. Additional information regarding the rules and procedures for participating in the Annual Meeting will be set forth in our meeting rules of conduct, which stockholders can view during the meeting at the meeting
website. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">By hosting the Annual Meeting virtually, we believe we are able to expand access, improve communication and lower costs while reducing the environmental
impact of the meeting. This approach also provides for the health and safety of our stockholders and employees in light of the evolving public health and safety considerations posed by the ongoing coronavirus (&#147;<B>COVID-19</B>&#148;) pandemic.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company anticipates that the Notice of Internet Availability in connection with these proxy solicitation materials will first be mailed on or about
January&nbsp;27, 2021 to all stockholders entitled to vote at the Annual Meeting and we will post our proxy materials on the website referenced in the Notice of Internet Availability. As more fully described in the Notice of Internet Availability,
all stockholders may choose to access our proxy materials on the website referred to in the Notice of Internet Availability or may request to receive a printed set of our proxy materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_2"></A>Record Date </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Only holders of record of our common stock at the close of
business on January&nbsp;25, 2021 (the &#147;<B>Record Date</B>&#148;) are entitled to notice of the Annual Meeting and to vote at the Annual Meeting. On that date, the Company had outstanding 103,789,410 shares of common stock (&#147;<B>Common
Stock</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_3"></A>Revocability of Proxies </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Any proxy given by a stockholder of record pursuant to this
solicitation may be revoked by the person giving it at any time before its use by delivering to the Secretary of the Company, at or before the taking of the vote at the Annual Meeting, a written notice of revocation or a duly executed proxy bearing
a later date or by attending the Annual Meeting and voting electronically. Stockholders may also revoke their proxy by entering a new vote over the Internet or by telephone. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>1</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>General Information Concerning Solicitation and Voting</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_4"></A>Voting and Solicitation </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Each share of the Company&#146;s Common Stock is entitled to one
vote on all matters presented at the Annual Meeting. Each stockholder may appoint only one proxy holder or representative to attend the Annual Meeting on his or her behalf. Stockholders do not have the right to cumulate their votes in the election
of directors. Shares of Common Stock represented by properly executed proxies will, unless such proxies have been previously revoked, be voted in accordance with the instructions indicated thereon. In the absence of specific instructions to the
contrary, properly executed proxies will be voted FOR the Proposals 1, 2, 3 and 4 and submitted to a vote of stockholders at the Annual Meeting pursuant to this proxy statement. No business other than that set forth in the accompanying Notice of
Annual Meeting of Stockholders is expected to come before the Annual Meeting. Should any other matter requiring a vote of stockholders properly arise, the persons named in the enclosed form of proxy will vote such proxy in accordance with the
recommendation of the Board of Directors (the &#147;<B>Board</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">If you will not be able to attend the Annual Meeting to vote, you may vote your shares via
the Internet or by telephone or by mail as set forth in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company has engaged a proxy solicitor, Alliance Advisors, LLC, to encourage voting by our
stockholders. It is estimated that the total cost for the solicitation campaign will be approximately $10,000. Proxies may also be solicited by certain of the directors, officers and employees of the Company, without additional compensation. The
Company will bear the costs of solicitation. In addition, the Company expects to reimburse brokerage firms and other persons representing beneficial owners of shares for their expenses in forwarding solicitation materials to such beneficial owners.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">If your shares are held in street name, the voting instruction form sent to you by your broker, bank or other nominee should indicate whether the institution has a
process for beneficial holders to provide voting instructions over the Internet or by telephone. If your bank or brokerage firm gives you this opportunity, the voting instructions from the bank or brokerage firm that accompany this proxy statement
will tell you how to use the Internet or telephone to direct the vote of shares held in your account. If your voting instruction form does not include Internet or telephone information, please complete and return the voting instruction form in the
self-addressed, postage-paid envelope provided by your broker. Stockholders who vote by proxy over the Internet or by telephone need not return a proxy card or voting instruction form by mail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_5"></A>Quorum; Abstentions; Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT> </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The required quorum for the transaction of business at the Annual
Meeting is a majority of the votes eligible to be cast by holders of shares of Common Stock issued and outstanding on the Record Date. Shares that are voted &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN&#148; on a matter are treated as being
present at the meeting for purposes of establishing a quorum with respect to such matter. For certain proposals, brokers may not have discretionary authority to vote on a particular matter if they have not received specific instructions from the
beneficial owner of the shares (&#147;<B>broker <FONT STYLE="white-space:nowrap">non-votes</FONT></B>&#148;). In accordance with the rules of the New York Stock Exchange, banks, brokerage firms and other nominees who hold Arrowhead shares in street
name for their customers have authority to vote on &#147;routine&#148; proposals when they have not received instructions from beneficial owners. However, banks, brokerage firms and other nominees are precluded from exercising their voting
discretion with respect to <FONT STYLE="white-space:nowrap">non-routine</FONT> matters. Shares subject to a broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will be counted as present for the purpose of determining the presence or absence of
a quorum for the transaction of business at the Annual Meeting; the effect of abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on the proposals presented herein is discussed below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">With regard to the election of directors, votes may be cast &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN&#148; for each director nominee. Because directors are
elected by a majority of votes cast in an uncontested election, abstentions from voting and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be excluded from the vote and will have no effect on its outcome. If a quorum is present at the
meeting, the nominees receiving more &#147;FOR&#148; votes than &#147;AGAINST&#148; votes will be elected. Abstentions and broker non-votes will be excluded from the vote and will have no effect on its outcome. Because Proposal Nos. 2, 3 and 4 must
be approved by the affirmative vote of a majority of the shares of Common Stock entitled to vote thereon and present in person or by proxy at the Annual Meeting (the &#147;<B>Required Vote</B>&#148;), abstentions will be counted in tabulations of
the votes cast on each such proposal and will have the same effect as a vote against the proposal, whereas broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be excluded from the vote and will have no effect on its outcome. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_6"></A>Deadline for Receipt of Stockholder Proposals </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Any stockholder who meets the requirements of the proxy rules
under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), who intends to present a proposal at the Company&#146;s 2022 Annual Meeting of Stockholders must ensure that the proposal is received by the Corporate
Secretary at Arrowhead Pharmaceuticals, Inc., 177 E. Colorado Blvd., Suite 700, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>2</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>General Information Concerning Solicitation and Voting</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Pasadena, CA 91105, not later than our close of business on September&nbsp;29, 2021, in order to be
considered for inclusion in our proxy materials for that meeting; provided, however, that if the Company&#146;s 2022 Annual Meeting of Stockholders is held before February&nbsp;16, 2022 or after April&nbsp;17, 2022, you must provide specified
information to us a reasonable time before we begin to print and send our proxy statement for our 2022 Annual Meeting. Proposals received after the specified dates may be excluded from the Company&#146;s proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Additionally, our Amended and Restated Bylaws (&#147;<B>Bylaws</B>&#148;) provide for notice procedures to recommend a person for nomination as a director or to propose
business to be considered by stockholders at a meeting. To be considered timely under these provisions, the stockholder&#146;s notice must be received by the Corporate Secretary at our principal executive offices at the address set forth above
between 90 and 120&nbsp;days prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of the 2021 Annual Meeting; <I>provided, however</I>, that if the 2022 Annual Meeting date is advanced by more than 30&nbsp;days
before or delayed by more than 60&nbsp;days after the anniversary date of the 2021 Annual Meeting, then stockholders must provide notice within time periods specified in our Bylaws. Our Bylaws also specify requirements as to the form and content of
a stockholder&#146;s notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>3</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_7"></A>Proposal One &#151; Election of Directors </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Board has nominated the following seven persons as directors to serve until the 2022 Annual Meeting and until their successors have been duly elected. Each of the
nominees is currently a director of Arrowhead. None of the nominees is related by blood, marriage or adoption to any other nominee or any executive officer of the Company. The nominees receiving more &#147;FOR&#148; votes than &#147;AGAINST&#148;
votes at the Annual Meeting will be elected to the seven director positions. Unless otherwise instructed, the proxy holders will vote the proxies received by them for the seven nominees named below. Under Delaware law, a director not receiving a
majority of votes cast in an uncontested election would continue to serve as a director as a &#147;holdover director&#148; until the director resigns or is replaced. Under the Company&#146;s director resignation policy, a director who is not
reelected by a majority of the votes cast in an uncontested election will be required to tender his or her resignation to the Board, and the Board will then decide whether to accept or reject the resignation, or whether other action is required.
Although we have no reason to believe this will occur, if any nominee is unable or declines to serve as director at the time of the Annual Meeting, the proxies will be voted for any nominee who is designated by our present Board to fill the vacancy
or, alternatively, the Board may reduce its size. The table below sets forth, with respect to each nominee for election, the nominee&#146;s age and current position with Arrowhead. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B>Nominees for Election as Directors</B></FONT><FONT STYLE="font-family:ARIAL">. The Board unanimously adopted a
resolution proposing the nominees set forth below for election as Directors of the Company for the next year. </FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle" NOWRAP STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-left:8pt"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g76219g08m78.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-right:2pt" BGCOLOR="#e5e5e5"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>OUR BOARD UNANIMOUSLY RECOMMENDS A VOTE</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL"><B><FONT COLOR="#0071ce">&#147;FOR&#148;</FONT> EACH OF THE NOMINEES LISTED BELOW.</B></P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Douglass Given, MD</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT
 COLOR="#0071ce"><B><I>Chairman</I></B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 68</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director since: </B>2010</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Serves&nbsp;on:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Science Committee</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience and Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr. Given is Chairman of the Board.&nbsp;He has been a director of the Company since 2010.&nbsp;Doug is Managing Partner at Health2047 Capital
Partners LLC, a healthcare-focused venture capital firm. He served as Health2047 Inc.&#146;s Chief Executive from its founding in August of 2015 until January 2018. Previously, Doug spent more than a decade in venture capital as an Investment
Partner and General Partner at life sciences investor Bay City Capital LLC participating in five sequential life sciences general funds and two sector-specific funds; he was associated with the partnership from 1999 to 2015. A physician and medical
scientist by background, Doug has been a global corporate and operating executive at Lilly, Monsanto, Schering Plough and Mallinckrodt and a serial entrepreneur, as well as a venture capitalist. In addition to a number of private companies, he led
three public biotechnology and biopharmaceutical companies as CEO.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr.
Given has served on more than 20 public and private boards. He is currently a Director at Health2047 Inc., board Chair at Akiri Inc., Managing Partner at G5 Partners LLC, and serves on the board at First Mile Care Inc. and Vivaldi Biosciences Inc.
He serves on advisory boards at the University of Chicago Medicine, Johns Hopkins Bloomberg School of Public Health, Stanford Medicine, Stanford Institute for Economic Policy Research (SIEPR), and The Houston Methodist Research Institute.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Given&#146;s
qualifications to serve on the Board include his extensive experience as a physician scientist, in finance and business transactions, particularly investments in the life sciences industry, as well as directorship roles in biopharmaceutical
companies. Dr.&nbsp;Given also has had significant leadership roles, including CEO of several biotech companies and Senior Vice President, at several large pharmaceutical companies.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>4</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Michael S. Perry, DVM</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><I>Independent Lead Director</I></B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 61</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director since:</B> 2011</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Serves on:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Audit&nbsp;Committee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Compensation&nbsp;Committee&nbsp;(Chair)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Nominating Committee</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Other Public Company Boards:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Avita&nbsp;Medical,&nbsp;Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Gamida&nbsp;Cell&nbsp;Ltd.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience and Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Perry has been Chief Executive Officer and President of Avita Medical Ltd., a regenerative medicine company based in Valencia, CA (ASX: AVH
and OTCQX: AVMXY), since 2017, and also currently is Managing Director of Bioscience Managers, a global Venture Capital firm. From 2014 &#150; 2017, Dr.&nbsp;Perry served as Chief Scientific Officer of Novartis&#146; Cell and Gene Therapy Unit, and
from 2012 &#150; 2014 he served as Vice President and Global Head of Stem Cell Therapy for Novartis Pharmaceuticals Corp, a US affiliate of Switzerland-based Novartis AG, a global pharmaceutical company. Dr.&nbsp;Perry is a former member of the
board of directors of Ampliphi Bioscience Corp. Dr.&nbsp;Perry has previously served as the Global Head of R&amp;D at Baxter Healthcare, President and CEO of Cell&nbsp;&amp; Gene Therapy at Novartis affiliates Systemix Inc. and Genetic Therapy,
Inc., VP Regulatory Affairs at Sandoz Pharmaceuticals Corp. and Syntex Corp, Director of Regulatory Affairs at Schering-Plough Corporation, and Chairman, CEO or CMO at several early stage biotech companies. He also previously served as a Venture
Partner with Bay City Capital, LLC, based in San Francisco, California. Dr.&nbsp;Perry holds a Doctor of Veterinary Medicine, a PhD in Biomedical Pharmacology, and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. He is a graduate
of the International Advanced Management Program at Harvard Business School.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Perry&#146;s
qualifications to serve on the board include his medical expertise and his extensive experience in preclinical and clinical drug development, including executive level leadership roles and directorships in several publicly held biotech
companies.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Christopher Anzalone, PhD</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><I>Chief Executive Officer, President&nbsp;&amp; Director</I></B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 51</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director</B><B></B><B>&nbsp;since:</B> 2007</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience&nbsp;&amp; Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Anzalone has been President, Chief Executive Officer and Director of the Company since December&nbsp;1, 2007 and has led the Company&#146;s
business and technical development since then. Prior to joining Arrowhead, Dr.&nbsp;Anzalone formed and served as CEO of the Benet Group LLC, a private equity firm focused on creating and building new nano-biotechnology companies from
university-generated science. Prior to his tenure at the Benet Group, from 1999 until 2003, he was a partner at the Washington, <FONT STYLE="white-space:nowrap">DC-based</FONT> private equity firm Galway Partners, LLC, where he was responsible for
sourcing, structuring and building new business ventures. Dr.&nbsp;Anzalone holds a PhD. in Biology from UCLA and a B.A. in Government from Lawrence University.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Anzalone&#146;s
qualifications to serve on the Board include his deep understanding of the business through his role as Chief Executive Officer; in addition, Dr.&nbsp;Anzalone has extensive experience in business development, biotechnology, drug development,
company-building and venture capital.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>5</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Marianne De Backer, PhD, MBA</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><I>Independent Director</I></B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 52</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director since:</B> 2019</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Serves&nbsp;on:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Compensation Committee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Nominating Committee (Chair)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Audit&nbsp;Committee</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Other Public Company Boards:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Kronos Bio, Inc.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience&nbsp;&amp; Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;De Backer brings over 25 years of experience in healthcare, biotechnology, innovation, strategy, business and corporate development. She has
served as member of the Executive Committee, Executive Vice President and Head of Strategy, Business Development and Licensing of Bayer AG (BAYRY) Pharmaceuticals division since 2019. She is also on the board of directors of Gladstone Foundation and
as an advisory member on the Stanford-Bayer Digital advisory board. Previously, from 1991 through 2018, she was at Johnson&nbsp;&amp; Johnson where she most recently held global Business and Corporate Development roles including the position of Vice
President of M&amp;A Operations and Divestitures globally for the Pharmaceuticals Group and head of Infectious Diseases&nbsp;&amp; Vaccines Business Development. Prior to that she led a commercial business unit in Europe as well as drug discovery
research in both Europe and the United States. Dr.&nbsp;De Backer holds an MBA from Erasmus University Rotterdam, a Master&#146;s degree in Molecular Biology and Biotechnology from Vrije Universiteit Brussels, and a Master&#146;s degree in
Engineering and a PhD in Biotechnology from Ghent University.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;De
Backer&#146;s qualifications to serve on the Board include her extensive background in the biopharmaceutical industry, her scientific, drug development, and pharmaceutical transaction experience, as well as her executive leadership experience.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Mauro Ferrari, PhD</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT
 COLOR="#0071ce"><B><I>Independent Director</I></B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 61</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director since:</B> 2010</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Serves&nbsp;on:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Compensation Committee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Nominating Committee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Science <FONT STYLE="white-space:nowrap">Committee&nbsp;(Co-chair)</FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience&nbsp;&amp; Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Ferrari currently serves as Affiliate Professor of Pharmaceutics at the University of Washington in Seattle, WA and CEO of DXT Pharmaceutics
in Menlo Park, CA. From 2010 to 2019, Dr.&nbsp;Ferrari was President and CEO of The Houston Methodist Hospital Research Institute (TMHRI), Executive Vice President of Houston Methodist Hospital and Senior Associate Dean of Weill Cornell Medical
College in New York. He also served as President of the European Research Council. Dr.&nbsp;Ferrari is an internationally recognized expert in nanomedicine and biomedical nanotechnology. Dr.&nbsp;Ferrari was formerly Professor and Chairman of The
Department of NanoMedicine and Biomedical Engineering at The University of Texas Health Science Center at Houston, Professor of Experimental Therapeutics at the MD Anderson Cancer Center, Adjunct Professor of Bioengineering at Rice University, and
Adjunct Professor of Biomedical Engineering at the University of Texas in Austin. His previous academic appointments include tenured professorships at his graduate Alma Mater UC Berkeley, and The Ohio State University. From 2003 to 2005,
Dr.&nbsp;Ferrari served as Special Expert on Nanotechnology and Eminent Scholar at The National Cancer Institute, where he led in the development of NCI&#146;s program in Nanotechnology, which remains the largest program in NanoMedicine in the
world. Dr.&nbsp;Ferrari has been serving as the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Editor-in-Chief</FONT></FONT> for &#147;Biomedical Microdevices: BioMEMS and Biomedical Nanotechnology&#148; since 1997.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications:</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Ferrari&#146;s
qualifications to serve on the Board include his extensive training and experience in the fields of nanotechnology, biotechnology and biomedical applications. Dr.&nbsp;Ferrari has significant technical training, several academic appointments, over
300 published articles, over 30 issued patents and is the recipient of most prestigious academic awards in nanomedicine and drug delivery technology. Additionally, Dr.&nbsp;Ferrari has extensive experience in developmental stage organizations having
founded several startup companies.</P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>6</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Oye Olukotun, MD, MPH</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><I>Independent Director</I></B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 76</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director since:</B> 2020</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Serves on:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Science&nbsp;Committee <FONT STYLE="white-space:nowrap">(Co-chair)</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Compensation Committee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Nominating Committee</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Other Public Company Boards:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Tonix Pharmaceuticals Holding Corp.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience&nbsp;&amp; Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Olukotun is a Mayo Clinic trained cardiologist who has served as Chief Executive Officer of CR Strategies, LLC, which consults on clinical
trial design and FDA strategy for pharmaceutical development , since 2001. He served as CEO of Epigen Pharmaceuticals, Inc., a discovery phase biotechnology company, from 2014 to 2017, and Vice Chairman of CardioVax, Inc., a clinical-stage
biopharmaceutical company, from 2012 to 2016. He spent the first 20 years of his career in roles of increasing responsibility in clinical development, including multiple product approvals, at Pfizer, Bristol-Myers Squibb, and Mallinckrodt. He has
over 35 years of experience in the pharmaceutical industry and has been instrumental in the approval and success of numerous cardiology and metabolic medicines, including the first daily beta blocker and the first approved ACE inhibitor, among
others. Dr.&nbsp;Olukotun received his Medical Doctor degree from the Albert Einstein College of Medicine in New York, and a Masters in Public Health from Harvard University School of Public Health. Dr. Olukotun was recommended as a director by our
Chairman.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Olukotun&#146;s
qualifications to serve on the Board include his extensive background in biopharmaceutical development, particularly in the cardiometabolic field, his scientific and public health expertise, and his board and executive leadership experience.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="69%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:11pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>William Waddill</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:ARIAL"><FONT
 COLOR="#0071ce"><B><I>Independent Director</I></B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Age:</B> 63</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Director since:</B> 2018</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Serves on:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Audit&nbsp;Committee (Chair)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Compensation Committee</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Nominating Committee</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Other Public Company Boards:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce">&#149;</FONT>&#8194;&#8202;Protagonist Therapeutics,&nbsp;Inc.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL"><B>Experience&nbsp;&amp; Expertise</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:-0.67em; font-size:9pt; font-family:ARIAL">Mr. Waddill began his career 30 years ago in commercial banking and public accounting and has been in the biotechnology industry for over 25 years.
Since 2016, he has served on the board of Protagonist Therapeutics, a Newark, CA clinical stage biopharmaceutical company and most recently was Senior Vice President and CFO of Calithera Bioscience, a clinical stage pharmaceutical company from 2014
to 2016. Prior to Calithera, Mr.&nbsp;Waddill was Senior Vice President and CFO at OncoMed Pharmaceuticals from 2007 to 2014. Mr.&nbsp;Waddill served as the Senior Vice President and CFO of Ilypsa, Inc., a biotechnology company that was acquired in
2007 by Amgen, Inc. Before joining Ilypsa, he served as the founder and principal at Square One Finance, a financial consulting business, and Mr.&nbsp;Waddill served as Senior Director of Finance and Administration at Exelixis, Inc., a biotechnology
company. Mr.&nbsp;Waddill received a BS in accounting from the University of Illinois, Chicago, and certification as a public accountant (inactive) after working at PriceWaterhouseCoopers and Deloitte in Boston.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL"><B>Qualifications</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.67em; font-size:9pt; font-family:ARIAL">Mr.&nbsp;Waddill&#146;s
qualifications to serve on the Board include his extensive background in the biopharma industry, his financial expertise, executive leadership roles and experience as a director of other public companies.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>7</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_8"></A>Board Composition and Nominating Process </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Nominating&nbsp;Committee of the Board annually considers the
size, composition and needs of the Board and, as appropriate, recommends the nominees for directors to the Board for approval. The Committee considers and evaluates suggestions from many sources regarding possible candidates for directors. Below are
general criteria for the evaluation of current and proposed directors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The highest ethical character and shared values with our Code of Corporate Conduct </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Reputation, both personal and professional, consistent with our image and reputation </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Accomplishment within candidate&#146;s field, with superior credentials and recognition </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Relevant expertise and experience and the ability to offer advice and guidance to the Chief Executive Officer based on such
expertise and experience </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Independence, without the appearance of any conflict in serving as a Director, and independence of any particular
constituency with the ability to represent all stockholders </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Ability to exercise sound business judgment </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Diversity, reflecting differences in skills, regional and industry experience, backgrounds, ages, and other unique
characteristics, such as race, gender and ethnicity </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Committee believes that the Board should represent a diverse mix of skills, regional and
industry experience, backgrounds, ages and other unique characteristics, such as race, gender and ethnicity. In furtherance of this goal, the Committee is committed to actively seeking out highly qualified diverse candidates (including women and
minority candidates) to include in the pool from which Board nominees are chosen. Currently, one of the Company&#146;s directors self-identifies as Black and one self-identifies as female. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Additionally, the Committee considers the mix of skills and experience among current and prospective directors with a goal of assembling a Board with complementary
skills for the benefit of the Company. Listed below are the relevant contributions of each current board member. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><FONT COLOR="#FFFFFF"><B>&nbsp;&nbsp;Expertise</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>Given</B></FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>Perry</B></FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>Anzalone</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>De&nbsp;Backer</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>Ferrari</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>Olukotun</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>Waddill&nbsp;</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="8"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>Director
Tenure</B></FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g76219g20a36.jpg" ALT="LOGO">
</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Biopharma Research</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>&amp; Development</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Healthcare</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Drug Development</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Executive Leadership</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Public Company</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Governance</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD>

<TD VALIGN="bottom" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Accounting/Audit</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0071ce"><B>X</B></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.47em; font-size:8.5pt; font-family:ARIAL"><B>Venture Capital</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#0071ce"><B>X</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#e5e5e5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8.5pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#0071ce"><B>X</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_9"></A>Corporate Governance Policies and Practices </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following is a summary of our corporate governance policies
and practices: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The positions of Chairman of the Board and Chief Executive Officer are separated, which allows our Chief Executive Officer
to focus on strategic planning and execution as well as our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business operations, while allowing the Chairman of the Board to lead the Board in its fundamental
role of providing advice to and oversight of management. While our Bylaws do not require that our Chairman and Chief Executive Officer positions be separate, our Board believes that having separate positions is the appropriate leadership structure
for us at this time and demonstrates our commitment to good corporate governance. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>8</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">A majority of the members of the Board are independent directors, as defined by Nasdaq Marketplace Rules. The Board has
determined that all of the Company&#146;s directors are independent, except Dr.&nbsp;Anzalone, due to his employment relationship with the Company, and Dr.&nbsp;Given, who is the brother of Bruce Given, the Company&#146;s former Chief Operating
Officer. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors do not receive consulting or other fees from the Company, other than Board and Committee compensation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The Board has appointed an independent Lead Director. The Lead Director is tasked with assuring that the Board committees
and other relevant issues have independent leadership. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The Board has overall responsibility for the oversight of the Company&#146;s risk management process, which is designed to
support the achievement of organizational objectives, including strategic objectives, to improve long-term organizational performance and enhance stockholder value. Risk management includes not only understanding company-specific risks and the steps
management implements to manage those risks, but also what level of risk is acceptable and appropriate for the Company. Management is responsible for establishing our business strategy, identifying and assessing the related risks and implementing
appropriate risk management practices. The Board regularly reviews our business strategy and management&#146;s assessment of the related risk and discusses with management the appropriate level of risk for the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">All the Company&#146;s employees, officers and directors are subject to the Company&#146;s Code of Business Conduct and
Ethics Policy, which is available on the Company&#146;s website at www.arrowheadpharma.com. The ethics policy meets the requirements of Nasdaq Marketplace Rules, as well as the code of ethics requirements of the SEC. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The Audit, Compensation and Nominating Committees consist entirely of independent directors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The independent directors meet separately in executive session on a regular basis to discuss matters relating to the Company
and the Board, without members of the management team present. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The Board reviews at least annually the Company&#146;s business initiatives, capital projects and budget matters.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The Audit Committee reviews and approves all related-party transactions or, if the size and nature of the transaction
warrants, a special committee of <FONT STYLE="white-space:nowrap">non-related</FONT> Board members is formed to negotiate and approve the transaction. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_10"></A>Stockholder Communications with Directors </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Stockholders who wish to communicate with the Board or any
individual director can write to: Patrick O&#146;Brien, Corporate Secretary, Arrowhead Pharmaceuticals, Inc., 177 E. Colorado, Suite 700, Pasadena, CA 91105. Your letter should indicate that you are an Arrowhead stockholder. Depending on the subject
matter, management will: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Forward the communication to the director or directors to whom it is addressed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Forward the communication to the Chairman of the Board, if addressed to the board of directors; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">If not addressed to any director or directors, attempt to handle the inquiry directly (for example, requests for information
or stock-related matters). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_11"></A>Board Meetings and Committees </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Board held a total of six meetings during the fiscal year
ended September&nbsp;30, 2020. The Board has three standing committees: Audit Committee, Compensation Committee and Nominating Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The functions of the Audit
Committee are to select independent public accountants, to review the scope and results of the <FONT STYLE="white-space:nowrap">year-end</FONT> audit with management and the independent auditors, to review the Company&#146;s accounting principles
and its system of internal accounting controls, to review the Company&#146;s annual and quarterly reports before filing with the SEC and to review any related-party transactions. The Audit Committee met four times during fiscal 2020. The current
members of the Audit Committee are William Waddill, Chairman, Marianne De Backer and Michael S. Perry. The Board has determined that all members of the Audit Committee who served during 2020 were independent directors under the rules of the SEC and
the listing standards of Nasdaq Marketplace Rules and are financially literate. The Board has determined that Mr.&nbsp;Waddill is an &#147;audit committee financial expert&#148; in accordance with the applicable regulations, based on his experience
as noted above. The Audit Committee Charter is available on the Company&#146;s website at www.arrowheadpharma.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The functions of the Compensation Committee are
to review the goals and achievements of the Company and the Chief Executive Officer for the prior year and approve the goals of the Company and the Chief Executive Officer for the next year, to review and approve salaries, bonuses, equity awards and
other benefits payable to the Company&#146;s executive officers and to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>9</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal One &#151; Election of Directors</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">administer the Arrowhead Pharmaceuticals, Inc. 2004 Equity Incentive Plan, 2013 Incentive Plan, and, if approved at the Annual Meeting, the 2021 Incentive Plan. The
Compensation Committee is specifically responsible for determining the compensation of the Chief Executive Officer and the other executive officers. The Compensation Committee reviews compensation recommendations made by the Chief Executive Officer
for other senior executives of the Company and the compensation of the Chief Executive Officer at least annually; the Chief Executive Officer is not present during discussions or deliberations regarding his compensation. In fiscal 2020, the
Compensation Committee engaged Compensia, Inc., a compensation consulting firm, to provide advice and guidance with regard to compensation for our NEOs. The decision to engage the consultant was not made or recommended by management and the
Compensation Committee has the sole discretion to engage or change the consultant. The Compensation Committee met five times during fiscal 2020. The current members of the Compensation Committee are Michael S. Perry, Chairman, Marianne De Backer,
Mauro Ferrari, Oye Olukotun, and William Waddill. The Board has determined that all members of the Compensation Committee are independent directors under the listing rules of Nasdaq Marketplace Rules. The Compensation Committee&#146;s charter is
available on the Company&#146;s website at www.arrowheadpharma.com. The Compensation Committee has not delegated any of its responsibilities or authorities granted under its charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Nominating Committee is responsible for proposing a slate of directors for election by the stockholders at each annual meeting and for proposing candidates to fill
any vacancies. The Nominating Committee met twice during fiscal 2020. The current members of the Nominating Committee are Michael S. Perry, Chairman, Marianne De Backer, Mauro Ferrari, Oye Olukotun, and William Waddill. The Nominating
Committee&#146;s charter is available on the Company&#146;s website at www.arrowheadpharma.com. The Nominating Committee manages the process for evaluating current Board members at the time they are considered for
<FONT STYLE="white-space:nowrap">re-nomination.</FONT> After considering the appropriate skills and characteristics required on the Board, the current makeup of the Board, the results of the evaluations and the wishes of the Board members to be <FONT
STYLE="white-space:nowrap">re-nominated,</FONT> the Nominating Committee recommends to the Board whether those individuals should be <FONT STYLE="white-space:nowrap">re-nominated.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">On at least an annual basis, the Nominating Committee reviews with the Board whether it believes the Board would benefit from adding new members and, if so, the
appropriate skills and characteristics required for any new members. If the Board determines that a new member would be beneficial, the Nominating Committee solicits and receives recommendations for candidates and manages the process for evaluating
candidates. All potential candidates, regardless of their source, are reviewed under the same process. The Nominating Committee (or its chairman) screens the available information about the potential candidate(s). Based on the results of the initial
screening, interviews with candidates are scheduled with Nominating Committee members, other members of the Board and senior members of management. Upon completion of these interviews and other due diligence, the Nominating Committee may nominate a
candidate to the Board for election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Candidates for independent Board member positions are identified through recommendations from directors or others associated
with the Company, as well as through a formal search process managed by an executive recruiter. Arrowhead stockholders may also recommend candidates by sending the candidate&#146;s name and resume to the Nominating Committee pursuant to the
procedures, set forth above, for communication with the Board. As described above, our Bylaws also provide for separate notice procedures to recommend a person for nomination as a director to be considered by stockholders at a meeting, including
requirements as to the timing, form and content of a stockholder&#146;s notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Nominating Committee has no predefined minimum criteria for selecting Board
nominees, although it believes that all directors should share qualities such as governance and business experience at the corporate level, relevant <FONT STYLE="white-space:nowrap">non-competitive</FONT> experience and strong communication and
analytical skills. Independent directors must meet the criteria for independence set forth by Nasdaq and, as applicable, the SEC. In any given search, the Nominating Committee may also define particular characteristics for candidates to balance the
overall mix of skills, backgrounds and characteristics of the Board and the needs of the Company. During any search, the Nominating Committee reserves the right to modify its stated search criteria for exceptional candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Nominating Committee assesses its effectiveness in achieving its goal of building a diverse board as part of its annual assessment of the composition of the Board.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In 2018, the Board established an ad hoc Science Committee to review and advise on science topics of interest to the Company. The current members of the committee
are Mauro Ferrari, <FONT STYLE="white-space:nowrap">Co-chairman,</FONT> Oye Olukotun, <FONT STYLE="white-space:nowrap">Co-Chairman,</FONT> and Douglass Given. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">No
incumbent director attended fewer than 75% of the aggregate of (i)&nbsp;the total number of meetings of the Board held during fiscal 2020, and (ii)&nbsp;the total number of meetings held by all committees of the Board during fiscal 2020 on which
such person served, in each case during the period in which such person served on the Board or committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In addition, all of the directors then serving on the
Board attended the virtual 2020 Annual Meeting of Stockholders. It is the Company&#146;s policy to encourage, but not require, that all directors attend our annual stockholder meetings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>10</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Director Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_12"></A>Director Compensation </B></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Directors who are also employees of the Company receive no separate compensation from the Company for their service as members of the Board. For 2020, the Company
maintained the structure of director compensation it adopted in 2019 to provide a base retainer for each director with higher base retainers for service by the Chairman of the Board and the Lead Independent Director. The Company provides additional
retainers for committee service with higher retainers for committee leadership. The Compensation Committee believes the structure aligns compensation according to specific leadership and committee service contributions by each director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table sets forth the total compensation paid to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in fiscal 2020. Dr.&nbsp;Anzalone&#146;s
compensation is set forth in the discussion of Executive Compensation and in the Summary Compensation Table. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Fee&nbsp;Earned<BR>or<BR>Paid&nbsp;in&nbsp;Cash<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Stock<BR>Awards&nbsp;($)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">(1)&nbsp;(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total&nbsp;($)&nbsp;&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-right:2pt">&nbsp;</TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;Douglass Given (3)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 125,417<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 507,440<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 632,857<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;Michael S. Perry</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 80,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 507,440<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 587,440<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;Mauro Ferrari (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 143,750<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,572,310<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,716,060<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;William Waddill</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 73,750<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 475,725<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 549,475<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;Marianne De Backer (5)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 52,500<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 812,325<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 864,825<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;Adeoye
Olukotun (6)</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 23,333<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 176,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 199,333<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">This column represents the total grant date fair value, computed in accordance with ASC 718, of restricted stock units
granted during fiscal year 2020 for each director. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The RSUs granted to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors vest one year from the date of grant.
RSUs granted to Dr.&nbsp;Ferrari vested as discussed in footnote 4 below. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s fees earned in cash include his annual fees of $83,750 and cash compensation relating to a special
board project of $41,667. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Ferrari&#146;s fees earned in cash include his annual fees of $68,750 and cash compensation relating to a special
board project of $75,000. Dr.&nbsp;Ferrari&#146;s stock awards include an award of 26,571 shares of common stock on 2/17/20, valued at $1,096,585. This was made to make up the difference between the number of shares awarded to Dr.&nbsp;Ferrari
originally in January 2019 and the number of shares awarded to other directors in January 2019. Additionally, Dr.&nbsp;Ferrari received an award of 7,500 RSUs in January 2020, valued at $475,725 and vesting 1 year from the grant date, which was
commensurate with the other directors. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;De Backer joined the board in December 2019. Upon joining the board, Dr.&nbsp;De Backer received an award of
5,000 RSUs, valued at $336,600 and vesting 1 year from the grant date. Additionally, Dr.&nbsp;De Backer received an award of 7,500 RSUs in January 2020, valued at $475,725 and vesting 1 year from the grant date, which was commensurate with the other
directors. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Olukotun joined the board in September 2020. Upon joining the board, Dr.&nbsp;Olukotun received an award of 5,000
RSUs, valued at $176,000 and vesting 1 year from the grant date. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">As of the last day of fiscal year 2020, the directors held the following
outstanding restricted stock unit grants in the aggregate: Douglass Given &#151; 8,000 restricted stock units; Michael S. Perry &#151; 8,000 restricted stock units; Mauro Ferrari &#151; 7,500 restricted stock units; William Waddill &#151; 7,500
restricted stock units; Marianne De Backer &#151; 12,500 restricted stock units; and Adeoye Olukoton &#151; 5,000 restricted stock units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Vote
Required; Recommendation of the Board </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The seven nominees receiving more &#147;FOR&#148; votes than &#147;AGAINST&#148; votes, assuming a quorum is present, will
be elected to the seven director positions to serve until their terms expire or until their successors have been duly elected and qualified. Because directors are elected by a majority of votes cast, abstentions from voting and broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will be excluded from the vote and will have no effect on its outcome. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-left:8pt"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-right:1.00em">&nbsp;&nbsp;


<IMG SRC="g76219g08m78.jpg" ALT="LOGO">
</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-right:2pt" BGCOLOR="#e5e5e5"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT
STYLE="font-size:12pt" COLOR="#0071ce">&#147;FOR&#148;</FONT> EACH OF THE NOMINEES FOR DIRECTOR IN PROPOSAL ONE.</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>11</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Two &#151; Advisory Vote to Approve Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_13"></A>Proposal Two &#151; Advisory Vote to Approve
Executive Compensation </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The compensation paid to our Named Executive Officers (&#147;<B>NEOs</B>&#148;) is described below in the Compensation Discussion
and Analysis of this proxy statement for the year ended September&nbsp;30, 2020. The Board is asking stockholders to cast a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote FOR the following resolution: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:9pt; font-family:ARIAL">&#147;RESOLVED, that the compensation paid to the Company&#146;s named executive officers, as disclosed pursuant to Item&nbsp;402 of Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> as set forth in the compensation tables and narrative discussion, is hereby APPROVED.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Although the vote we are asking
you to cast is <FONT STYLE="white-space:nowrap">non-binding,</FONT> the Compensation Committee and the Board value the views of our stockholders and will consider the outcome of the vote when determining future compensation arrangements for our
NEOs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Board has adopted a policy providing for annual advisory votes to approve executive compensation. Unless the Board modifies its policy on the frequency of
holding advisory votes to approve executive compensation, the next such advisory vote will occur in 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Vote Required; Recommendation of the
Board </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Proposal Two must be approved by the Required Vote, assuming a quorum is present. For this purpose, abstentions will be counted as a vote against the
proposal, while broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of the vote. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-left:8pt"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-right:1.00em">&nbsp;&nbsp;


<IMG SRC="g76219g08m78.jpg" ALT="LOGO">
</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-right:2pt" BGCOLOR="#e5e5e5"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL"><B><FONT
STYLE="font-size:12pt" COLOR="#0071ce">&#147;FOR&#148;</FONT> PROPOSAL&nbsp;TWO.</B></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>12</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_14"></A>Proposal Three &#151; Approval of the Arrowhead
Pharmaceuticals, Inc. 2021 Incentive Plan </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In Proposal 3, we are asking stockholders to approve the adoption of the Arrowhead Pharmaceuticals, Inc. 2021
Incentive Plan (the &#147;<B>2021 Plan</B>&#148;). The 2021 Plan was adopted by the Board on January 26, 2021and will become effective only after approval of stockholders at the Annual Meeting. We believe that employees, directors, consultants and
key advisors should have a significant stake in the Company under programs that link compensation to stockholder return. As a result, equity compensation is considered to be an integral part of the Company&#146;s compensation program. The Board
approved the 2021 Plan because our 2013 Incentive Plan (the &#147;<B>2013 Plan</B>&#148;) has very limited remaining shares in the 2013 Plan available for grant and the Company does not have any other plans under which equity awards can be granted.
If stockholders approve the 2021 Plan, available shares under the 2013 Plan will be cancelled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Board believes that the 2021 Plan will promote the interests of
stockholders and is consistent with principles of good corporate governance, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><I>Independent Committee</I>. The 2021 Plan will be administered by our Compensation Committee, which is composed entirely
of independent directors who meet the Nasdaq standards for independence and who meet the definition of &#147;non-employee directors&#148; under Rule 16b-3(b)(3). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><I>No Discounted Stock Options or SARs</I>. All stock option and stock appreciation rights (&#147;<B>SAR</B>&#148;) awards
under the 2021 Plan must have an exercise or base price that is not less than the fair market value of the underlying common stock on the date of grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><I>No Repricing</I>. Other than in connection with a corporate transaction affecting the Company, the 2021 Plan prohibits
any repricing of stock options or SARs without stockholder approval. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><I>No Dividends on Unvested Awards</I>. Dividends or dividend equivalent amounts payable in respect of awards are subject to
the same vesting and forfeiture restrictions as apply to the underlying awards. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><I>Minimum Vesting</I>. All awards are subject to a one-year minimum vesting requirement, provided that we may grant up to a
maximum of 5% of the aggregate number of shares available for issuance under the 2021 Plan without such a minimum vesting period and provided further that awards to non-employee directors need not comply with the one year minimum vesting requirement
so long as such awards do not vest earlier than the date of the annual meeting following the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Holding Period. All awards granted under the 2021 Plan to our Chief Executive Officer will be subject to a 12-month holding
period requirement pursuant to which the Chief Executive Officer may not transfer or dispose of any shares received upon exercise or settlement of an award (net of tax withholding) for a period of 12 months following the date of such exercise or
settlement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Existing Equity Plan Information </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We currently have two plans that provide for equity-based
compensation. Under the 2004 Equity Incentive Plan and 2013 Incentive Plan, as of January 14, 2021, 496,793 and 6,647,989 shares, respectively, of Arrowhead&#146;s Common Stock are reserved for the grant of stock options, stock appreciation rights,
restricted stock awards and performance unit/share awards to employees, consultants and others. No further grants may be made under the 2004 Equity Incentive Plan. As of January 14, 2021, there were options granted and outstanding to purchase
496,793 and 2,286,884 shares of Common Stock under the 2004 Equity Incentive Plan and the 2013 Incentive Plan, respectively, and there were 3,229,700 restricted stock units granted and outstanding under the 2013 Incentive Plan. Also, as of January
14, 2021, there were 1,231,449 shares reserved for options and 731,700 shares reserved for restricted stock units issued as inducement grants to new employees outside of equity compensation plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>13</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table includes aggregated information regarding awards outstanding as of January 14,
2021, and the proposed number of shares issuable under the 2021 Plan: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>


<TR BGCOLOR="#e5f0fa" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Outstanding Appreciation Awards Under All Plans</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0071ce" ALIGN="right">4,015,126</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0071ce">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Weighted Average Exercise Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#e5f0fa" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Weighted Average Remaining Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Outstanding Full Value Awards Under All Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,961,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#e5f0fa" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Number of Shares Available for Grant Under All Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,178,905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Number of Shares Requested for 2021 Plan</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">8,000,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Reasons for Seeking Stockholder Approval </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Board believes that equity grants are a critical part of the
Company&#146;s compensation program. Stockholder approval of the 2021 Plan would allow us to continue to attract and retain employees, directors, consultants and key advisors with equity incentives. The Board believes that the number of shares
authorized to be issued under the 2021 Plan is necessary in order to continue to meet our compensation objectives. Stock-based awards comprise a significant component of the compensation of our executive management team and are important tool in
attracting and retaining key employees. Furthermore, the Board believes the grant of equity based compensation awards aligns the long-term interests of stockholders and key employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">When approving the 2021 Plan and the number of shares available for issuance thereunder, the Board considered the burn rate with respect to the equity awards granted by
the Company, as well as the Company&#146;s overhang. The burn rate is equal to the total number of equity awards the Company granted in a fiscal year divided by the weighted average common stock outstanding during the year. Overhang is equal to the
total number of equity awards outstanding plus the total number of shares available for grant under the Company&#146;s equity plans, divided by the sum of the total common stock outstanding, the number of equity awards outstanding and the total
number of shares available for grant under the Company&#146;s equity plans. The Company&#146;s three-year average burn ratefor fiscal years 2020, 2019, and 2018, was approximately 2.8%. The Company&#146;s overhang as of September 30, 2020 was 7.6%.
If the 2021 Plan is approved, the Company&#146;s overhang would increase to 13.3%. If this Proposal Three is approved, it is expected we will have enough shares to fund future equity grants under the 2021 Plan for approximately the next five years.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our stockholders approved the 2013 Plan at our Annual Meeting in 2014. If stockholders do not approve this Proposal Three, the Company can continue to make awards
under the 2013 Plan, but we will have very limited shares available for future equity grants. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Summary of the 2021 Plan </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">On January 26, 2021, the Board adopted the 2021 Plan, subject to approval by our stockholders. This summary is not a complete description of all provisions of the 2021
Plan and is qualified in its entirety by reference to the 2021 Plan, which is attached as Exhibit A to this Proxy Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Purpose</I>. The purpose of the 2021
Plan is to advance the Company&#146;s interests by providing for the grant to participants of stock-based and other incentive awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Plan Administration</I>.
The 2021 Plan is administered by our Compensation Committee, who has the authority to, among other things, interpret the 2021 Plan, determine eligibility for, grant and determine the terms of awards under the 2021 Plan, and to do all things
necessary or appropriate to carry out the purposes of the 2021 Plan. Our Compensation Committee&#146;s determinations under the 2021 Plan are conclusive and binding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Term</I>. No awards will be made after the tenth anniversary of the plan&#146;s adoption, but previously granted awards may continue beyond that date in accordance
with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Authorized Shares</I>. Subject to adjustment, the maximum number of shares of our common stock that may be delivered in satisfaction of awards
under the 2021 Plan is 8,000,000, reduced by any shares of common stock subject to awards made under the 2013 Plan after January 1, 2021. Shares of common stock subject to outstanding awards under the 2013 Plan as of January 1, 2021 that, after
January 1, 2021, are canceled, expired, forfeited or otherwise not issued under such award (other than as a result of being tendered or withheld to pay the exercise price or withholding taxes in connection with any such awards) or settled in cash
will be added to the number of shares of common stock issuable under the 2021 Plan. There were no shares issued from the 2013 Plan after January 1, 2021 and before January 14, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>14</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Any shares of common stock underlying awards that are settled in cash or that otherwise expire,
terminate or are forfeited prior to the issuance of stock, would again be available for issuance under the 2021 Plan. Shares of common stock that are tendered to or withheld by the Company from an award in payment of the exercise price of any award
requiring exercise or in satisfaction of the tax withholding requirements with respect to any award and shares of stock purchased by the Company with proceeds from the exercise of stock options will not again be available for issuance under the 2021
Plan. Stock delivered under the 2021 Plan may be authorized but unissued stock or previously issued stock acquired by the Company. On January&nbsp;14, 2021, the closing price of our common stock as reflected on Nasdaq was $82.86. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Eligibility</I>. Our Compensation Committee selects participants from among the key employees, directors, consultants and advisors of the Company and its affiliates.
Eligibility for options intended to be incentive stock options (&#147;<B>ISOs</B>&#148;) is limited to employees of the Company or certain affiliates. As of January 14, 2021, approximately 250 employees and 6 directors would be eligible to
participate in the 2021 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Types of Awards</I>. The 2021 Plan provides for grants of options, SARs, restricted and unrestricted stock and stock units,
performance awards, cash awards and other awards convertible into or otherwise based on shares of our stock. Dividend equivalents may also be provided in connection with awards under the 2021 Plan. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="69%"></TD></TR>


<TR BGCOLOR="#e5f0fa" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Restricted and Unrestricted Stock</I></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #0071ce"><I></I>A restricted stock award is an award of common stock subject to forfeiture restrictions, while an unrestricted stock award is not subject to restrictions.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Stock Options and SARs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The 2021 Plan provides for the grant of ISOs, non-qualified stock options (&#147;<B>NSOs</B>&#148;), and SARs. The exercise price of an option, and the base price against which a SAR is to be measured, may not be less than the
fair market value (or, in the case of an ISO granted to a ten percent stockholder, 110% of the fair market value) of a share of common stock on the date of grant. Subject to the minimum vesting requirement described below, our Compensation Committee
determines when stock options or SARs become exercisable and the terms on which such awards remain exercisable. Stock options and SARs will generally have a maximum term of ten years. SARs are payable in cash, in shares of our common stock or in a
combination of cash and shares</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5f0fa">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5f0fa" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Stock Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">A stock unit award is denominated in shares of common stock and entitles the participant to receive stock or cash measured by the value of the shares in the future. The delivery of stock or cash under a stock unit may be subject
to the satisfaction of performance or other vesting conditions.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Performance Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">A performance award is an award the vesting, settlement or exercisability of which is subject to specified performance criteria.</TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5f0fa">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#e5f0fa" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Cash Awards</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">A cash award is an award denominated in cash.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Vesting</I>. Subject to the minimum vesting requirement described in the next sentence, our Compensation Committee has the authority
to determine the vesting schedule applicable to each award, and to accelerate the vesting or exercisability of any award. No award may be granted with terms providing for any right of vesting, exercise or lapse of vesting requirements earlier than a
date that is at least one (1) year following the date of grant (or, in the case of a performance award, earlier than the one (1) year anniversary of the commencement of the performance period). Notwithstanding the foregoing, the Compensation
Committee may grant up to a maximum of 5% of the aggregate number of shares available for issuance under the 2021 Plan without such a minimum vesting period and awards granted to non-employee directors may grant earlier than one (1) year from the
date of grant so long as such awards do not vest earlier than the date of the next annual meeting of stockholders following the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In addition, all awards
granted under the 2021 Plan to our Chief Executive Officer will be subject to a 12-month holding period requirement pursuant to which the Chief Executive Officer may not transfer or dispose of any shares received upon exercise or settlement of an
award (net of tax withholding) for a period of 12 months following the date of such exercise or settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Termination of Employment</I>. Our Compensation
Committee determines the effect of termination of employment or service on an award. Unless otherwise provided by our Compensation Committee or in an award agreement, upon a termination of employment or service all unvested options and other awards
requiring exercise will terminate and all other unvested awards will be forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Performance Criteria</I>. The 2021 Plan provides that grants of performance
awards may be made based upon, and subject to achieving, &#147;performance objectives&#148; over a specified performance period. Performance objectives may include, without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>15</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">limitation, a measure of performance relating to any, or any combination of, the following
(measured either absolutely or by reference to an index or indices and determined either on a consolidated basis or, as the context permits, on a divisional, subsidiary, line of business, project or geographical basis or in combinations thereof):
sales; revenues; assets; expenses; earnings before or after deduction for all or any portion of interest, taxes, depreciation, or amortization, whether or not on a continuing operations or an aggregate or per share basis; return on equity,
investment, capital or assets; one or more operating ratios; borrowing levels, leverage ratios or credit rating; market share; capital expenditures; cash flow; stock price; stockholder return; sales of particular products or services; customer
acquisition or retention; acquisitions and divestitures (in whole or in part); joint ventures and strategic alliances; spin-offs, split-ups and the like; reorganizations; or recapitalizations, restructurings, financings (issuance of debt or equity)
or refinancings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Transferability</I>. Awards under the 2021 Plan may not be transferred except by will or by the laws of descent and distribution, unless (for
awards other than ISOs) otherwise provided by our Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Corporate Transactions</I>. In the event of a consolidation, merger or similar
transaction, a sale or transfer of all or substantially all of the Company&#146;s assets or a dissolution or liquidation of the Company, our Compensation Committee may, among other things, provide for the continuation or assumption of outstanding
awards, for new grants in substitution of outstanding awards, for the accelerated vesting or delivery of shares under awards or for a cash-out of outstanding awards, in each case on such terms and with such restrictions as it deems appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Change in Control</I>. Unless otherwise expressly provided for in the award agreement or another contract, including an employment or severance agreement or severance
plan, or under the terms of a transaction constituting a Change in Control, in the event of a Change in Control, each outstanding award will fully vest and become exercisable, including to the maximal value of performance awards. Except as our
Compensation Committee may otherwise determine awards not assumed or exercised will terminate in connection with such corporate transaction. Change in Control has the meaning set forth in the 2021 Plan, but generally means a person or entity
becoming the owner of securities representing fifty percent (50%) or more of the combined voting power of the Company&#146;s then outstanding securities entitled to vote for directors; the consummation of a merger or consolidation of the Company
with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company continuing to represent more than fifty percent (50%) of the total voting power represented by the voting securities of the
Company or such surviving entity outstanding immediately after such merger or consolidation; the consummation of the sale or disposition by the Company of all or substantially all of its assets; or a change in the composition of the Board, as a
result of which fewer than a majority of the directors are incumbent directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Adjustment</I>. In the event of certain corporate transactions (including, but
not limited to, a stock dividend, stock split or combination of shares, recapitalization or other change in the Company&#146;s capital structure that constitutes an equity restructuring within the meaning of ASC 718), our Compensation Committee will
make appropriate adjustments to the maximum number of shares that may be delivered under the 2021 Plan, and will also make appropriate adjustments to the number and kind of shares of stock or securities subject to awards, the exercise prices of such
awards or any other terms of awards affected by such change. Our Compensation Committee may also make the types of adjustments described above to take into account distributions to stockholders and events other than those listed above if it
determines that such adjustments are appropriate to avoid distortion in the operation of the plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Amendment and Termination</I>. Our Compensation Committee can
amend the 2021 Plan or outstanding awards, or terminate the 2021 Plan as to future grants of awards, except that our Compensation Committee will not be able alter the terms of an award if it would affect materially and adversely a participant&#146;s
rights under the award without the participant&#146;s consent (unless expressly provided in the 2021 Plan or reserved by our Compensation Committee at the time of grant). Stockholder approval will be required for any amendment to the extent such
approval is required by law, including the Code or applicable stock exchange requirements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Federal Income Tax Consequences Under 2021 Plan </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following is a summary of some of the material federal income tax consequences associated with the grant and exercise of awards under the 2021 Plan under current
federal tax laws and certain other tax considerations associated with awards under the 2021 Plan. The summary does not address tax rates or non-U.S., state or local tax consequences, nor does it address employment-tax or other federal tax
consequences except as noted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Restricted Stock</I>. A participant who is awarded or purchases shares subject to a substantial risk of forfeiture generally does
not have income until the risk of forfeiture lapses. When the risk of forfeiture lapses, the participant has ordinary income equal to the excess of the fair market value of the shares at that time over the purchase price, if any, and a corresponding
deduction is generally available to the Company. However, a participant may make an election under Section 83(b) of the Code to be taxed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>16</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">on restricted stock when it is acquired rather than later, when the substantial risk of forfeiture
lapses. An 83(b) election must be made not later than thirty (30) days after the transfer of the shares to the participant and must satisfy certain other requirements. A participant who makes an effective 83(b) election will realize ordinary income
equal to the fair market value of the shares as of the time of acquisition less any price paid for the shares. A corresponding deduction will generally be available to the Company. Fair market value for this purpose is determined without regard to
the forfeiture restrictions. If a participant makes an effective 83(b) election, no additional income results by reason of the lapsing of the restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For
purposes of determining capital gain or loss on a sale of shares awarded under the 2021 Plan, the holding period in the shares begins when the participant realizes taxable income with respect to the transfer. The participant&#146;s tax basis in the
shares equals the amount paid for the shares plus any income realized with respect to the transfer. However, if a participant makes an effective 83(b) election and later forfeits the shares, the tax loss realized as a result of the forfeiture is
limited to the excess of what the participant paid for the shares (if anything) over the amount (if any) realized in connection with the forfeiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>ISOs</I>. In
general, a participant realizes no taxable income upon the grant or exercise of an ISO. However, the exercise of an ISO may result in an alternative minimum tax liability to the participant. With some exceptions, a disposition of shares purchased
under an ISO within two years from the date of grant or within one year after exercise produces ordinary income to the participant (and generally a deduction to the Company) equal to the value of the shares at the time of exercise less the exercise
price. Any additional gain recognized in the disposition is treated as a capital gain for which the Company is not entitled to a deduction. If the participant does not dispose of the shares until after the expiration of these one and two-year
holding periods, any gain or loss recognized upon a subsequent sale is treated as a long-term capital gain or loss for which the Company is not entitled to a deduction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>NSOs</I>. In general, a participant has no taxable income upon the grant of an NSO but realizes income in connection with exercise of the option in an amount equal to
the excess (at time of exercise) of the fair market value of the shares acquired upon exercise over the exercise price. A corresponding deduction is generally available to the Company. Upon a subsequent sale or exchange of the shares, any recognized
gain or loss is treated as a capital gain or loss for which the Company is not entitled to a deduction. An ISO that is exercised more than three months after termination of employment (other than termination by reason of death) is generally treated
as an NSO. ISOs are also treated as NSOs to the extent they first become exercisable by an individual in any calendar year for shares having a fair market value (determined as of the date of grant) in excess of $100,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>SARs</I>. The grant of a SAR does not itself result in taxable income, nor does taxable income result merely because a SAR becomes exercisable. In general, a
participant who exercises a SAR for shares of stock or receives payment in cancellation of a SAR will have ordinary income equal to the amount of any cash and the fair market value of any stock received. A corresponding deduction is generally
available to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Restricted Stock Units</I>. The grant of a restricted stock unit does not itself generally result in taxable income. Instead, the
participant is taxed upon vesting (and a corresponding deduction is generally available to the Company), unless he or she has made a proper election to defer receipt of the shares (or cash if the award is cash settled) under Section 409A of the Code
(&#147;Section 409A&#148;). If the shares delivered are restricted for tax purposes, the participant will instead be subject to the rules described above for restricted stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Section 409A</I>. Section 409A imposes an additional 20% income tax, plus, in some cases, a further income tax in the nature of interest, on nonqualified deferred
compensation that does not comply with deferral, payment-timing and other formal and operational requirements specified in Section 409A and related regulations and that is not exempt from those requirements. Stock options and SARs granted under the
2021 Plan are intended to be exempt from Section 409A. The 2021 Plan gives the Compensation Committee the flexibility to prescribe terms for other awards that are consistent with the requirements of, or an exemption from, Section 409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>Certain Change of Control Payments</I>. Under Section 280G of the Code, the vesting or accelerated exercisability of options or the vesting and payments of other
awards in connection with a change of control of a corporation may be required to be valued and taken into account in determining whether participants have received compensatory payments, contingent on the change in control, in excess of certain
limits. If these limits are exceeded, a substantial portion of amounts payable to the participant, including income recognized by reason of the grant, vesting or exercise of awards, may be subject to an additional 20% federal tax and may be
non-deductible to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>17</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Three &#151; Approval of the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Board is asking stockholders to cast a vote FOR the following resolution: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:9pt; font-family:ARIAL">&#147;RESOLVED, that the stockholders of the Company approve the 2021 Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan in a form substantially as
provided in Exhibit A to this Proxy Statement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Vote Required; Recommendation of the Board </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Proposal Three must be approved by the Required Vote, assuming a quorum is present. For this purpose, abstentions will be counted as a vote against the proposal, while
broker non-votes will have no effect on the outcome of the vote. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-left:8pt"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-right:1.00em">&nbsp;&nbsp;


<IMG SRC="g76219g08m78.jpg" ALT="LOGO">
</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-right:2pt" BGCOLOR="#e5e5e5"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL"><B><FONT
STYLE="font-size:12pt" COLOR="#0071ce">&#147;FOR&#148;</FONT> PROPOSAL&nbsp;3</B></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>18</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_15"></A>Executive Compensation </B></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><A NAME="toc76219_16"></A>COMPENSATION DISCUSSION AND ANALYSIS </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>The following compensation discussion and analysis contains
statements regarding future individual and Company performance targets and goals. These targets and goals are disclosed in the limited context of Arrowhead&#146;s compensation programs and should not be understood to be statements of
management&#146;s expectations or guidance. Arrowhead cautions investors not to apply these statements to other contexts. Fiscal years are denoted as fiscal years, all other year references refer to calendar years. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">This Compensation Discussion and Analysis describes the compensation program for our NEOs. During fiscal year 2020, these individuals were: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Christopher Anzalone, our President and Chief Executive Officer (our &#147;<B>CEO</B>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Kenneth Myszkowski, our Chief Financial Officer (our &#147;<B>CFO</B>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Javier San Martin, our Chief Medical Officer (our &#147;<B>CMO</B>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">James Hassard, our Chief Commercial Officer (our &#147;<B>CCO</B>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Curt Bradshaw, our former Chief Scientific Officer (our &#147;<B>CSO</B>&#148;); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Bruce D. Given, our former Chief Operating Officer (our &#147;<B>COO</B>&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">This Compensation Discussion and Analysis describes the material elements of our executive compensation program during 2020. It also provides an overview of our
executive compensation philosophy and objectives and summarizes our executive compensation policies and practices. Finally, it analyzes how and why the Compensation Committee of our Board of Directors (the &#147;Compensation Committee&#148;) arrived
at the specific compensation decisions for our executive officers, including our NEOs for 2020 including the key factors that the Compensation Committee considered in determining their compensation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_17"></A>Our Company </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We
develop medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and
durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead&#146;s RNAi-based therapeutics
leverage this natural pathway of gene silencing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically characterized by
the overproduction of one or more proteins. The depth and versatility of our RNAi technologies enable us to potentially address conditions in virtually any therapeutic area and pursue disease targets that are not otherwise addressable by small
molecules and biologics. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>2020 Business Highlights </U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Reported interim multiple-dose results on two cardiometabolic candidates <FONT STYLE="white-space:nowrap">ARO-APOC3,</FONT>
being developed as a potential treatment for patients with severe hypertriglyceridemia, and <FONT STYLE="white-space:nowrap">ARO-ANG3,</FONT> being developed for the treatment of dyslipidemias and metabolic diseases, showing high levels of reduction
in APOC3, ANGPTL3, triglycerides, and other lipid parameters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Dosed the first patients in AROHSD1001, a Phase 1/2 clinical study of <FONT STYLE="white-space:nowrap">ARO-HSD,</FONT> the
Company&#146;s investigational RNAi therapeutic being developed as a treatment for patients with alcohol related and nonalcohol related liver diseases, such as nonalcoholic steatohepatitis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Opened a second Research and Development facility in San Diego, which allows Arrowhead to tap into additional skill sets in
one the country&#146;s premier biotech hubs and also expands capacity for preclinical models to do more early research work in parallel; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Earned a $20&nbsp;million milestone payment from Amgen following the administration of the first dose of olpasiran, formerly
referred to as AMG 890 and <FONT STYLE="white-space:nowrap">ARO-LPA,</FONT> in a Phase 2 clinical study; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>19</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Completed planned enrollment and dosing of 93 subjects in AROANG1001, a Phase 1/2 clinical study of <FONT
STYLE="white-space:nowrap">ARO-ANG3,</FONT> the Company&#146;s investigational RNAi therapeutic being developed for the treatment of mixed dyslipidemia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Completed planned enrollment and dosing of 80 subjects in AROAPOC31001, a Phase 1/2 clinical study of <FONT
STYLE="white-space:nowrap">ARO-APOC3,</FONT> the Company&#146;s investigational RNAi therapeutic being developed for the treatment of hypertriglyceridemia, and expanded the study to include up 112 subjects; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Initiated a Phase 1b study of <FONT STYLE="white-space:nowrap">ARO-HIF2,</FONT> the company&#146;s first tumor targeted
investigational RNAi therapeutic being developed as a treatment for patients with clear cell renal cell carcinoma; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Presented new clinical data at The Liver Meeting Digital Experience, the Annual Meeting of the American Association for the
Study of Liver Disease (&#147;<B>AASLD</B>&#148;) on <FONT STYLE="white-space:nowrap">ARO-AAT,</FONT> Arrowhead&#146;s candidate against liver disease associated with <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency, showing
that <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> strongly reduced the production of mutant <FONT STYLE="white-space:nowrap">Z-AAT</FONT> protein and led to improvements in multiple biomarkers of <FONT STYLE="white-space:nowrap">alpha-1</FONT>
liver disease; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Executed and closed an agreement with Takeda to <FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT
STYLE="white-space:nowrap">co-commercialize</FONT> <FONT STYLE="white-space:nowrap">ARO-AAT,</FONT> which includes a $300&nbsp;million upfront payment, $740&nbsp;million in potential milestone payments, a 50/50 profit sharing agreement in the U.S.,
and <FONT STYLE="white-space:nowrap">20-25%</FONT> royalty on sales outside the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Ended fiscal 2020 with $453&nbsp;million in cash and investments; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Achieved 53% total stockholder return (&#147;<B>TSR</B>&#148;) in fiscal 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_18"></A>Business Development </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><I>Takeda Pharmaceutical Company Limited. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In October 2020, Arrowhead entered into
a collaboration and license agreement with Takeda Pharmaceuticals U.S.A., Inc. (&#147;<B>Takeda</B>&#148;) to develop and commercialize <FONT STYLE="white-space:nowrap">ARO-AAT,</FONT> a Phase 2 investigational therapy in development to treat <FONT
STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin-associated liver disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Under the terms of the agreement, Takeda and Arrowhead will <FONT
STYLE="white-space:nowrap">co-develop</FONT> <FONT STYLE="white-space:nowrap">ARO-ATT</FONT> which, if approved, will be <FONT STYLE="white-space:nowrap">co-commercialized</FONT> in the United States under a 50/50 profit-sharing structure. Outside
of the United States, Takeda will lead the global commercialization strategy and receive an exclusive license to commercialize <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> with Arrowhead eligible to receive tiered royalties of <FONT
STYLE="white-space:nowrap">20-25%</FONT> on net sales. In January 2021, Arrowhead received an upfront payment of $300&nbsp;million. Additionally, the Company is eligible to receive potential development, regulatory and commercial milestones up to
$740&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_19"></A>Platform </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In 2020, Arrowhead continued to develop and deploy our Targeted RNAi Molecule platform (&#147;<B>TRiM</B><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>) to
identify and develop new therapeutics, including <FONT STYLE="white-space:nowrap">ARO-Lung2</FONT> and <FONT STYLE="white-space:nowrap">ARO-COV.</FONT> TRiM<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> utilizes ligand-mediated delivery
and is designed to enable tissue-specific targeting, while being structurally simple. The TRiM<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> platform is designed to offer several potential competitive advantages including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">A more sophisticated RNAi trigger selection and screening process that identifies potent sequences rapidly in locations that
RNAi competitors may miss; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Multiple routes of administration including subcutaneous, intravenous, and inhaled; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Faster time to clinical candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Optimal pharmacologic activity and long
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">duration-of-effect;</FONT></FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Potentially wide safety margins; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Simplified manufacturing at reduced cost; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The promise of taking RNAi to tissues beyond the liver. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_20"></A>Pipeline </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We are
focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins. The depth and versatility of our RNAi technologies enable us to address conditions in virtually any
therapeutic area and pursue disease targets that are not otherwise addressable by small molecules and biologics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>The timing of our planned and already filed
clinical trial applications (&#147;</I><B></B><B><I>CTA</I></B><B></B><I>&#148;) discussed below are based on calendar years, not fiscal years. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>20</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Clinical Stage Candidates </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-ANG3</FONT></B> is designed to reduce production of angiopoietin-like protein 3 (&#147;<B>ANGPTL3</B>&#148;), a liver synthesized
inhibitor of lipoprotein lipase and endothelial lipase. ANGPTL3 inhibition has been shown to lower serum LDL, serum and liver triglyceride and has genetic validation as a novel target for cardiovascular disease. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2017: Target identified. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2018: Filed for regulatory clearance to begin a Phase 1 study. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: Clinical trial commenced. Initial results from AROANG1001 presented at the 2019 Global Summit on Cardiology and heart
Diseases and the November 2019 American Heart Association meeting. Key data include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Dose dependent reductions in serum ANGPTL3 (mean maximum reduction ranging from 55% in the 35 mg cohort to 83% in the 300 mg
cohort), which were maintained through the end of the study. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Dose dependent reduction in triglycerides and <FONT STYLE="white-space:nowrap">VLDL-C</FONT> (mean maximum triglyceride
reduction ranging from 31% in the 35 mg cohort and 66% in the 200 mg cohort and mean maximum <FONT STYLE="white-space:nowrap">VLDL-C</FONT> ranging from 30% in the 35 mg cohort to 65% in the 200 mg cohort). Reductions in trig2lycerides and <FONT
STYLE="white-space:nowrap">VLDL-C</FONT> in the 200 mg and 300 mg cohorts were maintained through end of study. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Completed planned enrollment in AROANG1001 and published additional preliminary data. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-APOC3</FONT></B> is designed to reduce production of Apolipoprotein <FONT STYLE="white-space:nowrap">C-III</FONT> <FONT
STYLE="white-space:nowrap">(apoC-III),</FONT> a component of triglyceride rich lipoproteins (&#147;<B>TRLs</B>&#148;) including VLDL and chylomicrons and a key regulator of triglyceride metabolism. The company believes that knocking down the hepatic
production of <FONT STYLE="white-space:nowrap">apoC-III</FONT> may result in reduced VLDL synthesis and assembly, enhanced breakdown of TRLs, and better clearance of VLDL and chylomicron remnants. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2017: Target identified. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: Clinical trial commenced. Initial results from AROAPOC31001 presented at the 2019 Global Summit on Cardiology and
heart Diseases and the November 2019 American Heart Association meeting. Key data include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Dose dependent reductions in serum APOC3 (mean maximum reduction ranging from 72% in the 10 mg cohort to 94% in the 100 mg
cohort), which were maintained through the end of the study. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Dose dependent reduction in triglycerides and <FONT STYLE="white-space:nowrap">VLDL-C</FONT> (mean maximum triglyceride
reduction ranging from 53% in the 10 mg cohort and 64% in the 100 mg cohort and mean maximum <FONT STYLE="white-space:nowrap">VLDL-C</FONT> ranging from 53% in the 10 mg cohort to 68% in the 50 mg cohort). These reductions were maintained through
the end of study. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Completed planned enrollment in AROAPOC31001 and published additional preliminary data. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-ENaC</FONT></B> is an orally inhaled investigational RNAi therapeutic being developed as a treatment for patients with cystic
fibrosis </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Investigational New Drug application (&#147;<B>IND</B>&#148;) filed and Phase 1/2a clinical trial commenced.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-HIF2</FONT></B> is being developed as a treatment for patients with clear cell renal cell carcinoma
(&#147;<B>ccRCC</B>&#148;). ccRCC is one of the most common forms of kidney cancer. Most patients with ccRCC have a mutation in the Von Hippel-Lindau gene, rendering them unable to degrade <FONT STYLE="white-space:nowrap">HIF-2a,</FONT> which leads
to accumulation during tumor hypoxia and promotes tumor growth. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: IND filed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Commenced patient enrollment in a Phase 1 study. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-HSD</FONT></B> is being developed as a treatment for patients with alcohol related and nonalcohol related liver diseases such as
nonalcoholic steatohepatitis <B>(&#147;NASH</B>&#148;). <FONT STYLE="white-space:nowrap">ARO-HSD</FONT> is designed to reduce the production of HSD17B13, a member of the hydroxysteroid dehydrogenase family involved in the metabolism of hormones,
fatty acids, and bile acids. Published genetic data indicate a loss of function mutation in HSD17B13 provides strong protection against alcoholic hepatitis, cirrhosis and NASH. This genetic validation gives us confidence about the target gene. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: Clinical trial application filed. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Dosed first patients in a Phase 1/2 clinical study. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>21</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Partnered Programs </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-AAT</FONT></B> is a clinical-stage RNAi therapeutic candidate for the treatment of liver disease associated with <FONT
STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency. <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> is designed to knock down the <FONT STYLE="white-space:nowrap">Alpha-1</FONT> antitrypsin (&#147;<B>AAT</B>&#148;) gene transcript and
reduce the hepatic production of the mutant AAT protein. <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> is a next-generation subcutaneously administered compound that follows a previous generation AAT compound
<FONT STYLE="white-space:nowrap">ARC-AAT.</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2017: <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> nominated; CTA filed. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2018: Clinical trial commenced. Initial results from AROAAT1001 were presented in November 2018 at The Liver Meeting<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, the Annual Meeting of the AASLD. Key data include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Three monthly doses of 300 mg <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> led to reductions in serum <FONT
STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin to below the level of quantitation in 100% of subjects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Reductions were sustained for greater than 14 weeks indicating that quarterly or less frequent dosing appears feasible.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Single and multiple doses of <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> appeared to be well-tolerated at all doses
tested. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: One phase 2/3 and one Phase 2 trial were initiated (enrolling concurrently): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">SEQUOIA, a potentially pivotal multi-center, multi-dose, placebo-controlled, adaptive Phase 2/3 study to evaluate the
safety, efficacy and tolerability of <FONT STYLE="white-space:nowrap">ARO-AAT,</FONT> administered subcutaneously to patients with <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">AROAAT2002, a pilot open-label, multi-dose, Phase 2 study to assess changes in a novel histological activity scale in
response to <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> over time in patients with <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency associated liver disease. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Presented new clinical data showing <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> strongly reduced the production of
mutant <FONT STYLE="white-space:nowrap">Z-AAT</FONT> protein and led to improvements in multiple biomarkers of <FONT STYLE="white-space:nowrap">alpha-1</FONT> liver disease; Signed an agreement with Takeda to
<FONT STYLE="white-space:nowrap">co-develop</FONT> and <FONT STYLE="white-space:nowrap">co-commercialize</FONT> <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> earning a $300&nbsp;million <FONT STYLE="white-space:nowrap">up-front</FONT> payment and
$740&nbsp;million in potential milestone payments, as well as a 50/50 profit sharing agreement in the United States, and <FONT STYLE="white-space:nowrap">20-25%</FONT> royalties on sales outside of the United States. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">JNJ-3989</FONT> (formerly <FONT STYLE="white-space:nowrap">ARO-HBV)</FONT></B> is an RNAi therapeutic candidate for the treatment of
chronic hepatitis B infection with the goal of achieving a functional cure. <FONT STYLE="white-space:nowrap">JNJ-3989</FONT> <FONT STYLE="white-space:nowrap">(ARO-HBV)</FONT> is a next-generation subcutaneously administered compound that follows
previous generation HBV compounds <FONT STYLE="white-space:nowrap">ARC-520</FONT> and <FONT STYLE="white-space:nowrap">ARC-521.</FONT> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2017: <FONT STYLE="white-space:nowrap">JNJ-3989</FONT> <FONT STYLE="white-space:nowrap">(ARO-HBV)</FONT> nominated; CTA
filed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2018: Clinical trial commenced. Clinical data presented at the World Gastroenterologists Summit and at the AASLD Liver
Meeting<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> 2018 demonstrating: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Mean HBsAg reduction of <FONT STYLE="white-space:nowrap">-1.9</FONT> Log10 <FONT STYLE="white-space:nowrap">(-98.7%)</FONT>
with a range of <FONT STYLE="white-space:nowrap">-1.3</FONT> Log10 <FONT STYLE="white-space:nowrap">(-95.0%)</FONT> to <FONT STYLE="white-space:nowrap">-3.8</FONT> Log10 <FONT STYLE="white-space:nowrap">(-99.98%).</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><FONT STYLE="white-space:nowrap">JNJ-3989</FONT> <FONT STYLE="white-space:nowrap">(ARO-HBV)</FONT> appeared to be
well-tolerated at monthly doses up to 400 mg. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2018: Signed a license agreement with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceuticals Companies of
Johnson&nbsp;&amp; Johnson, for <FONT STYLE="white-space:nowrap">JNJ-3989</FONT> <FONT STYLE="white-space:nowrap">(ARO-HBV)</FONT> and a collaboration agreement for up to three RNAi therapeutic candidates that use our proprietary TRiM<SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP> platform against new targets to be selected by Janssen. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The total potential deal value is approximately $3.7&nbsp;billion plus royalties on commercial sales. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Received $175&nbsp;million as an upfront payment and received $75&nbsp;million in the form of an equity investment by
Johnson&nbsp;&amp; Johnson Innovation &#151; JJDC, Inc., at a premium price of $23.00 per share of Arrowhead common stock. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: Arrowhead initiated dosing in the triple combination cohort (cohort 12) in the Company&#146;s ongoing Phase 1/2 study
of <FONT STYLE="white-space:nowrap">JNJ-3989</FONT> <FONT STYLE="white-space:nowrap">(ARO-HBV)</FONT> earning a $25&nbsp;million milestone payment. The Company earned an additional $25&nbsp;million milestone payment following the initiation of
dosing in Janssen&#146;s phase 2b study of <FONT STYLE="white-space:nowrap">JNJ-3989</FONT> <FONT STYLE="white-space:nowrap">(ARO-HBV).</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2019: Janssen selected one of its three potential targets under the 2018 collaboration agreement and the Company is
developing a drug, <FONT STYLE="white-space:nowrap">ARO-JNJ1,</FONT> under the collaboration. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Olpasiran (formerly AMG 890 and <FONT
STYLE="white-space:nowrap">ARO-LPA)</FONT></B> is designed to reduce production of apolipoprotein A, a key component of lipoprotein(a), which has been genetically linked with increased risk of cardiovascular diseases, independent of cholesterol and
LDL levels. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2016: Amgen, Inc. (&#147;<B>Amgen</B>&#148;) acquired a worldwide, exclusive license to develop and commercialize AMG 890 <FONT
STYLE="white-space:nowrap">(ARO-LPA).</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2018: Amgen administered the first dose of olpasiran (AMG 890 / <FONT STYLE="white-space:nowrap">ARO-LPA)</FONT> in a Phase
1 clinical study, which earned Arrowhead a $10&nbsp;million milestone payment. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>22</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">2020: Amgen administered the first dose of olpasiran (AMG 890 / <FONT STYLE="white-space:nowrap">ARO-LPA)</FONT> in a Phase
2 clinical study, which earned Arrowhead a $20&nbsp;million milestone payment. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Candidates in Development </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-Lung2</FONT></B> is being developed against an undisclosed target as a potential treatment for chronic obstructive pulmonary
disorder (COPD). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">ARO-COV</FONT> </B>is being developed to address the current novel coronavirus that causes <FONT
STYLE="white-space:nowrap">COVID-19</FONT> and other possible future pulmonary-borne pathogens. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Financial Results </U></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Revenue</I></B> &#151; Generated revenue of $88.0&nbsp;million, compared to revenues of $168.8&nbsp;million in fiscal
2019 and $16.1&nbsp;million in fiscal 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Net Loss</I></B> &#151; Recorded net loss of $84.6&nbsp;million, compared to net income of $68.0&nbsp;million in
fiscal 2019 and net loss of $54.5&nbsp;million in fiscal 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Net Loss Per Share</I></B> &#151; Recorded net loss per share (diluted) of $0.84, compared to net income per share
(diluted) of $0.69 in fiscal 2019 and net loss per share (diluted) of $0.65 in fiscal 2018; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Cash at end of fiscal 2020</I></B> &#151; Cash and investments of cash totaled $453&nbsp;million at September&nbsp;30,
2020; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Total Stockholder Return</I></B> &#151; 53% in fiscal 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Executive Compensation Highlights </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Based on our overall operating
environment and these results, the Compensation Committee took the following key actions and maintained key policies with respect to the compensation of our NEOs for 2020: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Base Salary</I></B> &#151; Approved base salary increases of up to 30% for our current NEOs. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Annual Incentive Compensation</I></B> &#151; Approved annual cash bonuses for 2020 of 100% of target annual incentive
compensation opportunities, including an annual cash bonus for our CEO in the amount of $820,000, equal to 100% of his target annual incentive compensation opportunity. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Equity Compensation</I></B> &#151; Granted our CEO a long-term incentive compensation opportunity in the form of a
performance-based restricted stock unit (&#147;<B>PRSU</B>&#148;) award. This CEO PRSU award will vest upon the achievement of nine equally weighted, <FONT STYLE="white-space:nowrap">pre-established</FONT> and rigorous performance milestones, each
with a grant date value of $6.3&nbsp;million. The Compensation Committee also granted our other NEOs long-term incentive compensation opportunities in the form of time-based restricted stock unit (&#147;<B>RSU</B>&#148;) awards that may be settled
for shares of our common stock with grant date values ranging from $5.4 to $15.9&nbsp;million. A minimum three-year vesting is required for time-based equity awards granted to our other executive officers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Clawback Policy</I></B> &#151; Maintained a clawback policy allowing the Company to recover compensation from any
executive officer should the Board of Directors determine that a material misstatement of the Company&#146;s financial statements was due to fraud, negligence, or intentional misconduct by any executive officer of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>Ownership Guidelines</I></B> &#151; Maintained the achievement of stock ownership guidelines of six times his annual
base salary for our CEO and twice the annual base salary for our CFO. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt"><B><I>&#147;Double Trigger&#148; Feature for Acceleration of Equity Awards</I></B> &#151; Maintained the agreements for
outstanding equity awards granted to our CEO pursuant to our 2004 Equity Incentive Plan and 2013 Incentive Plan to provide that, upon a change in control of the Company, the vesting of such awards will accelerate only in the event of a subsequent
involuntary termination of employment (a &#147;double-trigger&#148; arrangement). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>23</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Advisory Vote to Approve Named Executive Officer Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">At our 2020 Annual Meeting of Stockholders in March 2020, we conducted a <FONT STYLE="white-space:nowrap">non-binding</FONT> stockholder advisory vote to approve the
compensation of our NEOs (commonly known as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Say-on-Pay&#148;</FONT></FONT> vote). Our stockholders approved the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> proposal with approximately 98% of the votes cast in favor of the proposal. Based on the vote and feedback from our stockholders, we attribute the high
approval percentage primarily to the following factors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Continued practice of awarding 100% performance-based equity awards for our CEO which is preferred by stockholders and
unusual in our peer group; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Adjustments in our compensation practices including adoption of minimum vesting requirements; compensation recovery
(&#147;clawback&#148;) policy, double-trigger acceleration of equity awards for our CEO; and stock ownership guidelines for our CEO and CFO; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Achievement of aggressive corporate goals in 2019 and 2020; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Substantial increases in market capitalization and TSR from 2018 through 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Since 2018, we have continued our stockholder engagement program, reaching out to our top 20 institutional stockholders beneficially owning over 50% of our outstanding
common stock to solicit their views and concerns and reviewed the feedback and policies of ISS. Based on this review, as well as our commitment to good corporate governance, the Compensation Committee continued the above mentioned practices for the
executive compensation review in 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">At our 2019 annual meeting, we asked our stockholders to recommend the frequency of future stockholder advisory votes on the
compensation of the Company&#146;s NEOs. Stockholders recommended an annual <FONT STYLE="white-space:nowrap">non-binding</FONT> vote, and we are following that recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Additionally, at our 2020 annual meeting, in response to feedback from other stockholders we recommended and stockholders adopted changes to the Company&#146;s <FONT
STYLE="white-space:nowrap">by-laws</FONT> to adhere to a majority vote standard for director elections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We value the opinions of our stockholders and will continue
to consider the outcome of future <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> votes, as well as feedback received throughout the year, when making compensation decisions for our executive officers. The
Compensation Committee is committed to being responsive to stockholder feedback regarding our executive compensation program, policies, and practices, including concerns expressed through the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> vote. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Pay-for-Performance</FONT></FONT> Analysis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We believe our executive compensation program is reasonable, competitive and appropriately balances the goals of attracting, motivating, rewarding, and retaining our
executive officers with the goal of aligning their interests with those of our stockholders. To ensure this alignment and to motivate and reward individual initiative and effort, a significant portion of our executive officers&#146; target annual
total direct compensation opportunity is both performance-based and <FONT STYLE="white-space:nowrap">&#147;at-risk.&#148;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We emphasize performance-based
compensation that appropriately rewards our executive officers, including our NEOs, through two separate compensation elements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">First, we provide the opportunity to participate in our annual incentive compensation plan which provides cash payments if
they produce short-term financial, operational, and strategic results that meet or exceed the objectives set forth each year in our annual operating plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">In addition, we grant equity awards as long-term incentive compensation. For our CEO in fiscal 2020, these awards are to be
earned based entirely on the achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> corporate performance objectives which are both challenging and designed to drive our financial and operational performance and long-term growth,
and, in the case of our other executive officers, are either dependent on the future appreciation in value of our common stock or are subject to the risk of fluctuations in the value of our common stock and, therefore, are &#147;at risk.&#148;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>24</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The pay mix for our CEO for each of the last three fiscal years illustrates the ongoing emphasis on our performance-based compensation philosophy<B>:</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g76219g03z11.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We believe that, ultimately, the creation of sustainable
long-term stockholder value will depend on our ability to successfully bring to market the products we develop or partner with strategic collaborators to bring them to market. Consequently, the Compensation Committee strives to incent our executive
officers to create that value through a robust and attractive pipeline of drug candidates. As a result, our executive compensation program is designed to provide incentives that facilitate these efforts. Particularly for our CEO, the Compensation
Committee has awarded performance milestone-based equity awards directly linked to goals that promote the development of our pipeline and other related business and market-based objectives. The Compensation Committee closely tracks the progress
against these objectives to monitor our success over each product&#146;s development period and evaluates our executive officers primarily on that progress. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">To
ensure that we remain faithful to our compensation philosophy, the Compensation Committee regularly evaluates the relationship between the reported values of the equity awards granted to our executive officers, the amount of compensation realizable
(and, ultimately, realized) from such awards in subsequent years and our total stockholder return over this period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>25</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Executive Compensation Policies and Practices </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We endeavor to
maintain sound governance standards consistent with our executive compensation policies and practices. The Compensation Committee evaluates our executive compensation program on a regular basis to ensure that it is consistent with our short-term and
long-term goals given the dynamic nature of our business and the market in which we compete for executive talent. The following summarizes our executive compensation and related policies and practices: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8.5pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#0071ce"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#3fae2a"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" BGCOLOR="#0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>WHAT&nbsp;WE&nbsp;DO</B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#3fae2a">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#3fae2a"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#FFFFFF"><B>WHAT&nbsp;WE&nbsp;DON&#146;T&nbsp;DO</B></FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT
STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Maintain an Independent Compensation Committee.</I></B></FONT>&nbsp;The Compensation Committee consists solely of independent
directors.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT
STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Retain an Independent Compensation Advisor.</I></B></FONT>&nbsp;The Compensation Committee engaged its own compensation advisor to provide
information and analysis with its 2020 compensation review, and other advice on executive compensation independent of management. This consultant performed no consulting or other services for us in 2020.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Annual
Executive Compensation Review.</I></B></FONT>&nbsp;The Compensation Committee conducts an annual review and approval of our compensation strategy, including a review and determination of our compensation peer group used for comparative purposes and
a review of our compensation-related risk profile to ensure that our compensation programs do not encourage excessive or inappropriate risk-taking and that the level of risk that they do encourage is not reasonably likely to have a material adverse
effect on us.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT
STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Compensation <FONT STYLE="white-space:nowrap">At-Risk.</FONT></I></B></FONT> Our executive compensation program is designed so that a
significant portion of compensation is &#147;at risk&#148; based on our performance, as well as short-term cash and long-term equity incentives to align the interests of our executive officers and stockholders.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Stock
Ownership Policy.</I></B></FONT>&nbsp;We maintain a stock ownership policy that requires our CEO and CFO to maintain a minimum ownership level of our common stock.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Compensation
 Recovery (&#147;Clawback&#148;) Policy.</I></B></FONT>&nbsp;We have established a clawback policy allowing the Company to recover compensation should the Board determine that a material misstatement of the Company&#146;s financial statements was
due to fraud, negligence, or intentional misconduct by any executive officer of the Company.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Conduct an
Annual Stockholder Advisory Vote on NEO Compensation.</I></B></FONT>&nbsp;We conduct an annual stockholder advisory vote on the compensation of our NEOs.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>Use a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Pay-for-Performance</FONT></FONT> Philosophy.</I></B></FONT>&nbsp;The majority of our CEO&#146;s compensation is directly linked to corporate performance; we also structure target total
direct compensation opportunities with a significant long-term equity component, thereby making a substantial portion of the CEO&#146;s and each additional executive officer&#146;s target total direct compensation dependent upon our stock price
and/or total stockholder return.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT
STYLE="font-family:Times New Roman; " COLOR="#0071ce">&#10003;</FONT>&#8194;&#8202;<FONT COLOR="#0071ce"><B><I>&#147;Double Trigger&#148; Feature for Acceleration of CEO Equity Awards</I></B></FONT> &#151; The outstanding equity awards granted to
our CEO pursuant to our 2004 Equity Incentive Plan and 2013 Incentive Plan provide that, upon a change in control of the Company, the vesting of such awards will accelerate only in the event of a subsequent involuntary termination of employment (a
&#147;double-trigger&#148; arrangement).</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT
STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No Executive Retirement Plans.</I></B></FONT>&nbsp;We do not offer pension arrangements or retirement plans or arrangements to our
executive officers that are different from or in addition to those offered to our other employees.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No
Perquisites.</I></B></FONT>&nbsp;Currently, we do not provide perquisites or other personal benefits to our executive officers.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No Special
Welfare or Health Benefits.</I></B></FONT>&nbsp;Our executive officers participate in broad-based Company-sponsored health and welfare benefits programs on the same basis as our other full-time, salaried employees, except for a premium for life
insurance for our CEO.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT
STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No Post-Employment Tax Payment Reimbursement.</I></B></FONT>&nbsp;We do not provide any tax reimbursement payments (including <FONT
STYLE="white-space:nowrap">&#147;gross-ups&#148;)</FONT> on any severance or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> payments or benefits.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No Hedging
and Limit on Pledging of Our Equity Securities.</I></B></FONT>&nbsp;We prohibit our executive officers and the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board from hedging our equity securities. Our board members and
executive officers may pledge up to 50% of owned and vested shares with the approval of the Board.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No
Dividends or Dividend Equivalents Payable on Unvested Equity Awards.</I></B></FONT>&nbsp;We do not pay dividends or dividend equivalents on unvested RSU awards or PRSU awards.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:8.5pt; font-family:ARIAL"><FONT STYLE="font-family:Times New Roman; " COLOR="#3fae2a">&#10008;</FONT>&#8194;&#8202;<FONT COLOR="#3fae2a"><B><I>No Stock
Option <FONT STYLE="white-space:nowrap">Re-pricing.</FONT></I></B></FONT>&nbsp;Our employee stock plan does not permit options to purchase shares of our common stock to be repriced to a lower exercise or strike price without the approval of our
stockholders.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>26</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_21"></A>Executive Compensation Philosophy </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our executive compensation philosophy reflects our two fundamental objectives: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">to attract, motivate, and retain a highly skilled team of executives; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">to align our executive officers&#146; interests with those of our stockholders by rewarding short-term and long-term
performance and aligning compensation to increases in stockholder value. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We believe that the compensation of our executive officers should be
directly linked to the achievement of specific objectives that are expected to increase stockholder value. In furtherance of this goal, the Compensation Committee has established the following guidelines as a foundation for compensation decisions:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">provide a competitive total compensation package that enables us to attract, retain, and motivate highly-qualified
executives with the skills and experience required for the achievement of business goals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">promote the achievement of key strategic and financial performance measures by linking short-term and long-term compensation
to the achievement of measurable goals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">reward significant achievements outside of <FONT STYLE="white-space:nowrap">pre-established</FONT> goals;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">recognize that pharmaceutical research, development, and commercialization require sustained and focused effort over many
years, and involve a high degree of risk and therefore balance incentives for short-term and long-term compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">employ outside compensation expertise and market data from industry peers to help assure that our compensation policies and
practices are consistent with industry practice and meet our goals for our compensation program; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">consider our cash resources and cost of capital to balance cash and equity compensation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">align our executive officers&#146; incentives with the creation of stockholder value. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_22"></A>Executive Compensation Program Design </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our practice is to combine a mixture of compensation elements that balance achievement of our short-term goals with our longer-term performance. Currently, our executive
compensation program consists of three principal elements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">base salary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">an annual incentive compensation opportunity; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">long-term incentive compensation in the form of equity awards. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We believe that cash compensation in the form of base salary and an annual incentive compensation opportunity provides our executive officers with short-term rewards for
success in operations, and that long-term incentive compensation in the form of RSU and PRSU awards that may be settled for shares of our common stock, and options to purchase shares of our common stock, align the objectives of our executive
officers with those of our stockholders with respect to long-term performance and success. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee takes into consideration, among other things,
our financial and working capital condition when approving performance objectives and making compensation decisions for our executive officers. Since we seek to preserve cash and do not have marketed products, overall target total direct
compensation opportunities are weighted more heavily toward long-term incentive compensation in the form of equity awards. Thus, a significant portion of each executive officer&#146;s target total direct compensation is &#147;at risk,&#148; and
dependent on the increase in the value of our common stock. The Compensation Committee periodically reassesses the appropriate weighting of cash and equity compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In the case of long-term incentive compensation, typically the Compensation Committee designs these awards to vest, or be earned, over a multi-year period, meaning that
long-term value creation, contrasted with short-term gain, presents the best opportunity for our executive officers to benefit from their awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We do not maintain
a specific policy on the percentage allocation between short-term and long-term incentive compensation elements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_23"></A>Governance of Executive Compensation Program </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Role of the Compensation Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee
discharges many of the responsibilities of our Board relating to the compensation of our executive officers, including our NEOs, and the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board. The Compensation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>27</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Committee has overall responsibility for overseeing our compensation and benefits philosophy and policies generally, overseeing and evaluating the compensation plans,
policies, and practices applicable to our CEO and our other executive officers, and ensuring that the target total direct compensation opportunities of our executive officers, including our NEOs, are consistent with our compensation philosophy,
policies, and objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The members of the Compensation Committee are appointed by our Board, and each member is an independent director (as
&#147;independence&#148; is currently defined in Rule 5605(a)(2) of the Nasdaq listing standards). Currently, the members of the Compensation Committee are Michael S. Perry (Chairman), Marianne De Backer, Mauro Ferrari, Adeoye Olukoton and William
Waddill. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee reviews our executive compensation program annually on a calendar year basis, generally in December. The Compensation Committee
draws on a number of resources to assist in the evaluation of the various components of our executive compensation program including, but not limited to, input from our CEO, the advice of an external compensation consultant (as identified below)
retained by the Compensation Committee, information provided in the public filings of industry peers and industry data compiled yearly by Radford in its Global Life Sciences Survey, which represents a nationally-based assessment of executive
compensation widely used within the pharmaceutical and biotechnology industry sectors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee relies upon the judgment of its members in making
compensation decisions. In addition, the Compensation Committee incorporates judgment in the assessment process to respond to and adjust for the evolving business environment. The members of the Compensation Committee have extensive experience in
executive management, as well as compensation practices and policies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Compensation-Setting Process </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee develops recommendations for the target total direct compensation opportunities for our executive officers, including our NEOs. The
Compensation Committee does not use a single method or measure in making its compensation decisions, nor does it position compensation levels based upon a specific or target level relative to a peer group or other companies. Nonetheless, the pay
practices at other companies are an important factor that the Compensation Committee considers in assessing the reasonableness of compensation and ensuring that our compensation practices are competitive in the marketplace. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Generally, the Compensation Committee evaluates the compensation of our executive officers relative to the median of the competitive market. However, as discussed
hereafter, various other factors are taken into consideration in determining our executive officers&#146; compensation and the Compensation Committee does not target compensation at any specific level relative to the competitive market. When
reviewing our current executive compensation arrangements and approving each compensation element and the target total direct compensation opportunity for our executive officers, the Compensation Committee considers the following factors: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Our performance against the financial and operational objectives established by the Compensation Committee and our Board;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Each individual executive officer&#146;s skills, experience, and qualifications relative to other similarly-situated
executives at the companies in our compensation peer group; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The scope of each executive officer&#146;s role compared to other similarly-situated executives at the companies in our
compensation peer group; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The performance of each individual executive officer, based on a subjective assessment of his or her contributions to our
overall performance, ability to lead his or her business unit or function and work as part of a team, all of which reflect our core values; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The compensation practices of our compensation peer group and the positioning of each executive officer&#146;s compensation
in a ranking of peer company compensation levels; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">The recommendations provided by our CEO with respect to the compensation of our other executive officers.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">These factors provide the framework for compensation decision-making and final decisions regarding the compensation opportunity for each executive
officer. No single factor is determinative in setting pay levels, nor was the impact of any factor on the determination of pay levels quantifiable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>28</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Role of Chief Executive Officer </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In discharging its
responsibilities, the Compensation Committee works with members of our management, including our CEO. Our management assists the Compensation Committee by providing information on corporate and individual performance, market compensation data, and
management&#146;s perspective on compensation matters. The Compensation Committee solicits and reviews our CEO&#146;s recommendations with respect to the compensation levels for individual executive officers other than himself based on the
performance evaluation of each executive officer&#146;s manager and his own evaluation of the executive officer&#146;s performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee
reviews and discusses these recommendations and proposals with our CEO and considers them as one factor in formulating the recommendations for the compensation for our executive officers, including our other NEOs. Our CEO recuses himself from all
discussions and recommendations regarding his own compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Role of Compensation Consultant </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee engages an external compensation consultant to assist it by providing information, analysis, and other advice relating to our executive
compensation program and the decisions resulting from its annual executive compensation review. The Compensation Committee has the final authority to engage and terminate the engagement of any compensation consultant that it retains. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For the period from October 2018 through the present, the Compensation Committee engaged Compensia, Inc., a national compensation consulting firm, as its external
compensation consultant (&#147;<B>Compensia</B>&#148;). Compensia assisted the Compensation Committee in its review of executive and <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation practices for 2020, including the
competitiveness of compensation levels, executive compensation design, comparisons with our industry peers, and other technical considerations. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Review and update of our compensation peer group; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Review and analysis of the compensation arrangements for our executive officers, including our NEOs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Review and analysis of the compensation arrangements for the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of
our Board of Directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Review and update of the Compensation Discussion and Analysis section of our proxy statement for our 2021 Annual Meeting of
Stockholders; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Support on other <I>ad hoc</I> matters. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The terms of Compensia&#146;s engagement include reporting directly to the Compensation Committee and to the Compensation Committee chair. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In 2020, Compensia did not provide any other services to us. The Compensation Committee has evaluated Compensia&#146;s independence pursuant to the listing standards of
the Nasdaq and the relevant SEC rules and has determined that no conflict of interest has arisen as a result of the work performed by Compensia. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Competitive Positioning </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For each of the past seven years, the
Compensation Committee has directed its external compensation consultant to conduct a comparative study and report on compensation levels and practices relative to industry peers, including a competitive assessment of our executive compensation
program as compared to the market data for base salaries, target total cash compensation, long-term incentive compensation, and target total direct compensation. Typically, the findings of this study are presented to the Compensation Committee by
the compensation consultant in conjunction with the Compensation Committee&#146;s annual review of our executive compensation program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Because the biotechnology
sector is dynamic, the comparator group used by the Compensation Committee to assess the competitive positioning of the compensation of our executive officers is updated annually to ensure that peer companies continue to meet the established
criteria. For purposes of its review of our executive compensation program in fiscal 2020, the Compensation Committee directed Compensia to update its compensation peer group reflecting the competitive market for executive talent based on the
following criteria: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Publicly-held, <FONT STYLE="white-space:nowrap">pre-commercial</FONT> U.S. biotechnology companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Companies with market capitalizations between 0.5x to 2.0x our market capitalization at the time of the peer selection; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Companies with between 50 to 500 employees. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>29</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The compensation peer group was selected in such a manner that our market capitalization was very near the median for all peer companies. Consideration was also given to
the frequency or infrequency with which a company was identified as a peer with other peer companies. The increase in the Company&#146;s market capitalization indicated significant redesign of the peer group for 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For 2020, the compensation peer group consisted of the following companies: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="60%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Acceleron Pharma</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Global Blood Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Allakos</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Iovance Biotherapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Allogene Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Mirata Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Arena Pharmaceuticals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">MyoKardia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Atara Biotherapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Sangamo Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Audentes Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Tricida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Blueprint Medicines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Voyager Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Cytokinetics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Xencor</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">Dicerna Pharmaceuticals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Zogenix</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The compensation study prepared by Compensia and presented in December 2019 provided an assessment of our compensation practices as
compared to industry peers. Compensation levels for our executive officers, in the aggregate, were determined to be within the range of compensation provided to similarly placed executives and consistent with our compensation philosophy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_24"></A>Individual Compensation Elements </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In 2020, the principal elements of our executive compensation program were as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">base salary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">an annual incentive compensation opportunity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">long-term incentive compensation in the form of equity awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">welfare and health benefits; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">post-employment compensation arrangements. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Base Salary </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Base salary represents the fixed portion of the
compensation of our executive officers, including our NEOs, and is an important element of compensation intended to attract and retain highly-talented individuals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The initial base salaries for our executive officers were negotiated on an individual basis at the time of hire. Thereafter, using the competitive market data provided
by its compensation consultant, the Compensation Committee reviews and determines adjustments to the base salaries for each of our executive officers, including our NEOs, as part of its annual executive compensation review. In addition, the base
salaries of our executive officers may be adjusted by the Compensation Committee in the event of a promotion or significant change in responsibilities. Generally, the Compensation Committee sets base salaries with reference to the competitive range
of the market median of our compensation peer group and applicable executive compensation survey data, as well as its assessment of the factors described in &#147;Governance of Executive Compensation Program &#151; Compensation-Setting Process&#148;
above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>30</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The base salaries of our NEOs for 2019 and 2020 were as follows: The increase in base salary for our CEO, our CFO, and our former COO reflect the increased complexity of
the Company&#146;s business and their individual roles. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:23pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:23pt"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:23pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:23pt"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:24pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:24pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Named&nbsp;Executive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Officer</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020<BR>Base&nbsp;Salary</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">2019<BR>Base&nbsp;Salary</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Percentage&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Adjustment&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Christopher Anzalone</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">President&nbsp;&amp; CEO</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 820,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 682,500<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 20<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Kenneth Myszkowski</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Chief Financial Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 475,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 430,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 10<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Javier San Martin (1)</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Chief Medical Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 450,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>James Hassard (1)</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Chief Commercial Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 425,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Curt Bradshaw (2)</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Former Chief Scientific Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 425,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Bruce Given (3)</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Former Chief Operating Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 650,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 500,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 30<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;San Martin and Mr.&nbsp;Hassard&#146;s employment with the company began in November 2019 and January 2020,
respectively. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Bradshaw&#146;s employment with the company began in November 2019 and terminated in November 2020.
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s employment with the Company terminated in May 2020 upon his retirement. Dr.&nbsp;Given continues to
serve as a consultant to the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The actual base salaries paid to our NEOs in fiscal 2020 are set forth in the &#147;Fiscal 2020 Summary
Compensation Table&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Annual Incentive Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We provide our executive officers, including our NEOs, with the opportunity to earn performance-based annual incentive awards, payable in cash, which are designed to
reward them for our overall corporate performance as well as their individual performance. Generally, our executive officers are evaluated each year for eligibility to receive an annual incentive compensation opportunity. Through a collaborative
planning process involving our Board of Directors and management, corporate performance objectives are established at the beginning of each year and evaluated regularly by our Board for their continued relevance to our status. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>Target Annual Cash Bonus Opportunities </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For purposes of the 2020
performance-based incentive awards, each of our NEOs was assigned a target annual incentive award opportunity based upon a percentage of his or her base salary. The target annual incentive award opportunities for our executive officers, including
our NEOs, were recommended by our CEO (except with respect to his own target annual incentive award opportunity) based on each executive officer&#146;s accountability, scope of responsibilities, and potential impact on our performance, and approved
by the Compensation Committee. The determination of target annual incentive award opportunities was based on the factors described in &#147;Governance of Executive Compensation Program &#151; Compensation-Setting Process&#148; above. Based on higher
levels of control and accountability for our overall performance, a higher percentage of each executive officer&#146;s total target cash compensation was dependent on his or her performance-based annual incentive awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The target annual incentive award opportunities for our NEOs were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD style="width:37pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:37pt"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD style="width:37pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:37pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Named&nbsp;Executive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Officer</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">2020&nbsp;Target&nbsp;Annual<BR>Incentive&nbsp;Award<BR>Opportunity&nbsp;(as&nbsp;a<BR>percentage&nbsp;
of&nbsp;base<BR>salary)</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">2019&nbsp;Target&nbsp;Annual<BR>Incentive&nbsp;Award<BR>Opportunity&nbsp;(as&nbsp;a<BR>percentage&nbsp;of&nbsp;base<BR>salary)</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Anzalone</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 100<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 100<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Myszkowski</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 45<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 45<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr.&nbsp;San Martin (1)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Hassard (1)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Bradshaw (2)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> N/A<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Given (3)</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 70<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>31</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;San Martin and Mr.&nbsp;Hassard&#146;s employment with the company began in November 2019 and January 2020,
respectively. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Bradshaw&#146;s employment with the company began in November 2019 and terminated in November 2020.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s employment with the Company terminated in May 2020 upon his retirement. Dr.&nbsp;Given continues to
serve as a consultant to the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>Performance Objectives </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In determining the amount of the annual incentive award for each of our executive officers, including each of our NEOs, the Compensation Committee evaluated the corporate
performance objectives that had been established at the beginning of the calendar year (as set forth below) as well as other corporate and individual achievements and performance throughout the year. These performance objectives addressed milestones
for our lead products, research and development milestones for our drug pipeline and business development objectives. In December 2020, the Compensation Committee determined that we had largely achieved or exceeded our primary business objectives
set for calendar 2020, as described below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Goal</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-right:2pt"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Achievement Highlights</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B>Corporate
Development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Weight: 23%</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Meet certain goals related to capital formation, market capitalization; board interface with scientific leaders</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Met, including some stretch goals</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Ended fiscal year with $453M cash.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Completed employee engagement survey and related activities.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B>New Business
Development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Weight: 17%</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Meet certain goals with regard to new pharma collaborations</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Met and exceeded</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Entered a collaboration and licensing agreement with Takeda relating to <FONT
STYLE="white-space:nowrap">ARO-AAT.</FONT></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B>Manufacturing</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weight: 10%</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Meet certain requirements pursuant to manufacturing
capabilities</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Met</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Manufactured significant GMP materials <FONT STYLE="white-space:nowrap">in-house.</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Manufactured GLP material <FONT STYLE="white-space:nowrap">in-house</FONT> using novel manufacturing process.</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B><FONT STYLE="white-space:nowrap">Pre-Clinical</FONT>
Development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Weight: 14%</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Meet certain goals with regard to progress on the Company&#146;s <FONT STYLE="white-space:nowrap">pre-clinical</FONT> programs</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Not Met</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Some goals not met due to worldwide shortage of <FONT STYLE="white-space:nowrap">non-human</FONT>
primates relating to <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic.</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B>Clinical
Development&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Weight: 28%</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Met, except certain stretch goals due to
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Completed enrollment for <FONT
STYLE="white-space:nowrap">ARO-ANG3</FONT> and <FONT STYLE="white-space:nowrap">ARO-APOC3</FONT> Phase 1/2 trials</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Completed enrollment of <FONT STYLE="white-space:nowrap">ARO-AAT</FONT> Phase 2 open label study</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Presented AAT open label study data.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Completed enrollment of healthy volunteers in <FONT STYLE="white-space:nowrap">ARO-HSD</FONT>
Phase 1/2 trial</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B>Next
Generation&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>Weight: 8%</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Meet certain goals for Company&#146;s new capabilities</I></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Met and exceeded</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Achieved significant target knock down in new tissue type.</P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>32</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>Annual Incentive Award Payments </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The actual annual incentive award payments
earned by our currently employed NEOs was 100% of their target annual incentive award opportunities. Except for the award for our CEO, these awards were recommended by our CEO and approved by the Compensation Committee based on the overall
achievement of the Company&#146;s goals, their contributions to the goals, and the overall performance of each officer during the year. The following table sets forth the target annual incentive award opportunities, the actual award payment as a
percentage of each NEO&#146;s base salary, and the actual award payment made in cash to each of our NEOs based on their performance in 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD style="width:36pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:36pt"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD style="width:36pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:36pt"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD style="width:32pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:32pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Named&nbsp;Executive</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Officer</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target&nbsp;Annual<BR>Incentive&nbsp;Award<BR>Opportunity&nbsp;(as&nbsp;a<BR>percentage&nbsp;of&nbsp;
base<BR>salary)</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Actual&nbsp;Annual<BR>Incentive&nbsp;Award<BR>(as&nbsp;a&nbsp;percentage&nbsp;of<BR>base&nbsp;
salary)</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Actual&nbsp;Annual&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Incentive&nbsp;Award&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Anzalone</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 100<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 100<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 820,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Mr.&nbsp;Myszkowski</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 45<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 45<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 213,750<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;San Martin</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 180,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Mr.&nbsp;Hassard</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 170,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Bradshaw (1)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 40<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 0<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 0<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Given
(2)</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 70<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 0<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> %<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 0<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Bradshaw&#146;s employment with the company terminated in November 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s employment with the Company terminated in May 2020 upon his retirement. Dr.&nbsp;Given continues to
serve as a consultant to the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The annual incentive award payments made to our NEOs for fiscal 2020 are set forth in the &#147;Fiscal 2020
Summary Compensation Table&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Long-Term Incentive Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We view long-term incentive compensation in the form of equity awards as a critical element of our executive compensation program. The realizable value of these equity
awards over time bears a direct relationship to our stock price, and, therefore, these awards are an incentive for our executive officers, including our NEOs, to create value for our stockholders. Equity awards also help us retain qualified
executive officers in a competitive market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Long-term incentive compensation opportunities in the form of equity awards are granted to our executive officers by the
Compensation Committee. The amount and forms of such equity awards are determined by the Compensation Committee after considering the factors described in &#147;Governance of Executive Compensation Program &#151; Compensation-Setting Process&#148;
above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>2020 Long-Term Incentive Awards </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>Performance-Based RSU Award
for Chief Executive Officer </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Annual equity awards granted to our executive officers are solely in the form of restricted stock unit (&#147;RSU&#148;) awards that
may be settled for shares of our common stock. In the case of our CEO, the award is entirely performance-based (&#147;PRSU&#148;). On January&nbsp;1, 2020, Dr.&nbsp;Anzalone was granted a performance-based RSU (&#147;PRSU&#148;) of 900,000 shares to
be vested in nine equal installments on the achievement of the following milestones: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Initiate 4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> study that could be pivotal (either partnered or
wholly-owned) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">File first NDA (either partnered or wholly-owned) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Enter a material partnership on a particular tissue target as approved by the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Achieve market capitalization of $8&nbsp;billion and hold for 6 months. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">File a CTA for a candidate targeting a tissue other than hepatocyte, solid tumor, pulmonary epithelial cell, or skeletal
muscle. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">File a second CTA in a single extra-hepatic tissue. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>33</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Complete Sequoia enrollment and maintain leadership in the field </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Achieve largest strategically structured active clinical pipeline in the RNAi field. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT COLOR="#0071ce">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:9pt">Build a commercial team and launch plan for first commercial drug. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The milestones must be achieved by January&nbsp;1, 2025 or the grants will expire. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>Results from PRSU Awards Previously Granted </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In fiscal year 2020, the
Compensation Committee certified achievement of the performance milestones and the vesting of the following PRSUs. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Performance&nbsp;Goal</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Achievement</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">No.&nbsp;of&nbsp;Shares</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Certified&nbsp;as&nbsp;Vested</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">File a CTA/IND for a lung/muscle target</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Granted 01/01/2019</I></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">Certified in June 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">200,000 shares pursuant to a PRSU award</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Achieve market capitalization of $2&nbsp;billion and hold for
six months</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Granted 01/01/2019</I></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Certified in December 2019</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">200,000 shares pursuant to a PRSU award</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Initiate a study that could be pivotal or meet criteria that
big pharma would consider to be <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Granted 01/01/2018</I></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">Certified in December 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">166,666 shares pursuant to a PRSU award</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">Execute a business
development transaction for a target outside hepatocytes</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><I>Granted
1/1/2018</I></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The compensation committee deemed this
performance goal to be met on 12/22/2019 as the intent of the performance goal was substantially met.</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL">166,667 shares pursuant to a PRSU
award</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><U>Equity Awards for Other Named Executive Officers </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee approved the following aggregate equity awards for our NEOs for 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD style="width:40pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:40pt"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD style="width:42pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:42pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Named&nbsp;Executive</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Officer</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="padding-bottom:1pt ;BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Restricted&nbsp;Stock&nbsp;Unit<BR>Awards<BR>(number&nbsp;of&nbsp;shares)</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="padding-bottom:1pt ;BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Restricted&nbsp;Stock&nbsp;Unit&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Awards<BR>($)</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Myszkowski</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 85,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 5,391,550<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr.&nbsp;San Martin</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 150,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 7,225,500<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Mr, Hassard</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 125,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 7,430,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr. Bradshaw</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 125,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 6,021,250<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Dr.&nbsp;Given</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 250,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> $<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 15,857,500<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The awards vest over 4 years in 4 equal installments. Dr.&nbsp;Bradshaw&#146;s award was terminated upon his termination in November
2020. Dr.&nbsp;Given&#146;s awards continues to vest as he continues to provide service to the company as a consultant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The equity awards granted to our NEOs in
fiscal 2020 are set forth in the &#147;Fiscal 2020 Summary Compensation Table&#148; and the &#147;Fiscal 2020 Grants of Plan-Based Awards Table&#148; below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Welfare and Health Benefits </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our executive officers, including
our NEOs, are eligible to participate in all of our employee benefit plans, including medical, dental, vision, life, and disability insurance, in each case on the same basis as our other employees, subject to applicable law. In addition, we provide
additional life insurance for our CEO for the benefit of his heirs. We also provide vacation and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>34</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">paid holidays to all our employees, including our executive officers, all of which we believe to be comparable to those provided at peer companies. These benefit programs
are designed to enable us to attract and retain our workforce in a competitive marketplace. Our health, welfare, and vacation benefits are designed to ensure that we have a productive and focused workforce through reliable and competitive health and
other benefits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our retirement savings plan (&#147;401(k) plan&#148;) is a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement savings plan, pursuant
to which qualified employees, including our NEOs, are able to contribute certain amounts of their annual compensation, subject to limits prescribed by the Internal Revenue Service. Historically, we have made matching contributions of 100% of the
first 3% of base salary and of 50% of the next 2% of base salary contributed to the plan. The value of these benefits for each of our NEOs is reflected in the &#147;All Other Compensation&#148; column of the &#147;Summary Compensation Table&#148;
below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Perquisites and Other Personal Benefits </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Currently, we do not view perquisites or other personal benefits as a significant component of our executive compensation program. Accordingly, we do not provide
significant perquisites or other personal benefits to our executive officers, including our NEOs, except as generally made available to our employees, or in situations where we believe it is appropriate to assist an individual in the performance of
his or her duties, to make our executive officers more efficient and effective and for recruitment and retention purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In the future, we may provide perquisites
or other personal benefits in limited circumstances, such as those described in the preceding paragraph. All future practices with respect to perquisites or other personal benefits will be approved and subject to periodic review by the Compensation
Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_25"></A>Employment Arrangements </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We have entered into a written employment agreement with our CEO and have written employment offer letters with our other executive officers<B>. </B>In filling each of
our executive positions, we recognized the need to develop competitive compensation packages to attract qualified candidates in a dynamic labor market. At the same time, in formulating these compensation packages, we were sensitive to the need to
integrate new executive officers into the executive compensation structure that we were seeking to develop, balancing both competitive and internal equity considerations. Each of these arrangements provides for &#147;at will&#148; employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For detailed descriptions of the employment arrangements we maintained with our NEOs for 2020, see &#147;Termination Benefits &#151; Potential Payments Upon Termination
or Change in Control&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_26"></A>Post-Employment Compensation Arrangements </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We have entered into an employment agreement with our CEO, and we also have agreements with our CFO and General Counsel that provide for certain payments and benefits in
the event of certain involuntary terminations of employment. We believe that having in place reasonable and competitive post-employment compensation arrangements are essential to attracting and retaining highly-qualified executive officers. These
agreements are designed to provide reasonable compensation to executive officers who leave our employ under certain circumstances to facilitate their transition to new employment. Further, in some instances we seek to mitigate any potential employer
liability and avoid future disputes or litigation by requiring a departing executive officer to sign a separation and release agreement acceptable to us as a condition to receiving post-employment compensation payments or benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Compensation Committee does not consider the specific amounts payable under these agreements when establishing annual compensation. We do believe, however, that
these arrangements are necessary to offer compensation packages that are competitive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In addition, our 2013 Incentive Plan provides for the acceleration of vesting
of outstanding and unvested equity awards in the event of a change in control of the Company, as defined in the plan, except as otherwise determined by our Board. The Company has amended the agreements for outstanding equity awards granted to our
CEO pursuant to our 2004 Equity Incentive Plan and 2013 Incentive Plan to provide that, upon a change in control of the Company, the vesting of such awards will accelerate only in the event of a subsequent involuntary termination of employment (a
&#147;double-trigger&#148; arrangement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For detailed descriptions of the post-employment compensation arrangements we maintained with our NEOs for 2020, as well as
an estimate of the potential payments and benefits payable under these arrangements, see &#147;Termination Benefits &#151; Potential Payments Upon Termination or Change in Control&#148; below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>35</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_27"></A>Other Compensation Policies and Practices </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Equity Awards Grant Policy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We do not have any program, plan,
or obligation that requires us to grant equity awards on specified dates, although historically we have granted such awards to our existing executive officers and employees at least annually and to newly-hired employees on the commencement of their
employment. We do not have any program, plan, or practice to grant options to purchase shares of our common stock to our executive officers in coordination with the release of material nonpublic information. Equity awards may occasionally be granted
following a significant change in job responsibilities or to meet other special retention or performance objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Authority to grant equity awards to our
employees rests with the Compensation Committee, although the Compensation Committee has delegated authority to our CEO to grant equity awards to <FONT STYLE="white-space:nowrap">non-executive</FONT> employees within prescribed limits set by the
Compensation Committee. With respect to our executive officers, except for our CEO, recommendations for equity awards are made by our CEO and reviewed and approved by the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Under the terms of our 2013 Incentive Plan, pursuant to which new equity awards are granted, the exercise price of any option to purchase shares of our common stock
awarded under the plan must be equal to at least 100% of the fair market value of our common stock (which is determined based on the closing sales price of our common stock on the Nasdaq Global Market) on the date of grant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Stock Ownership Policy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We maintain a stock ownership policy
for our CEO and CFO to further align their respective interests with the interests of our stockholders, and to further promote our commitment to sound corporate governance. This policy requires our CEO to own a minimum number of shares of our common
stock equal to a value of six times his annualized base salary and our CFO to own a minimum number of shares of our common stock equal to a value of twice their annualized base salary. Each of these executive officers has achieved the required
ownership. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Compensation Recovery (&#147;Clawback&#148;) Policy </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In December 2017, our Board adopted a compensation recovery (&#147;clawback&#148;) policy as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:9pt; font-family:ARIAL">&#147;If Arrowhead Pharmaceuticals, Inc. (the &#147;Company&#148;) is required to materially restate any of its financial statements, the Board of
Directors (the &#147;Board&#148;) shall assess the degree to which any fraud, negligence, or intentional misconduct by any executive officer of the Company was responsible for such restatement. If the Board determines that any executive officer was
responsible for causing such restatement, the Board shall, in addition to any other lawful remedies the Board or the Company may take, seek recovery of all or a portion of the incentive compensation awarded to the executive officer for the
performance period covered by the restated financial statement, provided that such recovery shall not extend to payments made more than three years prior to the date the financial record was restated. In addition, the Board may, in its absolute
discretion, revoke any of the responsible executive officer&#146;s unpaid or unvested incentive compensation outstanding as of the date of the Board&#146;s determination of the executive officer&#146;s responsibility for the financial
restatement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In addition, our 2013 Incentive Plan (and, if approved, our 2021 Plan) provides for the recovery of awards made under the plan in accordance with
any applicable compensation recovery or recoupment policy, including as required by law, regulation, or national securities exchange rule. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Policy Prohibiting Hedging and Limiting Pledging </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our Insider
Trading Policy prohibits our employees, our executive officers, and the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board from short-term trading, options trading, trading on margin, pledging our common stock as collateral,
and all hedging transactions with respect to our securities, except for pledging up to 50% owned and vested stock as collateral for a loan subject to the approval of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I><A NAME="toc76219_28"></A>Tax and Accounting Considerations </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Deductibility of Executive Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Prior to the US Tax
Cuts and Jobs Act enacted in December of 2017 (the &#147;<B>US Tax Act</B>&#148;), compensation that satisfied conditions set forth under Section&nbsp;162(m) of the Internal Revenue Code to qualify as &#147;performance-based compensation&#148; was
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>36</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">not subject to a $1&nbsp;million limit on deductibility, and the limit did not apply to compensation paid to the Chief Financial Officer. The US Tax Act eliminates the
performance-based compensation exception and applies the limit to the Chief Financial Officer and certain former executive officers. However, it provides a transition rule with respect to remuneration provided under a written contract which was in
effect on November&nbsp;2, 2017 and which was not materially modified after that date. With elimination of the exemption for performance-based compensation, we expect that we will be unable to deduct all compensation in excess of $1&nbsp;million
paid to our Chief Executive Officer, Chief Financial Officer and our other NEOs covered by the new tax law, other than previously granted awards that comply with the transition rules. We monitor the application of Section&nbsp;162(m) and the
associated Treasury regulations on an ongoing basis and the advisability of qualifying executive compensation for deductibility. Notwithstanding the repeal of the exemption for &#147;performance-based compensation,&#148; the Compensation Committee
intends to maintain its commitment to structuring the Company&#146;s executive compensation programs in a manner designed to align pay with performance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:ARIAL"><I>Accounting for Stock-Based Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We follow the
Financial Accounting Standard Board&#146;s Accounting Standards Codification Topic 718&nbsp;(&#147;FASB ASC Topic 718&#148;) for our stock-based compensation awards. FASB ASC Topic 718 requires us to measure the compensation expense for all
share-based payment awards made to our employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our Board, including options to purchase shares of our common stock and other stock awards, based on the grant date &#147;fair
value&#148; of these awards. This calculation is performed for accounting purposes and reported in the executive compensation tables required by the federal securities laws, even though the recipient of the awards may never realize any value from
their awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>37</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_29"></A>Compensation Risk Assessment </B></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In reviewing our various compensation programs, the Compensation Committee considers how our compensation policies and practices may affect our risk profile and whether
such policies and practices may encourage undue risk-taking by our employees. More specifically, the Compensation Committee considers the general design philosophy of our policies and practices for our employees whose conduct would be most affected
by incentives established pursuant to these compensation policies. In considering these issues, the Compensation Committee concluded that the use of a performance-based annual incentive compensation plan and long-term incentive compensation
opportunities in the form of equity awards did not appear to create undue risks for us or encourage excessive risk-taking behavior on the part of our NEOs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">With
respect to the annual incentive awards for our executive officers, the amount of an individual&#146;s award depends principally on overall Company performance, as determined by the Compensation Committee, which reduces the ability and incentive for
an individual to take undue risks at the expense of our performance in an effort to increase the amount of his or her annual incentive award. Our performance objectives are reviewed regularly by the Compensation Committee and our Board and are
considered to be generally of the nature that promote the steady progression of our development programs and would not encourage or reward excessive risk-taking. In addition, our Board has the ability to intervene in instances where actions by our
executive officers <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> Company performance objective attainment would be considered unduly risky to prevent or penalize such actions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I>Compensation Committee Report </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The
Compensation Committee of the Company has reviewed and discussed with management the Compensation Discussion and Analysis required by Item&nbsp;402(b) of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K.</FONT> Based on this review and
discussion, the Compensation Committee recommended to the Board that the foregoing Compensation Discussion and Analysis be included in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Submitted by the Compensation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Committee of the Board of Directors </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Michael S. Perry, Chairman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Marianne De Backer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Mauro Ferrari </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Adeoye Olukotun </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">William Waddill </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>38</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B><I>Compensation Committee Interlocks and Insider Participation </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">During 2020, Dr.&nbsp;Perry, Dr.&nbsp;De Backer, Dr.&nbsp;Ferrari, and Mr.&nbsp;Waddill served on the Compensation Committee. During fiscal year 2020 and through December
2020, there were no compensation committee interlocks between the Company and other entities involving the Company&#146;s executive officers and directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT
 COLOR="#4c4c4c"><B><A NAME="toc76219_30"></A>Summary Compensation Table </B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table summarizes compensation earned for services rendered during fiscal 2020, 2019, and 2018 by our Chief Executive Officer, our Chief Financial Officer,
our Chief Medical Officer, our Chief Commercial Officer, our former Chief Scientific Officer, and our former Chief Operating Officer, collectively our &#147;Named Executive Officers&#148;: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:8pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:8pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:12pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:12pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:12pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:12pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:21pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:21pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:21pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:21pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:34pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:34pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:34pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:34pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:9pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:9pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name and</FONT></B></FONT><br><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Principal Position</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Year</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Salary<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Bonus<BR>(S)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Stock<BR>Awards&nbsp;(1)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Awards&nbsp;(1)<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff"><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive&nbsp;Plan<BR>Compensation&nbsp;(2)</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">All&nbsp;Other<BR>Compensation&nbsp;(3)</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total</FONT></B></FONT></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Christopher
Anzalone</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">President and Chief Executive Officer</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">785,625</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">12,686,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">(4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">820,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,892</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">14,294,517&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2019<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 674,375<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> (5)<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,540,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,889<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2,216,264&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2018<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 643,012<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> (6)<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 975,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,889<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,619,901&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Kenneth
Myszkowski</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">Chief Financial Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">463,750</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,391,550</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">213,750</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">12,802</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,081,852&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2019<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 422,500<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,055,700<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 251,550<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 11,799<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 1,741,549&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2018<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 384,841<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 276,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 180,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 12,177<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 853,018&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Javier San Martin
(7)</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">Chief Medical Officer</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">380,769</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7,225,500</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">180,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">12,802</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7,899,071&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2019<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2018<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>James Hassard
(8)</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">Chief Commercial Officer</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">302,404</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7,430,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">170,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,892</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7,918,296&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2019<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2018<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Curt Bradshaw
(9)</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">Former Chief Scientific</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">338,462</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,021,250</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">13,494</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,373,206&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2019<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2018<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" ROWSPAN="3" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL"><FONT
 COLOR="#0071ce"><B>Bruce D. Given (10)</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; font-size:9pt; font-family:ARIAL">Former Chief Operating
Officer</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">409,615</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,857,500</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">76,693</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">16,343,808&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2019<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 488,750<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 2,608,200<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 850,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 11,799<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 3,958,759&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 2018<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 450,362<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 644,000<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> &#151;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 445,900<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 11,799<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right"> 1,552,061&nbsp;&nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">These columns represent the total grant date fair value, computed in accordance with ASC 718, of stock options and
restricted stock units granted during fiscal year 2020, 2019 and 2018. The assumptions used to calculate the value of the stock underlying the option and restricted stock unit awards are set forth in Note 9 of the Notes to the Consolidated Financial
Statements included with the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">These bonus amounts represent the amounts earned for performance under the Company&#146;s Annual Bonus Incentive Plan
during calendar year 2020, 2019 and 2018 and paid in fiscal year 2021, 2020 and 2019, respectively. The Annual Bonuses are described in more detail in the &#147;Bonus Incentive&#148; section. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Amounts consist of 401(k) matching contribution, as well as life insurance premiums for the benefit of each executive
officer. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The amounts reported for Christopher Anzalone in the Stock Awards column reflect the grant date fair value of a January
2020 restricted stock unit award that is subject to vesting upon the achievement of specific performance conditions, as described above in the Compensation Discussion and Analysis. We determined the performance conditions that were probable and not
probable of being achieved as of the grant date, as defined under applicable accounting guidance, and assigned a grant date fair value of $12,686,000 based on this evaluation. If we had determined that as of the date of the grant it was probable
that 100% of the performance conditions would be achieved, we would have assigned a grant date fair value of $57,087,000 for the restricted stock units. The amounts reported in the Summary Compensation Table for these awards may not represent the
amounts that Christopher Anzalone will realize from the awards. Whether, and to what extent, an NEO realizes value will depend on our actual operating performance, stock price fluctuations and the NEO&#146;s continued employment.
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The amounts reported for Christopher Anzalone in the Stock Awards column reflect the grant date fair value of a January
2019 restricted stock unit award that is subject to vesting upon the achievement of specific performance conditions, as described above in the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>39</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compensation Discussion and Analysis. We determined the performance conditions that were probable and not probable of being achieved as of the grant date, as defined under applicable accounting guidance, and assigned a
grant date fair value of $0 based on this evaluation. If we had determined that as of the date of the grant it was probable that 100% of the performance conditions would be achieved, we would have assigned a grant date fair value of $7,452,000 for
the restricted stock units. The amounts reported in the Summary Compensation Table for these awards may not represent the amounts that Christopher Anzalone will realize from the awards. Whether, and to what extent, an NEO realizes value will depend
on our actual operating performance, stock price fluctuations and the NEO&#146;s continued employment. </TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The amounts reported for Christopher Anzalone in the Stock Awards column reflect the grant date fair value of a January
2018 restricted stock unit award that is subject to vesting upon the achievement of specific performance conditions, as described above in the Compensation Discussion and Analysis. We determined the performance conditions that were probable and not
probable of being achieved as of the grant date, as defined under applicable accounting guidance, and assigned a grant date fair value of $0 based on this evaluation. If we had determined that as of the date of the grant it was probable that 100% of
the performance conditions would be achieved, we would have assigned a grant date fair value of $1,840,000 for the restricted stock units. The amounts reported in the Summary Compensation Table for these awards may not represent the amounts that
Christopher Anzalone will realize from the awards. Whether, and to what extent, an NEO realizes value will depend on our actual operating performance, stock price fluctuations and the NEO&#146;s continued employment. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;San Martin&#146;s employment with the Company began in November 2019. Dr.&nbsp;San Martin received a $100,000
sign on bonus. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Mr.&nbsp;Hassard&#146;s employment with the Company began in January 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Bradshaw&#146;s employment with the Company began in November 2019 and was terminated in November 2020.
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s employment with the Company terminated in May 2020 upon his retirement. Dr.&nbsp;Given continues to
serve as a consultant to the Company. The &#147;All Other Compensation&#148; value includes payments made to Dr. Given for his consulting services of $66,667. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>40</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Grants of Plan Based Awards Table </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table sets forth cash bonus and equity grants made
to the NEOs in fiscal 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:20pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:20pt"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:49pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:49pt"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:29pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:29pt"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:33pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:33pt"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD style="width:17pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:17pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD COLSPAN="4" VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" NOWRAP ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce;border-bottom:1.00pt solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Estimated&nbsp;Future&nbsp;
Payouts<BR>Under <FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive&nbsp;Plan&nbsp;Awards&nbsp;(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" NOWRAP STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce;border-bottom:1.00pt solid #ffffff"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Estimated</FONT></B></FONT></P>
<P ALIGN="center" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:8pt"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Future&nbsp;Payouts<BR>Under&nbsp;Equity<BR>Incentive&nbsp;Plan<BR>Awards&nbsp;
(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ROWSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">All&nbsp;Other&nbsp;Stock<BR>Awards:&nbsp;Number<BR>of Shares
of<BR>Stock or Units<BR>(#) (3)</FONT></B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ROWSPAN="2" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date Fair<BR>Value</FONT></B></FONT></P></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.00em; font-size:8pt; font-family:ARIAL"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Name</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant&nbsp;Date</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Target</FONT></B></FONT></P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; line-height:12.0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Christopher
Anzalone</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">Cash Bonus</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">820,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,343,000&nbsp;&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,343,000&nbsp;&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">PRSUs (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">100,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; line-height:12.0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Kenneth
Myszkowski</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">Cash Bonus</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">213,750</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">RSUs</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">85,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1,055,700&nbsp;&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; line-height:12.0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Javier San
Martin</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">Cash Bonus</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">180,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">RSUs</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">11/18/2019</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">150,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7,225,500&nbsp;&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; line-height:12.0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>James
Hassard</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">Cash Bonus</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">170,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">RSUs</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/6/2020</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">125,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">7,430,000&nbsp;&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; line-height:12.0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Curt
Bradshaw</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">Cash Bonus</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">160,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">RSUs</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">11/18/2019</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">125,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,021,250&nbsp;&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.89em; line-height:12.0pt; font-size:9pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>Bruce D.
Given</B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">Cash Bonus</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">455,000</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; line-height:12pt; font-size:9pt; font-family:ARIAL">RSUs</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">1/1/2020</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">&nbsp;</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">250,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL">$</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,857,500&nbsp;&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:12pt; font-size:9pt; font-family:ARIAL"></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Amounts listed represent cash award targets for our NEOs in 2020. Actual payments were made in fiscal 2021 and the amounts
are reported in the Summary Compensation Table above. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">These RSU and PRSU are described above in the &#147;Compensation Discussion and Analysis&#148; under the heading
&#147;Equity Compensation&#148;. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">RSUs have various vesting parameters. The RSUs granted in 2020 vest in four equal annual installments beginning 1 year
from the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">We determined that as of the date of the grant it was not probable as defined under applicable accounting guidance that
any of the performance vesting conditions for these PRSU awards would be achieved and assigned a grant date fair value of $0 based on this evaluation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>41</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Outstanding Equity Awards at Fiscal Year End Table </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table provides information, with respect to the NEOs, concerning the outstanding equity awards covering shares of the Company&#146;s common stock as of
September&nbsp;30, 2020. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:10pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:10pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:24pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:24pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:29pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:29pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:17pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:17pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:20pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:20pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:20pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:20pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:18pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:18pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:21pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:21pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:19pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:19pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD COLSPAN="4" VALIGN="bottom" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="19" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce;border-bottom:1.00pt solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option&nbsp;Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="19" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce;border-bottom:1.00pt solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock&nbsp;Awards&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Grant</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Date</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options
(#<BR>Exercisable)<BR>(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options&nbsp;
(#<BR>Unexercisable)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Exercise<BR>Price&nbsp;($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Expiration<BR>Date</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;or<BR>Units&nbsp;of<BR>Stock</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">That<BR>Have&nbsp;Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)&nbsp;(3)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Market</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value&nbsp;of</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Shares&nbsp;or<BR>Units&nbsp;of<BR>Stock</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">That<BR>Have</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">($)&nbsp;(4)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares&nbsp;or<BR>Units&nbsp;
of<BR>Stock</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">That<BR>Have</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Not<BR>Vested</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">(#)&nbsp;(2)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value<BR>of<BR>Unearned<BR>Shares&nbsp;or<BR>Units&nbsp;of<BR>Stock</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">That<BR>Have</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Not<BR>Vested<BR>($)&nbsp;(4)</FONT></B></FONT></P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; line-height:15pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>&nbsp;&nbsp;Christopher&nbsp;Anzalone</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">10/21/2011</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">15,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">4.60</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">10/21/2021</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/16/2012</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">170,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">5.19</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/16/2022</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">9/28/2012</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">40,624</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2.62</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">9/28/2022</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">5/6/2013</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">159,928</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2.01</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">5/6/2023</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">9/21/2013</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">69,991</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">4.75</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">9/21/2023</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/6/2014</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">60,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">14.54</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/6/2024</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">3/6/2015</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">300,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">7.75</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">3/6/2025</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2016</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">80,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">6.15</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2026</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2019</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">200,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">8,612,000&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2020</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">900,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">38,754,000&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; line-height:15pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>&nbsp;&nbsp;Kenneth&nbsp;Myszkowski</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/6/2014</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">43,505</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">14.54</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/6/2024</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2016</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">29,166</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">6.15</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2026</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2018</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">37,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1,614,750</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2019</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">63,750</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2,745,075</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2020</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">85,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">3,660,100</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; line-height:15pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>&nbsp;&nbsp;Javier
San Martin</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">11/18/2019</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">150,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">6,459,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; line-height:15pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>&nbsp;&nbsp;James
Hassard</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/6/2020</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">125,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">5,382,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; line-height:15pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>&nbsp;&nbsp;Curt
Bradshaw</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">11/18/2019</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">125,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">5,382,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.50em; line-height:15pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>&nbsp;&nbsp;Bruce&nbsp;D.&nbsp;Given</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/16/2012</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">81,652</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">5.19</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/16/2022</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">9/21/2013</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">7,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">4.75</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">9/21/2023</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/6/2014</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">4,064</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">14.54</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">2/6/2024</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">3/6/2015</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">12,741</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">7.75</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">3/6/2025</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2016</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">60,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">6.15</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2026</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2018</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">(5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">87,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">3,767,750</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2019</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">(5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">157,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">6,781,950</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">1/1/2020</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">(5)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">250,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">10,765,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:15pt; font-size:8pt; font-family:ARIAL"></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Options are priced at the market closing price on the date of grant. Options have various vesting parameters, but
generally vest within 48 months after the award is granted. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">The amounts reported for Christopher Anzalone in this column reflect the January 2019 and January 2020 awards that contain
performance-based vesting conditions. These awards and their vesting conditions are described above in the &#147;Compensation Discussion and Analysis&#148; under the heading &#147;Equity Compensation&#148;. </P></TD></TR></TABLE>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Restricted stock units have various vesting parameters but generally vest in four equal annual installments beginning 1
year from the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Value is based on the Company&#146;s Common Stock closing price of $43.06 on September&nbsp;30, 2020.
</P></TD></TR></TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s awards will continue to vest as he continues to provide service to the company as a consultant.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>42</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Options Exercised and Stock Vested Table </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table provides information, with respect to the
NEOs, concerning options exercised or RSUs or PRSUs vested during fiscal 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:34pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:34pt"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:34pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:34pt"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:34pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:34pt"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD style="width:36pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:36pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="border-bottom:1.00pt solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option&nbsp;Awards</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="border-bottom:1.00pt solid #ffffff"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock&nbsp;Awards</FONT></B></FONT></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on<BR>Exercise</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value&nbsp;Realized&nbsp;on<BR>Exercise&nbsp;(1)</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on<BR>Vesting</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Value&nbsp;Realized&nbsp;on&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Vesting&nbsp;(2)</FONT></B></FONT></P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;Christopher
Anzalone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">106,325</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">3,072,081</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">733,333</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">43,547,642</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;Kenneth
Myszkowski</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">127,329</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">4,252,665</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">2,462,600</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;Javier San Martin</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;James Hassard</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;Curt Bradshaw</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">&nbsp;Bruce D. Given</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">184,043</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">5,934,362</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">96,250</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">5,925,150</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #0071ce"></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Value is calculated as the price of the Company&#146;s Common Stock upon exercise, less the exercise price, multiplied by
the number of shares exercised. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Value is calculated as the price of the Company&#146;s Common Stock upon vesting, multiplied by the number of shares
vested. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><I>Termination Benefits &#151; Potential Payments Upon Termination or Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company has the following severance or change of control arrangements with its NEOs: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Dr.&nbsp;Anzalone&#146;s employment agreement with the Company provides that, if the Company terminates Dr.&nbsp;Anzalone&#146;s employment without Cause or if
Dr.&nbsp;Anzalone terminates his employment for Good Reason, on his date of termination, Dr.&nbsp;Anzalone will receive a <FONT STYLE="white-space:nowrap">one-time</FONT> lump sum payment equal to the sum of: (i)&nbsp;one month of base salary and
(ii)&nbsp;premiums for thirty (30)&nbsp;days of medical and dental benefits. To receive such payments Dr.&nbsp;Anzalone is required to execute a general release in favor of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">For purposes of Dr.&nbsp;Anzalone&#146;s employment agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">&#147;<B>Cause</B>&#148; means (i)&nbsp;the conviction (by trial or upon a plea of nolo contendere) of a felony or other crime involving moral turpitude or the commission
of any other material act or omission involving dishonesty, disloyalty or fraud with respect to the Company or any of its subsidiaries or any of their customers or suppliers, (ii)&nbsp;reporting to work under the influence of alcohol or illegal
drugs, the use of illegal drugs (whether or not at the workplace) or other repeated conduct causing the Company or any of its subsidiaries substantial public disgrace or disrepute or economic harm, (iii)&nbsp;the engaging of gross misconduct and the
failure to cease such conduct and rectify any harm to the Company resulting therefrom within 30 days after written demand therefor by the Company identifying with reasonable particularity such conduct and harm, or (iv)&nbsp;any other material breach
of the employment agreement by Executive and the failure to cease such breach and rectify any harm to the Company within 30 days after written demand by the Company identifying with reasonable particularity such breach and harm; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">&#147;<B>Good Reason</B>&#148; means (i)&nbsp;Executive&#146;s duties, responsibilities, titles or offices are diminished as compared to those described in&nbsp;the
employment agreement without Executive&#146;s written consent, and the Company fails to reinstate such duties, responsibilities, titles or offices within 30 days after written demand by Executive identifying with reasonable particularity the
diminishment, (ii)&nbsp;the relocation of Executive&#146;s base office to an office that is more than thirty (30)&nbsp;highway miles from Pasadena, CA, (iii)&nbsp;the failure of the Company to obtain a satisfactory agreement from any successor to
assume and agree to perform the obligations under the employment agreement and (iv)&nbsp;any other material breach of this employment agreement by the Company and the failure to cease such breach and rectify any harm to Executive resulting within 30
days after written demand by Executive identifying with reasonable particularity the breach and harm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Pursuant to his offer of employment by the Company,
Mr.&nbsp;Myszkowski is entitled to severance pay equal to three months&#146; base salary plus an amount equal to the premiums on his medical and dental benefits for the same period upon termination of his employment without cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company has not entered into a severance arrangement with Dr.&nbsp;San Martin or Mr.&nbsp;Hassard. Dr.&nbsp;Bradshaw&#146;s employment was terminated in November
2020 and the Company entered into a severance agreement with Dr.&nbsp;Bradshaw whereby he received a lump sum payment of $100,000. Dr.&nbsp;Given&#146;s employment was terminated upon his retirement in May 2020 and no
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>43</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">severance agreement was entered into. Dr.&nbsp;Given continues to provide service to the company as a consultant at a rate of $200,000 annually, and his RSU awards
continue to vest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Additionally, pursuant to the 2004 Equity Incentive Plan and the 2013 Incentive Plan, any unvested awards held by plan participants, including the
NEOs, become fully vested upon a change of control, except as otherwise determined by the Board and except with respect to the outstanding awards held by the CEO whose awards will only become fully vested upon a qualifying termination of employment
following a change of control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following tables set forth information regarding potential termination and change of control arrangements with our executive
officers had their employment been terminated or a change in control of the Company taken place on September&nbsp;30, 2020: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Termination
Payments </B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:12pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:12pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:15pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:15pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:14pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:14pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:14pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:14pt"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD style="width:11pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:11pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;Triggering&nbsp;Event</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Salary<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Benefits<BR>($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Stock<BR>Awards<BR>(1)($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Option<BR>Awards<BR>(1)($)</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Total&nbsp;&nbsp;</FONT></B></FONT></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:-2.22em; line-height:14.0pt; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Termination by Employer without Cause</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Christopher Anzalone (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">68,333</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,048</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">70,381&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Kenneth Myszkowski</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">118,750</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">9,390</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">128,140&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Javier San Martin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">James Hassard</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Curt Bradshaw (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Bruce Given (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-2.22em; line-height:14.0pt; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Christopher Anzalone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Kenneth Myszkowski</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">118,750</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">9,390</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">8,019,925</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">8,148,065&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Javier San Martin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,382,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,382,500&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">James Hassard</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,459,000</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">6,459,000&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Curt Bradshaw (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,382,500</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">5,382,500&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Bruce Given (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">21,314,700</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">21,314,700&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:-2.22em; line-height:14.0pt; font-size:9pt; font-family:ARIAL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Involuntary Termination
Following a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; line-height:14pt; font-size:9pt; font-family:ARIAL">Christopher Anzalone</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">68,333</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,048</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">47,366,000</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL" ALIGN="right">47,386,381&nbsp;&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; line-height:14pt; font-size:9pt; font-family:ARIAL"></P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">For stock awards the value is calculated as the number of unvested shares multiplied by the Company&#146;s closing stock
price at September&nbsp;30, 2020 of $43.06. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Anzalone&#146;s employment contract also provides for payment of the values set forth above upon his resignation
for &#147;good reason&#148; as defined in his employment agreement. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Bradshaw&#146;s employment with the Company terminated in November 2020. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Dr.&nbsp;Given&#146;s employment with the Company terminated in May 2020. Dr.&nbsp;Given continues to provide consulting
services to the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>CEO Pay Ratio </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Pursuant to Item 402(u) of Regulation <FONT
STYLE="white-space:nowrap">S-K,</FONT> we are required to calculate and disclose the median annual compensation of all of our employees (excluding our CEO, Dr.&nbsp;Anzalone), the annual compensation of Dr.&nbsp;Anzalone, and the ratio of these two
amounts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>44</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Executive Compensation</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Based on the fact that we had a significant number of new hires during fiscal 2020, we did not elect to use the same median employee as the prior year. Our median
employee was identified using the entire population of our employees as of September&nbsp;30, 2020 based on a consistently applied compensation measure, or CACM, that reasonably reflects the annual compensation of employees. The CACM selected by us
for our disclosure included annual base salary, the cash bonus amount for fiscal 2020, the grant-date fair value for stock-based awards (calculated in accordance with requirements for the Summary Compensation Table), and welfare and health benefits
for fiscal 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Based on the CACM methodology described above, we identified the median employee and calculated the 2020 compensation for this selected employee in
the same manner we determine the annual total compensation of our NEOs for purposes of the Summary Compensation Table. The median employee total compensation is $295,000. Dr.&nbsp;Anzalone&#146;s 2020 compensation as disclosed in the Summary
Compensation Table is $14,294,517. As a result, our CEO to median employee pay ratio for 2020 is 48:1. This represents an increase from the 2019 ratio of 12:1 primarily due to the PRSU awards granted to Dr.&nbsp;Anzalone that were deemed probable of
achievement at the grant date, in accordance with ASC 718. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">This pay ratio is a reasonable estimate calculated by a method consistent with the SEC requirements,
described above, based on our payroll and employment records. As a result of a variety of factors, including employee populations, potential differences in the components used for the CACM, compensation philosophies and certain assumptions, pay
ratios reported by other companies may not be comparable to our pay ratio. The pay ratio is not utilized by our management or our compensation committee for compensation-related decisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>45</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Proposal Four &#151; Ratification of Appointment of Independent Auditors </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_31"></A>Proposal Four &#151; Ratification of
Appointment of Independent Auditors </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our Audit Committee, with the ratification of our Board, selected the accounting firm of Rose, Snyder&nbsp;&amp;
Jacobs, LLP (&#147;<B>RS&amp;J</B>&#148;) as the Company&#146;s independent auditors for the fiscal year ending September&nbsp;30, 2021, and that selection is now being submitted to the stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">A representative of RS&amp;J is expected to be available at the Annual Meeting to respond to appropriate stockholder questions or make any other statements such
representative deems appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Stockholders are not required to ratify the appointment of RS&amp;J as our independent auditor. However, we are submitting the
appointment for ratification as a matter of good corporate practice. If stockholders fail to ratify the appointment, the Audit Committee will consider whether or not to retain RS&amp;J. Even if the appointment is ratified, the Audit Committee may
direct the appointment of a different independent auditor at any time during the year if it determines that such a change would be in the best interests of the Company and our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Vote Required; Recommendation of the Board </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In order to be
ratified, Proposal Four must be approved by a majority of Required Vote, assuming a quorum is present. For this purpose, abstentions will be counted as a vote against the proposal. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-left:8pt"> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-bottom:0pt; margin-top:0pt" ALIGN="center">&nbsp;&nbsp;


<IMG SRC="g76219g08m78.jpg" ALT="LOGO">
</P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e5e5e5" STYLE=" BORDER-TOP:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:1px solid #0071ce; padding-right:2pt" BGCOLOR="#e5e5e5"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:ARIAL"><B>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE <FONT STYLE="font-size:12pt" COLOR="#0071ce">&#147;FOR&#148;</FONT> PROPOSAL FOUR.</B></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>46</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Audit Fees</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_32"></A>Audit Fees </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Audit
Committee regularly reviews and determines whether specific projects or expenditures with our independent auditors, RS&amp;J, may potentially affect their independence. The Audit Committee&#146;s policy is to
<FONT STYLE="white-space:nowrap">pre-approve</FONT> all audit and permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services provided by RS&amp;J. <FONT STYLE="white-space:nowrap">Pre-approval</FONT> is generally provided by the Audit
Committee for up to one year, detailed to the particular service or category of services to be rendered and is generally subject to a specific budget. The Audit Committee may also <FONT STYLE="white-space:nowrap">pre-approve</FONT> additional
services of specific engagements on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. All engagements of our independent registered public accounting firm in 2020 and 2019 were <FONT
STYLE="white-space:nowrap">pre-approved</FONT> by the audit committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table sets forth the aggregate fees invoiced by RS&amp;J for the fiscal years
ended September&nbsp;30, 2020 and September&nbsp;30, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD style="width:24pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:24pt"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD style="width:24pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:24pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Year&nbsp;Ended&nbsp;September&nbsp;
30,</FONT></B></FONT></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:2.00pt solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Audit fees
(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">226,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">231,325</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Audit-related fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">163,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">17,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Tax
Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">All other
fees</P></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff"></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" BGCOLOR="#ffffff"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Total</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">389,000</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">$</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">248,325</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce"></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Fees invoiced by RS&amp;J include <FONT STYLE="white-space:nowrap">year-end</FONT> audit and periodic reviews of Forms <FONT
STYLE="white-space:nowrap">10-Q</FONT> and <FONT STYLE="white-space:nowrap">10-K.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Fees invoiced by RS&amp;J related to Comfort Letters and Consents for financings and registration statements, and other
agreed-upon procedures. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>47</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Report of the Audit Committee</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_33"></A>Report of the Audit Committee </B></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following is the report of the Audit Committee with respect to the Company&#146;s audited financial statements for fiscal 2020, which include the consolidated
balance sheets of the Company as of September&nbsp;30, 2020 and September&nbsp;30, 2019, and the related consolidated statements of operations, stockholders&#146; equity and cash flows for the fiscal years ended September&nbsp;30, 2020,
September&nbsp;30, 2019 and September&nbsp;30, 2018, and the notes thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Composition.</B> At September&nbsp;30, 2020, the Audit Committee of the Board was
comprised of three directors and operates under a written charter adopted by the Board. The members of the Audit Committee were William Waddill, Marianne De Backer and Michael S. Perry. All members of the Audit Committee were
&#147;independent,&#148; as defined in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act and Rule 5605(c) of the Nasdaq Marketplace Rules, and are financially literate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Responsibilities.</B> The responsibilities of the Audit Committee include engaging an accounting firm as the Company&#146;s independent registered public accounting
firm. Management has primary responsibility for the Company&#146;s internal controls and financial reporting process. The independent registered public accounting firm is responsible for performing an independent audit of the Company&#146;s
consolidated financial statements in accordance with generally accepted auditing standards and for issuing a report thereon. The Audit Committee&#146;s responsibility is to oversee these processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Review with Management and independent registered public accounting firm.</B> On November&nbsp;20, 2020, the Audit Committee consisted of William Waddill, Marianne De
Backer and Michael S. Perry. On that date, the Audit Committee met separately to review the Company&#146;s consolidated audited financial statements and held discussions with management and RS&amp;J. Management represented to the Audit Committee
that the Company&#146;s consolidated financial statements were prepared in accordance with generally accepted accounting principles. The members of the Audit Committee discussed with RS&amp;J matters required to be discussed under the applicable
standards of the Public Company Accounting Oversight Board. The Company&#146;s independent registered public accounting firm also provided to the Audit Committee the written disclosures and the letter required by the Public Company Accounting
Oversight Board regarding the independent registered public accounting firm&#146;s communications with the Audit Committee concerning independence and the Audit Committee discussed the firm&#146;s independence with RS&amp;J. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Conclusion.</B> Based upon the Audit Committee&#146;s review of the financial statements and discussions with management and RS&amp;J, the Audit Committee&#146;s
review of the representations of management and the report of RS&amp;J to the Audit Committee, the Audit Committee recommended that the Board include the audited consolidated financial statements in the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended September&nbsp;30, 2020, as filed with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">This report is submitted by the Audit Committee of
the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">William Waddill, Chairman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Marianne De Backer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Michael S. Perry </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>48</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Voting Securities of Principal Stockholders and Management</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_34"></A>Voting Securities of Principal Stockholders and
Management </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table sets forth the beneficial ownership of the Company&#146;s Common Stock as of January&nbsp;14, 2021, by (i)&nbsp;each of
the NEOs named in the table under &#147;Executive Compensation and Related Information,&#148; (ii) each director, (iii)&nbsp;all current directors and executive officers as a group, and (iv)&nbsp;the holders of greater than 5% of our total shares
outstanding known to us. Unless otherwise specified in the footnotes to the table below, the persons and entities named in the table have sole voting and investment power with respect to all shares beneficially owned, subject to community property
laws, where applicable, and the address of each stockholder is c/o Arrowhead Pharmaceuticals, Inc., 177 E. Colorado Blvd, Suite 700, Pasadena, CA, 91105 unless otherwise indicated. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0071ce">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="6"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" STYLE="border-bottom:1.00pt solid #ffffff"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;and&nbsp;Percentage&nbsp;of&nbsp;Shares<BR>Beneficially Owned&nbsp;(1)</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Percentage&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></B></FONT></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B><U>5%&nbsp;Beneficial&nbsp;Owners</U></B></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL">BlackRock Inc (2)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">55 East 52nd Street, New York, NY 10055</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle" ALIGN="right"> 12,360,958<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center"> 11.9%<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.56em; text-indent:-1.00em; font-size:9pt; font-family:ARIAL">The Vanguard Group (3)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL">100 Vanguard Blvd., Malvern, PA 19355</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle" ALIGN="right"> 9,594,203<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> &nbsp;<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center"> 9.2%<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:0.44em; font-size:9pt; font-family:ARIAL"><B><U>Named Executive Officers and Directors</U></B></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Christopher Anzalone (4)</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">2,844,055</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">2.7%</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Kenneth Myszkowski</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">259,005</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Javier San Martin</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">18,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">James Hassard</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">15,625</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Douglass Given</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">109,868</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Michael S. Perry</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">81,000</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Mauro Ferrari</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">30,971</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">William Waddill</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">21,250</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Marianne De Backer</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">17,500</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">Adeoye Olukotun</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">&#151;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">*</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; font-size:9pt; font-family:ARIAL">All Executive
Officers and Directors as a group (12 persons)(5)</P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="right">3,638,149</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:9pt; font-family:ARIAL" ALIGN="center">3.5%</P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Less than 1% </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Based on 103,750,633 shares of Common Stock issued and outstanding as of January&nbsp;14, 2021. Shares not outstanding but
deemed beneficially owned by virtue of the right of a person to acquire them as of January&nbsp;14, 2021, or within sixty days of such date are treated as outstanding only when determining the percentage owned by such individual and when determining
the percentage owned by a group. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Based on Amendment No. 2 to Schedule 13G/A filed February 4, 2020 by BlackRock Inc.. According to Amendment No. 2,
BlackRock Inc. has sole voting power and sole dispositive power over 12,149,645 shares and 12,360,958 shares, respectively, and has shared voting power and shared dispositive power over 0 shares and 0 shares, respectively. </P></TD></TR></TABLE>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Based on Amendment No.&nbsp;1 to Schedule 13G filed on February 12, 2020 by The Vanguard Group. According to the Amendment
No.&nbsp;1, The Vanguard Group has sole voting power and sole dispositive power over 196,261 shares and 9,594,203 shares, respectively, and has shared voting power and shared dispositive power over 17,849 shares and 203,304 shares, respectively.
</P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 800,033 shares issuable upon the exercise of stock options that are exercisable within 60 days of
January&nbsp;14, 2021. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>49</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Equity Compensation Plan Information </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_35"></A>Equity Compensation Plan Information </B></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following table provides information as of September&nbsp;30, 2020 with respect to shares of our Common Stock that may be issued under our equity compensation plans.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD style="width:22pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:22pt"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD style="width:27pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:27pt"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD style="width:33pt"></TD>
<TD></TD>
<TD></TD>
<TD style="width:33pt"></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" STYLE="border-bottom:1.00pt solid #ffffff"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Equity&nbsp;Compensation&nbsp;Plan&nbsp;Information</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #0071ce; padding-left:8pt">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of<BR>Shares&nbsp;to</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">be&nbsp;Issued<BR>upon</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">exercise&nbsp;of<BR>outstanding</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">options,<BR>warrants</FONT></B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">and&nbsp;rights</FONT></B></FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Weighted<BR>average<BR>exercise&nbsp;price<BR>of&nbsp;outstanding<BR>options,<BR>warrants&nbsp;
and<BR>rights</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Number&nbsp;of&nbsp;&nbsp;<BR>securities&nbsp;&nbsp;<BR>remaining&nbsp;&nbsp;<BR>available&nbsp;for&nbsp;
&nbsp;<BR>future&nbsp;issuance&nbsp;&nbsp;<BR>under&nbsp;equity&nbsp;&nbsp;<BR>compensation&nbsp;&nbsp;<BR>plans&nbsp;(excluding&nbsp;&nbsp;<BR>securities&nbsp;&nbsp;<BR>reflected&nbsp;in&nbsp;&nbsp;<BR>column&nbsp;(a))&nbsp;&nbsp;
</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Equity compensation plans approved by security holders (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">5,872,887</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">12.24</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" >&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right">398,720</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Equity compensation plans not approved by security holders (2)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">2,190,541</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">28.28</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#e5e5e5">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD>
<TD HEIGHT="5" COLSPAN="5"></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Total</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">8,063,428</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce">$</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">16.67</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce" ALIGN="right">398,720</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #0071ce"></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes options outstanding representing 673,262 and 2,611,625 shares of Common Stock under the 2004 Equity Incentive
Plan and the 2013 Incentive Plan, respectively. Also includes 2,588,000 restricted stock units subject to the 2013 Incentive Plan. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:ARIAL; " ALIGN="left">Includes 1,254,516 inducement option grants and 936,025 inducement restricted stock unit grants issued to newly hired
employees. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Current Executive Officers of the Registrant </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The names, ages and positions of our current executive officers
serving as of January&nbsp;14, 2021 are provided below. Biographical information regarding these officers is set forth under the following table, except for Dr.&nbsp;Anzalone, whose biography is set forth above with our other directors. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="64%"></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0071ce">
<TD HEIGHT="5" STYLE="BORDER-TOP:2.00pt solid #0071ce">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:2.00pt solid #0071ce">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-TOP:2.00pt solid #0071ce; BORDER-RIGHT:1px solid #0071ce">&nbsp;</TD></TR>
<TR BGCOLOR="#0071ce" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:0.50em; font-size:8pt; font-family:ARIAL"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Name</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="BORDER-BOTTOM:2.00pt solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT
 COLOR="#ffffff"><B><FONT COLOR="#ffffff">Age</FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:2.00pt solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #0071ce; BORDER-BOTTOM:2.00pt solid #0071ce; padding-right:2pt"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Position&nbsp;with&nbsp;Arrowhead</FONT></B></FONT></P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>


<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Christopher&nbsp;Anzalone</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">51</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Chief Executive Officer&nbsp;&amp;
President and Director</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Kenneth A. Myszkowski</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> 54<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Chief Financial Officer</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Javier San Martin</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">55</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Chief Medical Officer</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">James Hassard</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">54</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Chief Commercial Officer</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR BGCOLOR="#e5e5e5" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">James Hamilton</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">43</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Senior Vice President, Discovery and
Translational Medicine</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">Patrick O&#146;Brien</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right">57</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:ARIAL">&nbsp;</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #0071ce">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #0071ce"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.40em; text-indent:-1.00em; font-size:10pt; font-family:ARIAL">General Counsel, Corporate Secretary, and Chief Compliance Officer</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Kenneth A. Myszkowski,</B> Chief Financial Officer, joined the Company in 2009. Prior to joining Arrowhead, Mr.&nbsp;Myszkowski served
as the corporate controller for Broadwind Energy, a public energy company which provides products and services to the wind energy industry. Previous to his position at Broadwind, Mr.&nbsp;Myszkowski was controller for Epcor USA, the U.S.
headquarters for Epcor Utilities, Inc., a public energy company. Prior to Epcor, Mr.&nbsp;Myszkowski was controller for two <FONT STYLE="white-space:nowrap">start-up</FONT> ventures: NanoInk, specializing in Dip Pen Nanolithography, a
nanofabrication technology, and Delphion, which provided <FONT STYLE="white-space:nowrap">on-line</FONT> tools for intellectual property research. Mr.&nbsp;Myszkowski also held several corporate roles at FMC Corporation and Premark International,
both Fortune 500 conglomerates. He began his career in the audit practice of Arthur Andersen&nbsp;&amp; Co. in Chicago, Illinois. Mr.&nbsp;Myszkowski received his undergraduate degree from the University of Illinois, and his MBA from the University
of Chicago Booth School of Business. He is a certified public accountant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>50</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Equity Compensation Plan Information</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Patrick C. O&#146;Brien</B>, General Counsel, Corporate Secretary, and Chief Compliance Officer, joined the Company in December 2014. Mr.&nbsp;O&#146;Brien has
practiced in the healthcare legal field for over 25 years. Before joining the Company, from 2012 to 2014, Mr.&nbsp;O&#146;Brien was with Shire, as global pharmaceutical company, where he was Group Vice President, Law. Immediately prior to working
with Shire he was a partner with the international law firm of Holland&nbsp;&amp; Knight LLP in its Washington, DC office. In 2010, Mr.&nbsp;O&#146;Brien <FONT STYLE="white-space:nowrap">co-founded</FONT> the law firm O&#146;Brien Gould PLLC which
joined Holland&nbsp;&amp; Knight in 2011. From 2009 to 2010, Mr.&nbsp;O&#146;Brien was a partner in Burke O&#146;Neil LLC. From 2001 to 2009, Mr.&nbsp;O&#146;Brien served in several legal roles with Johnson&nbsp;&amp; Johnson, including serving as
Vice President of Law for J&amp;J&#146;s Centocor Ortho-Biotech unit. Mr.&nbsp;O&#146;Brien previously served as Regulatory Counsel with the United States Food&nbsp;&amp; Drug Administration. Mr.&nbsp;O&#146;Brien was awarded a BS in Pharmacy and a
PharmD from the University of Arizona before completing a residency in Clinical Pharmacy with the University of Illinois at Chicago Hospital. He was also awarded his JD from the University of Arizona. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>Javier San Martin,</B> Chief Medical Officer, joined the Company in November 2019. Dr.&nbsp;San Martin&nbsp;previously served as Senior Vice President and Head
of&nbsp;Global Clinical Development&nbsp;at Ultragenyx from 2013 until November 2019. At Ultragenyx he led the development of burosumab, a novel drug for the treatment of <FONT STYLE="white-space:nowrap">X-Linked</FONT> Hypophosphatemia approved
across major regions including&nbsp;the United States, the&nbsp;European Union, and&nbsp;Canada. Before his tenure at Ultragenyx, he served as Senior Vice President of&nbsp;Clinical Development&nbsp;at Alder Biopharmaceuticals, where he was
responsible for managing the medical, regulatory, and clinical operations group focused on early clinical programs. From 2006 to 2011, Dr.&nbsp;San Martin&nbsp;was a Global Development Leader at&nbsp;Amgen, Inc., where he was responsible for two
major development programs. He directed the romosozumab clinical program through the end of phase II, and before that, was responsible for the development and approval of denosumab, the largest branded anti-osteoporosis treatment for postmenopausal
osteoporosis and the first monoclonal antibody to address a very prevalent disease treated by primary care physicians. Prior to his time at&nbsp;Amgen, he spent seven years at&nbsp;Eli Lilly and Company, supporting late stage clinical development as
well as medical affairs activities, including the successful launch of Evista and Forteo. He received his medical degree from the&nbsp;University of Buenos Aires Medical School&nbsp;and completed his residence in internal medicine at&nbsp;CEMIC
University Hospital&nbsp;in&nbsp;Buenos Aires, Argentina, serving as Chief Resident, and, thereafter, as Attending Physician responsible for the internal medicine ward. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>James Hamilton,</B> Senior Vice President, Discovery &amp; Translational Medicine, joined the Company in 2014. He is responsible for target discovery as well as
non-clinical and early clinical development. Previously, Dr. Hamilton served as Vice President, Clinical Development, responsible for clinical strategy, clinical trial design and execution including early translational and mid-stage development of
all Arrowhead programs. He is experienced in multiple disease areas including virology, hepatology, cardiovascular disease, rare disease and oncology. Dr. Hamilton led the clinical development of ARO-HBV (now JNJ-3989), which was licensed to Janssen
Pharmaceuticals. In parallel, Dr. Hamilton served as Head of Corporate Development and led Arrowhead&#146;s in-licensing transaction of Novartis&#146; RNAi assets, as well as the out-licensing of ARO-LPA (now AMG890) to Amgen and the ARO-AAT
partnership with Takeda. Dr. Hamilton started his employment at Arrowhead as Medical Director and Head of Corporate development. He holds both MD and MBA degrees from The Ohio State University. He is a licensed physician and completed residency
training with board certification in emergency medicine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><B>James Hassard,</B> Chief Commercial Officer, joined the Company in January 2020. Mr.&nbsp;Hassard served
as Senior Vice President of Marketing and Market Access at&nbsp;Coherus BioSciences&nbsp;from 2016 to December 2019, where he was instrumental in building the commercial organization and commercial capabilities. He
<FONT STYLE="white-space:nowrap">co-led</FONT> the launch of Coherus&#146; first product, a biosimilar, pegfilgrastim; one of the most successful pharmaceutical launches of 2019. Prior to his tenure at Coherus, Mr.&nbsp;Hassard served as Vice
President of Marketing at Medivation, prior to and through its acquisition by&nbsp;Pfizer Pharmaceuticals. From 1999 to 2016, he held multiple increasingly senior commercial roles at&nbsp;Amgen, Inc., across sales and marketing, domestic and
international, including an assignment as General Manager of Amgen Portugal. He was responsible for the launch, growth, and subsequent life-cycle management of several oncology and nephrology products, including darbepoetin alfa and cinacalcet.
Prior to Amgen, Mr.&nbsp;Hassard spent several years at Schering-Plough Canada, in sales and marketing roles, in the therapeutic areas of oncology, cardiovascular and hepatitis. He received his Bachelor of Science in pharmacology from
the&nbsp;University of Toronto&nbsp;and a master&#146;s in business administration from&nbsp;Nova Southeastern University,&nbsp;Florida. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Delinquent Section&nbsp;16(a) Reports </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Under Section&nbsp;16(a) of the Securities Exchange Act of 1934,
the Company&#146;s directors and officers and its significant stockholders (defined by statute as stockholders beneficially owning more than ten percent (10%)&nbsp;of the Common Stock) are required to file with the SEC and the Company reports of
ownership, and changes in ownership, of Common Stock. Based solely on a review of the reports received by it, the Company believes that, during the fiscal year ended September&nbsp;30, 2020, all of its officers, directors and significant
stockholders complied with all applicable filing requirements under Section&nbsp;16(a), except that, due to administrative error, Marianne De Backer filed a late Form 4 on June 24, 2020 with respect to 8 open market purchases that occurred between
January 13, 2020 and June 15, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>51</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Review and Approval of Related-Party Transactions</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_36"></A>Review and Approval of Related-Party
Transactions </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Our Board has adopted written policies and procedures for the review and approval of related-party transactions and has delegated to the
Audit Committee the authority to review and approve the material terms of any proposed related-party transactions. To the extent that a proposed related-party transaction may involve a <FONT STYLE="white-space:nowrap">non-employee</FONT> director or
nominee for election as a director and may be material to a consideration of that person&#146;s independence, the matter may also be considered by the other disinterested directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Pursuant to our Code of Business Conduct and Ethics and our Corporate Governance Committee Charter, each of our officers, directors and employees must disclose
related-party transactions to our Board. In order to avoid conflicts of interest, our executive officers and directors may not acquire any ownership interest in any supplier, customer or competitor (other than nominal amounts of stock in publicly
traded companies), enter into any consulting or employment relationship with any customer, supplier or competitor, or engage in any outside business activity that is competitive with any of our businesses, without first disclosing the proposed
transaction. After the proposed transaction has been disclosed, a determination will be made by our Board or Audit Committee as to what course to follow, depending on the nature or extent of the conflict. Furthermore, our executive officers and
directors may not serve on any board of directors of any customer, supplier or competitor unless such board service has been disclosed to us and approved by our Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">In determining whether to approve or ratify a related-party transaction, the Board and/or Committee may consider, among other factors it deems appropriate, the potential
benefits to us, the impact on a director&#146;s or nominee&#146;s independence or an executive officer&#146;s relationship with or service to us, whether the related-party transaction is on terms no less favorable than terms generally available to
an unaffiliated third party under the same or similar circumstances and the extent of the related party&#146;s interest in the transaction. In deciding to approve a transaction, the Board or Audit Committee may, in its sole discretion, impose such
conditions as it deems appropriate on us or the related party in connection with its approval of any transaction. Any transactions involving the compensation of executive officers, however, are reviewed and approved by the Compensation Committee. If
a related-party transaction will be ongoing, the Audit Committee may establish guidelines to be followed in our ongoing dealings with the related party. Thereafter, the Audit Committee reviews and assesses the ongoing relationship with each related
party to see that it is in compliance with the Audit Committee&#146;s guidelines and that the related-party transaction remains appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>52</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Certain Relationships and Related Transactions, and Director Independence</I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B><A NAME="toc76219_37"></A>Certain Relationships and Related Transactions,
and Director Independence </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">As of September&nbsp;30, 2020, a majority of the members of the Board are independent directors, as defined by the Nasdaq
Marketplace Rules. The Board has determined that all of the Company&#146;s directors are independent, except Dr.&nbsp;Anzalone, the Company&#146;s Chief Executive Officer, and Dr.&nbsp;Douglass Given, the brother of the Company&#146;s former Chief
Operating Officer. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors do not receive consulting, legal or other fees from the Company, other than Board compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Vincent Anzalone is the Company&#146;s Vice President, Investor Relations and the brother of Christopher Anzalone, the Company&#146;s Chief Executive Officer. Vincent
Anzalone earned base salary and bonus of $290,367 during fiscal year 2020. His current base salary is $252,206. In January 2020, Mr.&nbsp;Anzalone was awarded 32,000 restricted stock units, and this award vests in four annual tranches from the grant
date. The grant date fair value of this award is $2,029,760. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
</B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company will mail, without charge to any
stockholder upon written request, a copy of the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended September&nbsp;30, 2020 including the financial statements, schedules and a list of exhibits.
Requests should be sent to Arrowhead Pharmaceuticals, Inc., 177 E. Colorado Blvd., Suite 700, Pasadena, CA 91105, Attn: Corporate Secretary, Phone (626)<U></U><FONT STYLE="white-space:nowrap">&nbsp;304-3400.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Stockholders Sharing the Same Address </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">We may satisfy SEC rules regarding delivery of proxy statements
including the proxy statement, annual report and Notice, by delivering a single Notice and, if applicable, a single set of proxy materials to an address shared by two or more of our stockholders. This delivery method can result in meaningful cost
savings for us. To take advantage of this opportunity, we may deliver only one Notice, and if applicable, a single set of proxy materials to multiple stockholders who share an address, unless contrary instructions are received prior to the mailing
date. Similarly, if you share an address with another stockholder and have received multiple copies of our Notice and/or other proxy materials, you may write or call us at the address and phone number below to request delivery of a single copy of
these materials in the future. We undertake to deliver promptly upon written or oral request a separate copy of the Notice and/or other proxy materials to a stockholder at a shared address to which a single copy of these documents was delivered. If
you hold stock as a record stockholder and prefer to receive separate copies of a Notice, and if applicable, other proxy materials either now or in the future, please contact us at the address provided below. If your stock is held through a
brokerage firm or bank and you prefer to receive separate copies of a Notice and, if applicable, other proxy materials either now or in the future, please contact your brokerage firm or bank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Arrowhead Pharmaceuticals, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">177 E. Colorado Blvd., Suite 700 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Pasadena CA 91105 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Attn: Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Phone <FONT STYLE="white-space:nowrap">(626)&nbsp;304-3400</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT
 COLOR="#4c4c4c"><B>Other Matters </B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company
knows of no other matters to be submitted at the Annual Meeting. If any other matters properly come before the meeting, it is the intention of the persons named in the proxy card to vote the shares they represent as the Board may recommend. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="top">BY&nbsp;ORDER&nbsp;OF&nbsp;THE&nbsp;BOARD&nbsp;OF&nbsp;DIRECTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top">/s/ Patrick O&#146;Brien</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top">Patrick O&#146;Brien,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Secretary</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top">Pasadena, California</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<TD VALIGN="top">January&nbsp;27, 2021</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>53</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B><A NAME="toc76219_38"></A>Exhibit A </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>ARROWHEAD PHARMACEUTICALS, INC. </B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT
 COLOR="#0071ce"><B>2021 INCENTIVE PLAN </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>1. DEFINED TERMS </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I><U>Exhibit A</U></I>, which is incorporated by reference,
defines the terms used in the Plan and sets forth certain operational rules related to those terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>2. PURPOSE </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Plan has been established to advance the interests of the
Company by providing for the grant to Participants of Stock-based and other incentive Awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>3. ADMINISTRATION </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Administrator has discretionary authority, subject only to
the express provisions of the Plan, to interpret the Plan; determine eligibility for and grant Awards; determine, modify or waive the terms and conditions of any Award; prescribe forms, rules and procedures relating to the Plan; determine whether
Awards should be settled in cash and/or shares of Stock; and otherwise do all things necessary or appropriate to carry out the purposes of the Plan. Determinations of the Administrator made under the Plan will be conclusive and will bind all
parties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>4. LIMITS ON AWARDS UNDER THE PLAN </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(a)<I>&nbsp;<U>Number of Shares</U></I>. The maximum number of
shares of Stock that may be delivered in satisfaction of Awards under the Plan is 8,000,000, reduced by any shares of Common Stock subject to awards made under the Prior Plan after January&nbsp;1, 2021. Shares of Stock subject to outstanding awards
under the Prior Plans as of January&nbsp;1, 2021 that, after January&nbsp;1, 2021, are canceled, expired, forfeited or otherwise not issued under such award (other than as a result of being tendered or withheld to pay the exercise price or
withholding taxes in connection with any such awards) or settled in cash shall be added to the number of shares of Stock issuable under the Plan. No more than 8,000,000 shares of Stock may be delivered in satisfaction of ISOs awarded under the Plan.
Nothing in this Section&nbsp;4(a) will be construed as requiring that any, or any fixed number of, ISOs be awarded under the Plan. For purposes of this Section&nbsp;4(a), the number of shares of Stock delivered in satisfaction of Awards will be
determined (i)&nbsp;by treating as having been delivered any shares of Stock underlying the portion of any Award that is settled in Stock, (ii)&nbsp;by treating as having been delivered any shares of Stock tendered to or withheld by the Company from
any Award in payment of the exercise price of any Award requiring exercise or in satisfaction of the tax withholding requirements with respect to any Award, and (iii)&nbsp;by treating as having been delivered any shares of Stock purchased by the
Company with proceeds from the exercise of Stock Options. Stock underlying the portion of any Award that expires, terminates or is forfeited or is settled in cash prior to the issuance of Stock thereunder shall not be counted as having been
delivered under the Plan. To the extent consistent with the requirements of Section&nbsp;422 and the regulations thereunder, and with other applicable legal requirements (including applicable stock exchange requirements), Stock issued under awards
of an acquired company that are converted, replaced or adjusted in connection with the acquisition shall not reduce the number of shares of Stock available for Awards under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(b)<I>&nbsp;<U>Type of Shares</U></I>. Stock delivered by the Company under the Plan may be authorized but unissued Stock or previously issued Stock acquired by the
Company. No fractional shares of Stock will be delivered under the Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>5. ELIGIBILITY AND PARTICIPATION </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Administrator will select Participants from among key
Employees and directors of, and consultants and advisors to, the Company and its Affiliates. Eligibility for ISOs is limited to individuals described in the first sentence of this Section&nbsp;5 who are employees of the Company or of a &#147;parent
corporation&#148; or &#147;subsidiary corporation&#148; of the Company as those terms are defined in Section&nbsp;424 of the Code. Eligibility for Stock Options other than ISOs is limited to individuals described in the first sentence of this
Section&nbsp;5 who are providing direct services on the date of grant of the Stock Option to either the Company or to a subsidiary of the Company that would be described in the first sentence of Treas. Regs.
<FONT STYLE="white-space:nowrap">&#167;1.409A-1(b)(5)(iii)(E).</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>54</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>6. RULES APPLICABLE TO AWARDS </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(a)<I>&nbsp;<U>All Awards</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(1)<I>&nbsp;<U>Award Provisions</U></I>. The Administrator will determine the terms of all Awards, subject to the limitations provided herein. By accepting (or, under
such rules as the Administrator may prescribe, being deemed to have accepted) an Award, the Participant will be deemed to have agreed to the terms of the Award and the Plan. Notwithstanding any provision of this Plan to the contrary, awards of an
acquired company that are converted, replaced or adjusted in connection with the acquisition may contain terms and conditions that are inconsistent with the terms and conditions specified herein, as determined by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(2)<I>&nbsp;<U>Term of Plan</U></I>. No Awards may be made after ten years from the Date of Adoption, but previously granted Awards may continue beyond that date in
accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(3)<I>&nbsp;<U>Transferability</U></I>. Neither ISOs nor, except as the Administrator otherwise expressly provides in accordance with
the third sentence of this Section&nbsp;6(a)(3), other Awards may be transferred other than by will or by the laws of descent and distribution. During a Participant&#146;s lifetime, ISOs (and, except as the Administrator otherwise expressly provides
in accordance with the third sentence of this Section&nbsp;6(a)(3), SARs and NSOs) may be exercised only by the Participant. The Administrator may permit the gratuitous transfer (<I>i.e.</I>, transfer not for value) of Awards other than ISOs to any
transferee eligible to be covered by the provisions of Form <FONT STYLE="white-space:nowrap">S-8</FONT> (under the Securities Act of 1933, as amended), subject to such limitations as the Administrator may impose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(4)<I>&nbsp;<U>Vesting, etc</U></I>. Subject to Section&nbsp;6(a)(5), the Administrator will determine the time or times at which an Award will vest or become
exercisable and the terms on which a Stock Option or SAR will remain exercisable. Without limiting the foregoing, the Administrator may at any time accelerate the vesting or exercisability of an Award, regardless of any adverse or potentially
adverse tax or other consequences resulting from such acceleration. Unless the Administrator expressly provides otherwise, however, the following rules will apply if a Participant&#146;s Employment ceases: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(A) Immediately upon the cessation of the Participant&#146;s Employment and except as provided in (B), (C), and (D)&nbsp;below, each Stock Option and SAR that is then
held by the Participant or by the Participant&#146;s permitted transferees, if any, will cease to be exercisable and will terminate and all other Awards that are then held by the Participant or by the Participant&#146;s permitted transferees, if
any, to the extent not already vested will be forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(B) Subject to (C), (D)&nbsp;and (E)&nbsp;below, all Stock Options and SARs held by the Participant or the
Participant&#146;s permitted transferees, if any, immediately prior to the cessation of the Participant&#146;s Employment, to the extent then exercisable, will remain exercisable for the lesser of (i)&nbsp;a period of three months and (ii)&nbsp;the
period ending on the latest date on which such Stock Option or SAR could have been exercised without regard to this Section&nbsp;6(a)(4), and will thereupon immediately terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(C) All Stock Options and SARs held by a Participant or the Participant&#146;s permitted transferees, if any, immediately prior to the cessation of the
Participant&#146;s Employment due to his or her death, to the extent then exercisable, will remain exercisable for the lesser of (i)&nbsp;a period of twelve months and (ii)&nbsp;the period ending on the latest date on which such Stock Option or SAR
could have been exercised without regard to this Section&nbsp;6(a)(4), and will thereupon immediately terminate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(D) All Stock Options and SARs held by a
Participant or the Participant&#146;s permitted transferees, if any, immediately prior to the cessation of the Participant&#146;s Employment due to his or her &#147;permanent and total disability&#148; (within the meaning of Section&nbsp;22(e)(3) of
the Code, to the extent then exercisable, will remain exercisable for the lesser of (i)&nbsp;a period of six months and (ii)&nbsp;the period ending on the latest date on which such Stock Option or SAR could have been exercised without regard to this
Section&nbsp;6(a)(4), and will thereupon immediately terminate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(E) All Awards (whether or not exercisable) held by a Participant or the Participant&#146;s
permitted transferees, if any, immediately prior to the cessation of the Participant&#146;s Employment will immediately terminate upon such cessation of Employment if the termination is for Cause or occurs in circumstances that in the sole
determination of the Administrator would have constituted grounds for the Participant&#146;s Employment to be terminated for Cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(5) <I><U>Minimum Vesting;
Holding Period</U></I>. Except as otherwise provided in this Section&nbsp;6(a)(5), no Award shall be granted with terms providing for any right of vesting, exercise or lapse of vesting requirements earlier than a date that is at least one
(1)&nbsp;year following the date of grant (or, in the case of vesting based upon performance objectives, exercise and vesting restrictions cannot lapse earlier than the one (1)&nbsp;year anniversary measured from the date of the commencement of the
period </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>55</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">over which performance is measured). Notwithstanding the foregoing, the Administrator may grant up to a maximum of five percent (5%) of the aggregate number of shares
available for issuance under the Plan (for purposes of counting shares against the five percent (5%) limitation, the share counting rules under Section&nbsp;4(a) shall apply) that do not comply with the one (1)&nbsp;year minimum vesting and exercise
requirements set forth in the preceding sentence. In addition, Awards granted to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors need not comply with the one (1)&nbsp;year minimum vesting and exercise requirements so long as the
Awards provide for a right of exercise or lapse of any vesting obligations no earlier than the next annual stockholder meeting date following the grant date. In addition to the minimum vesting and exercise requirements in this Section&nbsp;6(a)(5),
any Awards granted to the Company&#146;s Chief Executive Officer shall be granted with terms providing that the shares issued upon exercise or settlement of any such Award (net of tax withholding) may not be transferred or otherwise disposed of by
the Company&#146;s Chief Executive Officer for at least twelve (12)&nbsp;months following the date of such exercise or settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(6)<I>&nbsp;<U>Additional
Restrictions</U></I>. The Administrator may cancel, rescind, withhold or otherwise limit or restrict any Award at any time if the Participant is not in compliance with all applicable provisions of the Award agreement and the Plan, or if the
Participant breaches any agreement with the Company or its Affiliates with respect to <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> or confidentiality. Without limiting the
generality of the foregoing, the Administrator may recover Awards made under the Plan and payments under or gain in respect of any Award in accordance with any applicable Company clawback or recoupment policy, as such policy may be amended and in
effect from time to time, or as otherwise required by law or applicable stock exchange listing standards, including, without limitation, Section&nbsp;10D of the Exchange Act, or any stock exchange or similar rule adopted under said Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(7)<I>&nbsp;<U>Taxes</U></I>. The grant of an Award and the delivery, vesting and retention of Stock, cash or other property under an Award are conditioned upon full
satisfaction by the Participant of all tax withholding requirements with respect to the Award. The Administrator will prescribe such rules for the withholding of taxes as it deems necessary or appropriate. The Administrator may, but need not, hold
back shares of Stock from an Award or permit a Participant to tender previously owned shares of Stock in satisfaction of tax withholding requirements (only up to the amount permitted that will not cause an adverse accounting consequence or cost).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(8)<I>&nbsp;<U>Dividend Equivalents, Etc</U></I>. The Administrator may provide for the payment of amounts (on terms and subject to conditions established by the
Administrator) in lieu of cash dividends or other cash distributions with respect to Stock subject to an Award whether or not the holder of such Award is otherwise entitled to share in the actual dividend or distribution in respect of such Award.
Any entitlement to dividend equivalents or similar entitlements will be established and administered either consistent with an exemption from, or in compliance with, the requirements of Section&nbsp;409A. Dividends or dividend equivalent amounts
payable in respect of Awards that are subject to restrictions will be subject to the same vesting and forfeiture restrictions as apply to the Awards to which they relate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(9)<I>&nbsp;<U>Rights Limited</U></I>. Nothing in the Plan or in any Award will be construed as giving any person the right to continued employment or service with the
Company or its Affiliates, or any rights as a stockholder except as to shares of Stock actually issued under the Plan; nor will anything in the Plan or in any Award affect the right of the Company or its Affiliates to discharge or discipline a
Participant at any time. The loss of existing or potential profit in Awards will not constitute an element of damages in the event of termination of Employment for any reason, even if the termination is in violation of an obligation of the Company
or any Affiliate to the Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(10)<I>&nbsp;<U>Coordination with Other Plans</U></I>. Awards under the Plan may be granted in tandem with, or in satisfaction
of or substitution for, other Awards under the Plan or awards made under other compensatory plans or programs of the Company or its Affiliates. For example, but without limiting the generality of the foregoing, awards under other compensatory plans
or programs of the Company or its Affiliates may be settled in Stock (including, without limitation, Unrestricted Stock) if the Administrator so determines, in which case the shares delivered will be treated as awarded under the Plan (and will
reduce the number of shares thereafter available under the Plan in accordance with the rules set forth in Section&nbsp;4). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(11)<I>&nbsp;<U>Section</U>&nbsp;409A</I>. Each Award will contain such terms as the Administrator determines, and will be construed and administered, such that the
Award either qualifies for an exemption from the requirements of Section&nbsp;409A or satisfies such requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(b)<I>&nbsp;<U>Stock Options and SARs</U>.</I>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(1)<I>&nbsp;<U>Time And Manner Of Exercise</U></I>. Unless the Administrator expressly provides otherwise, no Stock Option or SAR will be deemed to have been
exercised until the Administrator receives a notice of exercise (in form acceptable to the Administrator), which may be an electronic notice, signed (including electronic signature in form acceptable to the Administrator) by the appropriate person
and accompanied by any payment required under the Award. A Stock Option or SAR exercised by any person other than the Participant will not be deemed to have been exercised until the Administrator has received such evidence as it may require that the
person exercising the Award has the right to do so. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>56</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(2)<I>&nbsp;<U>Exercise Price</U></I>. The exercise price (or the base value from which appreciation is to be measured) of each Award requiring exercise will be no less
than 100% (or in the case of an ISO granted to a <FONT STYLE="white-space:nowrap">ten-percent</FONT> shareholder within the meaning of subsection (b)(6) of Section&nbsp;422, 110%) of the Fair Market Value of the Stock subject to the Award,
determined as of the date of grant, or such higher amount as the Administrator may determine in connection with the grant. Except in connection with a corporate transaction involving the Company (which term shall include, without limitation, any
stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination, or exchange of
shares) or as otherwise contemplated by Section&nbsp;7 of the Plan, the Company may not, without obtaining stockholder approval, (A)&nbsp;amend the terms of outstanding Stock Options or SARs to reduce the exercise price or base value of such Stock
Options or SARs, (B)&nbsp;cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an exercise price or base value that is less than the exercise price or base value of the original Stock Options or SARs, or
(C)&nbsp;cancel outstanding Stock Options or SARs that have an exercise price or base value greater than the Fair Market Value of a share of Stock on the date of such cancellation in exchange for cash or other consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(3)<I>&nbsp;<U>Payment Of Exercise Price</U></I>. Where the exercise of an Award is to be accompanied by payment, payment of the exercise price will be by cash or check
acceptable to the Administrator or by such other legally permissible means, if any, as may be acceptable to the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(4)<I>&nbsp;<U>Maximum Term</U></I>.
Stock Options and SARs will have a maximum term not to exceed ten (10)&nbsp;years from the date of grant (or five (5)&nbsp;years from the date of grant in the case of an ISO granted to a <FONT STYLE="white-space:nowrap">ten-percent</FONT>
shareholder described in Section&nbsp;6(b)(2) above); provided, however, that, if a Participant still holding an outstanding but unexercised NSO or SAR ten (10)&nbsp;years from the date of grant (or, in the case of an NSO or SAR with a maximum term
of less than ten (10)&nbsp;years, such maximum term) is prohibited by applicable law or a written policy of the Company applicable to similarly situated employees from engaging in any open-market sales of Stock, and if at such time the Stock is
publicly traded (as determined by the Administrator), the maximum term of such Award will instead be deemed to expire on the thirtieth (30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;day following the date the Participant is no
longer prohibited from engaging in such open market sales. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>7. EFFECT OF CERTAIN TRANSACTIONS </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(a)<I>&nbsp;<U>Mergers, etc</U></I>. Except as otherwise provided
in an Award agreement, the following provisions will apply in the event of a Covered Transaction: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(1)<I>&nbsp;<U>Assumption or Substitution</U></I>. If the Covered
Transaction is one in which there is an acquiring or surviving entity, the Administrator may (but, for the avoidance of doubt, need not) provide (i)&nbsp;for the assumption or continuation of some or all outstanding Awards or any portion thereof or
(ii)&nbsp;for the grant of new awards in substitution therefor by the acquiror or survivor or an affiliate of the acquiror or survivor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(2)<I>&nbsp;<U><FONT
STYLE="white-space:nowrap">Cash-Out</FONT> of Awards</U></I>. Subject to Section&nbsp;7(a)(5) below, the Administrator may (but, for the avoidance of doubt, need not) provide for payment (a
<FONT STYLE="white-space:nowrap">&#147;cash-out&#148;),</FONT> with respect to some or all Awards or any portion thereof, equal in the case of each affected Award or portion thereof to the excess, if any, of (A)&nbsp;the Fair Market Value of one
share of Stock (as determined by the Administrator in its reasonable discretion) times the number of shares of Stock subject to the Award or such portion, over (B)&nbsp;the aggregate exercise or purchase price, if any, under the Award or such
portion (in the case of an SAR, the aggregate base value above which appreciation is measured), in each case on such payment terms (which need not be the same as the terms of payment to holders of Stock) and other terms, and subject to such
conditions, as the Administrator determines, it being understood that if the exercise or purchase price (or base value) of an Award is equal to or greater than the Fair Market Value of one share of Stock (as determined in accordance with this
Section&nbsp;7(a)(2)), the Award may be cancelled with no payment due hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(3)<I>&nbsp;<U>Acceleration of Certain Awards</U></I>. Subject to
Section&nbsp;7(a)(7) below, the Administrator may (but, for the avoidance of doubt, need not) provide that any Award requiring exercise will become exercisable, in full or in part and/or that the delivery of any shares of Stock remaining deliverable
under any outstanding Award of Stock Units (including Restricted Stock Units and Performance Awards to the extent consisting of Stock Units) will be accelerated in full or in part, in each case on a basis that gives the holder of the Award a
reasonable opportunity, as determined by the Administrator, following exercise of the Award or the delivery of the shares, as the case may be, to participate as a stockholder in the Covered Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(4) <I><U>Change in Control</U></I>. Notwithstanding anything herein to the contrary, unless otherwise expressly provided for in the Award agreement or another contract,
including an employment or severance agreement or severance plan, or under the terms of a transaction constituting a Change in Control, in the event of a Change in Control, each outstanding Award will fully vest (which, in the case of Performance
Awards shall be to their maximal value) and become exercisable immediately prior to the consummation of such Change in Control, and the Administrator shall notify the Participant in writing or electronically that the Award will be fully vested and
exercisable for a period of at least fifteen (15)&nbsp;days </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>57</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">from the date of such notice, (which notice may be delivered prior to the consummation of the Change in Control) and the Award will terminate upon the expiration of such
period if not otherwise assumed or substituted pursuant to Section&nbsp;7(a)(1) above or <FONT STYLE="white-space:nowrap">cashed-out</FONT> pursuant to Section&nbsp;7(a)(2) above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(5)<I>&nbsp;<U>Termination of Awards Upon Consummation of Covered Transaction</U></I>. Except as the Administrator may otherwise determine in any case and except for the
<FONT STYLE="white-space:nowrap">15-day</FONT> exercise period set forth above in Section&nbsp;7(a)(4), each Award will automatically terminate (and in the case of outstanding shares of Restricted Stock, will automatically be forfeited) upon
consummation of the Covered Transaction, other than Awards assumed pursuant to Section&nbsp;7(a)(1) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(6)<I>&nbsp;<U>Additional Limitations</U></I>. Any share
of Stock and any cash or other property delivered pursuant to Section&nbsp;7(a)(2) or Section&nbsp;7(a)(3) above with respect to an Award may, in the discretion of the Administrator, contain such restrictions, if any, as the Administrator deems
appropriate to reflect any performance or other vesting conditions to which the Award was subject and that did not lapse (and were not satisfied) in connection with the Covered Transaction. For purposes of the immediately preceding sentence, a <FONT
STYLE="white-space:nowrap">cash-out</FONT> under Section&nbsp;7(a)(2) above or acceleration under Section&nbsp;7(a)(3) above will not, in and of itself, be treated as the lapsing (or satisfaction) of a performance or other vesting condition. In the
case of Restricted Stock that does not vest and is not forfeited in connection with the Covered Transaction, the Administrator may require that any amounts delivered, exchanged or otherwise paid in respect of such Stock in connection with the
Covered Transaction be placed in escrow or otherwise made subject to such restrictions as the Administrator deems appropriate to carry out the intent of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(b)<I>&nbsp;<U>Changes in and Distributions With Respect to Stock</U></I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(1)<I>&nbsp;<U>Basic Adjustment Provisions</U></I>. In the event of a stock dividend, stock split or combination of shares (including a reverse stock split),
recapitalization, reclassification or other distribution of the Company&#146;s equity securities without the receipt of consideration by the Company, or other change in the Company&#146;s capital structure that constitutes an equity restructuring
within the meaning of FASB ASC 718, the Administrator will make appropriate adjustments to the maximum number of shares specified in Section&nbsp;4(a) that may be delivered under the Plan and will also make appropriate adjustments to the number and
kind of shares of stock or securities subject to Awards then outstanding or subsequently granted, any exercise or purchase prices (or base values) relating to Awards and any other provision of Awards affected by such change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(2)<I>&nbsp;<U>Certain Other Adjustments</U></I>. The Administrator may also make adjustments of the type described in Section&nbsp;7(b)(1) above to take into account
distributions to stockholders other than those provided for in Section&nbsp;7(a) and 7(b)(1), or any other event, if the Administrator determines that adjustments are appropriate to avoid distortion in the operation of the Plan, having due regard
for the qualification of ISOs under Section&nbsp;422 and the requirements of Section&nbsp;409A, where applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(3)<I>&nbsp;<U>Continuing Application of Plan
Terms</U></I>. References in the Plan to shares of Stock will be construed to include any stock or securities resulting from an adjustment pursuant to this Section&nbsp;7. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>8. LEGAL CONDITIONS ON DELIVERY OF STOCK </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Company will not be obligated to deliver any shares of Stock
pursuant to the Plan or to remove any restriction from shares of Stock previously delivered under the Plan until: (i)&nbsp;the Company is satisfied that all legal matters in connection with the issuance and delivery of such shares have been
addressed and resolved; (ii)&nbsp;if the outstanding Stock is at the time of delivery listed on any stock exchange or national market system, the shares to be delivered have been listed or authorized to be listed on such exchange or system upon
official notice of issuance; and (iii)&nbsp;all conditions of the Award have been satisfied or waived. The Company may require, as a condition to exercise of the Award, such representations or agreements as counsel for the Company may consider
appropriate to avoid violation of the Securities Act of 1933, as amended, or any applicable state or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> securities law. Any Stock required to be issued to Participants under the Plan will be evidenced in
such manner as the Administrator may deem appropriate, including book-entry registration or delivery of stock certificates. In the event that the Administrator determines that Stock certificates will be issued to Participants under the Plan, the
Administrator may require that certificates evidencing Stock issued under the Plan bear an appropriate legend reflecting any restriction on transfer applicable to such Stock, and the Company may hold the certificates pending lapse of the applicable
restrictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>9. AMENDMENT AND TERMINATION </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Administrator may at any time or times amend the Plan or any
outstanding Award for any purpose which may at the time be permitted by law, and may at any time terminate the Plan as to any future grants of Awards; provided, that except as otherwise expressly provided in the Plan the Administrator may not,
without the Participant&#146;s consent, alter the terms of an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>58</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">Award so as to affect materially and adversely the Participant&#146;s rights under the Award, unless the Administrator expressly reserved the right to do so at the time
the Award was granted or unless the Administrator determines in its sole discretion and prior to the date of any Covered Transaction that such amendment or alteration either (i)&nbsp;is required or advisable in order for the Company, the Plan or the
Award to satisfy any law or regulation or to meet the requirements of or avoid adverse financial accounting consequences under any accounting standard, or (ii)&nbsp;is not reasonably likely to significantly diminish the benefits provided under such
Award, or that any such diminishment has been adequately compensated. Any amendments to the Plan will be conditioned upon stockholder approval only to the extent, if any, such approval is required by law (including the Code and applicable stock
exchange requirements), as determined by the Administrator. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>10. OTHER COMPENSATION ARRANGEMENTS </B></FONT></P>
<P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The existence of the Plan or the grant of any Award will not in
any way affect the Company&#146;s right to Award a person bonuses or other compensation in addition to Awards under the Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>11.
MISCELLANEOUS </B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(a)<I>&nbsp;<U>Waiver of Jury
Trial</U></I>. By accepting an Award under the Plan, each Participant waives any right to a trial by jury in any action, proceeding or counterclaim concerning any rights under the Plan and any Award, or under any amendment, waiver, consent,
instrument, document or other agreement delivered or which in the future may be delivered in connection therewith, and agrees that any such action, proceedings or counterclaim will be tried before a court and not before a jury. By accepting an Award
under the Plan, each Participant certifies that no officer, representative, or attorney of the Company has represented, expressly or otherwise, that the Company would not, in the event of any action, proceeding or counterclaim, seek to enforce the
foregoing waivers. Notwithstanding anything to the contrary in the Plan, nothing herein is to be construed as limiting the ability of the Company and a Participant to agree to submit disputes arising under the terms of the Plan or any Award made
hereunder to binding arbitration or as limiting the ability of the Company to require any eligible individual to agree to submit such disputes to binding arbitration as a condition of receiving an Award hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(b)<I>&nbsp;<U>Limitation of Liability</U></I>. Notwithstanding anything to the contrary in the Plan, neither the Company, nor any Affiliate, nor the Administrator, nor
any person acting on behalf of the Company, any Affiliate, or the Administrator, will be liable to any Participant or to the estate or beneficiary of any Participant or to any other holder of an Award by reason of any acceleration of income, or any
additional tax (including any interest and penalties), asserted by reason of the failure of an Award to satisfy the requirements of Section&nbsp;422 or Section&nbsp;409A or by reason of Section&nbsp;4999 of the Code, or otherwise asserted with
respect to the Award. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>12. ESTABLISHMENT OF <FONT STYLE="white-space:nowrap">SUB-PLANS</FONT> </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The Administrator may from time to time establish one or more <FONT STYLE="white-space:nowrap">sub-plans</FONT> under the Plan for purposes of satisfying applicable blue
sky, securities or tax laws of various jurisdictions. The Administrator will establish such <FONT STYLE="white-space:nowrap">sub-plans</FONT> by adopting supplements to the Plan setting forth (i)&nbsp;such limitations on the Administrator&#146;s
discretion under the Plan as it deems necessary or desirable and (ii)&nbsp;such additional terms and conditions not otherwise inconsistent with the Plan as it deems necessary or desirable. All supplements so established will be deemed to be part of
the Plan, but each supplement will apply only to Participants within the affected jurisdiction (as determined by the Administrator). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>13.
GOVERNING LAW </B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The laws of the State of Delaware
will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#146;s conflict of laws rules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>59</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>EXHIBIT A </B></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL"><FONT COLOR="#4c4c4c"><B>Definition
of Terms </B></FONT></P> <P STYLE="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #0071ce">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">The following terms, when used in the
Plan, will have the meanings and be subject to the provisions set forth below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Administrator</U></I><I>&#148;:</I>&nbsp;The Compensation
Committee, except that the Compensation Committee may delegate (i)&nbsp;to one or more of its members (or one or more other members of the Board (including the full Board)) such of its duties, powers and responsibilities as it may determine;
(ii)&nbsp;to one or more officers of the Company the power to grant Awards to the extent permitted by Section&nbsp;157(c) of the Delaware General Corporation Law; and (iii)&nbsp;to such Employees or other persons as it determines such ministerial
tasks as it deems appropriate. In the event of any delegation described in the preceding sentence, the term &#147;Administrator&#148; will include the person or persons so delegated to the extent of such delegation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Affiliate</U></I><I>&#148;:</I>&nbsp;Any corporation or other entity that stands in a relationship to the Company that would result in the Company and
such corporation or other entity being treated as one employer under Section&nbsp;414(b) and Section&nbsp;414(c) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Award</U></I><I>&#148;:</I>&nbsp;Any or a combination of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(i) Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(ii) SARs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(iii) Restricted Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(iv) Unrestricted Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(v) Stock Units, including Restricted Stock Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(vi) Performance Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(vii) Cash Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">(viii) Awards (other than Awards described in (i)&nbsp;through
(vii)&nbsp;above) that are convertible into or otherwise based on Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Board</U></I><I>&#148;:</I>&nbsp;The Board of Directors of the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Cash Award</U></I><I>&#148;:</I>&nbsp;An Award denominated in cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Cause</U></I><I>&#148;:</I>&nbsp;In the case of any Participant who is party to an employment or severance-benefit agreement that contains a
definition of &#147;Cause,&#148; the definition set forth in such agreement will apply with respect to such Participant under the Plan for so long as such agreement is in effect. In the case of any other Participant, &#147;Cause&#148; will mean, as
determined by the Administrator in its reasonable judgment, (i)&nbsp;a substantial failure of the Participant to perform the Participant&#146;s duties and responsibilities to the Company or subsidiaries or substantial negligence in the performance
of such duties and responsibilities; (ii)&nbsp;the commission by the Participant of a felony or a crime involving moral turpitude; (iii)&nbsp;the commission by the Participant of theft, fraud, embezzlement, material breach of trust or any material
act of dishonesty involving the Company or any of its subsidiaries; (iv)&nbsp;a significant violation by the Participant of the code of conduct of the Company or its subsidiaries of any material policy of the Company or its subsidiaries, or of any
statutory or common law duty of loyalty to the Company or its subsidiaries; (v)&nbsp;material breach of any of the terms of the Plan or any Award made under the Plan, or of the terms of any other agreement between the Company or subsidiaries and the
Participant; or (vi)&nbsp;other conduct by the Participant that could be expected to be harmful to the business, interests or reputation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Change in Control</U></I><I>&#148;:</I>&nbsp;The first to occur of (i)&nbsp;a &#147;person,&#148; as such term is used in Sections 13(d) and 14(d) of
the Exchange Act (other than the Company or one of its subsidiaries or an employee benefit plan of the Company or any of its subsidiaries, including any trustee of such plan acting as trustee) becoming the &#147;beneficial owner&#148; (as defined in
Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%)&nbsp;or more of the combined voting power of the Company&#146;s then outstanding
securities entitled to vote generally in the election of directors; (ii)&nbsp;a consummation of (x)&nbsp;a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting
securities of the Company outstanding immediately prior thereto continuing to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>60</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL" ALIGN="right"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL">represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%)&nbsp;of the total voting
power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, or (y)&nbsp;the sale or disposition by the Company of all or substantially all the Company&#146;s assets;
or (iii)&nbsp;a change in the composition of the Board, as a result of which fewer than a majority of the directors are Incumbent Directors. &#147;Incumbent Directors&#148; shall mean directors who either (A)&nbsp;are directors of the Company as of
the date the Plan is approved by the stockholders, or (B)&nbsp;are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but shall
not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company). For the avoidance of doubt, a transaction will not constitute a Change in
Control if: (i)&nbsp;its sole purpose is to change the jurisdiction of the Company&#146;s incorporation, or (ii)&nbsp;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held
the Company&#146;s securities immediately before such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Code</U></I><I>&#148;:</I>&nbsp;The U.S. Internal Revenue Code of 1986 as from
time to time amended and in effect, or any successor statute as from time to time in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Compensation
Committee</U></I><I>&#148;:</I>&nbsp;The Compensation Committee of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Company</U></I><I>&#148;:</I>&nbsp;Arrowhead Pharmaceuticals, Inc.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Covered Transaction</U></I><I>&#148;:</I>&nbsp;Any of (i)&nbsp;a consolidation, merger, or similar transaction or series of related transactions,
including a sale or other disposition of stock, in which the Company is not the surviving corporation or which results in the acquisition of all or substantially all of the Company&#146;s then outstanding common stock by a single person or entity or
by a group of persons and/or entities acting in concert; (ii)&nbsp;a sale or transfer of all or substantially all the Company&#146;s assets; or (iii)&nbsp;a dissolution or liquidation of the Company. Where a Covered Transaction involves a tender
offer that is reasonably expected to be followed by a merger described in clause (i)&nbsp;(as determined by the Administrator), the Covered Transaction will be deemed to have occurred upon consummation of the tender offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Date of Adoption</U></I><I>&#148;:</I>&nbsp;The earlier of the date the Plan was approved by the Company&#146;s stockholders or adopted by the Board,
as determined by the Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Employee</U></I><I>&#148;:</I>&nbsp;Any person who is employed by the Company or an Affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I>Employment</I><I>&#148;:</I>&nbsp;A Participant&#146;s employment or other service relationship with the Company and its Affiliates. Employment will be
deemed to continue, unless the Administrator expressly provides otherwise, so long as the Participant is employed by, or otherwise is providing services in a capacity described in Section&nbsp;5 to the Company or an Affiliate. If a
Participant&#146;s employment or other service relationship is with an Affiliate and that entity ceases to be an Affiliate, the Participant&#146;s Employment will be deemed to have terminated when the entity ceases to be an Affiliate unless the
Participant transfers Employment to the Company or its remaining Affiliates. Notwithstanding the foregoing and the definition of &#147;Affiliate&#148; above, in construing the provisions of any Award relating to the payment of &#147;nonqualified
deferred compensation&#148; (subject to Section&nbsp;409A) upon a termination or cessation of Employment, references to termination or cessation of employment, separation from service, retirement or similar or correlative terms will be construed to
require a &#147;separation from service&#148; (as that term is defined in <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)</FONT> of the Treasury Regulations, after giving effect to the presumptions contained therein) from the Company and
from all other corporations and trades or businesses, if any, that would be treated as a single &#147;service recipient&#148; with the Company under <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)(3)</FONT> of the Treasury Regulations. The
Company may, but need not, elect in writing, subject to the applicable limitations under Section&nbsp;409A, any of the special elective rules prescribed in <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)</FONT> of the Treasury Regulations
for purposes of determining whether a &#147;separation from service&#148; has occurred. Any such written election will be deemed a part of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Exchange Act</U></I><I>&#148;:</I>&nbsp;The Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Fair Market Value</U></I><I>&#148;: </I>As of any date, the value of the Stock determined as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:ARIAL; " ALIGN="left">If the Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a
share of Stock as of any date of determination will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the
Stock) on the date of determination, as reported in a source the Board deems reliable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:ARIAL; " ALIGN="left">Unless otherwise provided by the Board, if there is no closing sales price for the Stock on the date of determination,
then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT COLOR="#0071ce"><B>61</B></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT COLOR="#0071ce"><B>&nbsp;</B></FONT></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:ARIAL"><FONT COLOR="#0071ce"><B>2021 PROXY STATEMENT&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT><FONT
STYLE="font-family:arial" COLOR="#3fae2a"><B><I>Exhibit A </I></B></FONT><FONT STYLE="font-family:ARIAL" COLOR="#0071ce"><B> </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:ARIAL; " ALIGN="left">In the absence of such markets for the Stock, the Fair Market Value will be determined by the Board in good faith and in a
manner that complies with Sections 409A and 422 of the Code. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>ISO</U></I><I>&#148;:</I>&nbsp;A Stock Option intended to be an
&#147;incentive stock option&#148; within the meaning of Section&nbsp;422. Each Stock Option granted pursuant to the Plan will be treated as providing by its terms that it is to be an NSO unless, as of the date of grant, it is expressly designated
as an ISO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>NSO</U></I><I>&#148;:</I>&nbsp;A Stock Option that is not intended to be an &#147;incentive stock option&#148; within the meaning of
Section&nbsp;422. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Participant</U></I><I>&#148;:</I>&nbsp;A person who is granted an Award under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Performance Award</U></I><I>&#148;:</I>&nbsp;An Award subject to Performance Criteria. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Performance Criteria</U></I><I>&#148;:</I>&nbsp;Specified criteria, other than the mere continuation of Employment or the mere passage of time, the
satisfaction of which is a condition for the grant, exercisability, vesting or full enjoyment of an Award. Such criteria may include, without limitation, a measure of performance relating to any or any combination of the following (measured either
absolutely or by reference to an index or indices and determined either on a consolidated basis or, as the context permits, on a divisional, subsidiary, line of business, project or geographical basis or in combinations thereof): sales; revenues;
assets; expenses; earnings before or after deduction for all or any portion of interest, taxes, depreciation, or amortization, whether or not on a continuing operations or an aggregate or per share basis; return on equity, investment, capital or
assets; one or more operating ratios; borrowing levels, leverage ratios or credit rating; market share; capital expenditures; cash flow; stock price; stockholder return; sales of particular products or services; customer acquisition or retention;
acquisitions and divestitures (in whole or in part); joint ventures and strategic alliances; spin-offs, <FONT STYLE="white-space:nowrap">split-ups</FONT> and the like; reorganizations; or recapitalizations, restructurings, financings (issuance of
debt or equity) or refinancings. A Performance Criterion and any targets with respect thereto determined by the Administrator need not be based upon an increase, a positive or improved result or avoidance of loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Plan</U></I><I>&#148;:</I>&nbsp;The Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan as from time to time amended and in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Prior Plan</U></I><I>&#148;: </I>The Arrowhead Research Corporation 2013 Incentive Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Restricted Stock</U></I><I>&#148;:</I>&nbsp;Stock subject to restrictions requiring that it be redelivered or offered for sale to the Company if
specified conditions are not satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Restricted Stock Unit</U></I><I>&#148;:</I>&nbsp;A Stock Unit that is, or as to which the delivery of
Stock or cash in lieu of Stock is, subject to the satisfaction of specified performance or other vesting conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>SAR</U></I><I>&#148;:</I>&nbsp;A right entitling the holder upon exercise to receive an amount (payable in cash and/or in shares of Stock of
equivalent value) equal to the excess of the Fair Market Value of the shares of Stock subject to the right over the base value from which appreciation under the SAR is to be measured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Section&nbsp;409A</U></I><I>&#148;:</I>&nbsp;Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Section&nbsp;422</U></I><I>&#148;:</I>&nbsp;Section&nbsp;422 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Stock</U></I><I>&#148;:</I>&nbsp;Common stock of the Company, par value $0.001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Stock Option</U></I><I>&#148;:</I>&nbsp;An option entitling the holder to acquire shares of Stock upon payment of the exercise price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Stock Unit</U></I><I>&#148;:</I>&nbsp;An unfunded and unsecured promise, denominated in shares of Stock, to deliver Stock or cash measured by the
value of Stock in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:ARIAL"><I>&#147;</I><I><U>Unrestricted Stock</U></I><I>&#148;:</I>&nbsp;Stock not subject to any restrictions under the terms of the Award.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" ALIGN="center">

<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="middle"><FONT COLOR="#0071ce"><B>62</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g76219g27e04.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR></TABLE>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:16pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; margin-left:2.00em; font-size:8pt; font-family:Times New Roman"><I>ARROWHEAD PHARMACEUTICALS, INC.</I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:8pt; font-family:Times New Roman"><I>177 EAST COLORADO BLVD, SUITE 700</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:8pt; font-family:Times New Roman"><I>PASADENA, CA 91105</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY INTERNET</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>Before The Meeting </I>- Go to <B><U>www.proxyvote.com</U></B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off
date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><I>During The Meeting</I> - Go to
<B><U>www.virtualshareholdermeeting.com/ARWR2021</U></B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">You may attend the meeting
via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY PHONE - 1-800-690-6903</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Use any touch-tone telephone
to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>VOTE BY MAIL</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes
Way, Edgewood, NY&nbsp;11717.</P></TD></TR>
</TABLE> <P STYLE="margin-top:60pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">D30472-P48774&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;KEEP THIS PORTION FOR YOUR RECORDS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&#151;&nbsp;&#151;&nbsp;&#151; </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:6pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">DETACH&nbsp;AND&nbsp;RETURN&nbsp;THIS&nbsp;PORTION&nbsp;ONLY</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;
</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 2.00pt;border-radius:6pt; background-color:;;padding-top:2pt;padding-bottom:3pt"><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="7"><B>ARROWHEAD PHARMACEUTICALS, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>All</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>&nbsp;Against&nbsp; All</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;For&nbsp;All&nbsp;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Except</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="6"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"><B>The Board of Directors recommends you vote FOR ALL the following director nominees:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT COLOR="#4c4c4c">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT COLOR="#4c4c4c">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT COLOR="#4c4c4c">&#9744;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Election of Directors</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman; "><B>Nominees:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">01)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:8pt">Christopher&nbsp;Anzalone&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;05)&nbsp;&nbsp;&nbsp;&nbsp;Oye&nbsp;Olukotun</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">02)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:8pt">Marianne&nbsp;De&nbsp;Backer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;06)&nbsp;&nbsp;&nbsp;&nbsp;Michael&nbsp;S.&nbsp;
Perry</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">03)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-size:8pt">Mauro&nbsp;Ferrari&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
07)&nbsp;&nbsp;&nbsp;&nbsp;William&nbsp;Waddill</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">04)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">Douglass Given</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> </DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"><FONT STYLE="font-size:8pt">To vote against any individual nominee(s), mark &#147;For All Except&#148; and write the number(s) of the nominee(s) on the line below.</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.50pt solid #000000; BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:arial; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"><FONT STYLE="font-family:Times New Roman; "><B>The Board of Directors recommends you vote FOR proposals 2, 3, and 4:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman; "><B>For</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman; "><B>Against</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman; "><B>Abstain</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:8pt">To approve, in an advisory (non-binding) vote, the compensation paid to the Company&#146;s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the
compensation tables and narrative discussion.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">3.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:8pt">To approve the Arrowhead Pharmaceuticals, Inc. 2021 Incentive Plan.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD>
<TD HEIGHT="10" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt">4.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:8pt">To ratify the selection of Rose, Snyder &amp; Jacobs LLP as independent auditors of the Company for the fiscal year ending September 30, 2021.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-size:8pt">&#9744;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="12"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="11"><B>NOTE: </B>Such other business as may properly come before the meeting or any adjournment thereof.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary,
please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature&nbsp;[PLEASE&nbsp;SIGN&nbsp;WITHIN&nbsp;BOX]&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature&nbsp;(Joint&nbsp;Owners)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> </div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice
Regarding the Availability of Proxy Materials for the Annual Meeting: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The Notice and Proxy Statement and Form 10-K are available at
www.proxyvote.com. </P> <P STYLE="font-size:130pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;
&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;&nbsp;&#151;</TD></TR>
</TABLE> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">D30473-P48774&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:SEPARATE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="border-radius:6pt; BORDER:2.00pt solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ARROWHEAD PHARMACEUTICALS, INC.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Annual Meeting of Stockholders</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>March 18, 2021 10:00 AM, PT</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is solicited by the Board of Directors</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; margin-right:1.00em; font-size:10pt; font-family:Times New Roman">The stockholder(s) hereby
appoint(s) Christopher Anzalone and Patrick O&#146;Brien or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of
the shares of Common Stock of ARROWHEAD PHARMACEUTICALS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 10:00 AM, PT on March 18, 2021, online at www.virtualshareholdermeeting.com/ARWR2021,
and any adjournment or postponement thereof.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; margin-right:1.00em; font-size:10pt; font-family:Times New Roman"><B>This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this
proxy will be voted in accordance with the Board of Directors&#146; recommendations.</B></P> <P STYLE="font-size:100pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Continued and to be signed on reverse side</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g76219g01r22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76219g01r22.jpg
M_]C_X1!G17AI9@  34T *@    @ # $   ,    ! T@   $!  ,    !!#@
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   >    M $R  (    4    TH=I  0    !    Z    2  "  (  @ "OR
M   G$  *_(   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C R
M,3HP,3HR-R Q.3HT,3HU-0     $D   !P    0P,C(QH $  P    '__P
MH ( !     $   *\H , !     $   .$          8! P #     0 &   !
M&@ %     0   6X!&P %     0   78!*  #     0 "   " 0 $     0
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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MU<=@K9M/T3938[(]![HVM]>M_L_ZXNI%]K?I-$>1A.\XV74['R&-MJM$/IM
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M46=//^$?!\&B?^DY5>8RF^"/^%_WK#D,I>F/^$?^Y0TB 7?(*0N93D,L>Y[
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M!'LKACV7D]]3W*:4DTIR7__9_^T8&%!H;W1O<VAO<" S+C  .$))300$
M   :' %:  ,;)4<< @   @  ' (%  9G,#%R,C(X0DE-!"4      ! 5,J4*
M%<5Q_[W,;*.EUT5(.$))300Z      #W    $     $       MP<FEN=$]U
M='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
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M<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M    0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T
M=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT
M;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !
M2     $  0!(     0 !.$))300F       .             #^    X0DE-
M! T       0    >.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ !
M &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M   ! #4    ! "T    &       !.$))30/X      !P  #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      -'    !@             #A    KP    )
M &< ,  Q '( ,@ R $X 10!7     0                         !
M          *\   #A                      !
M     !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   #A     !29VAT;&]N9P   KP    &<VQI8V5S5FQ,<P
M  %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M   '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I
M9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP
M90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   X0
M    4F=H=&QO;F<   *\     W5R;%1%6%0    !        ;G5L;%1%6%0
M   !        37-G951%6%0    !       &86QT5&%G5$585     $
M  YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M  EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U
M;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E
M $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M        #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N
M9P      .$))300H       ,     C_P        .$))3001       ! 0 X
M0DE-!!0       0    !.$))300,      []     0   'P   "@   !=
MZ(    [A !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]L
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M(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@
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M#@   00" P$!              $" P0%!@<("0H+ 0$  @(# 0$
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MOL,9(X)QX,AO$UZL)"4D9@^V4228LG,D])[<<8 ;Q"<IB><H "K&0!.4^B<
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M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0!C^C;[H /M]N^ " " " " " " "
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M$$;XJ6)$MX 8]&_V1=0PK)T15RX#PV09R5AO&'LBT>1-4EB0VZ=@L9"HX"9
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M\S26PR;+)/61( 82&X[-D09$J&981Y;03TD]&,L-LY2@22'(]1]D 00 0 0
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MZB=R$2HA05N(,2U5-) VE(_9-JQF4C [)B<NR.,5=*NFP<GYA]MD 30 0 0
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MZ2!C.4IX]/% %M))^4YRRVP!?8?4L)1EPB0EM PGA+:( R:5D8@F1&T]^73
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M,[L 2)8;=THCFW15(C&56UB9)IF?ZH).(3+!(&>><07226!D&Z:123(\*L)
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M#"4.!*AQ9:0S,D %1SW=LYX&!<N-TY^960$P!T2P/5 $TAN&!G.6, 6<?O\
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M;?U'+Q_HN4OD/HW^%G+W+WFI"_&/L6-/OR;WKF48+[3/LTC\^#])11F.L>V
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MZ<R93&R<HM3%8DF\6RC' !A*83B)' RGUSAZ S?;31?M$B1( &.0XCAAA(D
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MO.J)<=<)4M1)CNH1C"*C&*44C7)2E.3G.3<F\3*J=#:@02%H4E22)@I4""%
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MW(]'76IGNEL$A@,AF!',.O(8 ( ( ( ( ( ( ( ( ( ( ( Q\ $ $ $ $ $
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M.!M?Y3__ -15HG_VTYA?XTHHOD/[-'O935/[7/N1Z03GG',.O*\ $ $ $ $
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M1R]])/IEY67AK46C.3.CZ"_4RP]17NZ,/W^OMS@F0[0.7IVL:HU@@$*2D*!
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M9-YB*:T">!Q(F.D0!&4* GNQV^Z (EXI(WCVF ,8^T0>($;R3A//'<(A*F[
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M#?O1L04Y1;3:1R<MEI9J4X0DDU&N/8=EE)X3*8,TH5,?ST)6!U@*C,<8; !
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M)/>V_@2V)*B2222225KE;7"V<VN3]T*PV+9S<Y;5Q6I24)1]+JZU.E14HA*
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MLW'9G3A ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! &/@
M@ @ @ @ @ @ @ @ @ @#_]'[%6'$2)4Z@B8$_,2K$3P 3B9".28B<.(X"0X%
M F6!'$0-H$IX;X,#45"5@\))()EB<AMPV>V(KZB"9+A(P498$SWX'N$3M6*!
M*EU<IAR6.W;+;,PHMY(XOO2Q<!W@!/A\,11+<11;1OG.;5$C=@/8(G#@2 >4
M,1F-Y)]T21Q'HJ5A0XLMLN+<>F4029)NH0I),PF><\L,@#CG%>6O-VDUV=A=
M86II2'F77&G6SQ-N-.*0M!)D5)6DA:3+<8JH1DFI*O%?R$\\DZIG7KG/Z/\
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M0@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @#'P 0 0 0
M0 0 0 0 0 0 0!__TOIU%?=F ."OJ6Q.<PX009C$$3,HY-4]CJ8BY3:DU(QB
MBZOJ;'PD!?&I4\MG%F>Z)!F*;6]_I9)46ZOB!/ \EP3'](I XD=>,0#9J3F4
MH!)K*!Y1$@L4Y;*,9":4K*< >Z -OMVO-.5:0':U-O=5/]C5(4%DY2_9I4)^
M$ ;E35=)5-\=-4TSJ3B'4+;.!D9J23Q"<]T/20*<22#Q &7$,4YG$'<8(D;_
M "0 H$\L9XB4 *"4^X_;. ,PPJ:4C'($;R?T^R*R6#2VA-/9B9EA14CI&!^[
MNB4URQ:#P+C2>))$IXD>$^R,5QTDB&7:=$N'<)].8VX;C!>U)-EE[K?:7DC$
M#*9V1E>">!5EY X1NG[)??'&"3=>P? @( 3?/WP9>>%*"%29&1V;O9A K5\3
M'U"P 1C.6!Z\QUQD3Y84WLM%8UW(PE09F6Y)^^+6U@V5K6K*4IX9]$9"2VPI
MUE4V7'&EJ!25MK4VJ4L4\2"%<)W;8-I*M-A#[2XE,@/A$\R98XXXDXDF><<9
MOFKC@RRC5-CC)0(.V((<6E4K.-G"73U$='3&2$^7!["J964F>"AEWXX>R,VU
M=A8KJ;Q& ]DQN WB%%P!7<;EB,L9&4IRD2#+KBDHI[,&B8NF[!E9?RF*0]Y%
MWL92=V_T??&8QE: (5_,9]'L@"%S9V_= &*?_4_S7W'[X K'(]1]D 00 HS'
M6( L %1D,\MWME %YEJ0QS.>WL Z 8=P+J$)2,NH; #CWF!!*,QUCVP),S3?
MU:3TGP,5ELPVDKMV&STBY+^'(I!D<QB.Z*R22C*7O$1Q:9L["AP@C 2SZ]_=
M&)[63#:T9JE<F@MYA,U [I8R["(&0G@ @ @ @ @ @ @ @ @ @ @ @ @ @ @
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MRF6.!!5G\(ZR#+9OG&%UK4/"3H\#,T:DDG"1D1US ]D#*7H ( ( ( ( ( (
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MHR%2D[M_I>^ ("9"?VQPB&JT!4<<QV"9EX9#IB08UR96J9)DH[3O@""<RO/
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MAA$4P2(QPHSF*P:ZM]S4W3W B@JU2;EB0\J4RN8P2#(F(<=E&6K@T<H,N)2
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M7];[;HE;9=_R$/<;'1_.G^@?8(P/YQ+]Q&>9V?YF()AL,FQ^O_F?O@7+$ $
M$ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ !P!.Z *_G_ ,S_ #W_ %L (7Y@
M@)QV'B/W" )F3\ Z0J?3\V< /@#'P 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0!
M_]#[*EJ34-H>1*;@ *0)<( G, Y 2ZXY"26!B>+*BDYC;L/<<.L1(*KE//$2
M,L)3.1P.V4X@@UNN3PI4<9IP.&U)X<.G&))6U'&=_4I#O$F>2A@9$@D3P\(
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M#XC+&>>V*F2/NHLI)!!&PSZY8R@22^>?PB #SS^$=Y@!0\20.$8D#" +$ $
M$ $ $ $ $ $ $ $ $ $ $ $ $ !P!.Z *I?)PX1EG/PE* (8 ( 4*4)241EW
M3REE $WGG\([S $$ $ $ $ $ $ $ $ $ $ $ $ $ $ ,69##?[X CF=Y[S '
M_]'[%[.^E+BV5$D*2C@)/PI^.1&1$<AJM'P,7$RM0TE*W E0Q"3CT9C"<YQ/
MQ J%$\-HQET;P8;F@8>OI00HB4CG/8J>&^<]L <;7FUK<4LC': 1\OQ8@;2D
M_;" -3<LSP*OAF 92&)/40902]8-JLMOX D<!"R<SM(2<3A,2'C '*-M:X&U
M 2PD!OWR&&TG"!!L+33DV^+(@[<I RGCOW1#:IM)I4R].S,@[!.>&)&<_&(2
MJTVJ);OP^ ETHU2K+GE(W>SW1;#A@057:,*23Q3.P$9S. $C$<N#2>#%:TJ:
MY54AXBF04DDRGAMG([<^Z)336 ,<JA2DXDC$X8'LSV& ,9542@DS(((P4!AC
MOVC#I@#5GV'J9X.L*+;K2@IM23PD*!!G\)3(;]A@#F?1^M6[NA%MN(+=R82$
M!05/ZF0_5!D>(@3E.,4XI*JV$<5+!T.2 =A()P.!G@<CVQB"3>X= @KK$^(;
MR?;$Q=))@Q-8@B8E/X<.J>,YQ:JYN:E$6W)F#?$A/# ',=4_",TFZ-K:%1M)
M["%MTS&?S">.,M_3"+KMVAJAE6%@&1,@<NC;EGG&.ZE@R-CJ74K*,)DB>SN'
M08HFUL9D3C(<IPD$8X] $2YRXCV5B1DG:3WF*A23=!!\:@)S*C*>>0VG<(+%
MI%G@JDZ6%3&(,S*4M_?%^1K%M4*\R&J86)RREE+'=@3**N+6-:HJ^63VD!9F
M",<>D1"JG5$<C["/Z:6.)[CX"+^)+L)Y9=@OE)Z/[$>^*UE])CDEQ#RD]']B
M/?"LOI,<DN(>4@@[#+"20,>N<%-II\WPD.,EB,^G/XHOXKX$*KP'?2])[Q$>
M)+@BW++L%332(..'2(ASE)4=!RR["0-[IS!&9&&,]F.44H.3B\"4-J493 GM
M^THE19912Q'!E0(,QACW19P:3;V#F3P*[IDE1SDHF4\Y X=L5I5I%)^\82I4
M9RV$9=<\8SR?*J;R4JLI#;U_<(EX1[$%BR_2HPZ5$=6,0L$V]NTBM=FPVNC0
M )C9+L&W9O$876B?%D-X(S3/R=IB#*MB[BZL#RD[Y)/3C DKP 0 Y/S)_I#V
MP!?.'3U0 D $ $ $ $ $ $ $ $ $ &_+[^R #?B!+''" " #;*  C C#+/9E
M &/@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @!B\NW[C $4 ?_]+[#BE+
M%8RI('"I<I8X!0 ,@, ?MA')3P?$Q&UJIRJ2A@2!OW3QPW'OBJEA[2H*%1VF
M<'RR^898$3.(RRB4TZ<11E1ZG6!PJ'S92QSRSQEA$]BV@P53:5.'$ S&)D$G
M^B<XBKWK @QB;$HJ,QMVA(']E(\43Z"3+4-H#8!4$YF>1),L)J PPW0?>#:*
M>E"/BF)RE*6"<B9;X;Z4!>2F4@/MG.<4<FVU%%DJ8LR+">$$["-IQR$L@,HN
ML$D5)X (D%9ZG#A*A*9&((&)Z,(KBM@6RC*:J(R)*0,L0H3D#TX2B*SWI4)]
MG"E3#U='(*,B4D?&D B6..$\#WQ*=6^!5X;C5JRA 49@$$D@C.6Y6&&?7$DF
MM5#%135"*JF4MMRG4'6EH*DJXDXX. @I$M^<*5P>PCB]YSEHS5K-\9-'5.)%
MSIQB)!(?0$B24;2I('1&&<&E5;!@JMF]"8SGQ$SD=@QRRC&&FL6\1%C"8W^_
M/? /Y#%U&*C/'+VQDE[L.XM%5@S!U")<0&/S';TX#.+VW6/:51BQ\Q Z8A?I
M&9'[J,BV<3.9PPQ(E&0H7FG)E*2>SLV1@E!JKW$<2Q%"!4XJ Z1W[/&)2J98
MI<J="ZAK"8"1[^C",O-&&#6)1LD\M6P@'?C^B'B1X,BH%M1S(/63[H>)'@*D
M*FBI8&1GC+#8<0<HK))^TMF\NI46P7Z;^<?[(_VL1[':1S]@GTHW^/\ UL/8
M[1S]@HIA,8##I]N^"<$ZXARP)/)Z$=WZ(N[D7A3X$5J-\C^CWGW15.VL:,GF
M'I:D03P]T_N$)3BTTHD5[27A3^$=PC&15B^6/P#^Q'NA5\15\0X?YOA$U?$@
M@=DG'*0)[HR1;<)%H[:;C#5"L-P,U892E,=IE%;:K)/@3)^T^PP=2X./'#(#
M+">,NF,K57RMDK94K\2=XF<I;XKRQ2QE5$U;>"1E:)!($S^L#OW8=\)5C"CV
ME71O#8S:Z5)2F>6 VG$[XQ/8D2\98+!&;I1,$;T'O/#C R$Y)6GRP,4 S,\)
M(&,L)P! #(@R!EL.1Z( E\[^8F #S?YB8 7SS^$=Y@ \\_A'>8 0O$B4AV&
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M-W1*)3PBG6OX;0\&:K64LB4$X$$SE@1B)&?3UX19.H->0Y5VRL:K*%SRGF7
MM*TS1Q)'S),C,A0F,8-)X,8[CL/IG4%-J"A2^R2'FDA#S2OG29#XCC/,1@G'
MEEMP8^<JFQD8'#J[!GXQ4O+8S'/HF29YB?C.+^]&O K!TP,/4I,P>@C=,CIZ
M8FW3%;R*4;1AG<P1AE*6&8G$SPHT\2T<:U'M*4"D\2LCM/3*+Q]U$2VLOH.*
M2#M@]C[B#()F0!/$SS[?='&1:"P]):2UAG(COZXR1@WB]A+E0NH3P@8G+$;
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MW=[']"?8\);G7 [J*0M!*7$E*TF2DG @XYC&4>=)U55L/4FFFT]HV " " "
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MPQV8X'QB?=E5?@BSHXU,.^W+B)D",<,CEC&9-25=Q3M*8("@2,OOB07$J"@
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MT:2$]9EG.<^CHBOTF'L1M5(R 0N0"0F6$\9R)RVD1A=:5>UC=R;S,LI,^(8
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M?-?SEN>.P]W\M^MIYM6NF]9O-YF*?@79.KG%?Y.;>V2QY7O6&T[\91Y>>QA
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M<,<3[)1*COD8Z.6.XPE54RXUS5EB ?D!&'05&)2JTV_9+-X**>TUVJJT[U8
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M0Z,]0\J=8>2UZ]I-R3^[9V&'!788Q?\ .C5>H]6,H\0/HH( ( ( ( ( ( (
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M TZN;X'%%)Q0KC0<N$RF2 ,B1CUP>*H#L!H^\IO-EIE%:?J*9"6'T @E0;/
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MY]"]!_O=:_\ @BT?XLI(^4KGZ6[]>7VF?:UG]!EOZJ'V46HH9 @ @ @ @ @
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M%_NOI/U9?:9\M^8/[XZU]:'V(G!$;0:8$ $ $ $ $ $ $ -XD[_;[H 9QSS
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MTS[#V0"53<N5:P*F_(XY\+5$ DF8"BI4\-DXI--I851#53F2,! 0 0 ]*C,
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MZ+_=?2/J2^TSY9\P?WQUKZT/L1. XV@TP( ( ( ( ( ( ( KP 0 0 U7ZO\
MKC7]U1#CW/XAP[SZ%Z#_ 'NM?_!%H_Q921\I7/TMWZ\OM,^UK/Z#+?U4/LHM
M10R! $/$K?[( ; ! ! ! "C;$%)MJC3$E$D\ZVU'1!C<GCC@$" [NZ!/,^(0
M(" " " /_]+ZXZ=<CAL)V\.!ZMHV1R:;#%7:9AI?$#.<^GJQ@#&5SDWVDS(#
M>)$\%%8RZ^F'H(:J3MKDD =<IB<^F(2)>+J3I7,Y#+;C]PB02<9E(2&[/WP!
M3?<(!D9*WC#:)G#(80!AWW?F423,SGGT=<C #+54*3<D*!(D5 2)E_5KF)Y;
M( W]-:DE0DH3D9JE(F>.1@"\V],!:%$S$R)_RQ%4VX[R-N%3-TSW$$D&1!QD
M1("4^G**X*C;Q2Q[2RWJF+,TA7$!OD/Y8OCO*CH$A !]L( >RI*7V01,E4AW
M'LP$1+W6%M1L1$U-K3-,\"$X X8<6$8*53QK0;.94Q)HJ5&K^4]43'WD%M-<
MKP.)8(!F/M*,L=_"K^(OO7H-(K#/BGC@K/K@Z\L,=Z(EM?>:1< .%> P*B.@
MRS&Z,KWA;C9N624IN=RX0!QM,E<OUBD'AGOX=FZ,5U+EKOJ2MDEV'-L82@0
M0 0 H,N\'N@"8&>(,":JC5!8$ 8$QVH;$F6BX"P(:5'@+$&(("KXA 5:WAA
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M^?OF)_A]!_BNCCZ'Z*_=?2OJR^TSY8\POWQUGZT/L1. XVDTP)RR@ @ @ @
M@ @ @ @ @ &8, /#@2IHA(!^HIDI.YQRH:;;V9>8L1#V2[G\3.5DK?BY[(VO
MI7H+_"1]!M'YB**WH<)\Q%LMB'!E\:+?3(<PV?&#'RG<=;MUIX.<OM,^T-B2
MX)+X">* ( ( ( ( )0*\T>(0+#H@PU?$($! ! ! ! ! ! "3&\=\":]B/__4
M^MAA4N_#/#(QR3$L49=E05($3^50ZAB#WP!BJX)16DX?M,C+<<?B.0@!.*0$
MC(=<"6]BH/2N6TS^W3 4;V;1Q<P.)R^VV%1RE9Q>8Z,<<!]A CXC%O*!420)
MX;LMA.\P!+8V?-NKC@3-*29@@'XBRH R'7 C8;UP?S/\[^B)),E2M*1\1,@9
MDC&7RF6<H@&9IDG!6PDY]G?C"M* SS&TX3!$C+$812*3<Z\0Z-*FRA>!) )S
MD/9%P$ 1K5PF>P#*?7 #:4%;Z"9R"ID9@2!(D,LXB7NR>XC9@S84K4"A1,^'
MASRSR/7&%8M*3P,DDJ.B+2'25 3&)R$MHQ[91+4*.FTQ\N\>Y\BNJ*1>(6W'
M8:K7N3"MGQ2)V8F9&<XS03Y4]["QVO$T^O*3YA "9H4,!*9SV;XLVUC3:R6:
M)6*):7,DR.&)PQV18@W#E@B=?>5@8I13XS ,BI6'2(QW/=)XG-,8"HD $ $
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M))2M*ANRCZ0M7;5^U:OY>[&=BY%2A*+3C*+V--;4=FFFJQ=42QD)" " " "
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MR@G&22Q%63<:58;\,HQ.$EBR*4'<(&0'=$5;VL@6( 0 0 0 0 0 0 0 0 0
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M@O0SV7CP0]0" " " " " " " &*)X1LQ^XP)>UD<SO/? @2 " " " " " "
M" /_T_J5\R674<3D<\I1F4V_F&$5+F.!(,6KQ5$34D\U7X_&(YX_2 ]+Q)(
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MLV;V8N0LV+4IWI;$EC_(NT8+%[#HUS8YZW#6(J=/Z6-1:M)KXFJA]7[*Y7]
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M",?0OA/KW3<A8TK(Y73\LEX-J"2PV\7Z6<J\2=_MCI3G5(IG>>\P("9WGO,
M/DC>?MV0 BB#*7LE #( ( ( ( ( ( ( ( ( ( ( ( :I82.G[9Q>$>9X[ 0<
M2OQ'O,9N6/T42?_6^J2BTEPJ"JJIXY":D)64D88)"B""!M&V.28J+;\XV^DM
M]%1-_P!Z,( &"W5*2M?%APRPG* ,LVX#PDD&0.P2&SMP@"?S.+"<^B4ON@"1
M"E&8GA++"6!'5 $Z5&8!.&7NZ8 E@"PAU(2< DX8;\L<!T0!;0XDI&/W],L.
MB +:5 Y9_;$0 L ."B,)X=\ 66W"<)YB1$I82]D 7$JX0#NVYC=W& +"5@C
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MMTS5^-+*:QC;WS['-[.P]L\.GIGOWQ\]GK8D"0@ @ @ @ @ @ @ @ @ @ @
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M#J"98SV80 X*!P!]L'A1L@>D\*@K=$-53506 _B)B0ZA&)VFMXK+B2><WO\
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M %ML 3.Z4LL,YRZX ESQ$ /0I()XDS&6.8Z1B( R32T2$CND=^R1D3*0S@\
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M%Z]F+OZ2Y)R?>W6GH&1)0( ( (D!/(245*4E*$H25J6I1X4H0A(*EN+40$I
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M?W0#P?$N(=  ).S.6!PE,[C."5"!34G)*03CCW2R$C!8 8GS77!,22)S,LY
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MOB[MR6(HQ'%$ 2PG"W%-NJP)1'QJWF,O)'@2'&K>8<D> #C5O,.2/ #(L @
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M4UO"6QJ/4? KS*/2MI<4%.JP74+ ;1,DD;UT+T/G^M=25FVW9T:TT[][@O\
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M0!I^IS.JI.BG5+_ND_OC1.KO[3D_J/XS7-;_ $UGZORFM1J1T@0 0 0 0 0
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M_;P_Z[>57_,ES_TUW\0_9;7?[FOZ:#_HR\[_ /D=3_\ O!:_[>'_ %W\JO\
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MKVDC9P;J#T7].KJ4\G-/$D8734TND?O)&1Q$S'AO7*_^Y\]_5VOLGTAY;O\
M^S=._KK_ -LY<=J29\,QG(S'1[(U*IO!1<J%*,BJ?29>,MD1BVG6B((%O2[,
M<#*?5OB.5X\TL0-^IZ%=\.6F+FQ0$U:DD$82W'&77(1;F7%$G#G-&I*[I:RH
MDRMRP.(XR\\SQZ8^:_/)5UO0J8K[K+[9U>>PNP^K\IQJE[=OZ"-^<>)8K?B<
M+:6$O89SQV^&W"<2VWM%.#)4K!&.&66.<]F>$,.)&*W#TJV@_;I$ 2!>\8=$
M0!X4DY9[H ?,[SWF %XU;_9 #TJG@>O=/W0!B=07VATS9ZZ^7!4J:B;X@T"
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M2D^5-F\E-Y1 &.R1[IQ58S;WT1&\QSKDE"1D#A+?/(&+DE5QSIP$_P"2><X
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M]1N336,+=/S5M\'1\TEQ9]&=!=/RT31H9C,QIJ.;2N26^$/\G#O2Q?:SM;3
M$N*EB )=LR?$1Z>;P9-'R))V@0KM[R"^RLS0"1L4,IS$H$F5!(.!E/ Q63I2
MG$E*M:DT7*B@X@[)SWS$020K,UF0PF<L^Z,<D\6ME465-CVT*3DBN1E+$XG"
M>8RZHRE2*9]A[<?9$ M-93VR'B(K)X/T$K<7$8 2WS\815$);2^CY1VQ8@O,
M9#J/^BCCS]YE63Q4! ! ! ! ! ! #)+WC[=D ,XU;_ >Z #C5O\  >Z &P 0
M 0 0 0 W@3N$6YY<0.BH'33^'Q, 0^: <IRC)X;XDT&>8K["+^''@*$<7)"
M" " " " /__0^RCA0$@"4\<<>B8E.1[I1R3$*%$3EA. 'H5\0XL1N,@#UY0
M\E*IB2<=Q)V]< ."B-I[<?; $J3, G[8P L +.6.Z )@0H>!QR(ZH =$.*EM
M%7N8"*N*2JHEDV]XLQN [_?%);/<H67>)!_-:"WE=:B"43^%1)(Z1EC&6B;K
MP,;W&/=X4KG@I,S\),P<P8D%%QY#0).P8 2GT#'" ,:[5*5,)'#Q3&9F<CLR
M,,$"KYKH4,2!O*B3T_S8<0/2X4DE*Y$YR.< 6&ZM:93/$ <\,NT$& /-3\T?
MFLK3G)/3G+*WU1I[GS.U,V]=V4'A=7I'32355:%2P\NKNRF$&>!"%"/9_)+1
M5G.H\[K5Z%;.2LTBWNNW,%ZHU?I3/+/-G5?NV@Y;2[<J7LU=5?ZNWB_7*B]9
MYE>G707T=,_KVXTTZRM:<H=/)<1-3%$J:*VXH$B4NU)3Y:%9\$R,X]SZHS]R
MY..FV.;E5'.F][5'N6U]IX#8M2]_EPW'9MU^G9F7JBG9W^8\VB6$Y24H2SC1
M[M[+Y>OCW[=OZTHQ^-F:<[=O])<C'O:15<OMF9^%ZZV]N0QG5M;L?UCLCK+_
M %%T_EFUF-<RD*<;L/QG'EG<G#WLU;7I135J;3H/PWF@ET/ X[=DXZ]]:](Q
MV]1Y3T33,?ZSR'][AZR!6J]-IP5>*/'<M1_T*3&)]=]'K;U!E_6_Q$?K3(;L
MU#UD'\6:<_\ .U+WK_M(C]O.CO\ F"QZW^(+5,A_>H>L:K56FY*(NE)Q'(S7
MAO\ U8?M[T=_S!8];_$/UGI_][AZR/\ BG3W_G:E[U_VD/V\Z._Y@L>M_B'Z
MST_^]P]9"O5.G1E=*7$[2Y/_ $$4EUST>]G4&7KWO\1/ZTT_^]P]9'_%.GO_
M #K2]Z_[2(_;CI#9^T&7]8_6FG_WN'K&JU1I[,7:FG*4OCD1N^2*OKGI#_F#
M+^M_B'ZTT_\ O<#O?R(YD: M_*FPT==JNTTE8U<=0J<I7W5H=0ARX)6VJ7 9
MA:<1'C/6?573F8ZCSMVSJ]J5IV[2JFZ81H]Q]#^7>OZ)9Z0T^W<U*W&:NWJI
MO'&9RJKFIRWQGK*S2.']>H@RQF/@P(G&J?M+H451ZK:KWLW5=1Z%NU2UZRLK
MFARUGAK"S@9X/KSVGY)1*ZET%JOZTM>O^0G]HM#_ .)VO6,/,_EP2/\ TRL\
MI_ZNKL_4B7U)H+I75;7K(_:/0O\ B=OX?Q"'F?RY_P"65G _UY4_]!$_M+H/
M_%+7K)_:/0_^)V_6_P 0\<S^6\B3K*SX?]E5GVHB/VFT&O\ O2UZQ^T6A_\
M$[7K.'^9',;0+]RMJZ?55L?0FA<2HMN+4 KSBJ1 ;G,B/GSSEU+)Y_6=%N9'
M,QN0CEI)TQH^<ZG4>IM C<MJ6J6O=XOB<:.<R="-)F;ZPO\ UIBJ=5LQ 0R5
M1X[S[*RQ.KEU;TY!5_646NQ2?Q(QS_-[0[")MU-=5$3^&GH'0I1&4O.4TD17
MGB\:G"N]<=/P3Y+UR?8H/Y:&LW#GK0-B5JL%14JD0%7"I13MSQD2ACC<E_FL
M8KXBI@L3I\SYB9:-5DM,G-\9RY5ZHX_"<>W?F]K>ZH6S3UE/9*=9,T6JG2AX
MIE()-6[YCV$\Q(Q7Q),UG.]<=09R+C:OPR]K_1JC_I.K.-JA^IK'E5-;4U-;
M4J,U5%6^Y4/$SG\[JE$=DHJVWM9JMV]<OW'=OWI7+KWRDY/ULCEF=YF>N(,3
MFD+*!1S>X(@J=E_2]RA_RGZ_I;G=J;SM':,J:6[7KC2"W7W%I7GVFS2."TU#
M[8<=&QI/3'I7EATC^T^OVLSFK5='R4E<N<)R6-NWVU:K+@EVF\="=.K6]7MY
MG,6ZZ=E9*<^$I;80]:K+L[SV0)*U*<5+C623(<($\DI2)!*4@  9 "4?8<FY
M2<GM9]&-N3<GM9.P2%* .!3B.H_IBI!F$X)2-P$.(+C$I G&4NO,[3U0!E$J
MGU[HB2J2G0L(4/UC/?.78!@,(A2HDI/$47S5@-4X,>$2W;.Z<.:NQ"G%E)UV
M2L#(C#KSSQSQB4J)*K(97FDF8">+'(G'/&0/3$UIM Z8D?A'7CAXQ'-'BB"R
MU\O8/9%9;^]?&67XRZV)J;3L,YB$6^:*W8A[)&0 D)"+D%YH#A!E+],C[8X\
MG63*DL5 0 0 0 DP=OB($U[$1<2M_@/= @.-6_P'N@ XE;X"HV " " " " "
M " 'S3^'_/& (7%@8)P/1LE[9Q>$>9U>P(@F=Y[XST7 FB$@2$ $ $ $ $ $
M $ ?_]'[)49$[9_;VQR3$.@ @!Z" 3EB,9X3EEN@":8. E/H)]\ .2J4@3A]
MNW. ) H'(P N8(V'/OG]T .3))&P;>Z0ZX E"@<!CWP>.QA=PZ*J+3JY$MX8
M((F5*.JJ0JU5&'&A*25$3&.. EU[,8HEA[N.ZNPENDE[6!BJA\%9\M0X1.9D
M)$]9&V+K9B16K9C*E[A0J2AQF1$\9]\2#$+=4HS6J?1T9Y" ,>]4M@I 5C/X
M>DXSED8 KJJ%!*W?B#2)E3JR$-(VGC=6?+2!CF8LD^5R^:M^Q>O8&FE5X+U+
MU[#BW5O/'E=HD+;U%KBRT]6D<0M]!4"ZW!6<@FFMX>D9C]92<8UG5NL>EM#C
M)ZEKF7A<7S8OGF_YL:G1ZAU+H.E5^^ZK:C/Z,7SR]4:G7347KHTK2$L:,T9?
M]35/Q);=NSR+)1K.(2M++**FM4"J1Q G'FNH^>&CPD[.B:+F,W>W.7YN/J59
M&DY[S3TZVW#3-+O7[GY;Y%ZE61Y'^JKFYK+U#<Y;=_$-';K,C3=II-,4%JMG
MU"Z:W,NNKN-R>7YRU.+J'779N+,LI2$>R] ^;_7VE=(7;V5LY33[V9N3N-*V
MKDTE[-M-SJJI+# ^;?,/KSJ/7^HW9BK.7M6+<;:45S4;]J3]JN.(C+US;I*>
MB5>[JNDI&&J2FIF:DTE,TS3I"$-H:I^ A(2-\:EGNJNKM5N7+VJ=4YZ]<G)M
MTN.$77;A"F!I4KF>N_VG4K]SNERKU1I@1EM)^8*<.<W5N/*[2ZI9.<=)<E.Z
MZWKDYRXRE*3]<FS'X<*4<:][;^.HX)2,DI'4 /9%%&,?=BD722V(6)HN " "
M) 0 0 A2%9P!&I,L1E[( 9 '.N@@#I6AG_X7<3/;_L@;8TS6O]Y7_JQ^(]@Z
M0_=_*?7N?:-N+:2"93.,A/;(1U1LI$&1M&9WSEXY0 [R4X8$S,MN'C #_IT?
M@/:3[X"G8.2P@'Y -\\3(=<$N""[C1=5)";BRE,O@I4G 2^=:LN@RCSOJ^Y7
M4;$%NM+X6=)J4_S\(M8*)K('VZXU.IP'/938+(0J1SNM4$O=V0(YY;:AT=L"
M&V]XL00) ! %VVVRY7JY6^S6:C>N-WNU8Q;[;0L)*W:JLJ5AIEM(&2>)4U*R
M2D$G*,V7RV9SN8L9/)V97,W=FHPC%5<I-T2_'P6)DLV+V:O6<KEK3GF+DE&,
M5M;;P_&V>XG)KE90<H-!VK2=(6GKH1^\M37).*KC?ZQ"%5B@K&=-1X,LC((1
M/;'VWT=TM8Z2T'*:5:DI9I^W>G].[+WOYL?=CV+M/J+IS0[/3^DY;3[>-Y+F
MN2^E<?O>A;%V(Y6QQGF,^D[2);(VH[TGI_ZSL^], 9@9#J'L@"=M9!E.2<)X
M=(QWP!=;<$I\1Z,_#;M@"P%)'^F>\]IAMVC9L(_.!_6!.8&72-@@]C!54M*R
M"H$G#:-F.R64XA<^Z@(5*$Y#:1V")Q] '#,=8]L 9-KY>P>R*2^=Z"5N+C8_
M:-=F$LL,NT02JXOL%?>7:9&+D%QHF21LX>V<A]T<:7O2[RI+,?B'>(@FJX"$
MB7S>(W0%>PCXU;_ >Z! <:M_@/= #8 ( ( ( ( ( ( ( ( =-/X?$Q (^-,]
MV>_VQ?DE2M!0KS.\]\<BBX%@@!( ( ( ( ( ( ( ( ( _]+[(DJ(PF99RCDF
M(<5B1E,& %021B9XF '0 H)&4 64X@DX_!/MPB&Z4[P.;S/5]X@]L>_Y&021
M)(@4DX ^!'M$ + "@E)!&8@!%U 2"-OV!S&T0!0<>"^*0.,_MG &.?="6U$'
MXCEATCJ$@()UW Q#CJU$)42I1P2-L^@#,PWT!H>M-?:/T%2+J]8:CMED3PJ+
M5/55"/KZ@@%24,439-2ZM6$APB.KU?6])T.Q+,:MJ%NS!;I-<S[H[6==J.J:
M;I-IW-1SD+2X-^T^Q1VLZ/ZY];E.VM^EY=Z7-2H32U>M2'@:XL05M6IE2E*1
MM'F+[(\7USSPRUISM=/:7XDMUR[A'O4%B_2SS/5/-*W!SM:/D:_EW-G>HKY6
M=.M;\W^9?,-YU>JM772HI7"2+10/KM=G;!P"&[?1K;;4!_.XB8\9UWK;J?J)
MR>IZQ=\&7^3@W;M]RC&E?2><:IU+K6L3<M0U.Y*VW[D6XP[N545.\UFTZ7=J
M E^H0:-A8"@"D_5/).,_BF4)4-IQW0TKI>_FE#,9NMJPW6GSY+T[$^+Q.'E\
MA*?+*:Y8?"S?*.FM]H:<>:92RU3-.5+[I^)Q3=,VIY1<</Q$21U1ON3T[*Y*
M"LY&PHN32KMDZNF+VG;VH6<M&5Q1I&*<F]]%CB_0='-'%R]WS4NKZD%3EPN5
M=].I1*@!4U"G5E!)/R-!*0=V$>U9_ERN5R6G0P4+<:^A?CJSYW5Z6<SF=S\]
MMRY.2]+?Q+ Y(CJ#.$ $ $ $ $ $ $ $ $ -4F>V6_"<]V,Q*4 <[:!2/X4H
M1(?[+N./_P!L"-,UK_>5[ZL?B/7^D/W?RG]9<^T;>4#9A'5FR^D4( S$^N I
MVCP@[!*!([@.T]TS $B6CC@3+'=X;8$.CWG&&I%>9>:K$_L@RSCC+@;!..$\
M51Y7U+<5W6LTT\(J,?4CH,[^<S-QUP5$83A$=$<917 )#=$D\JX!(;H#E7 )
M#= <JX"P)" &JX4@K40E*05*),@$C$DG"0 $0Z)-MX(JXQVMT1Z=>C+D:JSV
MAKG'J6CX+Q?:5YG1%'4MD+MMB=_9OWU3:TS15W< I9)DI#(F/FCZ4\G.BUE,
MK'J_4K-,W>BUEHO;"V\'=INE/9'A'O/;/+CIE93+KJ'.6Z9F\FK,7\VV]L^^
M>[A'O.]_D+WIE+><!TX1[L>HBI:^(34@C: HSD>P9P)):5*>-9(^60':3[H/
ML!DN-/3$5? >D>#M'V[XD$B7")YX[I0 _(=0Q^VV &<8Z?#WP!% "C,=8]L
M7FTI(3AC\1[<99=, 9!E!P$IY=PZY166+4>+)6";+S9,P?PX#=M!ZXMW,J6D
M$G/\7NB'@FZDHN##+"64<9XXE0@ @ @ @ @ @ @ @!8 ( =Q#\ PR.WLPP@"
M#S!N,_MU1D\.7%"@SS%;_",GAQX$T(XL2$ $ $ $ $ $ $ $ $ $ $ $ ?_3
M^Q^.28@@!Z% &1/3 %CX>&>WKZ?= #8 >'"!LW2EF.N(IC5L@4.D3D)&4M_W
M1+5:$DX62@SE@F> .V0AQQ U)D03]L( F2I$\3A+MGLSE $+M0$&2 -F,CAM
MSWQ"QH^9D&-=>$RM:L,#(X#/?TDQ8DQ[M6 2$ *21CL/9O,1P!QGS#YH:*Y8
MVXW/6E[8H''4K51VMLIJ+Q<%I1Q)12T"%>: J8'$OA1TQTNN=0Z-TYEGF=8S
ML;2IA';.7U8[?7@=3J^N:7H5A7]2S*A5816,Y=BCM^0\Y^9_K0UMJ(U%MY=4
MHT1:E<38O!4FJU)4MF8XT/+26+?QC8@%0GG'SYU/YTZMG?$RO3=E93+[/%>-
MUKL3PB>/Z[YEZEG%.QHL/NMA_/VW'W/9'T'3BXU]PO%:]<KM7U]VN-2XIRHK
MKE5OUE4ZMPS6I;KRUD$F> D.B/&<UF\YJ%Z69S^;N7\S)XRG)R?PGF]Z]?S5
MV5_,WIW+TMLI-MOUE=#:W%I;:0IQQPA"$(25*6I602)9XQAA;N7;D+5N#E=D
MZ)+:V8U"4FDHMLY%L^G&:)"'ZQ*'ZV4PDR6S3G8E ,TK6-JB,X]*T7IVSD(Q
MS&<A&>=>-'BH=BXOB_4=]ELC"THSNI.[M[%W&R<&&)/1/&703F8V9MMXLY^)
MHW,NZ&Q<O-8W)*@'4V6HI69X'S:^5(D)Q^8^:9;8[30\NLWK&FV'[OBIONCC
M\ATO4F;^Y:!J^83I+P7%=\O9^4ZX:8MB;1I^UT$@'$4K;S^PE]Y*7%E6.:20
M(WS.WGF,WF+NYR:7<CP^Q;\*S:A3%)&=CC&4( ( ( ( ( ( ( ( ( ( YZT"
M@?PK0F9_V5<O&H$:9K7^\K_U8_$>P=(5_9[*?UES[1N7ECI/1O\ ".K])LI(
M&YX$2&W])B*HK5;F3!E,AB=GVRA1\2')[D/#:1D-LS.?9$X*E7B0^)(D 3)D
M$I$U8;!BHF6'"$Q5W$MBV8U[%WD5V'"-:[]365=0<?.J7G!T)*SP@= 3'C.=
MO/,9S-7WMG<D_A-;N7'.Y.?%LK2$<8IS2XA(0'-+B$H$<TN(0"DZIUP$E MS
MTW 01$EE-/O.UGI8Y 'FYJ7^(M243J^76F*QM=Q2XE26-2W9L^8U86EX>92M
M*2%U92<$$(S5'IWEGT*^J]2^_:C:?[/Y:2<ZK"]-8JTGO6^=-V&\WOHCI;]?
M9Q9S.6O_ &BQ+VJ[+DEL@N*7SO5O/9'R6DH2TVVAEEMI##+#+:6F6&&FTM,L
M,-H"4LLLM)"4I2 $@ 1]=J,8J,8148)422HE%8**6Y)8(^@DEA2-%2B2V)+!
M)+<DMA372)_5!["3[9P)$%,@$$$S&(ZX <VC@F4IEQ?-CG(])@": '!1'5,>
M&Z%.T#^,;C]NV ))&(JN) D22$ 3H0DE.$SGMSEUB +[2)<.!P(PEL.9.&^&
M->P%U!DH2Z1ANE&--\^TM1<M2Z@###,>,C]\9"I8;2K=MGANPBLFDL06/,3T
M]T8O#D5HP\Q/3#PY=@HR+C7M.'4,NZ,O)'<B:(E\Q/3W1B\.781CP#S$],3X
M<NP49%QJW^ ]T9.2/ F@<:]_@/=#DCP% XU;_ >Z')'@*$OF)Z8Q^'+L(HP\
M\?@'=$^%VBC(RXK&+*W%=Y-!D7HN!-7Q" $@ @ @ @ @ @ @ @ @ @ @ @ @
M!LSQRV?HG '_U/L?CDF(( 4 G+[OOB02)"A*9PW8&((J2##,3@2.*DD$< Q$
MLXCE[6",) R$2"5"E3 G@1++H_1 $D ,?<X0 @ *SG+9+=/?"FT%%QU* I;B
M@)8DF4LP!,"6$X4V4!K-^O\ :[%:ZR\WRXT5IL]"E2ZFX5SJ&&4A(F$I4LA3
MKIE@A,U$QAS.9R^3L7,SF[T;>7BL92=%_*8,QF+&4LW,QFKT+>7BL92=%_VG
MG5S>]:56MZILO*=H4S* ME>K*]@*JEJ,PIRUTC@X:<#]5:P5;9"/!.KO.3P9
MWLATM!-JJ=Z2W_DH\BZA\RI\]S*Z!%*&QW9+%_4B]G8WB=";Q>;SJ.XOW>_W
M2NO%SJEE;]=<*ERIJ%J)F9*=*N!(.21(#9'@6?U'/ZKF9YS4<W.]F).M9-OU
M<#RG,9C-9Z]/,9N_*Y>;QE)MOX?D,>  )>W&.(444JH5""I24-I4M;BDH0A(
M)4M:C)*4@9DDQ,82G.$+<7*Y)T26UM[@HTP2Q.5K%8&K6UYSX2[7N)DXYF&0
M<2TUN(G\2A(F/4=$T.WI5M7;B4L])8O=%?17RO>=UELLK"4G^E^+L,Z6TR)
MQE(2F9=D]@COG6G%G+J]I'Y1GM[L/;%?:^C\(YNPX;YXI6]I.UV<97K5EEIW
M,/FIZ-Q5;4#I!0U&S=*I1U&_F'MM9>;]+]E?&:=UW=IH=O+K;=S$$^Y8M>DX
MQ5*9X1)(P2-P& '<(V)=NT\O$B2 @ @ @ @!BB0H">&'M@!\ $ $ $ $ <_\
MOD%6DZ$R,OJ[B!AG_? GU1IFM?[QO4X1^(]>Z1=.G\IA_E+GVC>$M 9XF>R8
MCJJ-[:4-D;J2RW>R)JEM(' >,8G-\R2V?&14>E$Y;HJ]M9O$@HWE\T5GN%2G
M I86VDG\;W[)./S&7$8ZW5LR\MIV<O+:H-+OE@OC,&9N>'8NR3]JGQG"0P '
M1'DQKP0 L '8!W_>8 2) L0#F'DAR8U'SPUDC3EG#E%9;=Y%5J[4?E*72V*V
M+4/V87@AR[5Z04T[,^(GXC)(C:ND.D\]UAJT=/RU892W25^[NMP?P.<MD([W
MCN-@Z9Z<S74VH+*6*K*PH[MS="/#MG+9%>G<>Z>F=(V'1&G;1I+2]N:ME@L5
M(W1T%*T %JX?ZZKJG!(OUM:[-QYQ4U*6>J/M+3-,R.C:=D]*TRRK>1L1Y8I;
M^,F]\I/%M[V?3.2R65TW)Y?(9*RK>5M1I&*^%OBV\6][,HMH#('/8,CLQF9@
MQSSE%<@@R[H C4B9PPWC[;8+ #2B0)GET?I@". " " 'H"CB5'K&V(44MP)8
MD#TI"I@B>0EU_P D-@+;:""-XR&[IG %YL*EGX#''PAP!::3,] ^QEWQCBJR
ME+<6E@DD\2^A(D#+[9>R,A4F2M2)RVYX1645+;M(&18D( ( ( ( ( ( ( (
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M=;^%%YV$)6[;>Y6XUY>YW)1;XT1Y/-:FU:-1-\PT:DO0YBBXIU*G62;E5)U
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M78/9[20"60[!$J,56B(;J6$HXOF ,\\) #<);8D$Z4A  2)2PZ8 6 " " "
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M:9GK<)7)V$H157BCR//>6/6^FY+-:AG-'C#*6+;G-^+;=(QQ;23JZ+<CL_\
MEUZRTKK[0O/+TAZONR+8KFQ8KM=M#N5#J6FZQVOLB[9J*BH$J$W;G0*13U_E
M \:V4+*1\!(Y^D7(7;69R%R5'<3Y?51_C-U\I,_D-5TSJ;H#4+Z@\_:E.S7#
MFYH<MQ1XRC[,Z;6JM;#J8CT.>JW^.4\K?\D>HA7BN%G.MN!H<OQ;0]]-_$_\
M3EWZ7Z$4@\\,XU15^SX./".!^J\_XG@K+NNSF^;WU-#_ .FG72U/]2?J"]XO
M-R>-AX'+6GB>)6E*>U3WMU*G:[\QO6>E=(:2Y'^DS2-TIKHUR?M%NO>N*BG+
M9;I;G;[&+5I^DJ2VM26+G5!^KKWF3BVVZB>*A'.UBY"U:RN0MOV;:3D^VE$N
M_:V;UYO:ED<AD.FN@\A?4UI]N,[S6Q2C#EA%TV2=97)+<FN)V@]*_ILU+Z=>
M03G.W2O+"GYG^IS7MAI7M,66ZW&@M%%I"T:@;0[;K8Y<;@ZTBUTK-$XFJN[C
M)-54JE3(DD3/.R.2N9/*/-6[//GIK!/"B>Q=F&+WO8;MT/T;G.D>E9=29'1E
MGNM,U:3MPG*,%:C/W8\TJ<J4?:NM>U+W$=&>8OHW]?\ S<U?<]>\R-&M:FU5
M=E$/5K^M--,T=!2!94Q:+);FZ[Z>T6:DG)MAH 2^)14LDGJKVG:KF+DKUZUS
M3?Y2P[%C@CS'5_+WS4U[4+VJZQIRO9ZYM;O6THK=&$:TC%;DN]U>)U-YN<D.
M:'(>]6G3O-;3K.F[Q?;4_>[53,76WW=%3;*:K30OU!?MSKS32FZI824*(5C.
M4<',9:_E90A?ARRDJK&IHNO]-:UTOF<OE-<RBLYB[!SBE*,ZQ3Y6ZQ;2QPH<
M1U7^Q:G_  =[^Y*CCO8^XZ"?N3[G\1ZX_F&?_4Q^AK_@&C';_DRT_P"Z-@U?
M^PZ;Z/LH]\\VOW,\LWN\-?\ RT#R:0<.J.@/GZZJ2KQ.Q_+=$]'V\G+ZRYY=
M%2(T377_ .Z7_JP^(]=Z0DET[DTMOB7?M&^  9"4=0;$VWM%@00U-2S1T[U7
M4+#;##9=<6=@3D!O6HX ;3&.]=MY>S=OWI4M056_PWAN,4Y2=(K:<%72XO76
MN?K7ICS3)I!Q#+",&VD_AD,2!MG'E.H9VYJ&;NYJYOP2X16Q?C[3H[MQW;DI
MOT=QCXX1C" &K6E"2M:@E ,BHY3.  WJ)P &).4&U%<S>!#:2JW@=]_3GZ+[
MMKIJW:XYL-5FG=%U :J[1I<%5+J'5-/\R7Z]/PO6.S/@#A)_;O). 2,8]HZ#
M\ILUK<;&L=2QGE]'E24+6R[>7%[[=M]OM26Q'J'2?E]>U%6=1UZ,K>0>,;6R
MY<7&6^$7PVL]:K/:+3IZTT%AL%KH+)9+4PFEMUIM=.BEH:-A D$M,M@#C7FM
M:IK6K$DF/IO*93*:?E;&1R.6A9R=I4A""2C%=RW\6\7O/;K&7LY6S;RV6M1M
MY:"I&,52*78OCXF0CD&8( ( 6 %XU;_ >Z %XE;]VP0 %DJ,RKP_1%>;M7K(
MKV#33@8C%0&&>>8)PD91#Y7BZ>LE2>P@+:Y$A4SNX1C$NM'1XA4WK CX7?PJ
M_L?T13\YP+5AQ#A=_"K^Q_1!<]5@*PIM)TMK& PV9;.Z,N"V+ J2!B1!*@1,
M3$CCT1%9?1()/*;!GPY=*O?$DCY 9;<3UP 0 0 0 0 0 0 0 LI_RB(YHK!L
MBHAF!/=TB',GL8J,XQT^'OB20XQT^'O@ XQT^'O@ XQT^'O@ XQT^'O@ XQT
M^'O@ XQT^'O@ XQT^'O@ XQT^'O@ XQT^'O@ XQT^'O@!O&K?X" &0 G"G=[
M8 DFC<?MVP OP?A.W[9P!5XU;_ 0 D ) ! ! #_@G+HZ=^[.%<:;P?_1^O.G
ME+'+_P#&CDF(BJW. $!0 ,L!B9G[IP!K595>7Q'C$DB:E2Q03,8$2D%;8 P2
M[H2M7QE0GG*4\9SRQ@09ZAN 4$&1!.]( X<P93D,LX$FUTRO,+82#-1P)($Y
MC#/!*1F3LB=Z2VA)O \[?55ZBEOU%9RWT-<!^[V2NFU%=Z1P']Z/H44O4-.Z
MG*VTS@X5$&3ZP?U1CX'YG^87W;Q-"TB_6;5)S6]]_P!%?X3[#QOKOK&LKFC:
M5>_-+"Y-/WGOBG]%/"OSGV(\]5K4M2EK45K42I2E&94HYDF/G*4YW)SN7)-W
M).K;VM\3R6+;JVZMLC!/%+[919I.%=XEL8^,1B')$SU1):*JR2),H0!O6C*8
M#ZVN5*0"*9LSQF3QN2\ 8W?HW+?VW.-8807?M9V.0AC<GZ/E-V6Y,$;^HR&Z
M<HWC';6AV:3P9#$U?$N+MQQB!CCB.XAL2!VPH^+*\KXB\?1+JBK3W2=2.7M.
M(>:"@7[/+_4*O^Z-1L_3T7&&:3V\R^)GG?72:N:;7Z,OC13T#SDYM<J6[HSR
MRYB:ET(U?':9^\MZ?J6:=-S>HT+:I'*H.L/<:Z9MU24$2D%'?&TVLQ?L<W@7
M90KMIO-9TKJ'7="68CHNK7LJKK3GX;2YFMC=4]E3D+_I@>JW_P"(/F1_QG2?
M?1&,OZPS_P#>Y^L[=>8'7/\ S7G/Z2_Q3%WSU1^I34UGN>GM1\\->WJPWJC?
MMUWM-=7TKE'<:"I06ZFCJ4)HT*4P^V2E0!$P91$L]G9QE">9FXO:NPP9GK?K
M#.Y>_E,YU)FKF5N1<9QE)4E%[4\-C.#*=U^CJ*.LH*FIM];;:IBNMM?05#U'
M76VMI5<5-64%93+;J*2J8/RK0H*&64<58--.C1K,)2MRMW+<Y1N0:<91;4HR
M6QQ:HTUQ3.S2_6IZL%V4V)7/36!I5-EE59_N;^^2R4\!0;O]%]9Q%&''Q>9M
MXIXQS?UEG^7E^]2I\/K-R?F-UV\M]U?4V8\.E*^SST^O2OIV]IUCJ%NUKM94
M5S]3<*JXOOU-QK*^H>K*VX5-42JJJ:ZKJ%N5%745*E$K6M14=\<)MRKS.K?$
MTR;=V5R=V3G.;;DY-MR;VMMXMO>V=A&/5SZIZ5ABFIN?W,5BGIF6Z>G8;N-(
MEMEAE"6F6D#Z+Y6VT@"<SA'+_6&>2HLW.G>;9'K[K>$8PAU3G%"*22YE@EL7
MNDO_ $P/5;_\0?,C_C*D_P!HP_6&?_O<_66_Z@=<_P#-><_I+_%.+=><S>8W
M-2Y4%XYEZUONN;M:Z%RV6VX7]]JHJ:&W//BJ=HF%-,LI2PY4CC(()*L8P7;]
MZ^U*]=<I)4QX'1ZIK>L:Y>M9C6=2NYF_"/+&4W5J+=6E2F#>)HRDA22A0XDJ
M24J!Q!21(@]!$8SK'C5/8;[JSFGS*U[9=,Z;UOK>^ZIT_HMI+.D+/=GF7:+3
MC2*)JVH1;4-LM*0$6]E#(*BHA"93SC)<OW[L80NW92A'8GN[CM,_K>LZKELG
MD]3U*[?RF65+4)4:MJG+[."^:DL=R-(1*73/'[HQG274^9/<=DN7! T;;1M-
M;=,.CZD3/9&B:ZO_ '7,?5C\1ZWT@J]/Y5[N>Y]HWJ.H-C$)E,JDD $DDR 2
M!,J).   AWNB).)-57TW-[Z.E</[OIEX\)DFK?&;BQFIMO) /7'G74&K_?[W
MW;+S_P!BAM_+DM_<MR])U&;O^+)0A^B7POCZ#4?M]MD:Z<4,>S[;( WGE[RU
MUOS5OJ=/:$L55>JQ*DBMJTI+-IM#*B)U-VN2Q]-1M(!G(DK,I $QW&B:!K'4
M><60T;)2O7J^TUA""XSELBN_'@CL])T;4]<S*RNF965R?SI;(07&4MB^/L/7
M#D;Z.M <L/H+]JYFDU_KIA2*EJLKZ8JTY8WPD* L]I>*VZAYE8PJ7P5DB:4I
MCZ>Z.\J-$Z>5K/:M&&>UF+34I+\U;>[D@\)-?2E5]B/=>F^@]+T56\SG(K-:
MFL>:2]B#_(ALP^E+'N.XZE*6HK49J.9PR D )"02 ) # "/5F^9MO%F]MMNK
M=6-B $ $ $ & Q.0SZH D^"1D#E]MIVQ&.] CB0)(=/>?? "@ ;SC/YCORS@
M!9@&>P&?9 $H4#E/MD/OB,=Z Z8WCO$2!)C>.\0 V2.CO_3 #IC>.\0 3&\=
MX@ F-X[Q !,;QWB "8WCO$ $QO'>( 4$'"8[Q $/&K?[/= !Q*W^ @!L*+@
MPV[C"@&\"=WB?? !P)W>)]\ ' G=XGWP <"=WB?? !P)W>)]\ ' G=XGWP <
M"=WB?? !P)W>)]\ ' G=XGWP <"=WB?? !PIW>)]\ .@ @!.)(PG[8 @@ @
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M"J[_ #&IQLW3_NYKOC\3/.NN_P!+IOU)?&CBZ-B//P@ @ @ @ @ @ @ @ @
M@!R3(CI@4N*L6=D.7!_]$;=,X)J[GXU(,:+KO^]+_P!6/Q'K71Z_^W,I18NY
M=^T;X7&P%*4XE"4 J6I7PI2D#%:U'!*4QT^Q-O"*Q;W)&Q.+2J]AQ?J75*JW
MS;?;5E-#/@>JA-+E9PG%+6U%-,9YKZHT/6]?>9\3)Y"5,KLE/?/BEPC\+.KS
M.:<JV[3_ #>]\>SL7QFCQJAP3)V2R7S4UU8L6FK-<]0WJJ6E%/:K/2.UM:KC
MDE*UML@^0UQ9K<*4#?&?*Y7-9[,0R>0RMR_FY;(0BY2?H6Q=KHC-ELMF<[>A
MELEEYWLS)X1@N9_!L7:Z(]#^4/H$N-6BFO7.R\*M+:_+>3H7352V]<%-F2O*
MOE_2"Q1*4#)35.%K&14(]UZ6\D\S?5O-]79OP8.C^[VG6XUPN7-D?JQJ^T]7
MT'RON2Y,QU%?Y%M\&V\?Y\]B[5'UGI-I;2FF-#6.ETSHVPVW3=BI$I#5OMC"
M6DNK D:BL?,ZBNJEG%3CJE*)CZ TO2].T7)6].TG)0R^2ALC%4KVR>V3[9-G
MKF2R64TW+6\GD,M"SEHK",51=[>UOM>)L*3)4S]L)1V'H.4/XQT^'OB '&.G
MP]\ +Y@QP)PPZ]AS@"1 XI3W X=D0W1-D#8DD( 3A3N\3 "P 0 0 0 G"G=X
MF %@ @ @ @ @!1B1UB )"E(GA/ F1./\D0E+Z7P$#)IV)ZL3$DC8 ?P_SD]\
M ,@ @ @ @ @ @ @!_#_.3WP R " " " " %@!9I_#XF (O,&X^[QR@!O&>CN
M_3 #8 2 " " "8WB(YDL*XBCX"Q+(6)#-/X1WF,55_FS)_.'>9T>,3SR^B1R
MKZ0WB$Y\*=^WWY1%=_)B*?EL_]/Z[&2"W,RF3@<<<982PPE'),16JFS\QG+(
MC<)9F ->JV5$G:<-V&<MVP0&ZF\Q1HFP9E GOFKHPPPA1"CX''O-OF50<I=*
M_O%[RW+U<DOT]@H,%$N-MGS+G4()XOHJ51 G^NY)(VQK'5G4N6Z8TR>:O37W
MB:?(N[YS[%L7%X&N=2Z_9Z?T]WI-/-7$U;CV[Y/A&/PO \@KW>:V_72MNMP>
M<?JZVH=J77'%%2E+?<4XM9Q/Q*49GNRCXNU;4\QK&>OY[,3;E.3HGN3=?6]K
M/FC.9J[G<S=S-Z3<Y-MUVU?XS%1UAQAN\[L8M%5:1D7N$:<53V3/L_3&6;PH
M2\%AM)8P&(<G.)+1]Y$D291I27%);2<7%);'25*2!OWQ'([CC;6V32];*2]I
MJ*WNAS,!Y24-)P2TVVV!@9<"$I/B(]OC!6X6[2V1BEZDC:4E%1BMB20TXY[8
MDD( )C:0.C; #2M,C(X[,#_)$D$?$K?[(@DXHYE+5Y]H_P!9JO\ 1M9QLW3_
M +N:[X_*><]=_I=-^K+XT<9A8VX>/W1L1H O&G?X'W0 <:9&1QV8&  *!Z#N
M@!T $ $ $ $ $ $ *,"(=Q#54T=@=%7.AM>BZ!VM>2W.JNA;92>*H>(J$R2V
MV#Q2GM,@-\><]59_*:?GLQ=S5U*L8TC\Z6&Y;?3L/5.E+T+'3>3E<E_E+F&]
M^UP,-?-1U%U2II)-+0"9+/%)3@_%4. R(&[!(Z8\HU77<QJ/-:C6WD_HUQ?U
MG\FPYV9S<[Z<?=M)[/QLR>AN6O,#F97-V_0>D+YJ-:U!"ZVCHG6K-2B8!55W
MA]*+<PE(,R2N<AA&#1]"UK7[T<OHNF7LQ)NE8Q?(OK3=(I>DSZ9HVK:S<C:T
MS3[MVOSDFH+OF_91WPY<_E_5ZG6*[FMJRFIV?@6O3ND5%^IGFMFKO=0@4[:9
MX$L(63L(CV;0?)+,RE;O=2ZE&%O_ #5G&7:I7'[*_FIGJ&D^55S"[KN?27^;
MM8ON<WA_13[ST*T%RYT+RPMG[IT)INVZ?84D"IJJ=L.76O4!(KK[H]QUU4HG
M&2E\(.0CW70] T/IO+++Z+D;=E-8R2K.7UINLGZZ'J>F:3I^C6/N^F9.-FWO
MHO:??)^T_2S=^(;\^F.Y4H[$SGT[ BP" " " " '!:AD2( 4+,Q,X3W" ).)
M._P, + ! ! ! ! ! ! ! ! ! ! "P LSM)(VXG+O@ X6OPGO/]M #IHQP,\<
MYYRZX CEU]Y]\ $ *.G* '30<>$_;M@!D $ $ $ $NOO/O@ @!8 ?\&?"<\]
MGM@"'C3O\#[H .-._P #[H CXU;_ &0 D ) ! ! "<0WB*\\>)-'P(RH[_9&
M+GEQ+<JX!Q*W^ B5.3WD\JX!,;4X]9B</\VR/YP[CZ/']$6YG]!D47TB*+E0
M@ @#_]3ZWV'4C GX<^B>R9ELCDF)[F9 $/)D2)=0P,NS$3@"H[2)*IHE^L-N
MW#:=T 8>\UENT_:[A?KP\EBUVFD=K:UPD ^4T"K@;F0%//K(0D9E1$8,UF;6
M3R][-9B5+,(MM]VY=KV&',9BQE,O>S.8E2S;BY-]B^5[%VGC-SEYFW'F?K*X
MWJJ4M%&E?TUNHN,^506Y@J%-0MC*38^)PR^-TG<(^.>O^J[W4NK7:3IE8.E$
M\%39%=D=KXRJ?,_4^O7M=U*]F9NEI.D8UPC%;(^C:^+.)8T$UH0Q),4G)5V#
M20,\09@C;%X5K@96L* @83W^P9#9"Y*M$BDGL'QC* ,#.!*='47B,23S,NVQ
MOS;E0-RF%534YY2!XL>Z.=I=OQM3R%MJJ=V/QU,F7CS7[$>,D<M*/Q*).9)G
MUQ[&\6S:&R,KW#M^^( SC5O\![H :3,S)Z-T2"%3DCG+HEC$ B\Y>.(SP,AA
MT;9P!Q9S(<XG;3B?ZFJGC(@^8S.6&4;+T_[N:[X_*>===U\735OY9_&CC>-C
M//P@ @ GCU8P!.DS$]H]L + ! ! ! ! %1VX4=.9.5"./$A"/VBS+8$IGC&&
MYF<O::A<N+Q'L2Q;]".->SF5L87+RYN"Q?J0^FH]37H^78[#<70H?[(73J;3
MUI6\$-I'3C'9Y#0.K=<]G1>F\U<C]-QY(T[Y\J,"EJV>3CINFW6OI.-/CHCO
MEZ>O19S%YF:)M.J;UJ2P:0L%97W=AOSU/WK4+IHJU+-44T%.$TK"0J?"5NXG
M9*-'ZC\D^K<YU1G)ZUFLODX>':JG+Q;B]G8HQ]E>L^AO+7RVUK5.F<AF]0SM
MK+V7=NI[9W,)T>"]E>OT'H/H'T5<D=&+:J[Q;:_F'=6E(6BIU6\!;FW$R^)F
MR4):HR K']H5X8&<;-HGE%TCI;C<SEBYG\PL:WG2"?9;C1/TU/;M*\N^FM-<
M;EZS+-7UONOV?1!47KJ=L*.GI;90M6NU4=':K93I2VQ;K92LT%"VA DA**:E
M0TS)(RF#'I=FW:RUF.7RUF-K+15%""48I=T:(WJW"%JW&S:@H64L(Q2BEW)8
M$L7)" %!EE$IM.J#51>)6_P$6YY$<JX!Q*W^ ASR'*A0HS$SAV1*FZJNPAQ5
M-@^8WCOC)S1XE*/@+,;Q#F7$4? (D! "P O&K?X#W0 H6J8F<-N @!_$G><^
MGW90 H4F8QVC8?= $DTS^7;O/L@!D $ $ $ $ $ $ +  0C'X#C_ #E9]6V
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MC0W^1<^.)U6!!R,>F'D00 0!.DS )Z8D%AL_#U$C[_OC+#W2"=O;V??%@20
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M ! "<*=WB8 6 %@\4UN8WI[T$4\.);F80\.(YF$5=MI-U)YD$8RP0 0 0 0
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M$VOE/(?-:U+PM%O_ #.:<?2TG\AU(CU4\:'I)[HE%9%D9#J$"I81\H[?:8E
ML(,P!M&$98NJ('S(Q&<6!+Q@C& (NPC'(X& " 'HS[/= %A QGN@"TUG/=+&
M4Y#&9[HE=A66"J>NGIIH7;;R.T2VXD)55-W2Y@3G^SN%R=6V3D>(I;F8^?NL
M[JO=4:E*+PCRQ_HQ2/IOH*S*QTCHT)*CDIS]$I-HYP\P[AX^^-9-P#C4<,,?
MMM,  2H$$"<L=_A $J3L6,3/A W^(@!02#/:(D#N,]'C[X@"A9GC*7; #^).
M_P # "P 0 0 0 G"G=XF#Q30'13PX\66YF$/#7%CF817P^+)Y@BWAQXLCF80
M\-<6.9B<0Z>X_HB/#[1SCAF(K2DZ;BU:QKO$BA(0 0 0 0 0 0 >, .FG\/B
M8FJ^B11\0FG\/B857 4?$28_#XQ-4Z+E(:=-HDQ%N3M0YEP"+\D>!7F?$(<D
M> YGQ"')'@.9\0AR1X#F?$(<D> YGQ"')'@.9A$>''BR>9A#PUQ8YF$2HI-N
MN)#=<!(L0+%>6;^<36/ ;Q)W^!BQ G&G?X& &\9Z/MVP G&>CQ]\ ,@ @ @!
M.%.[V^^ &%9F<!F=^^ &0 _S%='C[X C\_H\/TP!_]'Z_P#O/5G'),1YX>N'
M7014Z?T)1U'%]#2+NUT;1_I=QN7[*C0LI."F;>V5$'$%P1X9YR:['+6,OI=J
M[^<Y:M+Z4^/="O=4\A\SM547E-,MRKRQ<I+A*6"K_-QIVG0?3&G+GJR\4UCM
M*$>>_-Q^I<P8H:-N1?K*A0G\#2<$C-:B (^:$F\$>6Z3IF;UG.V=/R>$Y8N3
MV0BMLGV+AO>!W@TSIJUZ3M+-HM2/V:)+J:I:0*BOJ9 .5-21M49\*<DIP$<B
M*HJ'OFEZ5E-&RD,EDX>RL92?O3EO<OD6Y&?B3LA0HC*73/[80 X**CPG([NC
M'IW0 +V'K^WC %=>?9 $2@2,(LG2O<"NH2D<\CGX=<5)3W"%6["%2>4VW02R
MG5]D)/\ I[FP?Z@YU1O7EE^_?3W]9+[+.1EDOO%O [*/O(4A209DDY"0&.V9
MQ'VV1]CK8=P8MPSG_1]\5YFY46Q$&/<S5U?=$S]UDE!P24>G'OB(.L40M@R+
M$A '!_J#L[URY?FO83QKL%VI+@^!FFB>!I*ES(F38<!,;IT'FX9?7O FZ*_:
ME!?67M+UT//O,O(SS733S-N-99:]&;^H_9D_16IT:\>K'V1[2?/@]&WL^^)1
M66XLC(=0]D"I.@_#U>^)!(DR,^^)3H"4+2>CKC*I)D#IC>.^+ 6( 0!*@;=\
M 6$# G>1]AOSAL!=IZ9ZK>8HZ5!755CS%)3H XBNHJG$L,I2D?,KC6,(J[D+
M49W;C_-Q3;[DJLF-N=Z4+-M5N3DHI<6W1?">X&D[$C3&EM.::: ";+8[9;5;
M9OT]*@U2IC\54I9[8^9<]F7GL]G,[+;=NREZ&\/@H?7>G9..GZ=D,A!45FS"
M/I2Q^&IG^ ]'C[HXIS0X5)^+##IGA+/#^6 %#B@09##H_3 #2HDSPF-V$ +Y
MAW#Q]\ *%F8RQ('5 $AP$SEG "!:1C/P, .\X='<8 7SNKN, +QGH\?? !QG
MH\?? "\9Z/MVP O&.GP]\ '&.GP]\ (% ;5GK(@!>,=/A[X .,;CX>^#V,"^
M8G<?"**%&GS,ENJI1 '$C'&8RPS\8EQ3==XJZ4'QC\-]A;F01DY(D<S"(\.(
MYF$/#B.9A#PXCF80\.(YF$/#B.9A#D6XCF8D9"H1!(0 T( (.<OMV17D6XFK
M'18@( BXST=6, '&9RD/MVP!+%*3XHGV>T9QCI\/?%R XQT^'O@!>-,IS,YY
M2S&^>4 ,XST>/O@ XST>/O@!LSO/? "0 0 0 0 0!&5F9$LCNS\8 3C/1X^^
M %\P]'C[X CQVF9@!2I&X?V4 (Y\$P-\AU;.B *TL)35G/YON@#_TOKZ=JF*
M)AZMK%I:I:1EZKJ7%?*W34S:GGEJG@)-H,9Y7+=N$[MQTMQBY/L257\!@E.%
MJ,KMR5(13;?8E5_ >&/-W5-7KWF'>KRCS:IZ[71]VE82"M?!4O\ EV^E0G'^
MKI4H $L 8^+>O]6EJVOW[O,VDVWPK)X+T121\N]19ZYJ^LYB_%.5RY-\JV[7
M2*7HH=BN6^B&=%V-*'T(7?;FEM^\5(DK@.;5O95GY%+M_$N9C3X1I'':>O=+
MZ!;T'(*,XK]874G=EP>Z"?"/PNIR#%S9 @ @ !EB( 4J*I3.64 -(!S@")0D
M9=73L@"LM.8'01![ G1D!W=,$6EL-ET6K@U59SM#ZS_]B6<8WKRS_?KI[CXD
MOL,S97]/:=<*G8TKG'V$U<DJ.E#N:$"UC$=8Q]G7&2*25 4UD$GIW]T1-KE>
M(*J^$3G\Q&&W;X816'-188!$$9"0@"I<+?2W>W7"TUP"J.Z4-3;Z@$<7"U4M
M*:XY' EI1"AU1EL7[N5OV,U8?YZU-27?%UIZ=A@S&6M9W+9K)9A?F+T)0EW2
M5*^AXGF7?K#7Z7O5ST]<T*15VFJ73*4H$!]@&=+5(GFW44Y2H&/H[(YVSJ62
MRVH9=IV[L5+N?SH]Z=4?)VHZ=F-(S^:TS-Q:O69N/>OFR79)49C$;>S[XY:.
M#+<6$J! &Z0QV]4"I(%%.R8)$^@0!*"#E "Q.W"@%$P01LB4I+% D2X20",\
M,(LINM 2XX2$YF49""RD"8&R ++8D9#=]XBLMW>0MAV-],6AW=7\T;=<GZ8N
MV31:?W]<GEC]B*Y *+-2$D<*GG:H^8$_A;)C4>N-4CIVA7K$9TS69?AQ6_E^
M>^Y+#O9O7EWI$M4ZCL9B5NN3RB\2;>SFV6UWN6/H/58.*4N9 ,R23TF<^^<>
M$K!)'T?5MMLE\SH\?T0)#CV2SZ?T0 V:?P^)@!L $ *,"#N@"0*),B!(SW[C
MTP [@3NV':=W7$2=$V@01;T@49CK$0">8WCO@ @ @!)C>.\0 3&\=X@ F-X[
MQ "S&\=X@!8 2 " %F1V1'*N J^+'<9Z/'WQ(#C/1V?I@ZTPV@?QIZ>[],20
M)QCI^W;$$B<9W" $XST>/O@ XST>/O@ XST>/O@ XST>/O@!>,]'V[8 =QC<
M?MVP G&.GP]\ '&.GP]\ 10 0 L11<!5B1(" " " " " ") 3&\=\0 B01E9
M!(PS,0!.,]'C[X :<<8 (D"S3^'Q,0",K$S@1B>GQP@"* '*659R@!D ?__3
M^H'U':M3IOE%>G6G_)K-0/,:=I5))"_+J9OW'A$\"*)@B>,IQK?6^H+3NGLW
M-RI*ZU!=WO2_P4:EUEGON'3^;:E2Y>:MKN>,O\%'FIR5TR+S>;EK*N;XZ:V5
M"Z>VH6GX';D\DJ4^)X$45.0 -BU=$?%EV\\WF<QFI;9S;]>Q>H\IZ"TB.=SN
M:UJ_&MFS.D$]]Q[7_-C\+.T,0>N! ! ! ! ! ! $:Q,8B9(D)=NSH@"%0F.G
M9 %-0(.,-[)>/M4,_HN?\5V@F4OJ')C_ +4O*-[\LJ?MUT]7;XDOLLSY:OWB
MU3B=BW%R!X=FT]T?8RK3':=T45.':9D9F9EMW[8QRG1\L5[1%2NIV:IB4LNS
MVX1/)5>T_:%/61+6F<YRWS^V BZ5$D21EU !/$#(3E $7U*=TMTR/9.< .2\
M@@DD=6&/;.6, <!<^] '4%H1K&TM!5WL-,471E"27+A9435YB9 ERJMRC,#]
M9LD;(WWH;75D,U+2<U/_ &6_*L'NA<>[ZL_@9YEYC=-2U')K6\G"N<RT*7$O
MGVEC5<90W<8U.EJ583&1D1TC>)=<>PM--\#P?!T>XD"P"/OA4KRLE"\<<NB!
M!*#*1_D@"5*IX'. 'B+1VH,D0G]8CJ/MB\(X5:Q(+2$[2.J8W1D!,A)G/9[=
MD0#)6V@KKK<**UVNE=KKG<JEJBM]$PDJ=JJM]80TT@"<IG$DX)2"3A&.]>M9
M:U=S%^XH681<I-[$EO,N7L7LU?LY7+6W/,7)*,8K:Y/8OPV'KYR=Y;TO*O15
M'I\EM^]U2DW'4M<TD$5=V=3(LH7.9IK<T?);V&15MCYZZBUNYKVIW<XTUEH^
MS;CP@M_?+:_5N/J#I7I^'3>D6<C5/-R]N[);YO=W17LKU[SE,*!,L?MVQT1L
M@Z " %&&, .XST>/O@!0LF0,@)YR^_I@"7B1N']E #D+;XA,#L5. )BMN1D#
M/M'C.(:JF@0<2#A+N5,Q(&P NT'<9B 'A9) PQZ_? $D 5X 49B )>!.[Q/O
M@"(&1!&8,^Z '\9GC+I/M@!W&G?X'W0 <:=_@?= !QIW^!]T '&G?X'W0 <:
M=_@?= !QIW^!]T '&G?X'W0 <:=_@?= !QIW^!]T *% F0.)ZX; + ! ! !
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M'6($*$TD*$S(CH,L=Q^^/2*-8-8GDB::JG4E2<.J)162WDR#/#=*4"NY<2=
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M9#5PU-=2FHNU6)2<138>5;*59_TMF4]I,>2ZUU%JFO37WRZEEXOV;<<(KO\
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M)5C &&J7^(&<B#D ,3CF<IG[H Q:G@' )S,Y3R EEQ9#& +B7>(@&4\ 0-^
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MQY+2-*TY4R.G6;7;&"K_ $L7\)NA).9)ZS.."=C5O:) ! ! ! ! !  3+$P
MHEMG+H@!%%(QR W_ *( C\UO\7@?= #BL $SR!V'W0!"71G/+KEACC !]0D8
MD@@9@9]DSC!UW,""K:. X@3@"1(3Z\HA<U<6AZ1?.'XQX?8Q( /IX@.,3GNW
M=D'LVCOV#_.1O/=  '4S$E*G,; >J>$0E3&K%2>9SF9'IB0 41M)ZR8 D2L'
M//[_ !@!T $ $-@"%:@( !CV_=/W0(%@2) ! ! "@R,X =QGH\?? !QGH^W;
M #<S "0(%E+OEVP'8) D( ( ( 19 R!$R,L9=)SV"!&P3C3OVYR.< ,XU;A]
MNV!(<9Z/'WP _C3O\# #.,]'C[X .,]'C[X 3B,YS.>4S*  GBD3]L_? "0
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M.1MDT3J*]\P]4ZMH[_;-9V6LNX>L&C]+U&K+B+,JCKJ%5%7IMEOJ%<9#L^$
M)G&R>5'1/376E_J1=39K,V<ME+%IPE9G&%)W;JM1YZQES1YI1PP[S6_-7K7J
M/HRSTY+IO+9>]F,W?NJ<;T'.L+5MW9<E)1Y9<L98X[-AW9TQS#TGJ;EO8N;-
M-7AK1%XT'1\QEUY<3*ETXO3XU'7+<<,FDOT=(VX@@G!Y' <<(\VSFDY[):SF
M]"G:KJ=O-O+\M-MSQ/#CAP;H^YU/1\GJV1SNCY7787::;<RJS%:K"WR>(_2E
M5=ZH=)/0#ZL.;/JJJ.?3_,VP:4T_0Z(U-HP\M[=IJT5=MN)T5KFT7&_65W4S
MU56U9N-UJ;2W3.\:4,\/F*!3N])\UNA-!Z&CTK'1<W?NW<S9O?>)7)J4?&LS
MC;FK:27+%2<EM=:;3SCRLZYUWKB75$M9REBS;RUZS]WC;BXR\&]&4X.Y5OFF
MXJ+JDJ5>!W!I.=_)2X:T5RWH><'+"LYA)J%T:M$4VN=.O:I%8W_64?[F;KU5
M9JT2Q;"2L;H\_N=-=1VM._7%WI_.QTFE?&=FXK5.//RTIV[#?K?4G3MW47H]
MK7\E+5DZ>"KUMW:\.3FK7LVFV:OU?I/E_8ZK4VN]4Z<T5INA<0S5W_5EXH;!
M9Z=YPD(8<N%R?IZ</K(P1/B.Z.!D-/S^JYJWDM+R5W,YR6RW:A*<VN*C%-T[
M3GY_4,AI>6GG=4SMK+9.+HYW9QA!/@Y2:5>PPEAYI\M=5:0N','2W,/0^I="
MVE%2NYZPL6J+/<]-VX4;9=J!<+Q2U;E%0%I&*O-4B0,<C-:'K61U"SI.=TC,
MV=3N-<MJ=J<;DJNBY8-5E7LJ<?*ZWHV>R%W5<EJV6O:9;KS787(2MQHJOFFF
MU&G;0ZBZ ]6=]Y^^EW7O-/E1J'D=H'F]8K[>**BL_,;535UT)HFR4>K462PW
MKF2ZU5T==1,:MM;+KE(ZHLLO5"DAHJ2,=_U;H++=*]:Z5H>O934\WH%VU"3G
ME[7+?O3=KGN0RU4XR=J32DL6HUK1FA:5UWF>J.BM4US0LWIF5UZU=FE#,7.:
MS9@KO)">8HTXJ[%-Q;HG*BC6AV]NW,#1.E:5 UGKC1FG*VDTK0ZIO!N^H;9:
M*=FT*:IF*[4;2:^I:4WIIRZ.*2S4'X"E2!,F//<OI.IYZ;_5VF9B]:E?E:AR
M6Y3;G5N-M\J=;G+2L=M:F_WM5T[(PC^L=2R]F[&PKD^>Y&*4:)2N>T_T;E[L
MME*8DNA^8&@N9UF5J+EMK;2?,"P-U1H7+SHR_P!MU';6JT#B^C>JK745#;53
MPX\"I*(RB-3TG5-%S"R>L:;?RF;Y>;DO0E;DX\4I)57:BVFZMI>LY=YO1]2L
M9K*\W+SV9QN1KP;BW1]A@'^=G)FEU?5<OJGFYRT8UW0MU#M;HU[6VGV]34:*
M1A555&IM"JX5;)IZ9!<6%)"DH!)$A'+ATWU'<T^WJT- SKTN;2C>5FYX;JZ*
MDZ4=7@N+.+/J3IVWGYZ5/7LFM3C7FLN];\14576'-546+X+$W^UW2V7RV6Z]
MV2XT-XLMXHF;C:+O;*IJNMETM]0":>OM];3J6Q5T;X2>!Q"BE4L#'4W[%[*W
M[V6S-F5O,VY.,H23C*,EMC)/%-;T\3M;%^SF;-K,Y:]&YE[D5*,XM.,HO9*+
M6#3W-&J:[YG\M.5M%1W'F9S#T3R]H;BXXU;ZK6>IK3IQJO<:_K$41N=33JJE
M-SQX 0(Y^EZ)K.MW+MK1=)S.;NP7M*S;G<<>_E3IZ3@ZGK6C:);MW=9U;+92
MU-TB[UR-M2:VTYFJT["W8^8.@=3Z3<U[IK7&D=0Z&98JZI_65DU#:[GIBGIK
M>V7J^HJ+W25+E!3M43*2ITK6GRT@DR$8\SI.JY+/K2\YIF8M:FVDK,[<HW6Y
M812@TI-R>"HL=Q?+:MI>=R,M4R>I9>[IB3;NPN1E;2CC)N:;BDEBZO!&NO\
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M8N2]<VS6Y8SFWQ8UE7S"68!G/<1T1UQ5[.PL),C.! _S.CQ_1 #DGB$\H =
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M=$OYC*YV'AY:]"[*[;C"+_/NW;MPI&7Z/"3YN9.7LI+L5^7_ /\ JWZH?_\
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MT5S4YR\C==:\MMKM',JKY2:FH;7;M?TMC;+-JK+Q;+K;[C34FH:&G46V[@R
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M&/1VPJZ;09!FF *20<)3E[<H@&PT0(! 'PC:983E,CK'C &YVX"23N*?:-T
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MZ!T?2[&7U;3+5_/>&G>NW;C3<VO;I[248IX1WM*K=6=6N3MLTAR7]?=IY?\
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MX-4*.M36*K@"<5)'2/;$O8^X@S@R'4/9& D6 " " " "  "> @!92,B/'^6
M$@"-2Y #(D&8F/ SSB>\8O89O1[@1JFT*_\ &%REE_5+&4;SY9X===.T_P Y
M+[+.3EO[1:X5.;ZM[XC-0G/*6<]AD=FR/L9).C6X[GM-5K5@%70#U=72 #WB
M)!A*A!4VN4RJ0D,\B.B>4 8A22F8(/=+^2 (RVE1R[ ![H 0,B<^$X':![H
ML(:6J4AA,#J[IRP@#+LM\ "=ARGGB=FP#" -EH#\@'ZQECLV@P!O%K>X5-B8
M QG,;#X"<HB-=G C8<@4#_RD8D;\1CE*671.))-J:42 #C@DGHF#]XA5 E@
M@ @!R>$'X@2-P,CWP _B;2)I2KC!F)D<.6$]N, !>401).(EA/WP!%NZ/MC
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M3K%14=W)XM>3LV8&R\T)'\RKD> 9\6G;"A.]2U6F\A*$_B4HY 8F.PZDI_\
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M_,K4K_)KRW*C@GF8\!/]4"PO8= E.-O_ (A<>E^GO_J?_P"$S:?/;]VM!_\
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MP@!GGJW)Z,#_ &T 00!__];W1CX/-7'($UIE^(>V(DZ186)FQD.H1@)%@ @
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M;] :5#R/("4.._4<?G3F92E'G7EWY?KH&SK-K];?>OO=R,_<Y.7EKAM=:U^
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M"U?JDR*L09*(VF<* DXE#B ) 5\P_%(X3RF1 #9DYY]<X 2 " " " " " "
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M]L 6D $3V@^Z )( 3XIXD2V8&?3M@"9H8[<T[3[X L)S5U_>8 ? ! ! ! !
M! ! ! ! ! ! "P F1GM^WO@!22<223O., ) ! ! ! ! ! ! ! "<2=_M@!T
M) ! ! ! ! $7&KH^W; #9G>>\P 3.\]Y@#__U/>G4-)Y&HZUL(X4.+34HW%+
M_P 1(PR*IQ\@>8NG1TKK+6[$(-0NS5R/:KBYG3LYJFOYB')?N+YM:^OXQ0)R
M&,B9  2R$\-D:0WB<>M=X_Y ,Y$YG^39$$CL\H; (3(3@O@! HXE7VPR$0"L
MM4NN!+6+974)XXS!G(91*VI;B-HT<7$"01V&6 WQDE3DI4@?&(D:K(]GMBT?
M>0&2.X]QC*VFG[1!RMROMZEO7&YJ;5PMMMT;*R%24MP^:Z <R4I2F?7'NWDE
MI;EF=;UJ<?9A"-F#W5E[4Z=R2KWG8Y".-RXZ;*',)!,YIGV*]YVQ]"'9$"B1
M,<*1V>PP PY'JB)>ZP11QBI4CE%B)7S'L]D 5%J.!PW;>F %3CB9C $^'O@"
MRWP[S/ #<<Y##,B ,BV)A(Z(P43FT]A#VF2:$FT]/WQFKC3=0;R8))BKDW[M
M*=H)$#$ X X9]P$1&,DVWL8,E3F0(W2(WY2/LC(29ND7,@<6!._>-\ 9^E5P
M' SV$$[,YX2D-\!B9=!3.<\)8=?C  YP%*C,SS$LI],Q/&< 8ES(=1^Z *Q)
M)QB"Z5 @2$ -(G+$X8RGAVQ)7E6(AQP@5*C@E/KEW3@"$B?Q;0)]&$S %=0X
M@9])[8$IO84:ACS$\0^;$ ?><]L,"# OTQXQQI.$S(' @F>.$L8A)JJ>P%-=
M+_,$SM,LI"6PD2B=N"=&1L&"G4!^KU='1(;8IR8U<J@M,TY./"9[@-PZ!D8L
MZTI&E!W&=I&BE/Q#$XC++9,#:<8E;%4&6;XI 2VYYD;-L"SVEIM(&<_AD<>L
MG&!!9;45 92E/#^7+& +J")9C(]AZ>V >#[R1*4F1GCG*>[LR, 2H)/"-^.$
MQOPQV80!/ $'$1M, 3M+.& ^8?=TP!>2-OXI$_;M@!8 ( ( ( ( ( ( ( (
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MHDXF@YF$X4',PQZ,CGEET8P%60\9Z/'WP(&*'%/M/; %=84)"0ED3O!W8XB
M&E"9'#8=I@"JM,CD1 G:NT@6VE8,T@[<=XWX0(*QHVSL[ ?#* &BB;GDK,;4
MX=6$ 66V&VI<(.<YD[3OD!CA <$6T(V@3VB71B3 .FXG1D>OW0!81CQ3QR^^
M +20 !(;![(!*H\$C+;@>H_I@2FZHD3NW0#19;7*6.*>V6)]D"!_G=([C  "
MDY)Z,S $Z0 1+>/; %X9#J'L@!8 ( ( ( ( ( ( ( ( ( ( ( ( 9QCI\/?
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MSG+'9@0!E"FP&=IE!2!+ R'M..Z ,XRX0A*?AE+,X]'5 #^/AQ!!/VW&#5:
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M'RREA.<NF?3 ! ! "C[QGEVP _\ [G #( 2 " $&WYY89\4LS+/I@!8 ( (
M( ( ( ( ( ( ( ( ( ( ( ( ( ( A^/^=XP V " " "#V,$$%L0>UDPGMEV3
,@!/CG^K+MG. /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g76219g03z11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76219g03z11.jpg
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M"B,R-T)1=[<8-F%Q=H&X)"4F,S128QEB<H*1P?_$ !T! 0 !! ,!
M       " 0,$!@4'" G_Q !*$0 !! $" P0&!P0)! $"!P !  (#! 41(082
M,0<305$487&!L? (%2*1H<'1,C9"X18C,U)U=K2U\21B<G0E-()$4U22E*+"
M_]H # ,!  (1 Q$ /P#OXPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A%;=Q!M$G4K/&TBPQM2N4A 2X54M,S7EVV)K=B* ?8AIZ2JS<S7%
MV0&)D%CGE029^$W*LL+!_50/O_E-$7/9S>S^9<AX@>)_D>%Y*V2]6CFG:_*?
MF]GJEKGYJ&G?);I<AYTSG,^)5N1C:L*W5YP"=B*C(<?+A+ (%3^24N^G]2KK
M(Q7,8P3"GMN-.H:=?(:;_B0?,Z:>*V=?3I\E:_Y#\5E8Z-DNC62R<3L['+^A
M7?I2X9V8OUW<JM<O,Q;F&H.Q64>NL2R[@EQ?/9 B*F>;+3JFD5^*CXN*2\47
M#0^&XU&GE\^/BI^X5$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$4>5>6GC,EJM
M$:[IS-P:X].F>,5<EBU1A LYU*O60>FSE*CR6'G&'IF*N!D?5#F].:88LLI$
M0*W]2LO&"%%70^1\^G@=P?NW68:I<:O>8M^<J$V!88<:=L]9=DXQW9 6IZEV
M25J%JC6R-)TV\_!6>#F((_;*G&FI&-+'TXI3*_14^?O5RX1,(F$3")A$PB81
M,(L.^0/=>?>,W&>A]XZH;( 4#F< Y8+$_$QSLM*.,?DC !@QL>TIO\@^2DS0
MHX/3[XH39!3;L@:""V06P0#790ANWU0N64WDJ.S6[QF\OAZW"= BZ-8!"./5
M9Z2I=EL9?/8B@2;LDYT7^$+#!=$D.JUR(I=MYM:KI#%22IR)E)"'/B3Q4%73
M7Q'G\?5MT\=//HI3<!\DJ%VVS=8HM;H]^YU=.0O\]*Z74>@UF&K4Q$2_7*8-
MT.%8):A)V>$*E_T4QI<^O12_L2*E,I),UK;^RI\_DI-81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3"*ESD+%66%F*[.A,R<)/Q<A"S$:1I6QY"*E1'@9 )_2%(7M
MDL1]YAW2%I5\'%?%2=^MZ(M,E>^FDJM>-]\Y\#S&D1W1JUYC>0W4_%+^$[1)
MU2D\:H_8?)2.O//+/(UJLR%7@+)7N30,12.GE\3F8^8J\[.\OKM71&$NH#=;
MH/S/QV4M=3U/0 ^O0:>OKT!\-5+7P1YAY+<9B.F\P[0Y IY/1K+JK>-0<<]5
MRY 7F<+8+J)!K(/KT:!+2 17/$\N=D)#HSTKTJ2Z=KJ4I.2AD(=67E55#IMI
MY;^W0:_CKTVTT\=5/K"HF$3")A$PB81,(F$6&/(CE<UV[B71^45V\ZYO-7FN
MO0@-R>IE8Z-'Q2W"!WW&9V@W(<BM7.L3###L':JQ)[$3-UR2E(\64AS2!I4,
M@]FJUH<_^DP[4_&?O_ GNO4"K+[WW[A_=%1'$N#%\O\ '[E"^,7WCUW=K'*>
M#F]@N3U<UT%WE"UV^71T;\9R?LBYT6OMCQ#<+(%(NU.N_0C<ZG?7J=!KU6P#
ME/CO_ACY ^5?=?XP_6_^DW,\=E_X6_A_]-_@G_";ET?S;\?];_6Y#^)/U_\
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M.[A5$ZQ<UT.1T&L5SITG61.7VRY<[^ZAV[U&K7&8M%-4.7NPQ48J/-_'*NA
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MAXFM''H?/GJD-\R0 OG!<I?6O%_91B^7F%Z/$TW-TZ^E\>9Z%Q.W3NW-U)U
M )UTV&$IV7*L$W,SQJOD;-RLA+EJWO>]J*DBWC"%;WO]]^W7E[][_??]<\Z
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MT T_/V^:M$DG4K%>55$PB81,(F$4A/&C_K_8O^#_ &W_ )5VS-2X[_='/?\
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M[H<0KXNLNI<9>0V\VM"?1E:S7N5XK56:.Q7G8V2&:)P?'(QW1S7#[B.H(+2
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M>D;1;[3)D3$_/2S^R#I*0*5[<==7Z2AMMM.D,"BL(:%"%:8##88%8991F
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MF'I$7VGOQ<\A .0JM&KC'_\ K*S!_7,'>QM,\8;+U?1,K&3L7'3<+(!RT/,
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MUR+LI.SLF[IPDPES24(0A"$H8$"$';9#CH\-I@"- '& !''$'991F !H  T
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M)@'/:;$4!INKPON,G)<RJ8.=*IZ.>]"N]%;E/UMNGVJ=K:)?<:9#+DD0TD0
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M<F1ER&DE'O9FL:&#0=?$^95DG4Z_=[%'K)*B81,(F$3")A$PBSUXT_ZV1?\
MP#VC_DOT#."XH_=O/_X-D_\ 1S+6^,OW/XL_RSG_ /:K:NSIR=#2?DK+M_\
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M==6EMMMM*EN..+5I*$(0G6U+6M6])2E.MJ4K>M:UO>\J 20 "22  !J23L
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MO>ER#*5^B?HO]ESNU+M7PM&W7,O#^ <WB'B EI,3J=&5CJ]-Y\#?N&&OI_\
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MG;GW'B7FF&TJ=<0C>O\ %;7/X9XAC8TOD?ALDUC&@N>YSJ<P:UK1JYSG$@
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MP=9M973;^(M/GR^"J[ _ 8?TF&X1NP)UZU\NH]0N=@>WK^^]KYC_ (+L_/\
M^W>ATHUZU[;5^_O3KWTC>TJWKZ//A,7KKIZ!B6R<OL^L[&1W'_<#[/!;QC_H
MO]EM/E])AS^6TZ_6&8,8=TZ_55;&D#K^R0=^NRZ9?H.7.&F>?>0]3K]'J5!B
MJY<*'.M0M1U9G!''[3"S\>Z889;;+:IHTI;=0'8T\3+.JTTPA._Z>]]1<6<6
M\1<87H+_ !)DGY.W!7]&AF?7IUA'!WCY>Z9'2KUH@T22/?\ V>NKSOX+N3A'
M@OAG@BC/CN%\6S%4K-CTJ>%EF[:,MCNV1&5\MZS:F+C%'&S^TTT8-MEOSS55
MMB81,(F$3")A$PB81,(N&GZG=B<L_GCY'2#CFW/P[A&5U'O>]Z0W4ZE7:PEM
M.M[WZTC](WKUKUK:ODKU[WO,R(:,;[S]Y*LO_:*@;EQ13"*\N?<_M?4;A#42
MDQK<K99U9F@17Y".B0VQXV/+EY60D9:7+!BHF*B(B//EI:4DC10(Z-"*-+(:
M88<7JA( )/0(!KL%G9'A?Y"NDVT5NJ02E5(6)-V_KH% T';6)ZDR'2H3?-C%
M670W25RW/XJ1MP+5)=G'7H@56_@DMQ@1V'>-VZ[^H[;@;^6YT4N4_P ]1H?'
M;W*TK;XT]<HT2J<L\''QT0U1!.A$GIGX4Q@.&.EX*"&CC-A&D*&LZY2S08RJ
MTXG4NVD_\EP9(HISXL@\'IKUTZ'[_9ZU0M(Z_$>"P)DE1,(NI;Z&/C/%USEE
MH\GYZ.:>M71).3IM%+?:2M451:V:D6=+ <5K6VG[';!"P#]ZTI21JJ&EEU*"
MRVEXLSM7<O@WXG].BN,'CY]/5\_/5;\O>O?KW^_]?7]_6_?K?_GZW_\ YO+*
MN)[U_3W^^OZZ_P!WO^F$3WK]_P!_Z?MO_LWZ]^M_^6];_P"[>$7Q^V];U^V]
M?OK>OZZ_W;UO_P#[K"+B>^JIXT1?C9Y76(2IQ[<90.H1K'3:A'BM::"AMS)I
MP=EKXB$:2RP/&V0"1)CP64(:CX.2AQ$)^+25*RXG<S=#U;MX]/#=6GC0Z^?S
M_/WK6SEU03")A$PB81,(F$72U] 6VM-53R;JYA/V1HRP\MGADN*]-[?L,;>8
M\I3:??K2_MU@33N_6O:=-:WO?K7K&G&[3Y@C[C_-7&=#\GY_FM"'DHXX[Y&=
M^==W[=<[7U1QW?\ 7VXN]3RE[_KO^JM[_OO_ +\OL_8;_P"+?@%!W4^T_%84
MR2HF$3"+8C+>7',+5S+F',KO =MM\75Y6B29A4YT"MGE\P30.6S//P([A3C]
M9VU%P$O/'PUVF:Y/C)CRFZE"5@E9KORM+-GNW D@M&Q'0[ZG^+W?CNIEP/74
MZZ>6WL/MZ[;^I>">\U]F=7Z7?X@>_C5VS0%8&AZ63:4CQ]BO<97:92)_K/0&
M(;<="HO$U!0,Q:P2*["(1"]&=J4Z,ZM=0#)(KW9( VU!.^YT&NO*/4>A.VW@
M=534;]>FG0;^L[[GJ1Z_$*-GD)=^:]!Z4?9.44O^!*D_&Q8S4/\ I,-7_O'#
M,*04=^@5X@N$B?DG;(7VX\EW4A^#^M&?;D9,QIN; X#1QU/M)V\-SI[U0]=O
MAI\^KU+"&25%WZ>&@<>!XB^, T7I&@O^C_R!]M3>M:2ZZ708$LHC?K]ON$%/
MO/N_WVZXO>_W]Y@._:=KUU/Q5]O0>P?!<V?(>/\ -0/..T=.^G3,]&L@_AQ4
M/,M[RY\Q>E=(?M5H\UO(>^T.RFT_Q]C@F$Q4%UECBMO)CK%)62/IP]:KR(&&
MBH]QV75'3UCHKQ=]G1PW/+RM&P:W^\.NA=IIY[D]"-;"^EO6":;W+Z=4EP&]
MS,#TGSE^F;Y(])\K;X9*RW2%V/KL;=(XFE]TZ!6;'.$QECMM3Z5+2M;$,D%@
MNF@#G4]TY@-\QK"/W#]=/LO ;X$-WV Z:: ?B56(L21\:O%S_*1(N^^0?;K7
M8ZQ>*I"R_D!MJ,/Z[8+C>.%TN+#D4 PKU3AXB*DK/:!*XU#PI4)&TV@NHBXH
MH8:%'?T335T>PT(&WAIS..GCKML2>O4J8GT2:9,<"\FO.'QWN-"J7"K.CFGA
M]U.,X!Q.[S?3?'JNP,S0;+$R?1Z[<;#+$RK/3ND3Z5N]%AG8&%"='A*W*QLY
M?F"7)\=\/!1?N&G4G74:D:';3;;;;U:]?<(D_P"4B 1K?=_'*3:TW^KE\DL8
M!V]:U]W<;'7%XB*TO?\ 7[>BI29^UK?[:5M[U^^U9[>^BK)*>'>*H3KW#,U4
MDC_N][+1#9M!Y\D,'-ZN7R7@;Z7D4(XGX2F:!Z1)@;<4IVYNYAR#GP ^.@?/
M8Y==M2[3Q7-]GJI>15+#PSE>3Q'87'^X=>M7(^6O4^PC6Q51W>&3NE".* <%
MY-*2% BIN<B:Q;I%H1VSRGZ68V+"11OX36IQ<.M.E\>0YJ?!!G#V$IYO,-O5
MGTO3?J\QXEX[P/S4,62FKUY[=*)SVTX>^C+[$T?>.]'$X.\=GTV#@S[G<29Z
M]@<(['VV7C0^L6RYB,F(LP4\N+@LV8*5^5L;KL_<2AE:"3NV^DF C97:O.GD
MTIQ[O+4EUZ'G^L6F6\@Y.)D*SS?HD1+G6/I5FXU8^?\ ^$AD]'(K5<Y&+_AP
M.)TB+ZLA[HA.XA[==?+5..$YU-3[.LW%G>'#%@YZV%IP\,PS16\KBYX(ZN)J
M9ZKDOKME:7TNUG'_ %LY^)FPQ;BF=^WTIC/1PU=P7>TK!38#B839ZO:SMV?B
MN:":EA\K7L26\S<X>MXL8&2U"*=3 ,^J&,S$&<#LL_N'>B/D-GO%@>X>0W N
M]\EM,5W:]N,]&;HCG0PETFMV*M5^=[ ]3.I#TVE!1T94SQ3T<XFU<[ 4[:"H
M.M;<Z]Y'R<39"DC4E:]CH\,<2\-YNG-PYC0[%G(C%R#(6ZUJS7PC;^'=?R$L
MLUV)\7UK7&4D'H;+%O3!\*PSU6%^0 UB_P 5\+\48*[#Q-DRS+#&.RL?U=3M
MTZMK/''9MF.QT44-"9DHQ%HXF(FZ^M3UX@XOGKW'\F-)U.9W4NCDPB81=9'^
M37.N[HWEDSM6_LMVSDCK:?\ 9TZ]#WQ#JM?]JD,,Z5_V)3GB[Z5P'UEP6[3[
M1I9H$^.C9\<6CW%SOO*]S?0_<[ZMXZ:=>47L"X#PYG090.]Y#6Z^P+IPSR0O
M9281,(F$3")A$PB81,(N [S16XYY@^5*G=JVK7D7VE&MJ_;?VVNC6-IG7[_[
M.F4(TG_>G6MZ_;,V/]AOL5AW4^TJ-&35$PB](6Q$F"*D$/N ))8V:V*I""7!
M-.HV2@=;FMMH?4S\TM*7K:$N;3M6MIUO!Z'3KX(I:S'DS&2'6?)'J@=:/ .Z
M?1;9SOCXK)0J?\*ZS/FUZI1L?MQ.O:F8/A0$WS41,;MK[>I5MUK:!VU)RWR'
ME:W4'0@NU'7?7Y)\AKXJ1.I)WZ:#^>NOY[[['=7'Q3RG@*A5J_2.M!W#IE9;
M-G Y.-G=Q]PA*S4@JTPS0X&H5*T2J(,\!-U_'M-OA9;<=&2#E'YCL52W*D*V
MDYA)+FZ ^TC7S.W0Z;;>9/4H#IIJ 1ZP-M_#^:AQ93HF3L<_)0,5^@P<A-RI
MT-!_D++_ $:)+.??CHK\MS6G"OTX-QD/\AS6EO\ V?N*UI2MY,; #R 451<J
MB[QOI^A1X'A/XQ,1ND)'<X_4#7--ZUI/ZA) )D97>_7[?-4H48IS?]=N;7M7
M[[WF"_\ ;=_Y'XJ^WH/9\=UH2YMPWD4U]4",G? ^5Z%;[?XM],\@+OYU^9O1
M^FDS<EVWI%^J\^B"\)J\*&J#@NGIJ,[(Q2YR/BZR/ \CA(**"1)OW%W29**N
MDD,^U_$!RC3III]K7UC8Z;GQ4;?I=!'0/9?H^=;YC;YQ/<//_@WU*9?S>OYT
MU,VX_H-BH,T[,\XO/1J])S"XLN2HO2=;KL,I8\8K\<1VO:(:1LE.RD_3[>VP
M+>7PTVZ#;Q&_XK.?/N+]UI\E_E(?'*_Y43UB[NFB>)VT>379+56.8EFV:V>,
M<U<)]\JR ?P]3^25MW4[+4ZDZ#?BX/F=;77Q$2K;$%N544=1_5D@::G8>7-Z
M]=?S63OHW)D.:_4(\FN'<WX+=/&#@!GAMXW=9F.(67IE5ZA'Q':#9%^MN=%C
MSZ1T#I=8@W^LP;4[,-NCV$>8OT!"0%\G(P14H *&1V[0=0X\SAKN-1H"!N-=
MM?4!KH/-7]]>4^M5^V>-4N]0N?VJRGU[IP7ZI<H%RQ$149&25)( 8$C"SM5]
M]A\N5DW5ZEH625IQO>F%LH40A[<^&>..+.%JMVEP]G+>)K7I8I[3*K8 Z26-
MCHV/$LD,DT1##RGNI(PX <P<6M(T;B?L_P"#>+[E*_Q+@*>8M8^&2O4DM/L\
ML4,LC97QF**>."5I>T.'?1R%FKN0M#W Z#V>T7D#TJOMT6F/ZWK>C>?<GY5S
MN3UO7^BK<M1Z9 2BG$?T0ZLQ3J?6O2_>3O<:<89+49#BOB.XUW6.?-Y*2+0]
M0V$V>Z:#XAK&@^2KC^ N!\5RG'<'\,4WMTTE@P6,9-MIH73BMWSB-!H7/)'@
M53;!U[K%M&T':NH=$LPFD;;T+8+K9)D;3:O?R1IB1DR6M(5[W[3I'QW[W[U^
M^:T\F1SGR$O>XZN>\ESG'S<YVI)]I6U,8R)C8XVMCC8-&L8T,8T#H&M: UH]
M@"QWE%),(F$3")A%T=_Y/HMS1GEBWK>_M*&X@M6O7[?<2[UM*-[W_;?Q6YZU
M_?7O_=F//_#_ /=^7ZJY'X^[\UTFYCJXF$3")A$PB81,(F$3"+@I\\'%N^9_
ME$IS>]JUW#HC>M[_ /L9LAS+6O\ N2VA"=?]FLS8O[-OL/Q.BLN_:/SUW43<
MFHIA%EKA71F.3=8IO0#-SVP($TU,HW6G*\B8)B)>(D(*6#99MD%9:U("G1LF
M4'*0T["F1D[%/FPQ>Q63U&#Q<.9I'GY^W55!T(*V-C_4BI*"+LP[S.QL095;
MI50K\9$NT:'%NU1I/%K-R46G='C(^MC1%8KQIMHDK:TSS,.,W"M$KJX#3HPD
M;+"6NZ/F/'KKM]K7;V:>.VN^G76O-ZO+H=.@T]?Z^O8+ O)?+2F0]=K%0[G7
MKAVBOA#-NSXUI)"L[:4UF<@V:)2ZX#8I18T?58N@(Z166)5M84I69KK\G;(6
M--E*#4U/R=&==6Z-W&FGLW/38ZZ;#8@:;:IS>>^O7X>_;IJ-CO[8"[];WO>M
M>M;WOUKW[]:_MKW_ ']?[\NJ*^,(NZWZ;P<>!X,^-+$;I&AU\X$,<^WK6D_J
M$C)R<A+;WZ_;Y[E"C-N[_KMS:][_ ']YA/\ VW?^15]O0>Q:0N<\%XG:_JQ5
M-_PIG.A6:[>.'>^L=(^H!YK]%Z@1)F7RQ7R"FQ0/!BK-"?HD#T5J#DI&.U-U
M^+KC<'QB @H\!<J3;77P2(*[J0S[7B &MTZ::?:]0.FW]XZ^"AM].00G_$OZ
M0'>(RY7&"\BOJ!__ *L</YYWV.N$JFW78*@N7<ZKS-M'FBI2&@C^+6*)KG\$
M$D0K(L24R$RZ,8V^EE92<1]L=0.4L]^GEIU;U_715GG](IU#B_/#RE^F%(]"
MJ7CYX[?3V\IN4R7D39.C2T[T+SQ\FHZ/D)XWND7%NE#HLH7$GXJ:D!.W"P$&
MS.VYUV'J(1%:#*T \?NW^_X?FFNI:U^FI<#T Y 3N#[1OIX>.ZF;])&GU+A/
MG;2^3<$>-&XUV;Z,7BMY3=CCQK',V&&GO)RP=%7!;Z7*;DY.29"NE_IDC)2D
MRZ+^(J7;;0<ME32&/ME%YU:2>O.X#V:#;V#;3?;HKO\ \H)# 07XIR"=(3*/
MC]H#>5KU]QP 5SEKXVE[_K\&"#"]M>_V^1#WK]];S(@UU=Y:#[UCOTT!\?R^
M?BN</,A6TPB81,(F$3")A%N^^C6::'_TCOQ%$I^Y_A!]S\?W^_P_Q0^'S]?_
M ,E?'_\ MF//_!_]W_\ E2:-==QX=0#Y^:UJ^9<(Y7?+?R;B'$?;T-WGJ[HZ
M?7K_ -A-N\V?'J]?M_I@E#K_ -W\W[>]>MY>8=6-_P#$#[ME0]3[3\5&O)*B
M81,(IJ=)Y#NI<P\2NN5'D1UC@Y/DAEXZG(/Q%RE*389V$[ITZ&6+<9.(/#_1
MPBZO P,-)#0\U7"=1FD$BDA'DZD%6FG4O:7:;Z#?0C;P4W  -.G4;^OHI-=
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MV[/S"V, 2LQ)6GA?0^8-S(PJ 78GI)RPI8='1^-X_P"-+N+X@DG;P]CLUAL
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M[MQ3[BE>U*]Y:5PO<1H7'3IHLL<?\'/$7@'5;YW#B_CYS3F_6.F)D6[G=ZQ
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M/$.JVMUQ2G7-:4\\YOY*VIQYQ.E.+WO:W'-:WO:EZ]^[/L,#6_98T:-:-F@
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M(/"VL_E[M.U0M77RU+N8DS]J$QP-$N7EBDADNES(FO:]T4TC#&QS8 ':B($
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M/Q(Z/UNRR0;_ ,?C]Z#K<5!5<5'O^J],S<=9/YM;^.MN;1K6MH5M6),=7^P
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MQKX0<1#6H<38N&#%_6\TCL;D9Y*V7L3\3.PY@KC(5L?!39,V;_YQ\SH[S-/
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M_29^^F08AK,H+(04-8PZU$ID"=S413FD)&AZZ:[$C4@^S0?=YGHJ:#0^_3<
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MX!S7 ^((((/B"OCB]CHWN8]I:]CG,>UPT<US20YI!Z$$$$>!"_')**81;_\
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M>7L]2K"/*[OJ&KNUN^Z>_P 19^X6BVOEU:EFF'3W0(@6!NT@ >77'S:\NSQ
M$>%,,5PB)%,1&QBW&-O1P+C%.1NVW38;GP.H\=]_-.8^?4D^'4_!>-WR>[F1
M_$WY5Z<,1<=W15C:-KU3-'DGN@W.$Z):B]CEP3S IYMXK<%9P9 %L8Z EHL0
MBO$17V_CMR-VVZ: ;GP&@\?+[_%.8^?R?GW>"]EL\G.H7NHV>K6X^.D_XD!J
M=?28!!P%7#A:?5[)8+L]6(>MU*)@JX(-8;Q,AVN</3':D3)6&&==(<V46IP&
M-!!&VFNVI.^FFNI)Z#8!"2??[.FNOQW/GLH\9-43")A$PB81,(F$3")A$PB8
M1,(MF_TO?"@KRQ[>+.6R+=7Q+E9D?/7TE]I6@K-)H<T3!<^8<5KXOJFGF?RK
M EK]Q*T.8VMX0V4B%O6I7\HT'4^KP\5)HU._0+M/;;0TA#32$-MMH2VVVVG2
M$-H1K24(0A.M)2A*=:2E*=:TG6M:UK6M9B*\OMA$PB81,(F$3")A$PB81,(F
M$4=/*SQQJ7E7PZY<;MFT"?K@J3JS/_82^35+C&:<>KUB%3_*M6A"E*&D1VG&
M5R,(9*16WFFSG%ZDUQ:01X?CZE0C4:?(7"#U/F-SXST*V\NZ%$/0=QI4P3"S
M4>[\MHT\QM*V# GMI0DR+DQ'!Y*)D&M?8D(TL4T?:F7T*WF@AP!!U!5@C0D>
M2R!'>4G>(JI1M*C[ZZ/"1,?"PP+^J]4W+*BO5R:#L,#5G[J[ N7,VH1$S'@G
M1]1.GR:T,L,9IJ*2PRVTF/(S4G3<G7J>OGIKIKZU74_AIT'3R7KA?+'O]>!(
MCXB_?C,E621MKA"ZK2BY1$W+7*N=#DUC3)M<(EPXTZ\5&M6@F $.8@'9F&#,
M5&;<0KY"QIZCPTZG3333IKITV0$CQ^==?CU\_%4N-\F.VQ4>S%"71*XX8.)
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ML=]FR*?&L5Z.7E^R[]GS\OU'P4'-UW'7Q'G\[KE^-",C3"XZ1$*CY  E\(X
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M);]*>WJLN"MJ^2&S'M)^>[[96'QT/K_7HH%A'K^?GIJM>$W SE:DB(:QPTK
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M5JJNV&BM:WOWO_-L4B;KS+6OW_;33:-:_;6M:UK62[Q_]X_>H\K?+U?/Z]5
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),(F$3")A%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g76219g08m78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76219g08m78.jpg
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M 0$! 0'_P  1"  B "<# 1$  A$! Q$!_\0 '    00# 0
M!P0%"0H&" L#_\0 +Q   00! P(% @4%         P$"! 4&!P@1 !()%"$B
M,1,5"C=A<[0S5(&4T__$ !@!  ,! 0                 " P$$_\0 *Q$
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BY/1W*+RGHO1..*1EQ^? 6$_;:[^PA?ZH/^?6R=YYE27_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g76219g20a36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76219g20a36.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X6TJ:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F<R,&$S-CPO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @
M(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&<FD@
M2F%N(#$X(#(P,3D@,3(Z-3(Z,3 @1TU4+3 U,# F(WA!.U-C<FEP="!V,BXS
M+"!);&QU<W1R871O<B!V,C(N,"XQ)B-X03M'<F%P:&EC('1Y<&4Z($%R='=O
M<FLF(WA!.R8C>$$[XH"B(#(Y($--64L@8FQA8VL@8VAA<F%C=&5R<R!W97)E
M(&-H86YG960@=&\@9W)A>7-C86QE+B8C>$$[)B-X03OB@*(@-"!G<F%Y<V-A
M;&4@8VAA<F%C=&5R<R!H860@9W)A>2!P97)C96YT86=E<R!M;V1I9FEE9"XF
M(WA!.R8C>$$[XH"B(#$@8FQA8VL@<G5L97,@=V5R92!C:&%N9V5D('1O(&]V
M97)P<FEN="XF(WA!.R8C>$$[XH"B(#(Y(&)L86-K('1E>'0@8VAA<F%C=&5R
M<R!W97)E(&-H86YG960@=&\@;W9E<G!R:6YT+B8C>$$[)B-X03M4:&4@9F]L
M;&]W:6YG(&9O;G1S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#H@6U1E
M>'1&;VYT($%R:6%L350M0F]L9%TL+%M497AT1F]N="!!<FEA;$U472PL6U1E
M>'1&;VYT($%R:6%L350M0F]L9%TF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TF(WA!.U1U92!*86X@,C(@,C Q.2 R,CHR-SHU,R!'350M,#4P,"8C
M>$$[4V-R:7!T('8R+C,L($EL;'5S=')A=&]R('8R,BXP+C$F(WA!.T=R87!H
M:6,@='EP93H@07)T=V]R:R8C>$$[)B-X03OB@*(@,R!G<F%Y<V-A;&4@8VAA
M<F%C=&5R<R!H860@9W)A>2!P97)C96YT86=E<R!M;V1I9FEE9"XF(WA!.R8C
M>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C
M=6UE;G0Z(%M497AT1F]N="!!<FEA;$U4+4)O;&1=+"Q;5&5X=$9O;G0@07)I
M86Q-5%TL+%M497AT1F]N="!!<FEA;$U4+4)O;&1=)B-X03LF(WA!.RTM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM)B-X03M4:'4@2F%N(#(T(#(P,3D@,3(Z,#8Z,S4@
M1TU4+3 W,# F(WA!.U-C<FEP="!V,BXS+"!);&QU<W1R871O<B!V,38N,"XS
M)B-X03M'<F%P:&EC('1Y<&4Z($)A<B!#:&%R="8C>$$[)B-X03LJ*BI4:&4@
M9&]C=6UE;G0@:&%S('!A<W-E9"!P<F5F;&EG:'0N*BHJ)B-X03LF(WA!.U1H
M92!F;VQL;W=I;F<@9F]N=',@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT
M.B!;5&5X=$9O;G0@07)I86Q-5"U";VQD72PL6U1E>'1&;VYT($%R:6%L351=
M+"Q;5&5X=$9O;G0@07)I86Q-5"U";VQD72PL6U1E>'1&;VYT($%R:6%L351=
M+"Q;5&5X=$9O;G0@07)I86Q-5"U";VQD728C>$$[)B-X03LM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+28C>$$[1FEL92!.86UE.B @(" @(" @(" @(" @(&<P,FTV
M-BYA:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @("!R<C,R.#8T,28C>$$[
M3&]C86P@5&EM93H@(" @(" @(" @(" @,3,M2F%N+3(P,C @,#4Z,3DZ-34F
M(WA!.T535"!4:6UE.B @(" @(" @(" @(" @,3(M2F%N+3(P,C @,3DZ-#DZ
M-34F(WA!.U-C<FEP="!697)S:6]N.B @(" @(" @(#(N-28C>$$[26QL=7-T
M<F%T;W(@5F5R<VEO;CH@(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @
M(" @(" @($)A<B!#:&%R="8C>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H
M96-K(&ES(&-O;7!L971E+B!0;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@
M87)E(&-O;7!L971E9"!P97(@<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O
M;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X
M03LF(WA!.T%R:6%L350M0F]L9"8C>$$[07)I86Q-5"8C>$$[)B-X03LM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF
M(WA!.T9I;&4@3F%M93H@(" @(" @(" @(" @("!G,#)M-C8N86DF(WA!.U5S
M97)N86UE.B @(" @(" @(" @(" @<G(Q-3$Q.#$F(WA!.TQO8V%L(%1I;64Z
M(" @(" @(" @(" @(#$S+4IA;BTR,#(P(#$S.C Q.C(S)B-X03M%4U0@5&EM
M93H@(" @(" @(" @(" @(#$S+4IA;BTR,#(P(# S.C,Q.C(S)B-X03M38W)I
M<'0@5F5R<VEO;CH@(" @(" @(" R+C4F(WA!.TEL;'5S=')A=&]R(%9E<G-I
M;VXZ(" @(#$V+C N,"8C>$$[1W)A<&AI8R!T>7!E.B @(" @(" @("!"87(@
M0VAA<G0F(WA!.R8C>$$[*BHJ5&AE('!R969L:6=H="!C:&5C:R!I<R!C;VUP
M;&5T92X@4&QE87-E(&5N<W5R92!M86YU86P@8VAE8VMS(&%R92!C;VUP;&5T
M960@<&5R('!R;V-E<W,N*BHJ)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N
M=',@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[)B-X03M!<FEA
M;$U4+4)O;&0F(WA!.T%R:6%L350F(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03M&:6QE($YA
M;64Z(" @(" @(" @(" @(" @9S R;38V+F%I)B-X03M5<V5R;F%M93H@(" @
M(" @(" @(" @(')R-C Y-#@P)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @
M(" R,2U*86XM,C R,2 P,#HP-#HR.28C>$$[15-4(%1I;64Z(" @(" @(" @
M(" @(" R,"U*86XM,C R,2 Q-#HS-#HR.28C>$$[4V-R:7!T(%9E<G-I;VXZ
M(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q.2XP
M+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @0F%R($-H87)T)B-X03LF
M(WA!.RHJ*E1H92!P<F5F;&EG:'0@8VAE8VL@:7,@8V]M<&QE=&4N(%!L96%S
M92!E;G-U<F4@;6%N=6%L(&-H96-K<R!A<F4@8V]M<&QE=&5D('!E<B!P<F]C
M97-S+BHJ*B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S
M96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!!<FEA;$U4+4)O
M;&0F(WA!.R @(" @(" @("!!<FEA;$U4)B-X03LF(WA!.U1H92!F;VQL;W=I
M;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @
M(" @(" @("!004Y43TY%(#(X-2!#)B-X03L@(" @(" @(" @0FQA8VLF(WA!
M.R @(" @(" @("!004Y43TY%(#,V,2!#)B-X03LF(WA!.RTM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+28C>$$[1FEL
M92!.86UE.B @(" @(" @(" @(" @(&<P,FTV-BYA:28C>$$[57-E<FYA;64Z
M(" @(" @(" @(" @("!R<C(Y,SDY."8C>$$[3&]C86P@5&EM93H@(" @(" @
M(" @(" @,C<M2F%N+3(P,C$@,34Z,C$Z,C4F(WA!.T535"!4:6UE.B @(" @
M(" @(" @(" @,C<M2F%N+3(P,C$@,#4Z-3$Z,C4F(WA!.U-C<FEP="!697)S
M:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@(" @
M,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($)A<B!#:&%R="8C
M>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E+B!0
M;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P97(@
M<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@
M<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @07)I86Q-
M5"U";VQD)B-X03L@(" @(" @(" @07)I86Q-5"8C>$$[)B-X03M4:&4@9F]L
M;&]W:6YG(&-O;&]R<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X
M03L@(" @(" @(" @4$%.5$].12 R.#4@0R8C>$$[(" @(" @(" @($)L86-K
M)B-X03L@(" @(" @(" @4$%.5$].12 S-C$@0R8C>$$[)B-X03LM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!
M.T9I;&4@3F%M93H@(" @(" @(" @(" @("!G,C!A,S8N86DF(WA!.U5S97)N
M86UE.B @(" @(" @(" @(" @<G(R.3,Y.3@F(WA!.TQO8V%L(%1I;64Z(" @
M(" @(" @(" @(#(W+4IA;BTR,#(Q(#$U.C(Y.C,U)B-X03M%4U0@5&EM93H@
M(" @(" @(" @(" @(#(W+4IA;BTR,#(Q(# U.C4Y.C,U)B-X03M38W)I<'0@
M5F5R<VEO;CH@(" @(" @(" R+C8F(WA!.TEL;'5S=')A=&]R(%9E<G-I;VXZ
M(" @(#$V+C N,"8C>$$[1W)A<&AI8R!T>7!E.B @(" @(" @("!"87(@0VAA
M<G0F(WA!.R8C>$$[*BHJ5&AE('!R969L:6=H="!C:&5C:R!I<R!C;VUP;&5T
M92X@4&QE87-E(&5N<W5R92!M86YU86P@8VAE8VMS(&%R92!C;VUP;&5T960@
M<&5R('!R;V-E<W,N*BHJ)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@
M87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($%R
M:6%L350M0F]L9"8C>$$[(" @(" @(" @($%R:6%L350F(WA!.R8C>$$[5&AE
M(&9O;&QO=VEN9R!C;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT
M.B8C>$$[(" @(" @(" @(%!!3E1/3D4@,C@U($,F(WA!.R @(" @(" @("!"
M;&%C:R8C>$$[(" @(" @(" @(%!!3E1/3D4@,S8Q($,F(WA!.R8C>$$[+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M)B-X03M&:6QE($YA;64Z(" @(" @(" @(" @(" @9S(P83,V+F%I)B-X03M5
M<V5R;F%M93H@(" @(" @(" @(" @(')R,CDS.3DX)B-X03M,;V-A;"!4:6UE
M.B @(" @(" @(" @(" R-RU*86XM,C R,2 Q-3HS,#HS.28C>$$[15-4(%1I
M;64Z(" @(" @(" @(" @(" R-RU*86XM,C R,2 P-CHP,#HS.28C>$$[4V-R
M:7!T(%9E<G-I;VXZ(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S
M:6]N.B @(" Q-BXP+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @0F%R
M($-H87)T)B-X03LF(WA!.RHJ*E1H92!P<F5F;&EG:'0@8VAE8VL@:7,@8V]M
M<&QE=&4N(%!L96%S92!E;G-U<F4@;6%N=6%L(&-H96-K<R!A<F4@8V]M<&QE
M=&5D('!E<B!P<F]C97-S+BHJ*B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O
M;G1S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @
M("!!<FEA;$U4+4)O;&0F(WA!.R @(" @(" @("!!<FEA;$U4)B-X03LF(WA!
M.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN('1H92!D;V-U
M;65N=#HF(WA!.R @(" @(" @("!004Y43TY%(#(X-2!#)B-X03L@(" @(" @
M(" @0FQA8VLF(WA!.R @(" @(" @("!004Y43TY%(#,V,2!#)B-X03LF(WA!
M.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+28C>$$[/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @
M(" @(" @/"]D8SID97-C<FEP=&EO;CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX;7 Z365T861A=&%$
M871E/C(P,C$M,#$M,C=4,34Z,S Z-#$K,#4Z,S \+WAM<#I-971A9&%T841A
M=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(Q+3 Q+3(W5#$U.C,P
M.C0Q*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I#<F5A
M=&5$871E/C(P,C$M,#$M,C=4,34Z,S Z-#$K,#4Z,S \+WAM<#I#<F5A=&5$
M871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL;'5S=')A
M=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @
M/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U-CPO>&UP1TEM9SIW
M:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:&5I9VAT/C(U,CPO
M>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.F9O
M<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!0D%G14),045S04%$+S=1
M07-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!04%"04),04%!04%%
M028C>$$[05%%<T%!04%!44%"+RLT041K1FMB,DIL04=404%!04%!9B]B04E1
M04)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+0W=O2R8C>$$[1$)!
M341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C2'@X9DAX.&9(>#AF
M2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF+SA!04519T$O045!07=%4B8C>$$[04%)4D%135)!9B]%06%)04%!04A!
M445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K2T-W14%!9TE$05%%0D%1
M14%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!04-!44U$06=10T)G
M8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%54UP1VA">%=X46E0
M0B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-00TY546YK-D]Z3FAD
M55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y-"]0128C>$$[,4]4
M,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N9#1E6' W9D@Q*V8S
M3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[<6)N2C)E;C5+:G!+
M5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#04U$8E%%04%H141"
M0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T4TY#1E9*:6-V17I*
M1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H9UI*:EI&1VED:V1&
M53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&195U9P8EA&,658,5)L
M6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ
M;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ2VUQ<39Y=')Q*W8O
M84%!=T1!44%#15%-4D%$.$$Y531Q-T9867$W1EA9<3=&6%EQ-R8C>$$[1EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T95;C@T9CA!
M2TTV:B]W05E4*W-9<3A6=TLW1EA9<3=&6%EQ-R8C>$$[1EAO=C559C=Z86HO
M04LX6#9M=W%Z,T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W
M1EA9<3=&6%EQ-T9867$W1EA9<28C>$$[-T9867%K+VY$+VQ'9%(O-'=N.5EX
M5C1R9U8R2W5X5C)+=7A6,DMV4F9Y;R\S;3%(+UAI+U4R1E=E-'$W1EA9<3=&
M6%EQ-T9867$W1B8C>$$[6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1E5N.#1F.&]Z<5 X07AH4#9X:7)X6$%R<U9D:7)S5F1I<G-6
M928C>$$[:2]L4B]V3G%0*W9&*W!S2W,Y>%8R2W5X5C)+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,B8C>$$[2W!0
M-7<O-5)N568K34HO5TU694LT1F1I<G-69&ER<U9D:7(P6#AQ4#DU=%(O=T)E
M3#E4659:-VER<U9D:7)S5F1I<G-69&ER<U9D:28C>$$[<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U939GIH+WEJ3V\O.%E4*W-9<3A6
M=TLW1EA9<3=&6%EQ-T98;W8U528C>$$[9C=Z86HO<GAF<6)#<E!C5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U9D:7%4*R8C>$$[8U X06Q'9%(O=T--2B]7359E2S1&9&ER<U9D:7)S
M5F1I<C!8.'%0.35T4B\Q-'8Q3FA6;G5+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>"8C>$$[5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A62B]/
M2"]+339J+WAH4#9X:7)X6$%R<U9D:7)S5F1I<G-696DO;%(O=B8C>$$[3G%0
M*W9&*W!S2W,Y>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMP4#5W+R8C>$$[-5)N568K34HO5TU6
M94LT1F1I<G-69&ER<U9D:7(P6#AQ4#A!96)59CEE3#E4659:-VER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<B8C>$$[<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U939GIH+W=!;WIQ4"]!0FA0-GAI<GA807)S5F1I<G-69&ER
M<U9E:2]L4B]V3B8C>$$[<5 X07)X9G%B0W)-=%(Q9E,Y3E)*3E%U;W)62D1X
M4G!70T%K8C!&8VA03$=(,4=M13AK62]585%(*TYF2U X03%E3%0O:V-N.6-Q
M+R8C>$$[3EEV-7=A+WI/3"MC4&TW+T%"<C52+S9V1G O>4]4*W50-7)&+T]#
M+VUC6#@T9DXS*TYF2U O5C1T4#A!:V-N.6-F>E=,*V-&+TTT=B8C>$$[-7<K
M8G8X82M59CA!<3A7;B])-5 V-"]M<U@X-$PK6GAF>F@X,V8T,3AO+SE8:3 O
M-4A*+UA(.#%I+VY"9GI/3"MC4&TW+T=V;$@O<28C>$$[.%=N+T%#3U0K=5 U
M<D8O3T,O;6-8.#1F3DYR839T-W$S4S1T<$9M9VQ(2T]61%972&E#379J25-&
M:FLS4FM#3$-P:%,W1EA9<3=&6"8C>$$[67$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T95;C@T9CA!2TTV:B]W05E4*W-9<3A6=TLW1EA9<3=&6%EQ-T98
M;W8U568W>F%J+R8C>$$[04LX6#9M=W%G=GIV+W=#3U)P=B]!1$50+W=!47I5
M.7$O5$@S=7(W5BMG93DT+VUL9$4W1EA9<3=&6%EQ-T98,%@U0B\U43-39BM9
M9"8C>$$[9C%N3VXP9CDQ2#-05394*S9J-VLO=T%Y6$ED:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<50K8U K55HQ2"]J0R8C>$$[9C%J
M1EAI=4)867$W1EA9<3=&6%EQ.48O2VHO96)59CEE3#E465916#4S+SAC:E1F
M*UEH+RM)6G%E,69P:C<S5CEQ+U%093AF>E-U:28C>$$[9&ER<U9D:7)S5F1I
M<C9,.&<O.$%+1S94+W=!=S8O<D]D4&\O-W%0=65P,&XY,4@S2B]M4S5$<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5B8C>$$[9&ER<U9D:7)S5F1I<G-64V9Z:"]Y
M:D]O+W=$1T4O<D=+=D9C0W5X5C)+=7A6,DMU>%8V3"M62"LX,F\O-CA8-FUW
M<6=V>G8O04]/4B8C>$$[<'8X07I%4"]!35%Z53EQ+U1(,W5R-U8K9V4Y-"]M
M;&1%-T9867$W1EA9<3=&6#!8-4(O-5$S4V8K661F,6Y/;C!F.$%D4CEZ,4]K
M+R8C>$$[=6\K-5 X>5A)9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U9D:7%4*V-0*U5:,4@O:D-F,6I&6&EU0EA9<3=&6%EQ-R8C>$$[1EA9
M<3E&+TMJ+V5B568X05AI+U4R1E5&*V0O+T%">4Y.+S5I2"\T:&UP-U8K;5!V
M9%@R<CE!.3=X+TY+-DHR2W5X5C)+=7A6,DMV;R8C>$$[=GE$+T%-;V)P4#A!
M>D1R*W,U,"MJ+W5O*S4V;E-F,U5F8VXK6DQK3WA6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,DMU>"8C>$$[5DHO3T@O2TTV:B]X:% V>&ER>%A!
M<G-69&ER<U9D:7)S5F5I+VQ2+W9.<5 K=D8K<'-+;TPX-R]!4&IK86(O>D50
M.$$X47I5.7$O5"8C>$$[2#-U<C=6*V=E.30O;6QD13=&6%EQ-T9867$W1E@P
M6#5"+S51,U-F*UED9C%N3VXP9CDQ2#-05394*S9J-VLO>DIC:#)+=7A6,DMU
M>"8C>$$[5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W!0-7<O=T-56C%(
M+T%)=VXY67A6-')G5C)+;VI4<#=70RMH;75O4').=D<S2C1+."8C>$$[959/
M>$Y$,WA63U!.549U3&943&U/1T)*8FE*>E!,84%#,V1L9EE)0BLP;TY'=W%X
M+T%R<U9E:2]L4B]V3G%0*W9&*W!S2V],.#<O*R8C>$$[3U)P=B]-42\O14TQ
M4&%V,'@Y-W$K,69O2'9E4#5P6%)/>%8R2W5X5C)+=7A6.48K468X06Q$9$HO
M=T-99&8Q;D]N,&8Y,4@S4%4V5"8C>$$[*S9J-VLO>DIC:#)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMP4#5W+S52;E5F*TU*+U=-5F5+
M-$9D:7%),#8O=28C>$$[3E!V23=U,TDY5TEM9UEC;$E);U%W4%5%1VU+<3)Q
M87A0<4%G4F]O<F5#,T1#1S-G57!'=DTQ63!*63%*.3A+;TA!<G-696DO;%(O
M=B8C>$$[3G%0*W9&*W!S2V],.#<O*T]2<'8O35$O+T5-,5!A=C!X.3=Q*S%F
M;TAV95 U<%A23WA6,DMU>%8R2W5X5CE&*U%F.$%L1&1*+W=#628C>$$[9&8Q
M;D]N,&8Y,4@S4%4V5"LV:C=K+WI*8V@R2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+<% U=R\U4FY59BM-2B8C>$$[+U=-5F5+-$9D:7)S
M5F1I<G-69&ER,%@X<5 X065B568Y94PY5%E645@U,R]!4$A),#,O;4EF.$$T
M:&UP-U8K;5!V9%@R<CE!.3=X+R8C>$$[3DLV2C)+=7A6,DMU>%8R2W9O=GE$
M+WEH=6LO.'<V+W)/9%!O+W=#-FHW;G%D2B]D4CEY9C5K=5$W1EA9<3=&6%EQ
M-T9867$W1EA9<28C>$$[-T9867$W1EA9<3=&6%EQ-T95;C@T9CA!2TTV:B]W
M05E4*W-9<3A6=TLW1EA9<3=&6%EQ-T98;W8U568W>F%J+T%+.%@V;7=Q9W9Z
M=B8C>$$[+W=#3U)P=B]!1$50+W=!47I5.7$O5$@S=7(W5BMG93DT+VUL9$4W
M1EA9<3=&6%EQ-T98,%@U0B\U43-39BM99&8Q;D]N,&8Y,4@S4"8C>$$[5394
M*S9J-VLO=T%Y6$ED:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<50K8U K55HQ2"]J0V8Q:D98:75"6%EQ-R8C>$$[1EA9<3=&6%EQ.48O
M2VHO96)59CEE3#E465916#4S+SAC:E1F*UEH+RM)6G%E,69P:C<S5CEQ+U%0
M93AF>E-U:61I<DHO26MU=2]88B8C>$$[:3(P8WA7.&MY2S%Z<6-Q9VTQ9VIB
M:S=H;5!&43,W5E)V;59P5$]Y23=E9F-(3C!:;EI%3G4X.7=3+WIF9C)&+S5K
M=C=U=U5,85-Y9B8C>$$[=7EO-&AU2VA796YB;7=,9E1L96]M2EI#63AM<E94
M:DQ)5$AK;$=5=4\W1E@P6#5"+W=#54XP;B]!2F@Q+U=C-F92+S-59F,Y5'!0
M-R8C>$$[<5!U5"]-;'E(67$W1EA9<6QN;5!Z2G!(;#-41S%05EI41%IQ-GAL
M,5)N4$IZ469#;TIY,T1G;&QL=W@U=%=B4$A&2&EK841%+W=$;"8C>$$[978U
M8F8Y6$-4+W!(;2\U<'I.+VMN4#-F84A#+VQF5"]!33<W1"MP,R]+.69Y,B\V
M=45N+T%%:GIF.# T+W=!:S4K-S=1=CA!2RMN+R8C>$$[04HS,D@Y5'8K5C8O
M;'0O,6-*4"MK96(O04IP>"]K;E S9F%&+VQF5"]W03<W1"MP,R]+.69Y,B\V
M=45N+U-03B]W03 T+WE4;C=V="8C>$$[0R]Y=G O-3,R2#E4=BM6-B]L="\Q
M8TI0*VME8B]M;D@K4V,O9#EO6"M6.5 O3RMW+W%D+WEV6#AT=CA!<3139CE)
M.#,O3D]0.&LU*R8C>$$[-S=1=CAR-F8K9#EH+U5Y<GDQ-6\P8GI,<'@Q2%-*
M5VUT0DDP4F1K84TX,4%*1DA!4#=1>D1Z-$I9<&--=6)M64TX37-E2T)S2G)L
M3"8C>$$[8S=&6%EQ-T95;C@T9CAO>G%0.$%X:% V>&ER>%A!<G-69&ER<U9D
M:7)S5F5I+VQ2+W9.<5 K=D8K<'-+;TPX-R]W1&IK86(O04UX1"8C>$$[+W=$
M14TQ4&%V,'@Y-W$K,69O2'9E4#5P6%)/>%9.3D4X,&$U;UEM1VPS070O<DA(
M,7%X>%-C=49E4#A!94LO5&ME;5<T<S@X9#A*<28C>$$[,C=&<4HT-S145F]8
M53E4=G15=G!B-BMK.5<V;30K<$E&5DLX5D-J-%5#<C!59'-H:WE'6G,X,D=4
M25IN:6QZ475264]X5CE&*U%F*R8C>$$[54XP;B]M2%@Y6GIP.4@O9%(Y>C%/
M:R]U;RLU4#AY6$ED:7)S5F1I<GIN."]F+TIE5"\X04U40B]X235S*WE0-SAE
M-'5R-UDO>&,O1"8C>$$[-S-Z2&Y6=D=U>%8R2W5X5C)+=7A6.4LO.#0Y9CAO
M0R\O361.+W=!46IZ;'4R4#<W+TY$,DA9=CEX.%,Y3GI63S)D:7)S5F1I<50K
M8R8C>$$[4"M56C%(+VI#9C%J1EAI=4)867$W1EA9<3=&6%EQ.48O2VHO04AM
M,4@O6&DO53)&548K9"]W1'AY3DXO-6E(+T%/25IQ93%F<&HW,R8C>$$[5CEQ
M+U%093AF>E-U:61I<G-69&ER<U9D:7(V3#AG+SAO8G!0+TU/=C9Z;E0V4#A!
M=6\K-39N4V8S569C;BM:3&M/>%8R2W5X5C5Z*R8C>$$[9G8X035,>68O;4IG
M+W=#2DA.;C)2+V9J,T8Q9F)(*TQN-&9E*UDX-G0T,3)+=7A6,DMU>%8R2W9P
M6"]N2'(O;$%8+S5J<'8K25(U>28C>$$[,V)(.3DO;6@W1'-8*S0K2F5M-7%N
M8D]X5C)+=7A62B]/2"]+339J+T%-650K<UEQ.%9W2S=&6%EQ-T9867$W1EAO
M=C559C=Z86HO<B8C>$$[>&9Q8D-Q0R]/+SA!-#5';2]W1$U1+SA!>$1.5#)R
M.4UF939V=%@V0C<S:BMA5C!4<U9D:7)S5F1I<G-69E)F:T@O;$1D2B\U:#$O
M5R8C>$$[8S9F4B]W0C%(,U!5-E0K-FHW:R]Z2F-H,DMU>%8R2W9/9GHY+W=$
M2F54+SAX34@O04))-7,K>5 W.&4T=7(W62]W05A0=RLY.'@U,28C>$$[8GAR
M<U9D:7)S5F1I<G-69E-V.$%Z:C$O>6=,+T%0361.+WA#4$]7-UDO=G8X,%!9
M9&DO,TAX3# S3E4W6C)+=7A6,DMP4#5W+W=#528C>$$[6C%(+T%)=VXY67A6
M-')G5C)+=7A6,DMU>%8R2W929GEO+S-M,4@O6&DO53)&548K9"\X07AY3DXO
M=T-9:"\X06E'86YT6#99*SDQ9B8C>$$[878P1#-V2#@P<F]N67$W1EA9<3=&
M6%EQ*VDO25 O2T<V5"]Z1'(K<S4P*VHO=6\K-39N4V8S569C;BM:3&M/>%8R
M2W5X5C5Z*V9V+R8C>$$[04I,>68O;4IG+S1K8S)F6D@Y*U!C6%8Y<V8T=69H
M.3<U:GIQ,VI867$W1EA9<3=&6%EQ*VQF.$%N2'(O04I11B]W1&U/;2\T:$AN
M3"8C>$$[9'-F,S,K84AS3WAF-VHT;#9B;7%D<S=&6%EQ-T95;C@T9CA!2TTV
M:B]W05E4*W-9<3A6=TLW1EA9<3=&6%EQ-T98;W8U568W>F%J+R8C>$$[04LX
M6#9M=W%G=GIV+W=#3U)P=B]!1$50+W=!47I5.7$O5$@S=7(W5BMG93DT+VUL
M9$4W1EA9<3=&6%EQ-T98,%@U0B\U43-39BM99"8C>$$[9C%N3VXP9CDQ2#-0
M5394*S9J-VLO=T%Y6$ED:7)S5F1I<GIN."]F+T%#6&LO=T1Z17=F.%-/8E!S
M:BLO2'5,<2LR4#A84'<K.3AX-28C>$$[,6)X<G-65$A13'I3<E!627)R5DQ)
M-FAA=S%B-FU(.4Y:2$$K04\Q0V5(3#=11U8U;WEL1V]M:C-T*VYN0TUR;4])
M1&]Y5#@U9T(K6B8C>$$[971!0V=$455(+U)T2&U,,EHO8U(K4#-L>74Q=CA9
M;#A0=41#<WIN6$]X5CE++SA!3U!8+T%#9TPO=T1-9$XO>$-03U<W62]V=C@P
M4"8C>$$[661I+S-(>$PP,TY5-UHR2W5X5C)+<% U=R\U4FY59BM-2B]7359E
M2S1&9&ER<U9D:7)S5F1I<C!8.'%0.35T4B]W0F5,.5195E%8-28C>$$[,R\X
M04A),#,O;4EF+VE'86YT6#99*SDQ9F%V,$0S=D@X,')O;EEQ-T9867$W1EA9
M<2MI+TE0.$%Y:'5K+W=$34]V-GIN5#90*S9J-R8C>$$[;G%D2B]D4CEY9C5K
M=5$W1EA9<3=&6&Y0-2LO*U,X;B]!3UEM1"]I4GI:.6MF,S0Y>&18,G@O:34K
M2#-V;5!/<F5.9&ER<U92=71A>B8C>$$[<5=T86Y0<65P>F973#8T2VUA8FEI
M8W5+:$(X2T)62'=Q3V=Y1TQ&2$A%4FIS03(U8W-S:VI+4G5245=486Y9<2ML
M9BMC978K54)F+R8C>$$[04IJ<'8K25(U>3-B2#DY+VUH-T1S6"LT*TIE;35Q
M;F)/>%8R2W5X5DHO3T@O2TTV:B]X:% V>&ER>%A!<G-69&ER<U9D:7)S5F5I
M+R8C>$$[;%(O=DYQ4"MV1BMP<TMO3#@W+RM/4G!V+TU1+R]%33%0878P>#DW
M<2LQ9F](=F50-7!84D]X5C)+=7A6,DMU>%8Y1BM19CA!;$1D2B8C>$$[+W=#
M661F,6Y/;C!F.3%(,U!5-E0K-FHW:R]Z2F-H,DMU>%8R2W9/9GHY+SAL-5 O
M04UX34@O16IM>C=)+W9X-VDV=G1J+T9Z.%!V9B8C>$$[365D5SAA-T9867$W
M1EA9<3=&6#!R+WIJ,2]Y9TPO.$%-9$XO>$-03U<W62]V=CA!3D0R2%EV.$%C
M9D5V5&,Q5'1N67$W1EA9<6LO;B8C>$$[1"]L1V12+S1W;CE9>%8T<F=6,DMU
M>%8R2W5X5C)+=E)F>6\O,VTQ2"]8:2]5,D951BMD+R](23 S+VU)9B]I1V%N
M=%@V62LY,69A=B8C>$$[,$0S=D@X,')O;EEQ-T9867$W1EA9<2MI+TE0+T%#
M:'5K+SA!34]V-GIN5#90*S9J-VYQ9$HO9%(Y>68U:W51-T9867$W1EAN4#4K
M+R8C>$$[*U,X;B]W0UEM1"]I4GI:.6MF,S0Y>&18,G@O:34K2#-V;5!/<F5.
M9&ER<U9D:7)S5F1I<C96+S5X-B\U448O*UDV8B]!26A(;DQD<R8C>$$[9C,S
M*V%(<T]X9C=J-&PV8FUQ9',W1EA9<3=&56XX-&8X;WIQ4"]'12]R1TMV1F-#
M=7A6,DMU>%8R2W5X5C9,*U9(*S@R;R\V.%@V;28C>$$[=W%G=GIV.$$K3U)P
M=B]-42]W1'A$3E0R<CE-9F4V=G18-D(W,VHK858P5'-69&ER<U9D:7)S5F92
M9FM(+VQ$9$HO-6@Q+U=C-F92+R8C>$$[,U5F8SE4<% W<5!U5"]-;'E(67$W
M1EA9<3@U+U S+WE8:R\O041%=V8X4T]B4'-J*R](=4QQ*S)0.%A0=RLY.'@U
M,6)X<G-69&ER<R8C>$$[5F1I<G-69E-V+T]06"]+078O>DA49CA!14DX-6)T
M:BLK+WI1.6@R3"]C9D5V5&,Q5'1N67$W1EA9<6LO;D0O;$=D4B\T=VXY67A6
M-"8C>$$[<F=6,DMU>%8R2W5X5C)+=E)F>6\O=T(U=%(O,31V,4YH5E,O341Y
M+S5X.'I75G)B,C)N,C!$5SAH:UIP3'-K149A8F-9<W<Y6G!J;"8C>$$[04%.
M531E<S!X>7A!0C9S2"]W0U919FU"+W9I>"]W0VMP+SA!<6IM=B]K<69E2%@O
M04UL5#=W-R]!2E9"*UE(*RM,2"]!2U-N+W=#<28C>$$[3U X04I5*SA,+TI5
M*SA/+S560BM92"LK3$@O<$MF.$$V;S0O>590=D,O>590=D1V*U919FU"+W9I
M>"\V4VXO-F\T+WE64'9#+W=!;"8C>$$[5#=W-R]L54@U9V8W-'-F*VMP+RMQ
M3U X;%0W=W8X;%0W=S<O04I60BM92"LK3$@O04M3;B]W0W%/4#A!2E4K.$PO
M2E4K.%!54$QC9B8C>$$[;793=$-S=$]L,'%#4U,Q:D5B3W0S.$I).$MX6G0X
M1TUW9TEN;S=F1$1G9TDY=U1,.4EE6G8K<E!$+S!M1"]Q;&QR83<Y265:=BMR
M4"8C>$$[1"\P;40O<6QI<G8P:#5M+S9S.% O4UE0*W%72W4O4TAM8B]Q>G<O
M.4IG+S9P67%X9CAY3D,X-"MA+TQ%;6M7=6Y7,79+.'-C9VML=28C>$$[>59O
M:'%2.$U68WDY1G%":'EC4D9U2G)T36,R27="<3-K=CA!,$PU*UI(:' S+U-6
M2B\Q4GIC+WDS1"MA6%)F>41K+VY",R]1=FXU:R8C>$$[94=N9CE*56XO5DA(
M*U<T9GI3=CAG-5 U=V0O,$PU*UI(:' S+U-62B]W0E5C9C5B:"].2R]W06<U
M4#5W9"\P3#4K6DAH<#,O045L4R8C>$$[9CE58V8U8F@O3DLO>41K+VY",R]!
M14PU*UI(:' S+U-62B\Q4G@O;'5(.#!R+TE/5"MC2&8Y0RMF;5(T860O,&Q3
M9CE58V8U8F@O3B8C>$$[2R]Y1&LO;D(V="M76&PS>FPU4CAU3G!6,W Y<F-Y
M;31K;CE32S=)5VIQ;W X559F,F,P*W4Q27I:3TE#=&YD-D13;D)J-$-B,UI:
M*R8C>$$[:U!-,R]6;F@O=T-K=V8X059,34YZ6&9P1'I.+S%:-&8K:W=F.55S
M5F0K:U!-,R]6;F@O-E1"+S%3>%8S-E$X>F8Y5V5(+W!-2"]63"8C>$$[1E5$
M<FXK2W12,&TV<V\Y2V=2-3!+2S=897=R-#!I>%9G6"]+=7906"],2EHO=T13
M53,O5DA&6&8X<38X.68X04Q*6B\Y2E1F.55C5B8C>$$[9"]Y<G)Z,2]Y>5=F
M+U-5,R]62$989CA!2W5V4%@O3$I:+SA!4U4S+T%&4GA6,R]+=7906"],2EHO
M=T1353,O5DA&6&8X<38X.68X028C>$$[3$I:+SE*5&8Y56-66E(U3C!F>F9O
M358P:RMM,C!X;EI#<%,W27!X0D<Y679F1E=D-'%L2&UV54YF,"]1-3=R44Y.
M1W)A:VY(,#=.<"8C>$$[1FEQ<%!X=%9Q0FEQ-SAA:FPP<4U695HV=$IQ=FUR
M>3%0<&LR<'AA>'$Q>G%7;4IQ9FPO54EH;W-%155D=S%W649J;%=7-$EN141$
M;"8C>$$[>6PU:&%O3FII<DU0>3)85')7>#%F4F)(4F)4>2]F859E;4A53%=X
M8C%R4G U8F5+5DIO,S1W331A2C!Q1U971DMD<31Q>&I54'ID."8C>$$[=U$K
M6%AU8F4P=$1R1VMA8F8S;FU30C%K.4M+-7-P5&%P1D="27)Q2G P9&PU12]!
M=FEA-'%J9DY0;FYZ-35C:W1K=C1D3U=*3&,S5B8C>$$[+V9X,C$W4&%G;59G
M<TQT0S!K;'%Q>')5,T5Q36A.9FA&1&ER,'A(5C!6,4E:5T%+<W!Q0T1V54A&
M5SA69&ER<U9D:7)S5F1I<D%0>B8C>$$[53!#.#$K-SAT-F)$63)'<5<X9#-0
M95A/;39L8R]6-'!21F%Y4DE31E-E4G=J>FAJ>&I0871/=4MR=DIN;E1Y;%HV
M5G!U:E%A9$IO,"8C>$$[>EA&>%EP<&1N83-&>F%X6$56,TIB>D%8345*:$-'
M9%=93S5863AI0FER0W9+-WHV6')N:SEF,&1E4F5:-S=58G$Q.#!A<S9V-D8X
M1R8C>$$[=#=I5FE*>5-L=VY/3EI)=49F5%9E4'<Q;U97965C9E!T-S5:,5,X
M9W5)27!B95A3,G5T1$%$0U-A+VEL14PR<G-7-&YM,7A"=V]!9"8C>$$[,C8T
M<6Q.>C4P+TUE2S8X>7!"6C9B9$HU9"MP,C5H:E=:6C4W:39T3&5:>6=A6&IX
M:F5D:7%6-4]+24M..%1+<#DK6#-M>2\Q-E!5228C>$$[3E)K9V$K<TI),6MJ
M:G1B=7=M5EI5<5!7=$QZ;$I(.%-S1EE337)5-U5P:7),<U9D:7)S5F1I<G-6
M42MO>#,P=&I02%E42F)8:F]6="8C>$$[-VE24%933GE+0GI'1U1L5')4:TU6
M95%72#$K,2],5S@P*V4Y;G5H3C5U9E,Y4C%#4G5-,&QT3')G=' R6FLT.&95
M46Q4>' Y<F)&528C>$$[-#!N6&9,;FMF>F(U:3!14GI7;6A);6YZ,D9N6E=L
M,6124EA%.&-O=4523%=/8C!G>7A2=E-G1E-4,4IX5FIV;7HX>'1$,4PX>71#
M:B8C>$$[+U1C3G1:-D)R=W-7,#AY2T=K:RMQ,T-81C%+=E5*2$M59VIR,TQN
M;WDT<3E0.#$K6F)J44PS4DIP4D5U:5AT,F),534U2V@T5VUJ628C>$$[,C!I
M='E#:%1-;VIA;U R:%-L3C%71S98*UEF-6=A;F9-8E=Z,#!743!C82MK17=M
M:6YE0V4U=3!T64$W4V5M:GE145)->G-+2S-,-"8C>$$[84@T5E4U+TPW>G9R
M971A;&-A8G)99V=V571L=6QT4'%D-7 Y=V=,.%A(<#-2;%-E3F53:C%9<$M6
M4#)D>&ER3SA69&ER<U931'IT+R8C>$$[:% X05%B9C1N-"]O+W="5TQH+V4K
M<C8O3#EZ-DAO9G8O5C5F63E0-'9$1EAE4U X2V9O5"]N5V$O56979C$O53EB
M-G@Y63(Y5#9Z.28C>$$[6B\P:C%E;&96*TML3S%-5EE&;W8K1%!8+TY0+T%"
M4CE8-697668X045V,6(Q9E0K<&9562]3-"MN*RLV*W)Y-#<X*U9-5EI&-2LO
M-28C>$$[5F0K;$EF.$%&9&9R,S%F.34V9C%Y;C%0;3,K.78Q5#10<3-0;"]V
M4BLW*S$W-'%Z;$](0F5&3T9">#0Y2V1Q57A6=D9867$W1EA9<28C>$$[-T98
M67%X6'HY+V=J-G):9C1O-3AV5F(Y1R]69G)8,7HQ3T(U+U8O<5 K:R]9<GHT
M9'5U2W!T-5@O=T%0+V]#>2]W05!E;BMH*T@K:28C>$$[96I8:E-P-58U9D9Y
M-3$U.'9I-58U8C%X5FDO;%@O;%9N*THU4#!&+W@Q-C-(;V-V<F8Q9C=F.$%P
M4#%(,2\X05)Q8W8W>C9T.4]+;R8C>$$[9CAZ9C!F.$$T<3AH+W!J-G8K:E P
M,'8Q9FQ8,2]R=C%A9C9V4W9W*VXV=G Q-SAU3TMP='%8+TMU=E(X,2]P2#!V
M4SEA,R]X4#9V<B8C>$$[8V98*W)W9E9Q5B]A.4PP94AO+W15+V)X5F8U0B]W
M040K:F9F-%HY8C%U869P2#8W.6,K=3$T;C!V5R]32"MK.&5.94A,-&5V2$97
M5B8C>$$[-'$W1EA9<3=&6%EQ-T972THO>7(O=T1W=G)D9E,O=R\Y8W9V,'HV
M,W$X4')F,6QV<F8X065F2'DK<U8T.$\Y3TAB1E98>4@O04E.+R8C>$$[4G1Z
M+T%)6#4K;#8U*W8X03%J-GHY8CEF9W8X0794.60O=T)*-65N=S0K<"MZ4VTQ
M3592,VU(+T1N,791+W="368W,&9P0F8P3"]E9B8C>$$[-S-F5C4V9C-E,SEX
M-G8R+V@K;6U+<V$O4$@P4"M68F%P.60Y2#E&9G50,&HV=DQN-E Q:5!L-E!(
M+V1V.&QF,G%9<6UZ+S1$+U-L+R8C>$$[-FYO9E=F,$Q".68U."]1+U$O3V8P
M<3AV,TAP,3EA=$XV9&1Q67%L,VM(+VQ7,S91=5 X0410<F98+U%&9G)N,2]W
M0E@V<GE&4'$O,28C>$$[+V8V=GEP+V,O0E=N=&ER3TU69B\R43T]/"]X;7!'
M26UG.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T
M4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R
M8V52968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @
M(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#I#0T-$1#<X,S@V-C!%0C$Q
M.$0X,#A#,T,P,T$X0T8W.3PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @
M/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#I#0T-$1#<X,S@V-C!%0C$Q.$0X
M,#A#,T,P,T$X0T8W.3PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM
M<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y
M,31!.#4Y,$0S,34P.$,X/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @
M(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I2
M96YD:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN
M<W1A;F-E240^>&UP+FEI9#HU-41#0D,S03@S-C!%0C$Q.$0X,#A#,T,P,T$X
M0T8W.3PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O
M8W5M96YT240^>&UP+F1I9#HU-41#0D,S03@S-C!%0C$Q.$0X,#A#,T,P,T$X
M0T8W.3PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R
M:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y
M,$0S,34P.$,X/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD
M:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @
M(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)
M1#YX;7 N:6ED.CDX8V(T8S(P+3EC-V0M.38T-BTY.#(S+3 X,S,W.&(U.&8V
M.#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.G=H96X^,C Q.2TP,2TQ.%0Q,CHU,CHT,"TP-3HP,#PO<W1%=G0Z=VAE;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@
M26QL=7-T<F%T;W(@0T,@,C(N," H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E
M06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T
M179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.D-#0T1$-S@S.#8V,$5",3$X1#@P.$,S0S S03A#1C<Y/"]S=$5V=#II
M;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(Q
M+3 Q+3(W5#$U.C,P.C0Q*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O
M<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SII;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]I;&QU<W1R871O<B\Q+C O(CX*(" @(" @(" @/&EL;'5S=')A=&]R
M.E-T87)T=7!0<F]F:6QE/E!R:6YT/"]I;&QU<W1R871O<CI3=&%R='5P4')O
M9FEL93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S
M8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<%10
M9STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @
M(" @("!X;6QN<SIS=$1I;3TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W-4>7!E+T1I;65N<VEO;G,C(@H@(" @(" @(" @("!X;6QN<SIS=$9N=#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @
M(" @(" @("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O9R\B/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^
M5')U93PO>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^"B @(" @(" @(#QX
M;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3Y&86QS93PO>&UP5%!G.DAA
M<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX;7!44&<Z3E!A9V5S
M/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @(#QX;7!44&<Z36%X4&%G95-I
M>F4@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W1$
M:6TZ=SXR,38N,# P,# P/"]S=$1I;3IW/@H@(" @(" @(" @(" \<W1$:6TZ
M:#XR,38N,# P,# P/"]S=$1I;3IH/@H@(" @(" @(" @(" \<W1$:6TZ=6YI
M=#Y0;VEN=',\+W-T1&EM.G5N:70^"B @(" @(" @(#PO>&UP5%!G.DUA>%!A
M9V53:7IE/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@(" @(" @(" @(" \
M<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M
M93Y!<FEA;$U4+4)O;&0\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y!<FEA;"!-5#PO<W1&;G0Z9F]N=$9A
M;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86-E/D)O;&0\
M+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,# Q+C P,SPO<W1&;G0Z=F5R<VEO
M;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&
M86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9I;&5.86UE/F%R:6%B7U\N4$9".R!A<FEA8E]?+E!&33PO<W1&
M;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y!<FEA;$U4/"]S
M=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M86UI;'D^07)I86P\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @
M(" @(#QS=$9N=#IF;VYT1F%C93Y296=U;&%R/"]S=$9N=#IF;VYT1F%C93X*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E/D]P96X@5'EP93PO
M<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S
M:6]N4W1R:6YG/E9E<G-I;VX@-RXP,#PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&
M;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I
M;&5.86UE/F%R:6%L+G1T9CPO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z0F%G/@H@(" @
M(" @(" \+WAM<%109SI&;VYT<SX*(" @(" @(" @/'AM<%109SI0;&%T94YA
M;65S/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI/E!!
M3E1/3D4@,C@U($,\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y0
M04Y43TY%(#,V,2!#/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*
M(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @/'AM<%10
M9SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H
M($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM
M<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @
M(" @(" \>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y004Y43TY%(#(X-2!#/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4U!/5#PO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT:6YT/C$P,"XP,# P,# \+WAM<$<Z=&EN=#X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y,04(\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z3#XT-2XP.3@P,#,\+WAM
M<$<Z3#X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z03XM-3PO
M>&UP1SI!/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SI"/BTU
M.3PO>&UP1SI"/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^4$%.5$].12 S-C$@0SPO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E-03U0\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z=&EN
M=#XQ,# N,# P,# P/"]X;7!'.G1I;G0^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^3$%"/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.DP^-C,N,3,W,CDY/"]X;7!'.DP^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.D$^+34Q/"]X;7!'.D$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.D(^-3,\+WAM<$<Z
M0CX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X
M;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O
M=7!S/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0
M<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(^"B @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @
M(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I&;VYT2VEN9#Y0;W-T4V-R:7!T/"]%>'1E;G-I<T9O
M;G1396YS93I&;VYT2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES
M1F]N=%-E;G-E.D9A;6EL>3Y!<FEA;"!-5#PO17AT96YS:7-&;VYT4V5N<V4Z
M1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z
M3W5T;&EN949I;&53:7IE/C(W-S0W/"]%>'1E;G-I<T9O;G1396YS93I/=71L
M:6YE1FEL95-I>F4^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G13
M96YS93I&;W5N9')Y/DUO;F]T>7!E(%1Y<&]G<F%P:'D\+T5X=&5N<VES1F]N
M=%-E;G-E.D9O=6YD<GD^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O
M;G1396YS93I697)S:6]N/C P,2XP,#,\+T5X=&5N<VES1F]N=%-E;G-E.E9E
M<G-I;VX^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I+
M97)N:6YG0VAE8VMS=6T^,#PO17AT96YS:7-&;VYT4V5N<V4Z2V5R;FEN9T-H
M96-K<W5M/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z
M1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3XR,S$X,#,P,3<U/"]%>'1E;G-I<T9O
M;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/@H@(" @(" @(" @(" @
M(" @(" \17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^,C,Q.# S,#$W-3PO
M17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @
M(#Q%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93Y!<FEA;$U4+4)O
M;&0\+T5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I&;VYT2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I
M<T9O;G1396YS93I&;VYT2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N
M<VES1F]N=%-E;G-E.D9A;6EL>3Y!<FEA;#PO17AT96YS:7-&;VYT4V5N<V4Z
M1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z
M3W5T;&EN949I;&53:7IE/C \+T5X=&5N<VES1F]N=%-E;G-E.D]U=&QI;F5&
M:6QE4VEZ93X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E
M.D9O=6YD<GD^36]N;W1Y<&4@5'EP;V=R87!H>3PO17AT96YS:7-&;VYT4V5N
M<V4Z1F]U;F1R>3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E
M;G-E.E9E<G-I;VX^-2XR,#PO17AT96YS:7-&;VYT4V5N<V4Z5F5R<VEO;CX*
M(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#
M:&5C:W-U;3XP/"]%>'1E;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T^
M"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT4V5N
M<V5?,2XR7T-H96-K<W5M/C(S-38S-#,T.38\+T5X=&5N<VES1F]N=%-E;G-E
M.D9O;G1396YS95\Q+C)?0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%
M>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3XR,S4V,S0S-#DV/"]%>'1E;G-I
M<T9O;G1396YS93I#:&5C:W-U;3X*(" @(" @(" @(" @(" @(" @/$5X=&5N
M<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/D%R:6%L350\+T5X=&5N<VES
M1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z0F%G/@H@(" @(" @(" \+T5X=&5N
M<VES1F]N=%-E;G-E.G-L=6<^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@
M(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #- - # 1$  A$! Q$!
M_\0 '0 !  ,! 0 # 0            @)"@8' P0% O_$ #X0   %!  "!P,)
M" (#       $!08' 0(#" EV$3<X=[*TM1(V.1,5%A<86)>VUB$Q55:4EM/4
M05$B87'_Q  = 0$  04! 0$             " $" P8)! <%_\0 21$  0(#
M P4+" @% P4       $" P01!3%Q!@@A=;$'$A,R-U%TD;.TP30U-D%28;+1
M%5-5@9*4T_ 4(E23TD*AX2,S8G+Q_]H # ,!  (1 Q$ /P#?P
M                      RC[D]J2<.?%3P8![8?$;@8'7KBNTC.+R@    !
M;MPC.L&8.36_ZWG&"/<W%=A>R]</%"]H>8R@
M       91]R>U).'/BIX, ]L/B-P,#KUQ7:1G%Y0     MVX1G6#,')K?];S
MC!'N;BNPO9>N'BA>T/,90                               ,H^Y/:DG
M#GQ4\& >V'Q&X&!UZXKM(SB\H     6[<(SK!F#DUO\ K><8(]S<5V%[+UP\
M4+VAYC*                               !E'W)[4DX<^*G@P#VP^(W
MP.O7%=I&<7E     "W;A&=8,P<FM_P!;SC!'N;BNPO9>N'BA>T/,90
M                         ,H^Y/:DG#GQ4\& >V'Q&X&!UZXKM(SB\H
M   6[<(SK!F#DUO^MYQ@CW-Q787LO7#Q0O:'F,H
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M8B514KI13>=S.8F'9?Y(M='C.:MN22*UT5ZHJ<)<J*Y45,38D)C'1@
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M6>OO>@V/.VC9\B_2S)[6LIVJ&];F7*!DAKR2[0V0"9)T>
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M;'G;1L^1?I9D]K64[5#>MS+E R0UY)=H;(!,DZ/
M 91]R>U).'/BIX, ]L/B-P,#KUQ7:1G%Y0     MVX1G6#,')K?];SC!'N;B
MNPO9>N'BAQ_&G]]X'Y5>OJZ&(Y[M7EU@]$G>V@D2<YCSIDIT"T^\2I22/B1&
M(     E!I3VL]?>]!L>=M&SY%^EF3VM93M4-ZW,N4#)#7DEVAL@$R3H\
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MCWN:JHNE%I5/4;=ASX.EH    !E'W)[4DX<^*G@P#VP^(W P.O7%=I&<7E
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M4\0&PFLER/ @^(6S>[B4/R[4?",X[DPG]:V/WHD1FN<K=G:GMON9N7'.XZ<
M    &4?<GM23ASXJ># /;#XC<# Z]<5VD9Q>4     +=N$9U@S!R:W_6\XP1
M[FXKL+V7KAXH<?QI_?>!^57KZNAB.>[5Y=8/1)WMH)$G.8\Z9*= M/O$J4DC
MXD1B     )0:4]K/7WO0;'G;1L^1?I9D]K64[5#>MS+E R0UY)=H;(!,DZ/
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MV UHN1X$'Q"V;W<2A^7:CX1G'<F$_K6Q^]$B,USE;L[4]M]S-RXYW'3@
M RC[D]J2<.?%3P8![8?$;@8'7KBNTC.+R@    !;MPC.L&8.36_ZWG&"/<W%
M=A>R]</%#C^-/[[P/RJ]?5T,1SW:O+K!Z).]M!(DYS'G3)3H%I]XE2DD?$B,
M0    !*#2GM9Z^]Z#8\[:-GR+]+,GM:RG:H;UN9<H&2&O)+M#9 )DG1X
M P^<>_X@"MW21KY=7'0O-LY,X&N[6^* <SLZCE7F-06-\,P4M#[Z1P     +
MD>!!\0MF]W$H?EVH^$9QW)A/ZUL?O1(C-<Y6[.U/;?<S<N.=QTX     ,H^Y
M/:DG#GQ4\& >V'Q&X&!UZXKM(SB\H     6[<(SK!F#DUO\ K><8(]S<5V%[
M+UP\4./XT_OO _*KU]70Q'/=J\NL'HD[VT$B3G,>=,E.@6GWB5*21\2(Q
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#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g76219g27e04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76219g27e04.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X<"V:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N-BUC,30S(#<Y+C$V
M,3(Q,"P@,C Q-R\P."\Q,2TQ,#HR.#HS-B @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM
M<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+VEM9R\B"B @
M(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @
M(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z:6QL
M=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP
M+R(*(" @(" @(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B
M"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]G+R(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L
M:6-A=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT
M:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^-&-L;V=O<VUA;&P\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE
M/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#$Y+3 Q+3(R5#$Y.C(P
M.C,X+3 U.C P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \>&UP.DUO
M9&EF>41A=&4^,C Q.2TP,2TR,E0Q.3HR,#HS."TP-3HP,#PO>&UP.DUO9&EF
M>41A=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#$Y+3 Q+3(R5#$Y
M.C(P.C,X+3 U.C P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#
M<F5A=&]R5&]O;#Y!9&]B92!);&QU<W1R871O<B!#0R R,BXP("A7:6YD;W=S
M*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^
M"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z=VED=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @
M(" @(" @(" \>&UP1TEM9SIH96EG:'0^-38\+WAM<$=);6<Z:&5I9VAT/@H@
M(" @(" @(" @(" @(" @(" \>&UP1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM
M9SIF;W)M870^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.FEM86=E/B\Y
M:B\T04%14VM:2E)G04)!9T5!4T%"24%!1"\W44%S54=H=F1'.7IA1SEW241-
M=4U!0311:VQ.02LP04%!04%!0D%!4T%!04%!14$F(WA!.T%10DE!04%!05%!
M0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"9VM'
M0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%03A/
M1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"05E'
M:%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46=!3T%%04%W
M15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%0D%114%!04%!04%!04%!
M449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!.T%1
M04-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU20D%!
M1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2
M>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#:&=:
M:$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR
M:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\K
M0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V;U)!
M04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:>&=:
M17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,0T(S
M4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!.S K
M4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D
M;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM
M<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!1#A!
M.5-85C%B5VQT3&1857%W,CA+;#4F(WA!.UI825965E)5:VLT67A-:E$U;VQ)
M05=E5'=R>C4K9G0Y3DY,66562U<Y<W!+='%C:6=Y4#)0<$EW25)F8VEV>7IO
M=$HR3T%/3$IU934F(WA!.S5V5SET;2M(1B]P=C%02G13,6Y6.55L33)O,W,Y
M-4E46&Q023!H<C=C:6%:=5E9;W=&4D%$;W-M96,O<4I+:&)85C%A>4-7,FUE
M0U$F(WA!.V1(:EEO,S-Q4FMP4D(U:&A#8V]M-&UM9"M69GIR.#4V2DMI6&1W
M9%AS45)Z9W5J>6MP+VM48G5$+W)62'1M=3%(6F5,24YH=VYY+U4F(WA!.S=0
M5&1S6G-:.5(T-"MF4#5P,2MB;FXS>F)P9FYY+W-.33%A93%T655G<$)',496
M;FA2>E-O-SAQ-5(R9&\X53A);$M)2C,K.7EU,4XF(WA!.V9L>#5J1T5Q07!I
M9&XK6G8U9U-88T-(6$QP9SAI<58U1&-&9TMD37I*-D1#06932$-X9'!A9WE!
M-&IZ9E=/8V$Y<3=&6%EQ-T9867$F(WA!.S=&6%EQ-T9867$W1EA9<3=&6%EQ
M-T973F5F.$%Z4&5E5SE$5%5,4TM/859P,&A+>3AI=$=6:E@T4W!R.$]2:V%:
M4D9S;'E41C)+=7@F(WA!.U8R2W5X5C)+=7A6,DMU>%9J6&XO04UZ,VYL=E$P
M,4,P:6IM;&%D25-S=DER4FQ9,2M%<6$O1&M:1VU54F)Y<C@O9E!C,#DX4$ML
M:DLF(WA!.U9T8F-,2G%252\S:W!!6DEY4BMY9V]X2#@S>7IP97@Y24%015!-
M.&YL*S(Y86(X2U!X+U4X87IE=E!*,S5D.&PK85!-8D5A4' X;# F(WA!.VEN
M:3@R>5)+971$23562RLQ835J-3E6:GAF5V%C;E0V4$QM*V=7;6US9FQ.-2\P
M;3%A-G5T2V0W9$)6,W0S4V-Q4$5R1WI0465.2UHF(WA!.U1I-U)W>DY#5R]N
M<S,U97DX.$)::EDX=#),,D9U8FTK=#=90W!M;%-/;BMU=T@X8WDU>6]%=49I
M:GA403=Y>6HX,TQR-GHK63)U4U8F(WA!.W)X;5-,+VM616MF+T%"<&U*,F)'
M<T5F>#%C,W15,W%*9D0W9VMV;%,Q83<X,&%287)U6C<R,VHO04]#;%5::V%I
M6$1J:V9)=5!P23,F(WA!.VQG4#91*SDY;%IW<C,W<U99,35J+TU0>7IO17AT
M<G5:<')T9#-T<F11-W)8*UEK<7$O271826U11$E22E%E:B]!2G(K5714;CE!
M4$XF(WA!.V%3="]D<F-O1D1(=T1)>G)5.7%N151#;4)48E103BMJ-FQO5C%R
M9'-:1%DR9VM->%I+4"LU5&TQ1G)V.$]%1D)J=6Q&-RMB2&Q/,7,F(WA!.V)7
M-TQ4>F97,5HT-$DP0FM#<3=2.&U$37%J-&M.3CA(1T4X0E)+9FU2-61B5$Q,
M55-*,&=V<&UT-$9A36-U83!"<4%X1DXK=&-E24PF(WA!.W=&0E@S-78K56)3
M+V4P2#%I-#E.=414=WAQ,%92<V%&;E9J.'=-94U*-$-N6&U0>FXU9CAV2V\Q
M1S1P3S0U4C(P635Y:V50161"-W,F(WA!.U)H37%9:4I+4E=0-7@K5#=Q-%='
M5#9Z84)T:$Q01W9$-E1'.&A(,UE/34UU07-G,3-Z9&\R:3)T<F0S:G,Q<F5-
M1FAU25%*23EX>4(F(WA!.TQ!,&]2=4U*3DU21S U0D)!24Y196AW;U-',#@W
M841D95EP9$%H;%DV:$5856=R.$)A359D43%E;S,K-T)X8C!Y-%16<'IE6&-&
M;F$F(WA!.U189'<S0T,S4G!:5SA&46-I9G5'1FDX,2]-<EAR2%AF245/;U=)
M:T9S,3AI25I6-$5L56-%9V(W5C)Y16I98DEI:6YM<V9M,353,#(F(WA!.SAE
M,354,VMK6DMY3F))<DE'2%5C;EI!9F]R:$UW9U%+96584$Y7:2M98EIP.4YM
M3&U/9VUH8V-:27EA,#5,-S V:F)#1&)%:6UV368F(WA!.VTS42],,$MY86Q0
M=V54*S9G46-P6' Q;V\W935O35-A54,R3S)F-7EE5#=I-$559W5R5E=.4%=M
M:EAG4&XV8GE.*T=2-'=Y-$-Z94<F(WA!.V%+84I*;UA74TM243!C:6M&5U5I
M;TE)-F<U3F=X6%AF>E(X<6%09%!A>5-Y6&1X1V%3<&%Q<FA33WA:;5)A:G91
M-45Y05I#0DMZ5'8F(WA!.WI7.&\S,$4X9VQL9VMG:F%5,CAY05--<4-R8T]*
M6E=.3S-+=5!'1C1#>4Q3=&%S3E0P;5!68F1Y=&Q+<D](;"M#:6]31TQ6-E4T
M;D,F(WA!.T-G:&ET+SA!;D8U4'1:,FEJ*W,S9UA9>3(X83A+*WAK94UN-W-(
M1T=805=0+VU,-7@P2'I&-4Y5-F)/5$Q(9'A'5S-K2$-2455K,S0F(WA!.SEX
M-V=N27E.:$U9:T8T3G)M<'DV<G)..7%5<')*951Y5'18+T%)<UET5#9+-39"
M:7@X14)%9$$K8S4X;DAK;$QV2T\X:RM7,SAY96$F(WA!.TY0,%E-55,U:R]F
M=4]Q>$E#.&A&92]&5%0S>7)66B]#>&UF8S(V3%0K3FQ%3V@K-3E$96(O3T9J
M-4IS<E123D5T26A-<U%-55)"154F(WA!.U564T%31DE,37A"-RLU>GHO5V%Y
M46PS>4PQ3W,Q9S T14E$9C=!:UAL>C@T.5%F55ER9E=O669Q:WI"1%!#1U)O
M>514:U%3=UIF2$TF(WA!.UA&<FIF<35/3' K,7!'445W2TMZ>FPK6$9L1"M:
M4&PW6$Q+2EEB3S=U:DYQ8UE&23%K=%%B:WE%9$%*16I03#-(=FY7-F)7:S1*
M=U F(WA!.TU$8C0W33E4,F9(.'A$2D5B13<K.&(S*W0T6')U<$YQ;718*W!.
M5W0W8U,S1R]B,4A,52](3VAW=S1)0U!C2&U-*U1J>5-L,VMS:R\F(WA!.TM/
M,6EM."M71GAC345T3E!75RMU6D1U1E-#2FTU8F5$57I&-U-L5T5G8S5B9DYZ
M97E96&Y"-E)S=G$S3T]E,5%7=#-R,D=J6#DY1TLF(WA!.W9A,C P-D$Y0UDT
M>7<O5F=+47=R.'%03&QK*VIJ>D9E270Q<65O4WEU3&E58S)13$EY1VQE:DUY
M:VLU1T$V<W!N;VXO04HR.' V6G(F(WA!.W5J,U!R47%,-DM*;G1R;T%",61&
M2E5&=39N;U%C36AA26UM2"M24"]!0U4R=B\V;#DO,41$27@U37!C,%HK5$]G
M5VME:79R37-993<F(WA!.W5*1VIH:UE62U)2-U57=E-R8W$P=W=#>DM(+T]U
M0DET3S!I3S-2638S16A654%58VEO3F1Q9#A%,6=Z<E$O3&5M851O.$=M>%%2
M<VDF(WA!.TMV<DU60CE3441D,G(Q2D]405E%,G=B.'1.2W1V34XU<5AM=E9O
M,75R;5,U84LR:FM(2EDV2T=Q1DY2<TA65CA+6D=)=F1N23%S>B\F(WA!.T%&
M;E%D2S%M>65Z,4,S5V%*9U%R141M:% W4TXQ56HR>5)&<T%A95EA0G!6,W%N
M;$QZ3C55;&(Q-3E%=4,Q:3(Y439S+W=!2RMZ1THF(WA!.W8K0T]103)P<THS
M0EI0-58X-5)F.'$T3W%Z<T=N,'5&;TIG,S=5:U%!:4(S<CA92V938VM$<WA-
M9#-N,$]J-FAP1VAA5C4T<7HS:E@F(WA!.WI46$%*3E=I8S!5;B]72W18>#5$
M258Q6C-:<&Y8-7!A-D@X<U=L:G U.5=B6&YJ5S-#.5=I4$8Y=CE9<V<K;DI3
M3WI#03-14#5L-E8F(WA!.T9P2#5C861P<U9/3G)00VA)+V%B,#5#-V8W2G%N
M1U$R5$4R5V)E5R],;6YA2'!53FYB44EJ:4Y28U-G1&Q).5!I6C(V;F9*055W
M2G0F(WA!.VAD:F%W-E K8U0R,6MG:'1T4G1795-&0E)!4VAC,$@K=$98-F-J
M>6MZ-7A9.6)E62],6C@X-G9Q,VU:6'5$1$TP3VXR+W K;VER1W@F(WA!.U5&
M9U-".$MQ2V4U2C8U1WAE-F%.8DUJ,6HX>'9Y-3%I=V5X=F]P<$E757%H.4%C
M;WE244UH<CA*2'1K:DE&06E1:V9L6'I.93)F-6(F(WA!.RM923=E5FED3V1%
M<S5T=WEP9'5)+V@S*T=H<7<Y>F=",E-2=7I8.'0O2S)M85HU9'-R,5EK92]V
M655U2F)K:7)G4W%(5D9*,U5"4T(F(WA!.W0S>552<W=K9#!,*V%8;%!43#=Y
M+V1A;VM+>&%J6DPV=VY5048Q0DA.6' Y<F)P6$))8DIG9#)+86QE6%DO2S=Y
M-7!D=2]P+W!39&\F(WA!.W!7<E-Q:5HO:%!S5TE0,%E$>5I$;3E3,%!Y-W!/
M:5=+5V1H8F]I<6]74U=G-7E(=7IT,TIY649.6DYV3G9Z:CAP-F)A5S%V<F1J
M0VPF(WA!.W4X:S-O6%5C64-Q-5I3>79X1S%F9TYF1W51;4=C0RMF-VE#4T-E
M4T-156MI6FMC941+84A046]M>&(U=$]*:5-$,%IH*U0R<C(R;"\F(WA!.VU$
M<&LQ>5%K335E,DQM;$9A6D-Q2&8X07DV1$U,=%!'6C1*061.,UED:S521$],
M-C=05&9Z:3AU6"\V5517;UDR;',U26QJ;F115#8F(WA!.V)*=#A63VEK2')N
M;E=U>$AI-'5J='4Q=%!,:45X>7!H4&QZ>3=Q3W4V;$9:5V-B37)-4%=M02M'
M3DLO17I(;TM$-SAX365->DY",6TF(WA!.VTP.'-S9T$Y5"]/=GIB0F]F;$M7
M>FIC9G!05D$P1G-O4'A*1W<T>E-E22M":71F1G,W3'-V5$A*;'8X06AJ*T$W
M+W185D1&:4DO:6PF(WA!.W-0,&PX=S4Q<GAB3U!+-B]O:CAV+TUE=E X33)P
M8TY%<U0P<4IF,VQZ.4AP<4TQ,F\Y965%4#5V<5 V2&%A565(<#AM43@U96MF
M<"\F(WA!.TAK*V]B2U(U3$]#4GI6,VI2;5!3<$MG;G!N2E-&179:1&LQ9C)C
M5C=9,T9N3%@P<FU*-%I+9&5-:6Q4*T)Y2U$X>#AR*V%:9DDX<W8F(WA!.VQR
M>DQ&26QT2$EZ,E8V:6QK-$UA;EEB;$-D.7%K16M(2W=A,DQ94F4T4B]M8CAZ
M<D,O<W!D2CAS<$QF,SDT:E)#55)U:4EJ2V5B55DF(WA!.TLQ5DAT461A-UE4
M3'554C<P1C5%+W=$2E1A+R]!2VPY+W="47=W4C5,3&UY:CAQ+RM50S!V+VYV
M+W="4D5M4VIY67HU<$PK8T@O4V<F(WA!.R]W0UEZ+VUN0DYL0C9,:S)T-51P
M=6\S2#5C-C5E869Q3G9)+VPV*VQ-,6YD4FIL>%!194%*-#!$:G)T55I73FUW
M:FE4=E=0>F4X='<F(WA!.S)H1VM'5%5B*U%C64EH2$EI:'IS3U)C2U0X;')8
M0UIH06=56"M7;FQU+S!N4S=M.#%-1F13,5-8,34P4#)L1R]%3B]L5EII9FYH
M:44F(WA!.U-.=E!033)J-FY:*V%B=GEP6B]"638U9'=835,P3D%R1G5N*U-R
M36$O=T-Q36=2=E191'1B,3=64$PY<&4K5S5T1%5"3&1R8U<X3F0F(WA!.W=N
M0E%)>B]S4V]/5T5B3E%/.79,4'DV<W13,6IZ5%IX86EP34AL;49K0TU$=$E*
M1S1+9CAO33,S2FQC9'DR4S)$2R]Z<"\U4D=,+VTF(WA!.TUI+S1H2FMP.&U-
M3V)08VUW960S;B]K-G)(+VU#8B]K,TQK4#1M9CA+6%A5:BM29DXY+V18=&MB
M<GDY<D0K<4IL44]9-4-X86=R=%8F(WA!.U-Z1&I88U508D)Y2V595%164'I1
M.&MW,EIB5%E29C-Z:6M.=4QD:T%C.4$U9%8R<B],6$-:0D%I57ET.4DQ:GI"
M-49U8E!73&5#>'8F(WA!.S<Y2WAX=V]9=W9%:#142W!,9D9Y5W)$=SDX3E=%
M6%)31'EN*UE-3V=7<2M89DY-571L9&%F*S9J;DM--FU-9EI"0S%B66)+5D)"
M1T$F(WA!.U-R67-J1SEW:'906#5H,BMU859C-E(U96AL=5EI:&MV-W=O5E))
M67E'4$5':$933GEW2&@Q3T-5<C5,1TYC,7<X=%AE="]L4G!$,D$F(WA!.THQ
M0W=-;'AB;T]R05-U1U9F9G508UDQ65<V:VTK:69M-V]%;&]S971M5%0Y4FA(
M1S11>$]Y<S8W2&IW1$56.$=!<&A%,$="660K62\F(WA!.VY'6'I.86]D3W0U
M53!/>6Q!935K2$@Q2C-5.&1V6F563RLK*U)K8EI2:E1$9GIP.'!Y-D8U>75,
M<4Y+5T=R1G)Q,V-$64]X<DUN>D0F(WA!.VUV>4EZ<RMY.5(T;4E$<DAB.51X
M2&$K;#A035I$-EIB+TAQ=TA.:39P-T8U3"\U>4)U=%!S-#=(>DIA>5@V4D%+
M;#E!4C8U56)F=D8F(WA!.V-Q<FXO2S5$,W(Q>E-A<G-94TXT>EAL,&5G,&YB
M:&E+>4,O34HU<78O3U)8;#(S=&U44DY,=4HU-F9$-B]#0TE%.2]G85)J.'%$
M-34F(WA!.VDT=7<U,S9I05!*>7-V8G5)1#!22E!Y1'A8>DPU;#%F>DIQ,&UQ
M87).-G1Z24%Q:%)X4D5(,E5297EI=CED.#9$0F=J:6IW>#503V$F(WA!.VI5
M>GI4-'!C,$AP.6AD-FAF45=.;D=:8G$U9%EO63$V;&U.0FLU>D514V5183AE
M37IK27@U;&PO-6Q8;&Y:;E1V2BMN4T-3>CAV4FTF(WA!.T\V;%@W370Y2656
M=R]J.$QF0TLY3GAM1F]9;58U6F,U+V0P9&HR;$]-94A$2&Q$;B]7-G9P=E)*
M1VLP5W=K8C=4,C!,3CAZ1T1N2C4F(WA!.U)5>C<S<UE(,&A'-5=Y56)U>'-R
M>4PP<GDS:G59=79P>DES:2]C=TEX5D%7-#AT-F)Q165L,G-&=F%8;#%',&E7
M.$U):C5O=C)I94,F(WA!.VAF=G=B2C-2.&1L6GA13D)(0D=K1#$U>$MI:$1Y
M1D1644M';W=O6'=W47=2:4M'3EEO;')X4D%&559.5%%$8G)I<3)E,71B:FHV
M.$LF(WA!.U,X1%9/86AQ2'A&4G1I<7)I<7EE,V=U26UH;FI784IV=%)Y2T=5
M+TU(8D952F%A1F]L;$PV=&YP.71B4R]W0R])65DT,C,Y,4%/0VLF(WA!.S)J
M<TM&3C=A,F5:2C-I4G T>%-/57%#-F<K1&12:7%P:7%8>C,K:#9D8C-..#AK
M145+>4),=61E4#DT5S0P:TLW.'%T,W=*,U)K.70F(WA!.V)835E394I*;S8X
M9W-I:#%R-#!.8TM&5$950F0S5VI7=7!783-0<'!Q1C17:G1'2U9K8F=+<V]C
M03!O1#-/0DM.;6AH;6IA2UI&:VDF(WA!.V-594YW1U5J=TE/,D9#1'1D0C!/
M,&TY93 P-C%T-78Y*WA1>&\R+RM5;T)W56UY:G-+14YE-EAP="MO5RMT26)P
M5BMY<SAA4T%F3&LF(WA!.T1J4S(V,S!V5&)A,V$R=#=31T<S9EHT630P5D0R
M,U5!030P;3%A1T='1TY9;U573TYF<V]G0W%/*W='2T5,96%(;W0W2C9T-7 Y
M=&,F(WA!.WDO-SAM:&IK8F)P=7=*=U5M,54V9' U=#%T:F)21S)49$EE0SA!
M9EIA57<P:3!R.#5E54Y+.#$V3$IP;6]!<E4X-V4T569(1DM"44\F(WA!.W8V
M:4\T>DDP,G!L:&YX4F-F5F%A3V%(1$PK>#AS*V)V2FUU*U9D4V%Y,4]%:$-4
M.5AU;$)-57EJ;WE.*W-(8UHQ*VTQ54TP8FE8:70F(WA!.UAO-31*5DEB9$0P
M2U)::W5+-T964S)T<FDV;FIT-V%*-3=I5F=S54UA;#-::C!#<4MK;DEY:T%,
M4$I-66U2;T-Y.4%J1G0K6%=N>4\F(WA!.S=P3C4V=DEZ2$A%:DLV-EI%-&]Z
M3U)5975Y.4(K>B]X3%=M.59,+V%2+W-V,D\S1F%/4&9N4#A!<V8R+VHS.#A:
M;5II>D5S>D=R360F(WA!.WE3935Z6G5N2G0Y8F9L,S5P,&989DQ.:#E3=6ML
M=6)A,FAI=DE+9U-X>4EG5G539%%#=S)0435X970P.'-E43).:61N=DY(<5E:
M8UDF(WA!.TU4,#-:4FU)-6)Z=5A6+T]..7%F;4YB4%=93$<S,%8R36-$=U)/
M6%5+5V]Z34MQ=G<O83-Y1FQS;V))5G(W5CEE.'AE5W)Y>FU45'(F(WA!.S8X
M,'E6;FY-9G)"3GE'2TEX04YA8F-J9S5L95%+=$@U>CAY4V%(85=V<G=X-G)C
M87!*<&(V;7E$,#%%9$0V;D1:95)R44-L35!%5C0F(WA!.U)A=5!-2&UM>#%0
M6#E.=3E2:797,'I32F)U0V5/1DEZ-GER>59P14A+:F(O04=A,'!41WEI9W1N
M,5AZ<%IE4S0Y8FTQ5T]E.'9X84XF(WA!.V%X9E8T,%-%5'-+,4E(>#AL658R
M,C-P:EIP849T4% K64DQ;2]W0D='=7=L<E,R1CAT-&)334UW24E%4$1D479)
M9F$S4#9S9#$R6'@F(WA!.RMA=DUE<G U8W-B3S9H,'DV,5,R935U8C%O>$Q5
M>$5R=VIJ9C1A;6Q4:EI79T9!*V1036QR<#)U0V4T=')I.'1,-D=W=')K245G
M:CDF(WA!.U0T5VM90W R<'95-T@R>#1I;FA#4#%J5E!.9FQR4612=3=V5DE.
M5VY":&IT:4E&:6%&<%11<S9O854S*T=V6#A-4U-%04%L05=(;7(F(WA!.WIB
M0V16=')L<FDT.4Q46C=U0S5U8DY,5U-+84Y'2V9U,$QQ>4Y466YV=&I:4UEH
M3TQF>DAQ53 S:S9&8FQE5W-7<W-L.5)52EHP=$(F(WA!.TE'07 X3DI01#59
M8C5-835S83 V-#%R4V9,;FUY*U,K5U=32%=(:$MT0DA2<&IC47)*3G959D=R
M530Y0C)Y4%%S=5I#9EAM<"MA3E4F(WA!.SAW879:-F)Q='9P1G1O+W!!<DQ%
M:W)3;5)E4EIY+S)%.7AH<S)I:%,V-#%0>E9F95I.4C V>C%3,3 K4%)925AM
M16M)8UA$>7AI4FTF(WA!.V)K,TM/261#5F)B,W<R8E=H4U173W(S,G)Y95$Y
M4G9N16PQ4&-8+W%-;T-J-$-56%ID=G-Q348X:S%6;W)Y=#5R.'A86&UE3S$Q
M4SDF(WA!.U516%14:4,R14M'0GA(57(Y6'59:3--:6YX8W8Q-&=M,4E&4%)-
M;3%U>%8R2W5X5C)+=7A6,DMU>%9$86QP;6YA;F%06C9H8E(S9'(F(WA!.THY
M<4=:438O3V@W:G-C;D1*2T)U2F]S2G=J359)5TAN;7%F.#0K*U)R=5)P3%8W
M=E1Y5%@P-%I&94UF4DMR="]W,F)02#)X;6IZ<50F(WA!.W$X=EEM0U)S6$@S
M9G1T0U<O=T1Z:FPU4E-13E!Q1CE+9R]91%)*52LU.4TU3UAB95AO22]A,7@W
M0W=G-VU8,F9Q6G)O6#5F955D0W0F(WA!.W!)3DUS0D$X>4=/5S9$=CE92W1S
M851G*V]V.$%S4TUW33)S>35$8VIF,V9*,D](4C1S47%)<C<O04HX,')F.$%*
M9CA!3%(S6C,P9W,F(WA!.S=%;&U.,61K:VYC:VMY-6%/,4Y2+T\K=V9Q840R
M5'!Y8DUF=&PK='(O;%-N-5IF.5=B+W U=2\K<75(*U9.4B]/*W=F<5(O2D=M
M+VTF(WA!.R]B3#EA8V57+TE8;%!Y,5!.8V%*62]62F)H0DA+,W%Z4U951V]&
M2EAC1&9W>6I0<DUM559-,UAU8VI4-E!&:$I-0E8K+W=$4VXK67HF(WA!.VQ-
M271F>3<P-C@Q<E=B,UAB2EHP=6)N,6)*:$LV;C!Y3G=W:EIE-$=Z6DAH6CA8
M8WEK849P2S,Q=&9,8G%L>EIX1S-T;55S<7!%97$F(WA!.VA!46Q0;W<P>'1#
M=C51.'538610<#!L:W(R9'I-,3%.17I/87I0.$%A8TU7-4MF.55J1V=V159+
M>3AJ*U9R2F)H8E=X15%U-V1R4S0F(WA!.W!*3%8T6"LP<$IB<68U=G1E*U!#
M1C1I:EHY03!M9E,T3DQL9S571G-):$1$>F-C4D)4,"]I1&-J>#1J<6-A5S%1
M-E!P>'8U<CAW+S8F(WA!.UAC46DS;6LU3CA544I)5VQE238Y44LT,'1O1S4X
M;6578FY48EA46C=&6'1,3"]E5F5C9V%097 T>4)V53,O,7-A0SA26%<S;$1Y
M,6(F(WA!.U=D,UI15T5A5VPY>"MT4599;S-!554P2E!%:C(W-SEC84,X4E4W
M1'E2-59S3&$U=')B5#!70SA52F-O-U!*>E5D0E=2;4EP,49-944F(WA!.TQX
M1E4P:GEF-6(P9WIN5#=&26UU13E/6FU:-5-Y9GE6:UIZ>#EH:4%&36E63%1F
M22]L6%1,>4<Y<V)"66)Q074P36]E46QF555Q=RLF(WA!.TII2U59-V1",GA%
M47!K55,O;&91;G-R,GEA,G)A-FAC1SAV22MC;GAZ<WEU6')Y<79X27!O<$%X
M<&)+:G)(:W9Y>').,DQV56)"6C<F(WA!.VM!3#9G6C!*039"=41,>2MN17A"
M55-)9&8K4R]+*V]4=U0S96Y2>5-7-DQ(16%S;S1,<W%S1DE$065$5G@T479%
M5E,S.'%A0F),<#8F(WA!.U%7=D)D3&%2-T%"-40V8E1%;51Q,WA62B]A<FI3
M,E9/=SAL*U=.4#%--G!:,D-1,W!,15-";DE5=4M.>%%S55=O3DYH:G=H5$EP
M,6@F(WA!.U$W1EA9<3=&6%EQ-T9867$O=T0O,E$]/3PO>&UP1TEM9SII;6%G
M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @(" @/'AM
M<$U-.DEN<W1A;F-E240^>&UP+FEI9#ID-#@T968T92TS,&-E+3<T-#<M.#0S
M82TS-F4P.6,V-S8U,C<\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX
M;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z9#0X-&5F-&4M,S!C92TW-#0W+3@T
M,V$M,S9E,#EC-C<V-3(W/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \
M>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q
M,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*
M(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM<$U-
M.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z
M:6YS=&%N8V5)1#YU=6ED.C4R9F-A,C4S+3AB9&0M-&(X82TX,S5B+30P-#,X
M968T8C(U8SPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F
M.F1O8W5M96YT240^>&UP+F1I9#ID-C5B.#)B-2TY,S<U+38Y-&(M8F$R-RUE
M,3$Y83DU.31F8C@\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @(#QS
M=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I9#HU1#(P.#DR-#DS0D9$0C$Q
M.3$T03@U.3!$,S$U,#A#.#PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@
M(" @(" @(" @(" \<W12968Z<F5N9&ET:6]N0VQA<W,^9&5F875L=#PO<W12
M968Z<F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R
M;VT^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F
M.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V
M960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN
M<W1A;F-E240^>&UP+FEI9#ID-C5B.#)B-2TY,S<U+38Y-&(M8F$R-RUE,3$Y
M83DU.31F8C@\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IW:&5N/C(P,3DM,#$M,3=4,C Z,38Z,SDM,#4Z,# \+W-T179T
M.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT
M/D%D;V)E($EL;'5S=')A=&]R($-#(#(R+C @*%=I;F1O=W,I/"]S=$5V=#IS
M;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E
M9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E
M240^>&UP+FEI9#ID-#@T968T92TS,&-E+3<T-#<M.#0S82TS-F4P.6,V-S8U
M,C<\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,3DM,#$M,C)4,3DZ,C Z,S@M,#4Z,# \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M($EL;'5S=')A=&]R($-#(#(R+C @*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @
M(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P4')O9FEL93Y0<FEN=#PO:6QL
M=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @(" @(" @(#QX;7!44&<Z2&%S
M5FES:6)L94]V97)P<FEN=#Y&86QS93PO>&UP5%!G.DAA<U9I<VEB;&5/=F5R
M<')I;G0^"B @(" @(" @(#QX;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC
M>3Y&86QS93PO>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @
M(" @(#QX;7!44&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @
M(#QX;7!44&<Z36%X4&%G95-I>F4@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" \<W1$:6TZ=SXQ."XP,# P,# \+W-T1&EM.G<^"B @
M(" @(" @(" @(#QS=$1I;3IH/C$X+C P,# P,#PO<W1$:6TZ:#X*(" @(" @
M(" @(" @/'-T1&EM.G5N:70^4&EC87,\+W-T1&EM.G5N:70^"B @(" @(" @
M(#PO>&UP5%!G.DUA>%!A9V53:7IE/@H@(" @(" @(" \>&UP5%!G.E!L871E
M3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI/E!!3E1/3D4@,C@U($,\+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:3Y004Y43TY%(%=A<FT@1W)A>2 Y($,\+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:3Y004Y43TY%(#,V,2!#/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE
M<SX*(" @(" @(" @/'AM<%109SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @
M(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.
M86UE/D1E9F%U;'0@4W=A=&-H($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @
M(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4
M>7!E/@H@(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^"B @(" @
M(" @(" @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y7:&ET93PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM
M<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G
M96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D)L86-K/"]X;7!'.G-W871C:$YA;64^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP
M1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E
M/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C$P,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#35E+(%)E9#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+(%EE;&QO
M=SPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0TU92R!'<F5E;CPO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC>6%N
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#35E+($-Y86X\+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C$P,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D--64L@0FQU93PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M,3 P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+($UA9V5N
M=&$\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],34@33TQ,# @63TY,"!+/3$P
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ-2XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXY,"XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXQ,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TY,"!9/3@U($L],#PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM
M<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G
M96YT83XY,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C@U+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STP($T].# @63TY-2!+/3 \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M.# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXY-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P
M,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIS=V%T8VA.86UE/D,],"!-/34P(%D],3 P($L],#PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],"!-/3,U(%D].#4@2STP/"]X;7!'.G-W871C:$YA
M;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU9
M2SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C,U+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^.#4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/34@33TP(%D].3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP
M1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E
M/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8WEA;CXU+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXY,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,],C @33TP(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M-3 @33TP(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^-3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-S4@
M33TP(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^-S4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP
M,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,].#4@33TQ
M,"!9/3$P,"!+/3$P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXX-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XQ,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP
M,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXQ,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3DP($T]
M,S @63TY-2!+/3,P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXY,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XS,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDU+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C,P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-S4@33TP
M(%D]-S4@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXW
M-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^-S4N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@P($T],3 @63TT
M-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C@P+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C$P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^-#4N,# P,# P/"]X
M;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3<P($T],34@63TP($L]
M,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-S N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,34N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STX-2!-/34P(%D],"!+/3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C@U+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C4P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,],3 P($T].34@63TU($L],#PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC
M>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A
M/CDU+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIY96QL;W<^-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P
M,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIS=V%T8VA.86UE/D,],3 P($T],3 P(%D],C4@2STR-3PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC
M>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A
M/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C(U+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C(U+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,]-S4@33TQ,# @63TP($L],#PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-S4N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P
M,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIS=V%T8VA.86UE/D,]-3 @33TQ,# @63TP($L],#PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^-3 N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],S4@33TQ,# @63TS-2!+/3$P/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXS-2XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXS-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXQ,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3$P($T],3 P(%D]-3 @2STP/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXU,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],"!-/3DU(%D],C @2STP/"]X;7!'.G-W871C:$YA
M;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU9
M2SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/CDU+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3(U($T],C4@63TT,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C(U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C(U+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^-# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/30P($T]-#4@63TU,"!+/34\+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C0P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C0U+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^-3 N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-2XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/34P($T]-3 @63TV,"!+/3(U/"]X;7!'.G-W871C:$YA;64^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!2
M3T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8WEA;CXU,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP,# P,# \+WAM<$<Z
M;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L
M;&]W/C8P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C(U+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,]-34@33TV,"!9/38U($L]-# \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/C4U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C8P+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^-C4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8FQA8VL^-# N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STR-2!-/30P(%D]-C4@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXR-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XT,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C8U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STS
M,"!-/34P(%D]-S4@2STQ,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^,S N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXW
M-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXQ,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3,U
M($T]-C @63TX,"!+/3(U/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXS-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XV,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C@P
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C(U+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-# @
M33TV-2!9/3DP($L],S4\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C0P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C8U+C P,# P,#PO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.3 N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^,S4N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STT,"!-
M/3<P(%D],3 P($L]-3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C0P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C<P+C P,# P,#PO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P
M+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F)L86-K/C4P+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-3 @
M33TW,"!9/3@P($L]-S \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C4P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C<P+C P,# P,#PO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.# N
M,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8FQA8VL^-S N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @
M(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^4$%.5$].
M12 V-C @0SPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E-03U0\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z=&EN=#XQ,# N,# P,# P/"]X;7!'
M.G1I;G0^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M3$%"/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.DP^-3 N.3@P,SDR/"]X;7!'.DP^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.D$^+3$\+WAM<$<Z03X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z0CXM-#<\+WAM<$<Z0CX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/E!!3E1/3D4@5V%R;2!'
M<F%Y(#D@0SPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E-03U0\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z=&EN=#XQ,# N,# P,# P/"]X;7!'
M.G1I;G0^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M3$%"/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.DP^-3$N,S<R-3 Q/"]X;7!'.DP^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.D$^-#PO>&UP1SI!/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SI"/C8\+WAM<$<Z0CX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/E!!3E1/3D4@,C@U($,\+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y34$]4/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1I;G0^,3 P+C P,# P,#PO>&UP1SIT:6YT/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/DQ!0CPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SI,/C0U+C Y
M.# P,#PO>&UP1SI,/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SI!/BTU/"]X;7!'.D$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.D(^+34Y/"]X;7!'.D(^"B @(" @(" @(" @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y004Y43TY%(#,V,2!#/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4U!/5#PO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT:6YT/C$P,"XP,# P,# \+WAM<$<Z=&EN=#X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y,04(\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z3#XV,RXQ,S<R.3D\+WAM
M<$<Z3#X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z03XM-3$\
M+WAM<$<Z03X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z0CXU
M,SPO>&UP1SI"/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" @(" @
M(" @(" \+WAM<$<Z0V]L;W)A;G1S/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y'<F%Y
M<SPO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R
M;W5P5'EP93XQ/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @(" @
M/'AM<$<Z0V]L;W)A;G1S/@H@(" @(" @(" @(" @(" @(" @(" \<F1F.E-E
M<3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STQ,# \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P
M,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 P+C P,# P,#PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D,],"!-/3 @63TP($L].3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^.#DN.3DY-# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STP($T],"!9/3 @2STX,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXW.2XY.3@X,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @
M33TP(%D],"!+/3<P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C8Y+CDY.3<P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP
M($L]-C \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^-3DN.3DY,3 P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STU,#PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM
M<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G
M96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXU,"XP
M,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/30P/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C,Y+CDY.30P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L],S \+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \
M+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,CDN.3DX.# P/"]X;7!'.F)L
M86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C
M:$YA;64^0STP($T],"!9/3 @2STR,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXQ.2XY.3DW,# \+WAM<$<Z8FQA8VL^"B @
M(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#
M/3 @33TP(%D],"!+/3$P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/CDN.3DY,3 P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9
M/3 @2STU/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C0N.3DX.# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'
M.F=R;W5P3F%M93Y"<FEG:'1S/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @
M(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C$\+WAM<$<Z9W)O=7!4>7!E/@H@
M(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TQ,# @63TQ
M,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3<U(%D],3 P
M($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P
M,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6%G96YT83XW-2XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3$P(%D].34@2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO
M>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M86=E;G1A/C$P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.34N,# P,# P/"]X;7!'.GEE
M;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^
M,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U($T],3 @63TQ,# @2STP/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXX-2XP,# P,# \+WAM
M<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G
M96YT83XQ,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L
M;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,],3 P($T].3 @63TP($L],#PO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/CDP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,]-C @33TY,"!9/3 @2STP/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXV,"XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# S,3 P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,#,Q,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(" @
M(" @(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G
M.E-W871C:$=R;W5P<SX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!0
M1$8@;&EB<F%R>2 Q-2XP,#PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
M& !S P$1  (1 0,1 ?_$ !T   $$ P$!              8 !0<* P@) @3_
MQ  E$  " @,!   ' 0$!       $!0,& 0('"  )$A,4%181)"+_Q  = 0 !
M! (#                 0(("0,&! 4'_\0 -1$  @$# P,# P,"! <
M 0(#! 41!A(A "(Q!Q-!%%%A,E)Q%8$C,T)R""1B@I&AT?_:  P# 0 "$0,1
M #\ WB^;+\U_L'0.PW'S+YJN#VB<QH;XRCV>R4@PM=<>HW)<5NK?AC/E>\;0
M&G@-="4*U6C(A_J,P%,F13%:Q6K5\Y_1?T7L=ML=#JW5E#37&[W&FCN%'27!
M$EH+102H)J:1Z:8&&2NDA*5,LU0K?1ADBB2*6*666OOUU]=-0774%PT9HVX5
M5LLMLJ9+96UEMD>*X7NXQ.8:N-*J B>.WQ3AZ6&"E=?K=LDTSS0S0PP\WG/A
M+YBW&:?OZ,8<7[31DX N;(?=U;; EU0AZZ?F3O'R=$_WZ'6X X\9+8L7:==J
MMCCD(82C:1;[Z^JP>HWI;?JX:6COU@N,\C_2QV^> O;ZB3.Q:>FGJ:86NJ:0
MX2**GGE,I(6)7) Z\@J/3'U<T];SJ^73NH[93Q1_62W*&H$=RI8P/<:IJJ>F
MJC=J-8U!>:6IIX?9 +2E "02^J_5WIAXB\GL7'?.N;6HGRXHFM;$&^V1*2Z-
M([7W$FO,W6B9@!$R<9H4U/!G='13MF@P0A+(PPG;:??B:,T9I.GJ=:10:;LG
MT::PG6BBDMM).E/&E@T\M3#3F>*0Q0?U(5TBT\96&%I'6*-$PHYFN-<ZRJ:7
M0LU1JB_?7/HF!JZ:*Z5E/)4R-J34K4DU3]/-$LU1_2S;XVJ) T\R1QO-)(Y+
M&\KY2&=!>7?-P=E-8,[&+P3CX[]BV*(.:GNXN>U[1J:R-,DE++/*/U(G+)*E
MD(G(WDDFDWDVVVS7EK)Z>35^JGI(XXJ1]27QJ6*%$CABIVN=48(XHXP$2-(B
MJHB *J@!0 !U9=H=*F/16D(ZR26:L32]@6KEG=Y9I:D6JD$\DTDA+R2/+O9W
M<EF8DL223T//_9'G:L-'2]S>C8 JVR+26"W#4?H#/G29\#)F M PZ4LJQE"'
M=CDZ[ S+-K%^7$RQA5)'JSVT$VU4U$2D@MP#@MM8H#XP7 V@_'GSQYXZW 4T
MS $*,D A=Z!R",A@A;=@CG./'/CIS;>K^%*&BI#O:V[1^[K=0N2Q!6J!T2U/
M":C>86)-?LWZBN51H?$DV'5&2-CYAXX:[G(4-@RL(:JH30SQ @;B20K *K,=
MK9PV "<<<GXXSC(R@IY2"=H #,I)=% 9,;ER6 SR,#_5SMR <)=ZPX*V<.DZ
M^[$3XK&]PAMCW>HW8:F4\JAE.Q+.#;[R77(*?5CP=ZXWF'#>NP"&H,(C%5H:
M W3$, 3Q$D!OT[MQVMM7;G=N8KM&,'R1D8(R",AIY0%)7]6S:-R;FW@%2JAM
MQ!R.0.#P<$'&!!ZVX38R2 Q+-85Q.E?=VM9#9N:]-J,ELKM<72MW3.AZ6BGJ
M-[]H$L@F/V$INKMC*''DH<.6#;23<$\9^2."1N1UW #)V[E&[CX7)_'0U/*N
M,J#DA3M=&VL3@!]K'9D\=V!GCR#T=/>Y<GK*SE[EY=5@*OM#VM5OF!F8F$\5
MN<6\#+*MCA?BAS["PM _HDB/9:A+H9"!!BBX"3!(9G&6-0A+ "0@(?W%AD8_
MD?)X\<\CIHBD8N A)B#,XX[0IPV?X/P,G[=0GZJ[LCYXG!4KKS_,6.M=&\UV
M*]2Z:F#"I>6W3NJ&K-R7CK<3*8->]4J[8"0%,?HQE6!L2\"ZAQ_D_&.:4( -
MVTJ\+-YX1I IR?&" W&<XSQUD@B+DDIN5DG5/',BPLPP/.02ISXR0.I6H?HK
MD71B["O06-@O85=)K:'"^[U&Y<V.BJ6^\T>EO%#Z$@K!#&IYW'ETDL:Z,I0/
MOC70DN'>2+7=Z31OD D%1N(960[?W8< E>//@?/3'AD3:6 (8X!5E<$\=N4+
M8;GP>>F>E>J>'= LB>JUNUM,LK/@O:G%O:/?:G7;U@$>0PO^#M=JK*:LW3:$
M.&8W72M-F>Y $,K 36<&+<G46>-R K'+?IRKJ&_VEE ;CGM)XY\=*T$J*6*C
M"_JPZ,5R<=RJQ9>>.0.3CSTW6+U_Y\JKQTD=7<V&.LM)45FM =(OS;GM:?0;
MZQ3H[!TE36#:$G;C3[8&, /L4$X)G_";H.9G6#9#/$I(+>"03M8J"/(+@;01
M\@GCYZ5:>9E#!0=P!5=R!V!\%4+;R/R%Y'(XZ<K#ZGXC7 J:9/9W#J2_5!9T
M"KJ*;0N@WJS%T9N/"4OMI]5IU6>61"A(AGU^A@_5JXLD1D!8SDX8@:,,\8V\
MD[U#J%5F8J?#%0"0#^0/_1Z18)6W=H&QBC%G1%##RNYF"D_@$_?QSU7)]?>\
M.[P>CNGQ\6]!VV#E^62:6HP5UG]E1"#/5T<Y,(X\XNI(DT3*0W0X(N.$P)AJ
M4(9! 3#+#IU,]3+[K^W*VS/;@\8P/_'Y!Y!\\]=U34D)@C]V%?<P=V1SG)_/
M/&,$<$<CCKD=X,=U'DOS'^,LO1\@:]73^TOEMV.LGVX@D5\BAL:1&[=SEXQ"
M!#7NDRI7![$O,<*O $AY,L,8V\NEJOJ/3UU[]*[]%I4/+-76&FEM\=)DR5%N
M9J2HJ*>G6/F0U-J%1!'$@)F]P1HK%P#4!Z7U-OL/J_IZ;6!CB@M^HJJ*Y2UA
M"QTMT5:RGIJFI:3MB6DO!IZB6:0A8/:,KLJH2+'_ "+E7M'G'LZ[]F[G<S%/
MGI65T"P](O\ :[\MFY78.9$K7,B4<904YF$A6Q1SJIP )E@458'$S][ N!]!
MBJ<-,:;]07]0%)6X5"SU\\8$4[3+7"4R)1TU)21R-*9?<:'V(5A1Z4IR(RFT
MRXT_8O4BS^H]RU%J>XRP:2A>ZU=XNM==86L=796AJ32HE.]2T:PJ&IVBB:&(
M421]X0+L>M+T#-*]=>XQJWS$7:J\1-M%<H-+VFTE&BI_G[E2(-.9<F,.^F)@
M(5O.:HXZ+9--H\RB3;MM]M=M]<XS<M;?K]$>G;5=W85FH(Z.JN5> 0S5VIKS
M4//'01L"1(TMUK8+72D'#J(0, ]0^NO].U]ZEK1V6,T.FY*VDM=O)#*MOTI8
MZ6.GDN,RD9B6&T4,]WK!MRCF<X+>;Y_F/HT/8_.O&NH"A:J!>@\XK-H#6CZ1
MPZJ!'*N$H1=#'IC:/3"T>2(33&/KQC[&/JSOG_=LUPZOM36/4]_L[2&5[;=*
MRB>9B6:62"5D>8D\DR."^>,[O \=6@Z+O"Z@TGIV]I$(([K:**NC@4!5ACJ(
M5>.$ < 1(1&!D_I\D\]:;@%]*H7EIUY1G\V]'N'05'-K7S!>U5*497([S$8M
M:KQNA%W8ES&*(._'+Q9; B9!QW/+PD]4,G/.D@)GU#+K"8#"[.$9 0 8VX(#
M[L_/DJ1NSD8/GK=3L><5'O(BEU<@DB1,$'8%QSMQM!SMQ@Y'4P>9^8V2K]+=
M6>T50Y1)KY9\FT):U/&UCSAM6PNFR7RO02_[MM@A49)5\MX,9QKK)N!G;.^<
M:YUR0H5;++C$$"9/W&_</[=N?[=8YG5D"JV?^8J'('V;V]C?WPV/[]""[A5V
M.\G](I:VIP#7IOZ#Z3U?6J/9(5(U\'1^IF/1TB1J9+KN/"#T.CUU,C'--_X]
M5S4+<[.H&DVN&B-S ZA>XRLX4\;L3;P"?^I0!D_!Z<94%1&^[*B%(RP&=I,
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C_D_R>N,P 8@'(!(!^XSP? ^/P/X'1!\+TG2^#HZ7P='7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g76219g70d20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76219g70d20.jpg
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M_3"$1I'5$%V8V Z;_,[#&%T_N37&^J+';)U58D6>GRI4D$))X DXI[!D2:\
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MSJEAM#&0ON[#H/IM_O8PO IA7&3E+R=X3&O$-5=R09W-I=)KSCOOUN29 'D
MFBG\Y5(&MPAE9$)6CQ4LRJ6$A:,YP[EO%+]S--3GI_.1_(V!^>VD?-3C-7]_
M!!5;:K<J6W9@38V[7-S\F7'B^8_UI^Z+0J(G_O#6W#6JYO-B3_Q 7MD2:XR3
M!:0[CU8R4/+$4A*QEI6YA51L#'JG*7<-8;[^L5?ZE.NH_P!ZX/\ '3M_9.,I
M_)Z!GZ/4MH'KRQ?_ .VK_,,5!R-T?7^0G=FI>O+EDEZD9TW V2XQ(Q9 ?ZBA
MZSFP2H]?)>%=:>^!(SK,,F02VXA[ ;;RQ71S$#DLHEC$M<J-^'0"P]0+FWR)
MM?\ XX<AE:'+V=?Q<TJI_=+6&H>X%[8<!.\=-%6*A&ZQD=2Z_31S8UV+^@ J
MD+&B!,.,Y90_%_!"8<BY 7UP\#) *8."*0V4,0V^VES$\PQ%=!C73:UM(%OE
MZ6['&N$TH?6)'U7O<L22?>YWPK#M\;5FM+\1^8$<:6[8@N+-VVX[4$'J4I+H
M<-7B9<>&PE&489#-L<6<>M#?MX01.F*QE*<I\85*YC@J!>_)9ROY7M]6!/U.
M)]9&):BF(%C4)'JMZDV)^BD?0>M\47P2VCP6J%:D-V\F=H5"V\G-DV*>L5G.
MO=;L%G,I[3LL4R"'%8S6Y&($D9$=G$R;)QWH4TS)LPC+S(,?AA;5,],H,DSJ
MTSDDEE9M._;RD GK<>MNF':N.J9A%!&RP1@!0A"AC;<G<$@=+'TOU-\6;S9V
MEVW.0.H[435MDZ_A]UUJ(+G]:VNN5*S0-@)L4.RH^/K9LH+5@?F1D\XQ]2A$
MH^X/$E&-2XF1B1<.Y74/22QL591( 2K*K DC<*3I%P>F_0F^&Z5*V&1=2.8F
M-I%8AETG8L!JZCKMUZ;@X].X.7.S+7VNM*3D3+%-;3WO80=#35@;(6/)N?52
M%J@[#,Y-1G^4=; JB*/(D-8PM"+0<Z/AAUI"F22=VHXR#YY&Y9;OMJ!/UL 3
M[G&8Z9%KI00.7"#*%[;A646]%U=#MY1>XPS;CMPUT9QUH,+4Z[1:O+S[,:,W
M:;S,P4=)66U2^64?8FER1XY!8T>\5EY8$(,\W&QHZTLL,>YEYYZ9%3QQ*%"J
M3;S,0"6/?<]O0=!B#-4RS.69V OY5!(51V  VO;J>IPMSNQ<-=8P^FIOD7K"
MMQ>O[/5Y"  V %5!68.#NE6LE@C(5ER3A8Y \>N9C;,;!')D&AVUF#_+5*8-
M?%C'P(E=3H$,R#2P(#@;!@2!N!M<&V_?O<VM-R^ID,HA<EU8,4+&Y1@I;8G>
MQ (M^7>_YY36FW6+C)VZ>*50FB*YGE#6]15JUS0BE8=9J,+4=< F@OX2I"G(
M\DRUARIPS:DK.8@%QSF5"&$L/XF9C#1P*;<Y8PQ_LZ4%C[>:Y^5N^"G55GK*
MAA?D&0J#^\6<@_/RV'I>_;#5=5<7=":9IP-)HVKZ@+&#!-"''2,#%2L]87$M
MX0\?9)HT-TZ9-+5Y+>64YEAO"OCACBAMLC-3DABC72J+;O< D^Y)Z_\ 5ML0
M))YI6U/(Q/:Q( ]E V PD/N[\0-=ZGKE9WOJ2$#HH-HMPU+V%3JZTF,K$C)E
MQDO-U^RA08OLQ\80U]-)@R; ;#89+Y4<:R(.;]D4?KJZ!$"RH-(9M+*-EO8D
M&PZ=#?L;CH>NTRZI>1FBD.HJNI&.[  @,M^O<$?(XY&['"GUNPSU=E$+;DX"
M:E(61;<QG#C9\6<^"8AS"OW86DAAQ*L*_.%8SZ_GKV6I*B.KI::JA(,533PU
M$17H8YHUD0CV*L+>V/#:LII:.LJZ2<%9J6IGII@>HE@E:*0'W#J0??#"^T->
MZ]KON+<:)VSOCB1DC9+12V2R5)0AB:V%K^V46M82XOT2A9=BL,7'^6<XQX%K
MQZXSGUZK'QORZIS3PMXLIZ16>6*EHZ]D4$EJ?+,SHLQJK@;D)2TTTOS08MCP
M"S.ERGQ<X-J:QUCAFJZW+@[D +49KE5?EM'N=@7JZJ"+?]\XZ!^]IJ2Z'2NJ
M=TQP!TG2(BO'4:PD"-.OCUF57,.RT4;)81A6!1; B0? :-5C ^#(I@-]UL@R
M/;(\7_%O+*MY<MS:-'DHXH&HYV4$K3R&4R1/)8>59^84#GRZXU0D,Z!NI?M*
M9!F4L^1<20Q2S993TDN65;(&9**<U#3P2S 7T)5B5HA(;+S($C=@TD09$M2J
M5EO=EA*=3H60L5GL<@/%0D+%CK).D#BEX0TRRTC^B<?EQYYS*&!V$.$$.-,-
M..)IRFIJBLJ(:6EA>>HG=8X88UU/([= !^I)L% +,0 2.7:"@K<TK:;+LNII
MJRMK)D@IJ:!"\LLKFRJJC\V8V5%!=RJJ2.Q[9&PZMPLX3C7#;!$=-,:'T]2(
MY;!:FW$6R_4^$A(FJ1D:HE&<JE)Z[@13<25X8="+>9E%*82&M]KNCPZX4S3/
M<QX8X2H'D-;/#1Y945,1;[FEBI%AS.KD(L3!'1K423*=I8]41#&32?1+-LUH
MO#GPXCK\]>*I7A?A[+82LA#?'9IEU+304,,1<;SU6910"![:HY&6:Z\LLOSL
MKA:YR^6VTWBSF*D;+<['-VNPR"\>BSYRQ294O+&+QZY]%%'F$/JQZY],KS^<
M]>L]#14^745'E])&(J2@I:>BI8ATCIZ6)((8Q[)&BK],>2N85U3FE?6YG6R&
M:LS&KJ:ZKE.QEJ:N9YYY".VN61FM[X9QV<]<1-@Y=L[GN:?9UEQ2UW>N0M[D
MG48^*(U48,H:OX]Y?HVDX:;D![$*SE25OL5PY2,X2RXM%1^.N:S4O!#9#0'5
MFW&>:9=PQET0/G<UM0CU/E&YC>GB:E=K$*U5&#<L ;F^S[E$%5Q\O$68C3DW
M V4YGQ9F<S#[N-:"F=*3S&RB1*F5*N-2066CEM8*2.NSMF;)E]Q<*-0[5L"O
M*=V'*;>M\SGSRYA,G.[OV0><VE:L8SE#1+SC:/QCT0E.,8QC&,8XD\6LI@R+
MC_/,FIO^S97#D=#!L!]U3\/Y5'&2!L"54$^Y]<=[>#6<3\0^'&09Y5&]3FT_
M$%?4;W^^J>)<XEE%^X#L0/8#8=,'CU7&+0PD:[7$GM\\]-@;7O<3*N<;.5XL
M8N2N$4 3)-TZ]1R$//9DVA6W'GW Y%<](.1P[63"Z]9,FQ#<H; 'Q[FN9OA:
MIG8'E3#=@+V;_P#AOMZ&XO:V-HJ_&4B1H1SJ>]E)_$A]/I8>EQ8]1A@4YSRX
M=P%7<MQ7(G5QL<@7):(^#LX,]:'D^'FEANGQ"S+0DI?X1@9Z):<0O/H]AK"5
MY3*-3 %U<U+>@-V_RCS?I[8ABDJ2VGDR ^I4A?\ ,;+^N%1<3MRSG(+NERFW
MI&M2]4K]QT_8B-=14X/\8]S7D8/&PE?EW6_):?6=<C3YAW++KXF"37T E%@H
M&*>A02&6L,A!4-&= /[HL ?K8GYDV-L3ZB(0T C#!F64:R.FL@DCZ @?QWP3
MVJDISWE>2N<XQG*.,L"I.<X_PJSC0"?7'^6?%2D^O^6<X_OT['_2$_\ A#^$
M.&9/Z-@_QS_^;#=NI^-=A1/9AQC'&;9N<8QC*N2%YRK.,8QG.<4C66,9SG^_
MIC&,8]?[8QCJ!EW\PW^*W_D3&QS/^?C_ ,!/_/)C<^YCK#89$1I+DYJ>'=L=
MTXL7M=V,K@S;KK\O33"8,^=7A@9#A);,>368W[ <=M3S4"?.'-JQD/*7%UB/
M:.9!=H6U$=RMP3^5A?T%SVPBA=+RP2'2LZ:03T#"^GY?B-O< 8NS4W<+XD[7
MJ -H1N>BT(YP-IZ7J>R;/#4JPPAOMX43'K8GS !Y?XZ_5"#H%^2!)3XJ9?\
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MVNEQ5<4BC4ZQO_65CIL>]B=B/3>_KA$U%-&YT(TB'=60%K@]+@7(/KV[@D8
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MZO@\M:LN.E2(M6D88.0*?<SEPDDP=]XEQ2ED+<4K.<LM30,=1B6_7:XO\P"
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*,&)T8,3HP8__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
